0001193125-22-091035.txt : 20220331 0001193125-22-091035.hdr.sgml : 20220331 20220331102152 ACCESSION NUMBER: 0001193125-22-091035 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220331 DATE AS OF CHANGE: 20220331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Healthcare Acquisition Corp. CENTRAL INDEX KEY: 0001839185 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40466 FILM NUMBER: 22789935 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 212-446-4800 MAIL ADDRESS: STREET 1: UGLAND HOUSE, BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 10-K 1 d190177d10k.htm FORM 10-K Form 10-K
false0001839185FY--12-31000000This number includes up to 750,000 Class B ordinary shares subject to forfeiture as of December 31, 2020. On July 23, 2021, the 750,000 Class B ordinary shares were forfeited when the overallotment option expired. 0001839185 2021-12-31 0001839185 2020-12-31 0001839185 2021-01-01 2021-12-31 0001839185 2020-12-22 2020-12-31 0001839185 2021-04-30 0001839185 2021-06-30 0001839185 2020-12-21 0001839185 smihu:ForwardPurchaseAgreementsMember 2021-12-31 0001839185 us-gaap:CommonClassBMember 2021-12-31 0001839185 us-gaap:CommonClassAMember 2021-12-31 0001839185 us-gaap:IPOMember 2021-12-31 0001839185 us-gaap:CommonClassBMember smihu:FounderSharesMember smihu:SponsorMember 2021-12-31 0001839185 us-gaap:CommonClassBMember smihu:SponsorMember 2021-12-31 0001839185 smihu:SponsorMember smihu:PromissoryNoteMember 2021-12-31 0001839185 smihu:WorkingCapitalLoanMember 2021-12-31 0001839185 smihu:AdministrativeServiceFeeMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001839185 us-gaap:MeasurementInputPriceVolatilityMember smihu:PublicAndPrivateWarrantsMember 2021-12-31 0001839185 us-gaap:MeasurementInputRiskFreeInterestRateMember smihu:PublicAndPrivateWarrantsMember 2021-12-31 0001839185 us-gaap:MeasurementInputSharePriceMember smihu:PublicAndPrivateWarrantsMember 2021-12-31 0001839185 us-gaap:MeasurementInputExpectedTermMember smihu:PublicAndPrivateWarrantsMember 2021-12-31 0001839185 us-gaap:MeasurementInputPriceVolatilityMember smihu:FpaLiabilityMember 2021-12-31 0001839185 us-gaap:MeasurementInputSharePriceMember smihu:FpaLiabilityMember 2021-12-31 0001839185 us-gaap:MeasurementInputExpectedTermMember smihu:FpaLiabilityMember 2021-12-31 0001839185 smihu:MeasurementInputEstimatedTermToBusinessCombinationsMember smihu:FpaLiabilityMember 2021-12-31 0001839185 smihu:MeasurementInputProbabilityOfBusinessCombinationsMember smihu:FpaLiabilityMember 2021-12-31 0001839185 smihu:MeasurementOfPurchasePriceOfFpaUnitMember smihu:FpaLiabilityMember 2021-12-31 0001839185 smihu:FpaLiabilityMember 2021-12-31 0001839185 smihu:SponsorMember 2021-12-31 0001839185 smihu:SponsorMember us-gaap:CommonClassAMember 2021-12-31 0001839185 smihu:PublicWarrantsMember 2021-12-31 0001839185 smihu:PrivatePlacementWarrantsMember 2021-12-31 0001839185 smihu:PublicWarrantsMember us-gaap:CommonClassAMember smihu:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2021-12-31 0001839185 us-gaap:CommonClassAMember smihu:PublicWarrantsMember smihu:SharePriceEqualOrExceedsTenRupeesPerDollarMember 2021-12-31 0001839185 smihu:PublicWarrantsMember smihu:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2021-12-31 0001839185 smihu:SharePriceEqualOrExceedsTenRupeesPerDollarMember smihu:PublicWarrantsMember 2021-12-31 0001839185 us-gaap:CommonClassAMember smihu:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember smihu:PublicWarrantsMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember smihu:PrivateWarrantsMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember smihu:FpaLiabilityMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember smihu:PublicWarrantsMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel2Member smihu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001839185 us-gaap:CommonClassBMember 2020-12-31 0001839185 us-gaap:CommonClassAMember 2020-12-31 0001839185 us-gaap:CommonClassBMember smihu:FounderSharesMember smihu:SponsorMember 2020-12-31 0001839185 smihu:WorkingCapitalLoanMember 2020-12-31 0001839185 smihu:SponsorMember 2020-12-31 0001839185 us-gaap:CommonClassBMember smihu:SponsorMember 2020-12-31 0001839185 smihu:ClassACommonStockSubjectToPossibleRedemptionMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassBMember 2021-01-01 2021-12-31 0001839185 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001839185 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001839185 smihu:SponsorMember smihu:PrivatePlacementWarrantsMember 2021-01-01 2021-12-31 0001839185 us-gaap:IPOMember 2021-01-01 2021-12-31 0001839185 smihu:SponsorMember 2021-01-01 2021-12-31 0001839185 smihu:FounderSharesMember us-gaap:CommonClassBMember smihu:SponsorMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassBMember smihu:SponsorMember 2021-01-01 2021-12-31 0001839185 smihu:PublicWarrantsAndPrivateWarrantsMember us-gaap:IPOMember 2021-01-01 2021-12-31 0001839185 smihu:PublicWarrantsMember 2021-01-01 2021-12-31 0001839185 smihu:PrivatePlacementWarrantsMember 2021-01-01 2021-12-31 0001839185 smihu:FpaLiabilityMember 2021-01-01 2021-12-31 0001839185 smihu:PublicAndPrivateWarrantsMember 2021-01-01 2021-12-31 0001839185 srt:MaximumMember smihu:PrivatePlacementWarrantsMember 2021-01-01 2021-12-31 0001839185 srt:MaximumMember us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassAMember 2021-01-01 2021-12-31 0001839185 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001839185 us-gaap:CapitalUnitsMember 2021-01-01 2021-12-31 0001839185 smihu:PublicWarrantsMember smihu:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2021-01-01 2021-12-31 0001839185 smihu:SharePriceEqualOrExceedsTenRupeesPerDollarMember smihu:PublicWarrantsMember 2021-01-01 2021-12-31 0001839185 smihu:PublicWarrantsMember smihu:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassAMember smihu:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassAMember smihu:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2021-01-01 2021-12-31 0001839185 smihu:CommonClassAClassBMember smihu:SponsorMember 2021-01-01 2021-12-31 0001839185 us-gaap:IPOMember smihu:SponsorMember 2021-01-01 2021-12-31 0001839185 smihu:UsGovernmentSecuritiesMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001839185 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001839185 smihu:DerivativeWarrantLiabilitiesMember 2021-01-01 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2021-01-01 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member smihu:FpaLiabilityMember 2021-01-01 2021-12-31 0001839185 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-06-11 2021-06-11 0001839185 us-gaap:IPOMember 2021-06-11 2021-06-11 0001839185 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-06-11 0001839185 us-gaap:IPOMember 2021-06-11 0001839185 us-gaap:MeasurementInputPriceVolatilityMember smihu:PublicAndPrivateWarrantsMember 2021-06-11 0001839185 us-gaap:MeasurementInputRiskFreeInterestRateMember smihu:PublicAndPrivateWarrantsMember 2021-06-11 0001839185 us-gaap:MeasurementInputExpectedTermMember smihu:PublicAndPrivateWarrantsMember 2021-06-11 0001839185 us-gaap:MeasurementInputSharePriceMember smihu:PublicAndPrivateWarrantsMember 2021-06-11 0001839185 us-gaap:MeasurementInputPriceVolatilityMember smihu:FpaLiabilityMember 2021-06-11 0001839185 us-gaap:MeasurementInputSharePriceMember smihu:FpaLiabilityMember 2021-06-11 0001839185 smihu:MeasurementInputEstimatedTermToBusinessCombinationsMember smihu:FpaLiabilityMember 2021-06-11 0001839185 smihu:MeasurementInputProbabilityOfBusinessCombinationsMember smihu:FpaLiabilityMember 2021-06-11 0001839185 us-gaap:MeasurementInputExpectedTermMember smihu:FpaLiabilityMember 2021-06-11 0001839185 smihu:MeasurementOfPurchasePriceOfFpaUnitMember smihu:FpaLiabilityMember 2021-06-11 0001839185 srt:ScenarioForecastMember 2021-07-01 2023-06-30 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember 2020-12-31 2020-12-31 0001839185 us-gaap:CommonClassBMember smihu:AnchorInvestorsMember 2021-04-30 2021-04-30 0001839185 smihu:FounderSharesMember smihu:SponsorMember 2021-04-30 2021-04-30 0001839185 srt:DirectorMember smihu:FounderSharesMember smihu:SponsorMember 2021-04-30 2021-04-30 0001839185 us-gaap:CommonClassAMember smihu:AnchorInvestorsMember 2021-04-30 2021-04-30 0001839185 smihu:RedeemableWarrantsMember smihu:AnchorInvestorsMember 2021-04-30 2021-04-30 0001839185 us-gaap:CommonClassBMember smihu:SponsorMember 2021-04-30 2021-04-30 0001839185 smihu:AnchorInvestorsMember us-gaap:CommonClassBMember smihu:FounderSharesMember 2021-04-30 2021-04-30 0001839185 us-gaap:CommonClassAMember smihu:SponsorMember 2021-04-30 2021-04-30 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember 2021-04-30 0001839185 smihu:AdministrativeServiceFeeMember 2021-12-31 2021-12-31 0001839185 smihu:SponsorMember 2021-07-23 2021-07-23 0001839185 us-gaap:CommonClassBMember 2021-07-23 2021-07-23 0001839185 smihu:ClassACommonStockSubjectToPossibleRedemptionMember 2020-12-22 2020-12-31 0001839185 us-gaap:CommonClassBMember 2020-12-22 2020-12-31 0001839185 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-22 2020-12-31 0001839185 us-gaap:AdditionalPaidInCapitalMember 2020-12-22 2020-12-31 0001839185 us-gaap:RetainedEarningsMember 2020-12-22 2020-12-31 0001839185 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-22 2020-12-31 0001839185 us-gaap:CommonClassAMember 2022-03-31 0001839185 us-gaap:CommonClassBMember 2022-03-31 0001839185 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001839185 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001839185 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001839185 us-gaap:RetainedEarningsMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2020-12-31 0001839185 us-gaap:FairValueInputsLevel3Member smihu:FpaLiabilityMember 2020-12-31 0001839185 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member smihu:FpaLiabilityMember 2021-12-31 0001839185 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-21 0001839185 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-21 0001839185 us-gaap:AdditionalPaidInCapitalMember 2020-12-21 0001839185 us-gaap:RetainedEarningsMember 2020-12-21 0001839185 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001839185 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001839185 us-gaap:RetainedEarningsMember 2020-12-31 0001839185 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 iso4217:USD xbrli:shares utr:Month utr:Day xbrli:pure iso4217:USD xbrli:shares smihu:Nominees utr:Year utr:Y
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-K
 
 
(Mark One)
☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2021
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to
                    
.
Commission File Number
001-40466
 
 
SUMMIT HEALTHCARE ACQUISITION CORP.
(Exact Name of Registrant as Specified in Its Charter)
 
 
 
Cayman Islands
  
98-1574360
(State or Other Jurisdiction of
Incorporation or Organization)
  
(I.R.S. Employer
Identification No.)
   
Unit 1101, 11th Floor
1 Lyndhurst Tower
1 Lyndhurst Terrace
Central, Hong Kong
  
N/A
(Address of Principal Executive Offices)
  
Zip Code
Registrant’s telephone number, including area code: +852 9162 5199
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
  
Trading
Symbol(s)
  
Name of Each Exchange
on Which Registered
Class A ordinary shares, par value $0.0001 per share
  
SMIH
  
The Nasdaq Stock Market LLC
Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
  
SMIHW
  
The Nasdaq Stock Market LLC
Units, each consisting of one Class A ordinary share and one half redeemable warrant
  
SMIHU
  
The Nasdaq Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act:
 
 
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ☐    No  ☒
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.    Yes  ☐    No  ☒
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days    Yes  ☒    No  ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
       
Non-accelerated
filer		   ☒    Smaller reporting company   ☒
       
         Emerging growth company   ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule
12b-2
of the Act).    Yes  ☒    No  ☐
As of June 30, 2021 (the last business day of the registrant’s second fiscal quarter), the registrant’s Class A ordinary shares had not become separately traded and, therefore, cannot calculate the aggregate market value of its voting and
non-voting
Class A ordinary shares held by
non-affiliates
as of such date.
As of March 31, 2022
, 20,000,000 Class A ordinary shares, par value $0.0001 per share, and 5,750,000 Class B ordinary shares, par value $0.0001 per share, were issued and outstanding, respectively.
DOCUMENTS INCORPORATED BY REFERENCE
Portion of the Registrant’s prospectus filed with the Securities and Exchange Commission on June 10, 2021 pursuant to Rule 424b(4) under the Securities Act (Securities Act File
No.333-255722)
are incorporated by reference into Part I – Item IA. of this annual report on Form
10-K.
 
 
 
SUMMIT HEALTHCARE ACQUISITION CORP.
ANNUAL REPORT ON FORM
10-K
TABLE OF CONTENTS
 
 
  
Page
 
  
 
iv
 
  
 
1
 
  
 
1
 
  
 
19
 
  
 
60
 
  
 
60
 
  
 
61
 
  
 
61
 
  
 
62
 
  
 
62
 
  
 
63
 
  
 
64
 
  
 
67
 
  
 
67
 
  
 
68
 
  
 
68
 
  
 
69
 
  
 
69
 
  
 
69
 
  
 
77
 
  
 
77
 
  
 
81
 
  
 
83
 
  
 
84
 
  
 
84
 
  
 
86
 
  
 
F-1
 
 
i
CERTAIN TERMS
Unless otherwise stated in this Annual Report on Form
10-K
(this “Annual Report”), references to:
“we,” “us,” “our,” “company” or “our company” are to Summit Healthcare Acquisition Corp., a Cayman Islands exempted company;
“anchor investors” are to Snow Lake Capital (HK) Limited and the Valliance Fund, with whom we have entered into forward purchase agreements;
“amended and restated memorandum and articles of association” are to our Amended and Restated Memorandum and Articles of Association;
“Class A ordinary shares” are to our Class A ordinary shares, par value $0.0001 per share;
“Class B ordinary shares” are to our Class B ordinary shares, par value $0.0001 per share;
“Companies Act” are to the Companies Act (2021 Revision) of the Cayman Islands as the same may be amended from time to time;
“forward purchase agreements” are to the agreements providing for the sale of forward purchase shares and forward purchase warrants to the anchor investors in a private placement that will close concurrently with the closing of our initial business combination;
“forward purchase securities” are to the forward purchase shares and forward purchase warrants;
“forward purchase shares” are to the 3,000,000 Class A ordinary shares issued to the anchor investors pursuant to the forward purchase agreements;
“forward purchase warrants” are to the 750,000 warrants to purchase Class A ordinary shares issued to the anchor investors pursuant to the forward purchase agreements;
“directors” are to our current directors;
“founders shares” are to our Class B ordinary shares initially purchased by our sponsor in a private placement prior to our initial public offering and the Class A ordinary shares that will be issued upon the automatic conversion of the Class B ordinary shares at the time of our initial business combination (for the avoidance of doubt, such Class A ordinary shares will not be “public shares”);
“initial shareholders” are to our sponsor and other holders of our founders shares;
“letter agreement” refers to the letter agreement entered into between us and our initial shareholders, directors and officers on January 8, 2021;
“management” or our “management team” are to our officers and directors;
“ordinary shares” are to our Class A ordinary shares and our Class B ordinary shares;
“private placement warrants” are to the warrants issued to our sponsor in a private placement simultaneously with the closing of our initial public offering;
“public shares” are to our Class A ordinary shares sold as part of the units in our initial public offering (whether they were purchased in our initial public offering or thereafter in the open market) and for the avoidance of doubt, do not include the Class A ordinary shares that will be issued upon the automatic conversion of the Class B ordinary shares;
“public shareholders” are to the holders of our public shares, including our sponsor, officers and directors to the extent our sponsor and/or officers, directors purchase public shares, provided that our sponsor’s, officers’ and directors’ status as a “public shareholder” will only exist with respect to such public shares;
 
ii
“sponsor” are to Summit Healthcare Acquisition Sponsor LLC, a Cayman Islands exempted company;
“warrants” are to our redeemable warrants sold as part of the units in our initial public offering (whether they were purchased in the initial public offering or thereafter in the open market) and the private placement warrants; and
“$,” “US$” and “U.S. dollar” each refer to the United States dollar.
 
iii
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Some statements contained in this Annual Report are forward-looking in nature. Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Annual Report may include, for example, statements about:
 
  •  
our ability to select an appropriate target business or businesses;
 
  •  
our ability to complete our initial business combination;
 
  •  
our expectations around the performance of a prospective target business or businesses;
 
  •  
our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;
 
  •  
our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination;
 
  •  
the proceeds from the sale of the forward purchase securities being available to us;
 
  •  
our potential ability to obtain additional financing to complete our initial business combination;
 
  •  
our pool of prospective target businesses;
 
  •  
our ability to consummate an initial business combination due to the uncertainty resulting from the recent
COVID-19
pandemic;
 
  •  
the ability of our officers and directors to generate a number of potential business combination opportunities;
 
  •  
our public securities’ potential liquidity and trading;
 
  •  
the lack of a market for our securities;
 
  •  
the use of proceeds not held in the trust account or available to us from interest income on the trust account balance;
 
  •  
the trust account not being subject to claims of third parties; or
 
  •  
our financial performance following our initial public offering or following our initial business combination.
The forward-looking statements contained in this Annual Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
 
iv
PART I
Item 1. Business
We are a newly incorporated blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Annual Report as our initial business combination.
Our efforts to identify a prospective target business will not be limited to a particular geographic region or industry, although we intend to focus on healthcare. We believe our management team, advisory board members and board of directors have the relevant skills and experience to identify companies to best capture market opportunities.
Our Officers, Directors and Senior Advisor
Bo Tan, our Chief Executive Officer
and Co-Chief Investment
Officer, has over 20 years of extensive experience in the financial and pharmaceutical industries and was the President and Chief Financial Officer of 3S Bio from December 2016 to December 2019. During his tenure at 3S Bio, Mr. Tan led the privatization of 3SBio and
its re-listing in
Hong Kong in 2015, as well as the acquisition and integration of Sciprogen, Sirton (Italy), Wanma and CP Guojian, as well as investments in various landmark healthcare assets, including Ascentage, Sorrento and Refuge. In 2018 and 2019, Mr. Tan was voted the “Best CFO” for two consecutive years in the Institutional
Investor All-Asia Executive
Team poll. Mr. Tan joined 3SBio in 2009 and 3SBio’s market capitalization increased approximately 10 times from 2009 to 2018. Before joining 3S Bio, Mr. Tan served as the executive director and a member of Investment Committee of Bohai Industrial Investment Fund Management Company,
a PRC-based private
equity firm, and presided over the investment in The Chengdu Commercial Bank, from April 2007 to September 2008. Prior to that, Mr. Tan served as a vice president in the equity research division of Lehman Brothers Asia Limited from March 2006 to March 2007 and as a senior analyst at Macquarie Securities Asia in Hong Kong from October 2004 to February 2006. Mr. Tan is widely acclaimed for his stellar track record of combining business operations and capital market prowess and has long-standing strategic relationships with major MNCs. Mr. Tan received his Bachelor’s degree in Economics from Renmin University of China in July 1994, Master’s degree in Economics from the University of Connecticut in December 1996 and a Master of International Management from Thunderbird School of Global Management in August 1998.
Ken Poon, our President
and Co-Chief Investment
Officer, has nearly 30 years of capital markets experiences in Asia and is the founding partner of XCap Partners Limited, a boutique advisory firm in Hong Kong. Prior to founding XCap Partners Limited in 2019, Mr. Poon served as the Asia Pacific Head of Capital Markets Origination at Citigroup, running the Equity Capital Markets, Debt Capital Markets and Acquisition Finance businesses for all
Asia ex-Japan. Prior
to his tenure at Citigroup, Mr. Poon served as the Head of Asia Equity Capital Markets at Merrill Lynch from August 1998 to May 2004. Mr. Poon has led a series of landmark transactions globally, including Alibaba’s US$25 billion NYSE IPO, Luye Pharmaceutical’s US$878 million HKSE IPO, Samsung Biologic’s US$2 billion KOSE IPO, Chungwha Telecom Taiwan’s US$1.6 billion NYSE IPO and privatization, Melco’s US$1.3 billion Nasdaq IPO, TSMC’s US$2.0 billion registered ADR offering, China Mobile’s US$7.2 billion simultaneous placement of equity and convertibles, China Netcom’s US$1.2 billion dual listed NYSE and HKSE IPO, China CITIC Bank’s US$5.9 billion HKSE IPO, Longor Group’s US$1.0 billion HKSE IPO, CRCC’s US$2.3 billion HKSE IPO, Global Logistics Property US$3 billion SGX IPO, PetroChina’s US$2.4 billion Equity Placement, Sands China’s US$2.5 billion HKSE IPO and AIA’s US$20 billion HKSE IPO. He also led numerous billion-dollar bond offerings for companies such as Hutshison/Vodafone, Temasek/Singapore Telecom and Korea Telecom. Mr. Poon holds a Bachelor of Commerce degree in Finance from The University of British Columbia.
Wei Fu, our Honorary Chairman and Senior Advisor, is the founder and Chief Executive Officer of CBC Group, a healthcare-focused private equity firm in Asia, since April 2014. In particular, Mr. Fu played a key role in CBC Group’s successful incubation and investment in multiple companies, including
I-MAB
and Everest, where Mr. Fu participated in operations from ground up. For
I-MAB,
the CBC team led by Mr. Fu implemented and facilitated major initiatives, including the merger between Third Venture Biotech and Tasgen Bio to
form I-MAB, the
series A and B financings and key strategic decision making as well as strong support for its successful US$114 million NASDAQ IPO in January 2020. Everest is a company that Mr. Fu and CBC founded in 2017 with a vision to
in-license,
develop and commercialize innovative specialty drugs in the PRC. Mr. Fu and CBC led all the strategic decision making and financing efforts of Everest that led to its successful IPO listing on HKEX in October 2020. Prior to founding CBC, Mr. Fu also worked at Far East, Standard Chartered Infrastructure Fund, Goldman Sachs, Macquarie and Tamasek. Mr. Fu received his bachelor’s degree in electrical and electronic engineering from Nanyang Technological University in Singapore. Wei Fu is not an officer nor director of our Company.
Ian Stone, our independent director, joined Pontis Partners, a consulting business specializing in the telecom, internet and media industries, in 2001, where he is currently a director. Through his position at Pontis Partners, Mr. Stone serves as a board member and advisor to a number of listed and private companies in the Asia and Middle East North Africa regions. In particular, Mr. Stone currently serves as an independent director of Tencent Holding Company (HKEX: 0700), one of Chinese largest online technology companies, and an independent director at Panther Media Group, a MENA region media company, between October 2018 and September 2021. From 2001 to 2014 Mr. Stone served in various positions at PCCW, a leading telecommunications and media company in Hong Kong, including as managing director of various business units.
Thomas Folinsbee, CFA, our independent director, has over 25 years of experience as a financial and securities professional. Mr. Folinsbee has been the business development consultant of Shanghai Alebund Pharmaceuticals Ltd., a China-based pharmaceutical company, since 2019, where he is responsible for pharmaceutical inlicensing and outlicensing transactions. Prior to joining Alebund, Mr. Folinsbee was Director of Corporate Development of the strategic investment division of 3SBio Inc., a biotechnology company, from 2009 to 2019, focusing on sourcing business development opportunities in Canada, Australia, and Japan, including licensing, distribution, and M&A. Mr. Folinsbee joined 3SBio to manage its investor relations activities and was a member of the management group that delisted 3SBio from Nasdaq in May 2013 and relisted it on the Hong Kong Stock Exchange in June 2016. From 2017 to 2019, Mr. Folinsbee also served as independent director of Bison Capital Acquisition Corporation, a special purpose acquisition company that acquired Xynomic Pharmaceuticals Holdings, Inc. in 2019. Mr. Folinsbee continued to serve as independent director and was a member of the audit and compensation committees after the acquisition. From 2011 to 2016, Mr. Folinsbee also worked for Hisanaga Seisakusho Co. Ltd., a Japanese manufacturing company. Before joining 3SBio Inc., Mr. Folinsbee also worked at Macquarie Equities, BNP Paribas and Optivest Systems Ltd. Mr. Folinsbee graduated in 1990 from McGill University with a Bachelor of Commerce degree concentrating in finance and international business (with distinction).
Tao Bai, our independent director, is a partner at the Beijing and Tianjin offices of JunHe Law Offices. Prior to joining JunHe Law Offices in 2002, Ms. Bai was a founding partner at Commerce & Finance Law offices from 1992 to 2002. Prior to that, Ms. Bai practiced with C&C Law Offices in Beijing from 1989 to 1992. Over the years, Ms. Bai has provided comprehensive legal services to many international clients, including multinational corporations and international organizations, as well as large Chinese enterprises and trade organizations, in the fields of IP protection, anti-dumping, M&A, project financing, IPOs, litigation, arbitration and administrative actions. Ms. Bai is a member of the
All-China
Bar Association, a Standing Director of Beijing Intellectual Property Protection Association, a member of the Chinese Society of International Law and the Inter-Pacific Bar Association, the Vice President of Beijing Bar Association and an arbitrator of the China International Economic and Trade Arbitration Commission, Shanghai International Economic and Trade Arbitration Commission and Hainan Arbitration Commission. Ms. Bai received the Outstanding and Lifetime Achievement for Asia Women in Business Law award from the Euromoney Legal Media Group in 2016. Ms. Bai received her LL.B. degree from Peking University Law School in 1985 and her J.D. degree from Cornell Law School in 1988.
Our officers, directors and senior advisor may have conflicts of interest in pursuing an acquisition target arising from fiduciary duties they have towards other entities. See “Item 1A. Risk Factors—Risks Relating to our Sponsor and Management Team—Our officers, directors and senior advisor presently have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities, including another blank check company, and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.”
 
2
Company History
On December 31, 2020, our sponsor paid $25,000, or approximately $0.004 per share, to cover certain expenses on our behalf in consideration of 5,750,000 Class B ordinary shares, par value $0.0001. Following a share capitalization on April 30, 2021, our sponsor held an aggregate of 6,500,000 founder shares and then, in connection with entering into the forward purchase agreements, transferred to the anchor investors an aggregate of 375,000 founder shares for no cash consideration, which represent 6.52% of the Class B ordinary shares issued and outstanding immediately after the initial public offering completed on June 11, 2021 (“IPO”). These 375,000 founder shares were not subject to forfeiture. Prior to the initial investment in the company of $25,000 by the sponsor, we had no assets, tangible or intangible. On April 30, 2021, our sponsor transferred 25,000 founder shares to each of our independent directors. These 75,000 founder shares were not subject to forfeiture.
On June 11, 2021, we completed our IPO of 20,000,000 units at a price of $10.00 per unit (the “units”), generating gross proceeds of $200,000,000. Each unit consists of one of the Company’s Class A ordinary shares, par value $0.0001 per share, and
one-half
of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments.
Substantially concurrently with the completion of the IPO, our sponsor purchased an aggregate of 6,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per warrant, or $6,000,000 in the aggregate. A total of $206,000,000, comprised of $200,000,000 of the proceeds from the IPO, including $7,000,000 of the underwriters’ deferred discount, and $6,000,000 of the proceeds of the sale of the Private Placement Warrants, was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee.
On July 27, 2021, we announced that, commencing on July 30, 2021, holders of the 20,000,000 units sold in the IPO may elect to separately trade the Class A ordinary shares and the warrants included in the units. Those units not separated continued to trade on the Nasdaq under the symbol “SMIHU” and the Class A ordinary shares and warrants that were separated trade under the symbols “SMIH” and “SMIHW,” respectively.
Initial Business Combination
So long as our securities are then listed on Nasdaq, our initial business combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the net assets held in the trust account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account) at the time of signing a definitive agreement in connection with our initial business combination. If our board of directors is not able to independently determine the fair market value of the target business or businesses, we will obtain an opinion from an independent investment banking firm or an independent valuation or appraisal firm with respect to the satisfaction of such criteria. While we consider it unlikely that our board will not be able to make an independent determination of the fair market value of a target business or businesses, it may be unable to do so if the board is less familiar or experienced with the target company’s business, if there is a significant amount of uncertainty as to the value of the company’s assets or prospects, including if such company is at an early stage of development, operations or growth, or if the anticipated transaction involves a complex financial analysis or other specialized skills and the board determines that outside expertise would be helpful or necessary in conducting such analysis. Since any opinion, if obtained, would merely state that the fair market value of the target business meets the 80% of net assets threshold, unless such opinion includes material information regarding the valuation of a target business or the consideration to be provided, it is not anticipated that copies of such opinion would be distributed to our shareholders. However, if required under applicable law, any proxy statement that we deliver to shareholders and file with the SEC in connection with a proposed transaction will include such opinion.
We anticipate structuring our initial business combination so that the post-business combination company in which our public shareholders own shares will own or acquire 100% of the equity interests or assets of the target business or businesses. We may, however, structure our initial business combination such that the post-business combination company owns or acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete such business combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. Even if the post-business combination company owns or acquires 50% or more of the voting securities of the target, our shareholders prior to the business combination may collectively own a minority interest in the post-business combination company, depending on valuations ascribed to the target and us in the business combination. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of new shares, our shareholders immediately prior to our initial business combination could own less than a majority of our outstanding shares subsequent to our initial business combination. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-business combination company, the portion of such business or businesses that is owned or acquired is what will be valued for purposes of the 80% of net assets test. If the business combination involves more than one target business, the 80% of net assets test will be based on the aggregate value of all of the target businesses. In addition, we have agreed not to enter into a definitive agreement regarding an initial business combination without the prior consent of our sponsor. If our securities are not then listed on Nasdaq for whatever reason, we would no longer be required to meet the foregoing 80% of net assets test.
 
3
To the extent we effect our initial business combination with a company or business that may be financially unstable or in its early stages of development or growth, we may be affected by numerous risks inherent in such company or business. Although our management will endeavor to evaluate the risks inherent in a particular target business, we cannot assure you that we will properly ascertain or assess all significant risk factors.
The time required to select and evaluate a target business and to structure and complete our initial business combination, and the costs associated with this process, are not currently ascertainable with any degree of certainty. Any costs incurred with respect to the identification and evaluation of a prospective target business with which our initial business combination is not ultimately completed will result in our incurring losses and will reduce the funds we can use to complete another business combination.
Other Acquisition Considerations
We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors. In the event we seek to complete our initial business combination with a company that is affiliated with our sponsor or any of our officers or directors, we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that such initial business combination is fair to our company from a financial point of view. We are not required to obtain such an opinion in any other context.
We currently do not have any specific business combination under consideration. Our officers and directors have neither individually selected nor considered a target business nor have they had any substantive discussions regarding possible target businesses among themselves or with our underwriter or other advisors. Our management team is regularly made aware of potential business opportunities, one or more of which we may desire to pursue for a business combination, but we have not (nor has anyone on our behalf) contacted any prospective target business or had any substantive discussions, formal or otherwise, with respect to a business combination transaction with our company. Additionally, we have not, nor has anyone on our behalf, taken any substantive measure, directly or indirectly, to identify or locate any suitable acquisition candidate for us, nor have we engaged or retained any agent or other representative to identify or locate any such acquisition candidate.
In addition, certain of our officers or directors presently have, and any of them in the future may have additional, fiduciary and contractual duties to other entities. As a result, if any of our officers or directors becomes aware of a business combination opportunity that is suitable for an entity to which he, she or it has then-current fiduciary or contractual obligations, then, subject to their fiduciary duties under Cayman Islands law, he, she or it will need to honor such fiduciary or contractual obligations to present such business combination opportunity to such entity, before we can pursue such opportunity. If these other entities decide to pursue any such opportunity, we may be precluded from pursuing the same. However, we do not expect these duties to materially affect our ability to complete our initial business combination. Our amended and restated memorandum and articles of association provide that we renounce our interest in any business combination opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the company and it is an opportunity that we are able to complete on a reasonable basis.
Our sponsor, officers, directors and senior advisor may sponsor, form or participate in other blank check companies similar to ours during the period in which we are seeking an initial business combination. Any such companies may present additional conflicts of interest in pursuing an acquisition target, particularly in the event there is overlap among investment mandates. However, we do not currently expect that any such other blank check company would materially affect our ability to complete our initial business combination. In addition, our sponsor, officers, directors and senior advisor are not required to commit any specified amount of time to our affairs, and, accordingly, will have conflicts of interest in allocating management time among various business activities, including identifying potential business combinations and monitoring the related due diligence.
 
4
Emerging Growth Company Status and Other Corporate Information
Our executive offices are located at Unit 1101, 11th Floor 1 Lyndhurst Tower, 1 Lyndhurst Terrace, Central, Hong Kong, and our telephone number is +852 9162 5199.
We are a Cayman Islands exempted company. Exempted companies are Cayman Islands companies conducting business mainly outside the Cayman Islands and, as such, are exempted from complying with certain provisions of the Companies Act. As an exempted company, we have applied for and received a tax exemption undertaking from the Cayman Islands government that, in accordance with Section 6 of the Tax Concessions Act (2020 Revision) of the Cayman Islands, for a period of 20 years from the date of the undertaking, no law which is enacted in the Cayman Islands imposing any tax to be levied on profits, income, gains or appreciations will apply to us or our operations and, in addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax will be payable (i) on or in respect of our shares, debentures or other obligations or (ii) by way of the withholding in whole or in part of a payment of dividend or other distribution of income or capital by us to our shareholders or a payment of principal or interest or other sums due under a debenture or other obligation of us.
We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a
non-binding
advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.
In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.
We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of the initial public offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our Class A ordinary shares that are held by
non-affiliates
equals or exceeds $700 million as of the prior June 30, and (2) the date on which we have issued more than $1.0 billion in
non-convertible
debt during the prior three-year period.
Additionally, we are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation
S-K.
Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of any fiscal year for so long as either (1) the market value of our ordinary shares held by
non-affiliates
is less than $250 million as of the end of that year’s second fiscal quarter or (2) our annual revenues are less than $100 million during such completed fiscal year and the market value of our ordinary shares held by
non-affiliates
is less than $700 million as of the end of that year’s second fiscal quarter.
 
5
Status as a Public Company
We believe our structure will make us an attractive business combination partner to target businesses. As an existing public company, we offer a target business an alternative to the traditional initial public offering through a merger or other business combination with us. In a business combination transaction with us, the owners of the target business may, for example, exchange their shares of stock, shares or other equity interests in the target business for our Class A ordinary shares (or shares of a new holding company) or for a combination of our Class A ordinary shares and cash, allowing us to tailor the consideration to the specific needs of the sellers. We believe target businesses will find this method a more expeditious and cost effective method to becoming a public company than the typical initial public offering. The typical initial public offering process takes a significantly longer period of time than the typical business combination transaction process, and there are significant expenses in the initial public offering process, including underwriting discounts and commissions, that may not be present to the same extent in connection with a business combination with us.
Furthermore, once a proposed business combination is completed, the target business will have effectively become public, whereas an initial public offering is always subject to the underwriter’s ability to complete the offering, as well as general market conditions, which could delay or prevent the offering from occurring or have negative valuation consequences. Once public, we believe the target business would then have greater access to capital, an additional means of providing management incentives consistent with shareholders’ interests and the ability to use its shares as currency for acquisitions. Being a public company can offer further benefits by augmenting a company’s profile among potential new customers and vendors and aid in attracting talented employees.
While we believe that our structure and our management team’s backgrounds will make us an attractive business partner, some potential target businesses may view our status as a blank check company, such as our lack of an operating history and our ability to seek shareholder approval of any proposed initial business combination, negatively.
We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a
non-binding
advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.
In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.
We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of the initial public offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our Class A ordinary shares that are held by
non-affiliates
equals or exceeds $700 million as of the prior June 30, and (2) the date on which we have issued more than $1.0 billion in
non-convertible
debt during the prior three-year period.
Additionally, we are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation
S-K.
Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of any fiscal year for so long as either (1) the market value of our ordinary shares held by
non-affiliates
is less than $250 million as of the end of that year’s second fiscal quarter or (2) our annual revenues are less than $100 million during such completed fiscal year and the market value of our ordinary shares held by
non-affiliates
is less than $700 million as of the end of that year’s second fiscal quarter..
 
6
Financial Position
With funds available for a business combination initially in the amount of $223,000,000 (including amounts to be received pursuant to the forward purchase agreements), after payment of the estimated
non-reimbursed
expenses of the initial public offering and $7,000,000 of deferred underwriting fees, we offer a target business a variety of options such as creating a liquidity event for its owners, providing capital for the potential growth and expansion of its operations or strengthening its balance sheet by reducing its debt ratio. Because we are able to complete our initial business combination using our cash, debt or equity securities, or a combination of the foregoing, we have the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business to fit its needs and desires. Other than the forward purchase agreements, we are not a party to any arrangement or understanding with any third party with respect to raising any additional funds through the sale of securities or otherwise.
Effecting Our Initial Business Combination
We are not presently engaged in, and we will not engage in, any operations for an indefinite period of time following the initial public offering. We intend to effectuate our initial business combination using cash from the proceeds of the initial public offering and the sale of the private placement warrants and forward purchase securities, the proceeds of the sale of our shares in connection with our initial business combination (pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of the initial public offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing or other sources. We may seek to complete our initial business combination with a company or business that may be financially unstable or in its early stages of development or growth, which would subject us to the numerous risks inherent in such companies and businesses.
If our initial business combination is paid for using equity or debt, or not all of the funds released from the trust account are used for payment of the consideration in connection with our initial business combination or used for redemptions of our Class A ordinary shares, we may apply the balance of the cash released to us from the trust account for general corporate purposes, including for maintenance or expansion of operations of the post-business combination company, the payment of principal or interest due on indebtedness incurred in completing our initial business combination, to fund the purchase of other companies or for working capital.
We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions with any business combination target. Additionally, we have not engaged or retained any agent or other representative to identify or locate any suitable acquisition candidate, to conduct any research or take any measures, directly or indirectly, to locate or contact a target business, other than our officers and directors. Accordingly, there is no current basis for investors in the initial public offering to evaluate the possible merits or risks of the target business with which we may ultimately complete our initial business combination. Although our management will assess the risks inherent in a particular target business with which we may combine, we cannot assure you that this assessment will result in our identifying all risks that a target business may encounter. Furthermore, some of those risks may be outside of our control, meaning that we can do nothing to control or reduce the chances that those risks will adversely affect a target business.
We may need to obtain additional financing to complete our initial business combination, either because the transaction requires more cash than is available from the proceeds held in our trust account, or because we become obligated to redeem a significant number of our public shares upon the completion of the business combination, in which case we may issue additional securities or incur debt in connection with such business combination. There are no prohibitions on our ability to issue securities or incur debt in connection with our initial business combination. Other than the potential availability of the backstop arrangement with our sponsor, we are not currently a party to any arrangement or understanding with any third party with respect to raising any additional funds through the sale of securities, the incurrence of debt or otherwise.
 
7
Sources of Target Businesses
We anticipate that target business candidates will be brought to our attention from various unaffiliated sources, including investment market participants, private equity groups, investment banking firms, consultants, accounting firms and large business enterprises. Target businesses may be brought to our attention by such unaffiliated sources as a result of being solicited by us through calls or mailings. These sources may also introduce us to target businesses in which they think we may be interested on an unsolicited basis, since some of these sources will have read this annual report and know what types of businesses we are targeting. Our officers and directors, as well as their affiliates, may also bring to our attention target business candidates that they become aware of through their business contacts as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In addition, we expect to receive a number of proprietary deal flow opportunities that would not otherwise necessarily be available to us as a result of the business relationships of our officers and directors. While we do not presently anticipate engaging the services of professional firms or other individuals that specialize in business acquisitions on any formal basis, we may engage these firms or other individuals in the future, in which event we may pay a finder’s fee, consulting fee or other compensation to be determined in an arm’s length negotiation based on the terms of the transaction. We will engage a finder only to the extent our management determines that the use of a finder may bring opportunities to us that may not otherwise be available to us or if finders approach us on an unsolicited basis with a potential transaction that our management determines is in our best interest to pursue. Payment of finder’s fees is customarily tied to completion of a transaction, in which case any such fee will be paid out of the funds held in the trust account. In no event, however, will our sponsor or any of our existing officers or directors, or their respective affiliates be paid by us any finder’s fee, consulting fee or other compensation prior to, or for any services they render in order to effectuate, the completion of our initial business combination (regardless of the type of transaction that it is). We have agreed to pay an affiliate of our sponsor a total of $10,000 per month for office space, utilities, administrative services and remote support services and to reimburse our sponsor for
any out-of-pocket expenses
related to identifying, investigating and completing an initial business combination. Some of our officers and directors may enter into employment or consulting agreements with the post-business combination company following our initial business combination. The presence or absence of any such fees or arrangements will not be used as a criterion in our selection process of an acquisition candidate.
We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors. In the event we seek to complete our initial business combination with a company that is affiliated with our sponsor or any of our officers or directors, we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that such initial business combination is fair to our company from a financial point of view. We are not required to obtain such an opinion in any other context.
Each of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations to other entities, including entities that are affiliates of our sponsor, pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity that is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such entity, subject to their fiduciary duties under Cayman Islands law. See “Item 10. Directors, Executive Officers and Corporate Governance—Conflicts of Interest.”
Evaluation of a Target Business and Structuring of Our Initial Business Combination
In evaluating a prospective target business, we expect to conduct an extensive due diligence review that may encompass, as applicable and among other things, meetings with incumbent management and employees, document reviews, interviews of customers and suppliers, inspection of facilities and a review of financial and other information about the target and its industry. We will also utilize our management team’s operational and capital planning experience. If we determine to move forward with a particular target, we will proceed to structure and negotiate the terms of the business combination transaction.
The time required to select and evaluate a target business and to structure and complete our initial business combination, and the costs associated with this process, are not currently ascertainable with any degree of certainty.
 
8
Any costs incurred with respect to the identification and evaluation of, and negotiation with, a prospective target business with which our initial business combination is not ultimately completed will result in our incurring losses and will reduce the funds we can use to complete another business combination. The company will not pay any consulting fees to members of our management team, or their respective affiliates, for services rendered to or in connection with our initial business combination. In addition, we have agreed not to enter into a definitive agreement regarding an initial business combination without the prior consent of our sponsor.
Lack of Business Diversification
For an indefinite period of time after the completion of our initial business combination, the prospects for our success may depend entirely on the future performance of a single business. Unlike other entities that have the resources to complete business combinations with multiple entities in one or several industries, it is probable that we will not have the resources to diversify our operations and mitigate the risks of being in a single line of business. By completing our initial business combination with only a single entity, our lack of diversification may:
 
  •  
subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination, and
 
  •  
cause us to depend on the marketing and sale of a single product or limited number of products or services.
Limited Ability to Evaluate the Target’s Management Team
Although we intend to closely scrutinize the management of a prospective target business when evaluating the desirability of effecting our initial business combination with that business, our assessment of the target business’s management may not prove to be correct. In addition, the future management may not have the necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role of members of our management team, if any, in the target business cannot presently be stated with any certainty. The determination as to whether any of the members of our management team will remain with the combined company will be made at the time of our initial business combination. While it is possible that one or more of our directors will remain associated in some capacity with us following our initial business combination, it is unlikely that any of them will devote their full efforts to our affairs subsequent to our initial business combination. Moreover, we cannot assure you that members of our management team will have significant experience or knowledge relating to the operations of the particular target business.
We cannot assure you that any of our key personnel will remain in senior management or advisory positions with the combined company. The determination as to whether any of our key personnel will remain with the combined company will be made at the time of our initial business combination.
Following a business combination, we may seek to recruit additional managers to supplement the incumbent management of the target business. We cannot assure you that we will have the ability to recruit additional managers, or that additional managers will have the requisite skills, knowledge or experience necessary to enhance the incumbent management.
Shareholders May Not Have the Ability to Approve Our Initial Business Combination
We may conduct redemptions without a shareholder vote pursuant to the tender offer rules of the SEC subject to the provisions of our amended and restated memorandum and articles of association. However, we will seek shareholder approval if it is required by law or applicable stock exchange rule, or we may decide to seek shareholder approval for business or other reasons.
 
9
Under Nasdaq’s listing rules, shareholder approval would be required for our initial business combination if, for example:
 
  •  
We issue ordinary shares that will be equal to or in excess of 20% of the number of our ordinary shares then outstanding (other than in a public offering);
 
  •  
Any of our directors, officers or substantial shareholders (as defined by Nasdaq rules) has a 5% or greater interest earned on the trust account (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in outstanding ordinary shares or voting power of 5% or more; or
 
  •  
The issuance or potential issuance of ordinary shares will result in our undergoing a change of control.
The decision as to whether we will seek shareholder approval of a proposed business combination in those instances in which shareholder approval is not required by law will be made by us, solely in our discretion, and will be based on business and reasons, which include a variety of factors, including, but not limited to:
 
  •  
the timing of the transaction, including in the event we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company;
 
  •  
the expected cost of holding a shareholder vote;
 
  •  
the risk that the shareholders would fail to approve the proposed business combination;
 
  •  
other time and budget constraints of the company; and
 
  •  
additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to shareholders.
Permitted Purchases of Our Securities
If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, initial shareholders, directors, officers, advisors or their affiliates may purchase shares or public warrants in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. There is no limit on the number of shares our initial shareholders, directors, officers, advisors or their affiliates may purchase in such transactions, subject to compliance with applicable law and Nasdaq rules. However, they have no current commitments, plans or intentions to engage in such transactions and have not formulated any terms or conditions for any such transactions. None of the funds in the trust account will be used to purchase shares or public warrants in such transactions. If they engage in such transactions, they will not make any such purchases when they are in possession of any material
non-public
information not disclosed to the seller or if such purchases are prohibited by Regulation M under the Exchange Act.
In the event that our sponsor, directors, officers, advisors or their affiliates purchase shares in privately negotiated transactions from public shareholders who have already elected to exercise their redemption rights, such selling shareholders would be required to revoke their prior elections to redeem their shares. We do not currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer rules under the Exchange Act or a going-private transaction subject to the going-private rules under the Exchange Act; however, if the purchasers determine at the time of any such purchases that the purchases are subject to such rules, the purchasers will comply with such rules.
The purpose of any such purchases of shares could be to (i) vote such shares in favor of the business combination and thereby increase the likelihood of obtaining shareholder approval of the business combination or (ii) to satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our initial business combination, where it appears that such requirement would otherwise not be met. The purpose of any such purchases of public warrants could be to reduce the number of public warrants outstanding or to vote such warrants on any matters submitted to the warrantholders for approval in connection with our initial business combination. Any such purchases of our securities may result in the completion of our initial business combination that may not otherwise have been possible.
 
10
In addition, if such purchases are made, the public “float” of our Class A ordinary shares or public warrants may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange.
Our sponsor, officers, directors and/or their affiliates anticipate that they may identify the shareholders with whom our initial shareholders, officers, directors or their affiliates may pursue privately negotiated purchases by either the shareholders contacting us directly or by our receipt of redemption requests submitted by shareholders (in the case of Class A ordinary shares) following our mailing of proxy materials in connection with our initial business combination. To the extent that our sponsor, officers, directors, advisors or their affiliates enter into a private purchase, they would identify and contact only potential selling shareholders who have expressed their election to redeem their shares for a pro rata share of the trust account or vote against our initial business combination, whether or not such shareholder has already submitted a proxy with respect to our initial business combination but only if such shares have not already been voted at the general meeting related to our initial business combination. Our sponsor, officers, directors, advisors or any of their affiliates will select which shareholders to purchase shares from based on a negotiated price and number of shares and any other factors that they may deem relevant, and will only purchase shares if such purchases comply with Regulation M under the Exchange Act and the other federal securities laws.
Our sponsor, officers, directors and/or their affiliates will not make purchases of shares if the purchases would violate Section 9(a)(2) or Rule
10b-5
of the Exchange Act. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements.
Redemption Rights for Public Shareholders upon Completion of Our Initial Business Combination
We will provide our public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of our initial business combination at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters. Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares and any public shares they may hold in connection with the completion of our initial business combination.
Limitations on Redemptions
Our amended and restated memorandum and articles of association provide that in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001. In addition, our proposed initial business combination may impose a minimum cash requirement for (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions. In the event the aggregate cash consideration we would be required to pay for all Class A ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed initial business combination exceed the aggregate amount of cash available to us, we will not complete the initial business combination or redeem any shares, and all Class A ordinary shares submitted for redemption will be returned to the holders thereof. We may, however, raise funds through the issuance of equity-linked securities or through loans, advances or other indebtedness in connection with our initial business combination, including pursuant to forward purchase agreements or backstop arrangements we may enter into following consummation of our initial public offering, in order to, among other reasons, satisfy such net tangible assets or minimum cash requirements.
 
11
Manner of Conducting Redemptions
We will provide our public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of our initial business combination either (i) in connection with a general meeting called to approve the business combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether we will seek shareholder approval of a proposed business combination or conduct a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require us to seek shareholder approval under applicable law or stock exchange listing requirement or whether we were deemed to be a foreign private issuer (which would require a tender offer rather than seeking shareholder approval under SEC rules). Asset acquisitions and share purchases would not typically require shareholder approval while direct mergers with our company and any transactions where we issue more than 20% of our issued and outstanding ordinary shares or seek to amend our amended and restated memorandum and articles of association would require shareholder approval. So long as we obtain and maintain a listing for our securities on Nasdaq, we will be required to comply with Nasdaq’s shareholder approval rules.
The requirement that we provide our public shareholders with the opportunity to redeem their public shares by one of the two methods listed above will be contained in provisions of our amended and restated memorandum and articles of association and will apply whether or not we maintain our registration under the Exchange Act or our listing on Nasdaq. Such provisions may be amended if approved by holders of two thirds of our ordinary shares who attend and vote at a general meeting of the company, so long as we offer redemption in connection with such amendment.
If we provide our public shareholders with the opportunity to redeem their public shares in connection with a shareholder meeting, we will, pursuant to our amended and restated memorandum and articles of association:
 
  •  
conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules, and
 
  •  
file proxy materials with the SEC.
Upon the public announcement of our initial business combination, if we elect to conduct redemptions pursuant to the tender offer rules, we and our sponsor will terminate any plan established in accordance
with Rule 10b5-1 to
purchase our Class A ordinary shares in the open market, in order to comply with
Rule 14e-5 under
the Exchange Act.
In the event that we seek shareholder approval of our initial business combination, we will distribute proxy materials and, in connection therewith, provide our public shareholders with the redemption rights described above upon completion of the initial business combination.
If we seek shareholder approval, we will complete our initial business combination only if we obtain an ordinary resolution under Cayman Islands law, being the affirmative vote of a majority of the shareholders represented in person or by proxy and entitled to vote thereon who attend and vote at a general meeting of the company. A quorum for such meeting will be present if the holders of a majority of issued and outstanding shares entitled to vote at the meeting are represented in person or by proxy. Our sponsor, officers and directors will count toward this quorum and, pursuant to the letter agreement, our sponsor, officers and directors have agreed to vote their founder shares, private placement shares and any public shares purchased during or after our initial public offering (including in open market and privately-negotiated transactions) in favor of our initial business combination. For purposes of seeking approval of an ordinary resolution,
non-votes
will have no effect on the approval of our initial business combination once a quorum is obtained. As a result, in addition to our initial shareholders’ founder shares, we would need 8,625,001, or 37.5%, of the 23,000,000 public shares sold in our initial public offering to be voted in favor of an initial business combination in order to have our initial business combination approved (assuming all outstanding shares are voted). These quorum and voting thresholds, and the voting agreement of our sponsor, officers and directors, may make it more likely that we will consummate our initial business combination. Each public shareholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction or whether they were a public shareholder on the record date for the general meeting held to approve the proposed transaction.
 
12
If a shareholder vote is not required and we do not decide to hold a shareholder vote for business or other legal reasons, we will:
 
  •  
conduct the redemptions pursuant to Rule
13e-4
and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and
 
  •  
file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.
Upon the public announcement of our initial business combination, if we elect to conduct redemption pursuant to the tender offer rules, we or our sponsor will terminate any plan established in accordance with Rule
10b5-1
to purchase our Class A ordinary shares in the open market, in order to comply with Rule
14e-5
under the Exchange Act.
In the event we conduct redemptions pursuant to the tender offer rules, our offer to redeem will remain open for at least 20 business days, in accordance with Rule
14e-1(a)
under the Exchange Act, and we will not be permitted to complete our initial business combination until the expiration of the tender offer period. In addition, the tender offer will be conditioned on public shareholders not tendering more than the number of public shares we are permitted to redeem. If public shareholders tender more shares than we have offered to purchase, we will withdraw the tender offer and not complete the initial business combination.
Limitation on Redemption Upon Completion of Our Initial Business Combination If We Seek Shareholder Approval
If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), is restricted from seeking redemption rights with respect to Excess Shares without our prior consent. We believe this restriction will discourage shareholders from accumulating large blocks of shares, and subsequent attempts by such holders to use their ability to exercise their redemption rights against a proposed business combination as a means to force us or our management to purchase their shares at a significant premium to the then-current market price or on other undesirable terms. Absent this provision, a public shareholder holding more than an aggregate of 15% of the shares sold in our initial public offering could threaten to exercise its redemption rights if such holder’s shares are not purchased by us, our sponsor or our management at a premium to the then-current market price or on other undesirable terms. By limiting our shareholders’ ability to redeem no more than 15% of the shares sold in our initial public offering, we believe we will limit the ability of a small group of shareholders to unreasonably attempt to block our ability to complete our initial business combination, particularly in connection with a business combination with a target that requires as a closing condition that we have a minimum net worth or a certain amount of cash.
However, we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination.
 
13
Delivering Share Certificates in Connection with the Exercise of Redemption Rights
Public shareholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” will be required to either tender their certificates (if any) to our transfer agent prior to the date set forth in the proxy solicitation or tender offer materials, as applicable, mailed to such holders, or to deliver their shares to the transfer agent electronically using The Depository Trust Company’s DWAC (Deposit/ Withdrawal At Custodian) System, at the holder’s option, in each case up to two business days prior to the initially scheduled vote to approve the business combination. The proxy solicitation or tender offer materials, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination will indicate the applicable delivery requirements, which will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. Accordingly, a public shareholder would have from the time we send out our tender offer materials until the close of the tender offer period, or up to two business days prior to the initially scheduled vote on the proposal to approve the business combination if we distribute proxy materials, as applicable, to tender its shares if it wishes to seek to exercise its redemption rights. Given the relatively short period in which to exercise redemption rights, it is advisable for shareholders to use electronic delivery of their public shares.
There is a nominal cost associated with the above-referenced tendering process and the act of certificating the shares or delivering them through the DWAC System. The transfer agent will typically charge the tendering broker a fee of approximately $80.00 and it would be up to the broker whether or not to pass this cost on to the redeeming holder. However, this fee would be incurred regardless of whether or not we require holders seeking to exercise redemption rights to tender their shares. The need to deliver shares is a requirement of exercising redemption rights regardless of the timing of when such delivery must be effectuated.
The foregoing is different from the procedures used by many blank check companies. In order to perfect redemption rights in connection with their business combinations, many blank check companies would distribute proxy materials for the shareholders’ vote on an initial business combination, and a holder could simply vote against a proposed business combination and check a box on the proxy card indicating such holder was seeking to exercise his or her redemption rights. After the business combination was approved, the company would contact such shareholder to arrange for him or her to deliver his or her certificate to verify ownership. As a result, the shareholder then had an “option window” after the completion of the business combination during which he or she could monitor the price of the company’s shares in the market. If the price rose above the redemption price, he or she could sell his or her shares in the open market before actually delivering his or her shares to the company for cancellation. As a result, the redemption rights, to which shareholders were aware they needed to commit before the general meeting, would become “option” rights surviving past the completion of the business combination until the redeeming holder delivered its certificate. The requirement for physical or electronic delivery prior to the meeting ensures that a redeeming shareholder’s election to redeem is irrevocable once the business combination is approved. .
Any request to redeem such shares, once made, may be withdrawn at any time up to the date set forth in the proxy materials or tender offer documents, as applicable. Furthermore, if a holder of a public share delivered its certificate in connection with an election of redemption rights and subsequently decides prior to the applicable date not to elect to exercise such rights, such holder may simply request that the transfer agent return the certificate (physically or electronically). It is anticipated that the funds to be distributed to holders of our public shares electing to redeem their shares will be distributed promptly after the completion of our initial business combination.
If our initial business combination is not approved or completed for any reason, then our public shareholders who elected to exercise their redemption rights would not be entitled to redeem their shares for the applicable pro rata share of the trust account. In such case, we will promptly return any certificates delivered by public holders who elected to redeem their shares.
If our initial proposed business combination is not completed, we may continue to try to complete a business combination with a different target until 24 months from the closing of the initial public offering.
 
14
Redemption of Public Shares and Liquidation if No Initial Business Combination
Our amended and restated memorandum and articles of association will provide that we will have only 24 months from the closing of the initial public offering to consummate an initial business combination. If we have not consummated an initial business combination within 24 months from the closing of the initial public offering, we will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to consummate an initial business combination within 24 months from the closing of the initial public offering. Our amended and restated memorandum and articles of association will provide that, if we wind up for any other reason prior to the consummation of our initial business combination, we will follow the foregoing procedures with respect to the liquidation of the trust account as promptly as reasonably possible but not more than ten business days thereafter, subject to applicable Cayman Islands law.
Our sponsor, officers and directors have entered into an agreement with us, pursuant to which they have agreed to waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if we fail to consummate an initial business combination within 24 months from the closing of the initial public offering or during any Extension Period (although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within the prescribed timeframe).
Our sponsor, officers and directors have agreed, pursuant to a written agreement with us, that they will not propose any amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of the initial public offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares, unless we provide our public shareholders with the opportunity to redeem their Class A shares upon approval of any such amendment at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares, subject to the limitations described herein. However, we may not redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that we do not then become subject to the SEC’s “penny stock” rules). If this optional redemption right is exercised with respect to an excessive number of public shares such that we cannot satisfy the net tangible asset requirement, we would not proceed with the amendment or the related redemption of our public shares at such time. This redemption right shall apply in the event of the approval of any such amendment, whether proposed by our sponsor, any officer, director, or any other person.
We expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be funded from amounts remaining out of the $1,000,000 held outside the trust account plus up to $100,000 of funds from the trust account available to us to pay dissolution expenses, although we cannot assure you that there will be sufficient funds for such purpose.
If we were to expend all of the net proceeds of the initial public offering and the sale of the private placement warrants, other than the proceeds deposited in the trust account, and without taking into account interest, if any, earned on the trust account, the
per-share
redemption amount received by shareholders upon our dissolution would be $10.00. The proceeds deposited in the trust account could, however, become subject to the claims of our creditors which would have higher priority than the claims of our public shareholders. We cannot assure you that the actual
per-share
redemption amount received by shareholders will not be less than $10.00. While we intend to pay such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide for all creditors’ claims.
 
15
Although we will seek to have all vendors, service providers (other than our independent registered public accounting firm), prospective target businesses and other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public shareholders, there is no guarantee that they will execute such agreements or even if they execute such agreements that they would be prevented from bringing claims against the trust account including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such third party’s engagement would be significantly more beneficial to us than any alternative. Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. BofA Securities will not execute an agreement with us waiving such claims to the monies held in the trust account. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. In order to protect the amounts held in the trust account, our sponsor has agreed that it will be liable to us if and to the extent any claims by a third party for services rendered or products sold to us (other than our independent registered public accounting firm), or a prospective target business with which we have discussed entering into a transaction agreement, reduce the amounts in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, provided that such liability will not apply to any claims by a third party or prospective target business that executed a waiver of any and all rights to seek access to the trust account nor will it apply to any claims under our indemnity of the underwriter of the initial public offering against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims. However, we have not asked our sponsor to reserve for such indemnification obligations, nor have we independently verified whether our sponsor has sufficient funds to satisfy its indemnity obligations and we believe that our sponsor’s only assets are securities of our company. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
In the event that the proceeds in the trust account are reduced below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the amount of interest that may be withdrawn to pay our income tax obligations, and our sponsor asserts that it is unable to satisfy its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against our sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so in any particular instance. Accordingly, we cannot assure you that due to claims of creditors the actual value of the
per-share
redemption price will not be less than $10.00 per public share.
 
16
We will seek to reduce the possibility that our sponsor will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors, service providers (other than our independent registered public accounting firm), prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to monies held in the trust account. Our sponsor will also not be liable as to any claims under our indemnity of the underwriter of the initial public offering against certain liabilities, including liabilities under the Securities Act. We will have access to up to $1,000,000 following the initial public offering and the sale of the private placement warrants with which to pay any such potential claims (including costs and expenses incurred in connection with our liquidation, currently estimated to be no more than approximately $100,000). In the event that we liquidate and it is subsequently determined that the reserve for claims and liabilities is insufficient, shareholders who received funds from our trust account could be liable for claims made by creditors, however such liability will not be greater than the amount of funds from our trust account received by any such shareholder. In the event that our offering expenses exceed our estimate of $1,000,000, we may fund such excess with funds not to be held in the trust account. In such case, the amount of funds we intend to be held outside the trust account would decrease by a corresponding amount. Conversely, in the event that the offering expenses are less than our estimate of $1,000,000, the amount of funds we intend to be held outside the trust account would increase by a corresponding amount.
If we file a bankruptcy or
winding-up
petition or an involuntary bankruptcy or
winding-up
petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy or insolvency law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our shareholders. To the extent any bankruptcy claims deplete the trust account, we cannot assure you we will be able to return $10.00 per public share to our public shareholders. Additionally, if we file a bankruptcy or
winding-up
petition or an involuntary bankruptcy or
winding-up
petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor and/or bankruptcy or insolvency laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy or insolvency court could seek to recover some or all amounts received by our shareholders. Furthermore, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or may have acted in bad faith, and thereby exposing itself and our company to claims of punitive damages, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons.
Our public shareholders will be entitled to receive funds from the trust account only (i) in the event of the redemption of our public shares if we do not complete our initial business combination within 24 months from the closing of the initial public offering, (ii) in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of the initial public offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares, or (iii) if they redeem their respective shares for cash upon the completion of the initial business combination. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (ii) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent completion of an initial business combination or liquidation if we have not consummated an initial business combination within 24 months from the closing of the initial public offering, with respect to such Class A ordinary shares so redeemed. In no other circumstances will a shareholder have any right or interest of any kind to or in the trust account. In the event we seek shareholder approval in connection with our initial business combination, a shareholder’s voting in connection with the business combination alone will not result in a shareholder’s redeeming its shares to us for an applicable pro rata share of the trust account. Such shareholder must have also exercised its redemption rights described above. These provisions of our amended and restated memorandum and articles of association, like all provisions of our amended and restated memorandum and articles of association, may be amended with a shareholder vote.
Competition
In identifying, evaluating and selecting a target business for our initial business combination, we may encounter intense competition from other entities having a business objective similar to ours, including other blank check companies, private equity groups and leveraged buyout funds, public companies and operating businesses seeking strategic acquisitions. Many of these entities are well established and have extensive experience identifying and effecting business combinations directly or through affiliates. Moreover, many of these competitors possess greater financial, technical, human and other resources than us. Our ability to acquire larger target businesses will be limited by our available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition of a target business. Furthermore, our obligation to pay cash in connection with our public shareholders who exercise their redemption rights may reduce the resources available to us for our initial business combination and our outstanding warrants, and the future dilution they potentially represent, may not be viewed favorably by certain target businesses. Either of these factors may place us at a competitive disadvantage in successfully negotiating an initial business combination.
 
17
Facilities
We currently maintain our executive offices at Unit 1101, 11th Floor, 1 Lyndhurst Tower, 1 Lyndhurst Terrace, Central, Hong Kong. The cost for our use of this space is included in the $10,000 per month fee we will pay to an affiliate of our sponsor for office space, utilities, administrative services and remote support services. We consider our current office space adequate for our current operations.
Employees
We currently have two executive officers. These individuals are not obligated to devote any specific number of hours to our matters but they intend to devote as much of their time as they deem necessary to our affairs until we have completed our initial business combination. The amount of time they will devote in any time period will vary based on whether a target business has been selected for our initial business combination and the stage of the business combination process we are in. We do not intend to have any full time employees prior to the completion of our initial business combination.
Periodic Reporting and Financial Information
We have registered our units, Class A ordinary shares and warrants under the Exchange Act and have reporting obligations, including the requirement that we file annual, quarterly and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual reports will contain financial statements audited and reported on by our independent registered public accountants.
We will provide shareholders with audited financial statements of the prospective target business as part of the proxy solicitation or tender offer materials, as applicable, sent to shareholders. These financial statements may be required to be prepared in accordance with, or reconciled to, GAAP, or IFRS, depending on the circumstances, and the historical financial statements may be required to be audited in accordance with the standards of the PCAOB. These financial statement requirements may limit the pool of potential target businesses we may acquire because some targets may be unable to provide such statements in time for us to disclose such statements in accordance with federal proxy rules and complete our initial business combination within the prescribed timeframe. We cannot assure you that any particular target business identified by us as a potential acquisition candidate will have financial statements prepared in accordance with the requirements outlined above, or that the potential target business will be able to prepare its financial statements in accordance with the requirements outlined above. To the extent that these requirements cannot be met, we may not be able to acquire the proposed target business. While this may limit the pool of potential acquisition candidates, we do not believe that this limitation will be material.
We will be required to evaluate our internal control procedures for the fiscal year ending December 31, 2022 as required by the Sarbanes-Oxley Act. Only in the event we are deemed to be a large accelerated filer or an accelerated filer and no longer qualify as an emerging growth company will we be required to comply with the independent registered public accounting firm attestation requirement on our internal control over financial reporting. A target business may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of their internal controls. The development of the internal controls of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.
We have filed a Registration Statement on
Form 8-A with
the SEC to voluntarily register our securities under Section 12 of the Exchange Act. As a result, we are subject to the rules and regulations promulgated under the Exchange Act. We have no current intention of filing a Form 15 to suspend our reporting or other obligations under the Exchange Act prior or subsequent to the consummation of our initial business combination.
 
18
We are a Cayman Islands exempted company. Exempted companies are Cayman Islands companies conducting business mainly outside the Cayman Islands and, as such, are exempted from complying with certain provisions of the Companies Act. As an exempted company, we have applied for and received a tax exemption undertaking from the Cayman Islands government that, in accordance with Section 6 of the Tax Concessions Act (2020 Revision) of the Cayman Islands, for a period of 20 years from the date of the undertaking, no law which is enacted in the Cayman Islands imposing any tax to be levied on profits, income, gains or appreciations will apply to us or our operations and, in addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax will be payable (i) on or in respect of our shares, debentures or other obligations or (ii) by way of the withholding in whole or in part of a payment of dividend or other distribution of income or capital by us to our shareholders or a payment of principal or interest or other sums due under a debenture or other obligation of us.
We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding
a non-binding advisory
vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.
In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.
We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of the initial public offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our Class A ordinary shares that are held
by non-affiliates equals
or exceeds $700 million as of the prior June 30, and (2) the date on which we have issued more than $1.0 billion
in non-convertible debt
during the prior three-year period.
Additionally, we are a “smaller reporting company” as defined in Item 10(f)(1) of
Regulation S-K. Smaller
reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of any fiscal year for so long as either (1) the market value of our ordinary shares held
by non-affiliates is
less than $250 million as of the end of that year’s second fiscal quarter or (2) our annual revenues are less than $100 million during such completed fiscal year and the market value of our ordinary shares held
by non-affiliates is
less than $700 million as of the end of that year’s second fiscal quarter.
Legal Proceedings
There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.
Item 1A. Risk Factors
Risk Factor Summary
We are providing the following summary of the risk factors to enhance the readability and accessibility of our risk factor disclosures. We encourage you to carefully review the full risk factors discussed below in their entirety for additional information. Some of the factors that could materially and adversely affect our business, financial condition, results of operations or prospects include:
 
  •  
Past performance by our management team or their respective affiliates may not be indicative of future performance of an investment in us.
 
19
  •  
Our shareholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even though a majority of our shareholders do not support such a combination.
 
  •  
We are a recently incorporated company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.
 
  •  
Your only opportunity to effect your investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash.
 
  •  
The recent
COVID-19
pandemic and the impact on business and debt and equity markets could have a material adverse effect on our search for a business combination, and any target business with which we ultimately complete a business combination.
 
  •  
If we seek shareholder approval of our initial business combination, our sponsor, officers and directors have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote.
 
  •  
The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target.
 
  •  
The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure.
 
  •  
The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.
 
  •  
The requirement that we consummate an initial business combination within 24 months after the closing of the initial public offering may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our shareholders.
 
  •  
We may not be able to consummate an initial business combination within 24 months after the closing of the initial public offering, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate
 
  •  
If we seek shareholder approval of our initial business combination, our sponsor, directors, officers, advisors and their affiliates may elect to purchase public shares or warrants, which may influence a vote on a proposed business combination and reduce the public “float” of our Class A ordinary shares or public warrants.
 
  •  
If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed.
 
  •  
You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.
 
  •  
If the net proceeds of the initial public offering and the sale of the private placement warrants not being held in the trust account are insufficient to allow us to operate for the 24 months following the closing of the initial public offering, it could limit the amount available to fund our search for a target business or businesses and our ability to complete our initial business combination, and we will depend on loans from our sponsor, its affiliates or members of our management team to fund our search and to complete our initial business combination.
 
20
  •  
In evaluating a prospective target business for our initial business combination, our management may consider the availability of all of the funds from the sale of the forward purchase securities, which may be used as part of the consideration to the sellers in the initial business combination. If the sale of some or all of the forward purchase securities fails to close, we may lack sufficient funds to consummate our initial business combination.
 
  •  
We may only be able to complete one business combination with the proceeds of the initial public offering and the sale of the private placement warrants, which will cause us to be solely dependent on a single business that may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability.
 
  •  
The securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the
per-share
redemption amount received by public shareholders may be less than $10.00 per share.
 
  •  
If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial business combination.
 
  •  
We have identified a material weakness in our internal control over financial reporting as of December 31, 2021. If we are unable to develop and maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results.
 
  •  
We may face litigation and other risks as a result of the material weakness in our internal control over financial reporting.
 
  •  
Our warrants are accounted for as a warrant liability and are recorded at fair value upon issuance with any changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our securities or may make it more difficult for us to consummate an initial business combination.
Risk Factors
An investment in our securities involves a high degree of risk. You should consider carefully all of the risks described below, together with the other information contained in this Annual Report, before making a decision to invest in our securities. If any of the following events occur, our business, financial condition and operating results may be materially adversely affected. In that event, the trading price of our securities could decline, and you could lose all or part of your investment.
Risks Relating to our Search for, Consummation of, or Inability to Consummate, a Business Combination
and Post-Business Combination Risks
Past performance by our management team or their respective affiliates may not be indicative of future performance of an investment in us.
Information regarding performance is presented for informational purposes only. Any past experience or performance of our management team and their respective affiliates is not a guarantee of either (i) our ability to successfully identify and execute a transaction or (ii) success with respect to any business combination that we may consummate. You should not rely on the historical record of our management team or their respective affiliates as indicative of the future performance of an investment in us or the returns we will, or are likely to, generate going forward. Our management has no experience in operating special purpose acquisition companies.
 
21
Our shareholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even though a majority of our shareholders do not support such a combination.
We may choose not to hold a shareholder vote before we complete our initial business combination if the business combination would not require shareholder approval under applicable law or stock exchange listing requirement. For instance, if we were seeking to acquire a target business where the consideration we were paying in the transaction was all cash, we would typically not be required to seek shareholder approval to complete such a transaction. Except for as required by applicable law or stock exchange listing requirement, the decision as to whether we will seek shareholder approval of a proposed business combination or will allow shareholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors, such as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek shareholder approval. Accordingly, we may complete our initial business combination even if holders of a majority of our issued and outstanding ordinary shares do not approve of the business combination we complete.
Please see the section entitled “Item I. Business—Shareholders May Not Have the Ability to Approve Our Initial Business Combination” for additional information.”
We are a recently incorporated company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.
We are a recently formed company, incorporated under the laws of the Cayman Islands with no operating results, and we will not commence operations until obtaining funding through the initial public offering. Because we lack an operating history, you have no basis upon which to evaluate our ability to achieve our business objective of completing our initial business combination with one or more target businesses. We have no plans, arrangements or understandings with any prospective target business concerning a business combination and may be unable to complete our initial business combination. If we fail to complete our initial business combination, we will never generate any operating revenues.
Your only opportunity to effect your investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash.
At the time of your investment in us, you will not be provided with an opportunity to evaluate the specific merits or risks of our initial business combination. Since our board of directors may complete a business combination without seeking shareholder approval, public shareholders may not have the right or opportunity to vote on the business combination, unless we seek such shareholder vote. Accordingly, your only opportunity to effect your investment decision regarding our initial business combination may be limited to exercising your redemption rights within the period of time (which will be at least 20 business days) set forth in our tender offer documents mailed to our public shareholders in which we describe our initial business combination.
The recent
COVID-19
pandemic and the impact on business and debt and equity markets could have a material adverse effect on our search for a business combination, and any target business with which we ultimately complete a business combination.
On January 30, 2020, the World Health Organization declared the outbreak of the
COVID-19
a “Public Health Emergency of International Concern.” On January 31, 2020, U.S. Health and Human Services Secretary Alex M. Azar II declared a public health emergency for the United States to aid the U.S. healthcare community in responding to the
COVID-19,
and on March 11, 2020 the World Health Organization characterized the outbreak as a “pandemic”. A significant outbreak of the
COVID-19
and other infectious diseases could result in a widespread health crisis that could adversely affect the economies and financial markets worldwide, business operations and the conduct of commerce generally and could have a material adverse effect on the business of any potential target business with which we complete a business combination. Furthermore, we may be unable to complete a business combination if continued concerns relating to the
COVID-19
restrict travel, limit the ability to have meetings with potential investors or the target company’s personnel, vendors and services providers are unavailable to negotiate and complete a transaction in a timely manner. The extent to which the outbreak of
COVID-19
impacts our search for a business combination will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the
COVID-19
pandemic and the actions to contain the
COVID-19
or treat its impact, among others. If the disruptions posed by the
COVID-19
or other matters of global concern continue for an extensive period of time, it could have a material adverse effect on our ability to complete a business combination, or the operations of a target business with which we ultimately complete a business combination.
 
22
In addition, our ability to complete a transaction may be dependent on the ability to raise equity and debt financing and the
COVID-19
and other related events could have a material adverse effect on our ability to raise adequate financing.
If we seek shareholder approval of our initial business combination, our sponsor, officers and directors have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote.
Our initial shareholders will own, on
an as-converted basis,
20% of the sum of the total number of our issued and outstanding ordinary shares immediately following the completion of the initial public offering plus 3,000,000 Class A ordinary shares to be sold pursuant to the forward purchase agreements. Our sponsor, officers and directors also may from time to time purchase Class A ordinary shares prior to our initial business combination. Our amended and restated memorandum and articles of association will provide that, if we seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. A quorum for such meeting will be present if holders of
one-third
of the issued and outstanding shares entitled to vote at the meeting are represented in person or by proxy. As a result, in order to have our initial business combination approved, (i) in addition to our initial shareholders’ founder shares, we would need 7,125,001, or 35.6% (assuming all issued and outstanding shares are voted), of the 20,000,000 public shares sold in the initial public offering to be voted in favor of an initial business combination; and (ii) no votes represented by the public shares would be required if only the minimum number of shares representing a quorum are voted. Accordingly, if we seek shareholder approval of our initial business combination, the agreement by our initial shareholders to vote in favor of our initial business combination will increase the likelihood that we will receive the requisite shareholder approval for such initial business combination.
The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target.
We may seek to enter into a business combination transaction agreement with a prospective target that requires as a closing condition that we have a minimum net worth or a certain amount of cash. If too many public shareholders exercise their redemption rights, we would not be able to meet such closing condition and, as a result, would not be able to proceed with the business combination. Furthermore, in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that we do not then become subject to the SEC’s “penny stock” rules). Consequently, if accepting all properly submitted redemption requests would cause our net tangible assets to be less than $5,000,001 or such greater amount necessary to satisfy a closing condition as described above, we would not proceed with such redemption and the related business combination and may instead search for an alternate business combination. Prospective targets will be aware of these risks and, thus, may be reluctant to enter into a business combination transaction with us.
The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure.
At the time we enter into an agreement for our initial business combination, we will not know how many shareholders may exercise their redemption rights, and therefore will need to structure the transaction based on our expectations as to the number of shares that will be submitted for redemption. If a large number of shares are submitted for redemption, we may need to restructure the transaction to reserve a greater portion of the cash in the trust account or arrange for additional third-party financing. Raising additional third-party financing may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. The above considerations may limit our ability to complete the most desirable business combination available to us or optimize our capital structure. The amount of the deferred underwriting commissions payable to the underwriter will not be adjusted for any shares that are redeemed in connection with an initial business combination.
The per-share amount
we will distribute to shareholders who properly exercise their redemption rights will not be reduced by the deferred underwriting commissions and, after such redemptions, the amount held in trust will continue to reflect our obligation to pay the entire deferred underwriting commissions.
 
23
The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.
If our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount of cash at closing, the probability that our initial business combination would be unsuccessful is increased. If our initial business combination is unsuccessful, you would not receive your pro rata portion of the funds in the trust account until we liquidate the trust account. If you are in need of immediate liquidity, you could attempt to sell your shares in the open market; however, at such time our shares may trade at a discount to the pro rata amount per share in the trust account. In either situation, you may suffer a material loss on your investment or lose the benefit of funds expected in connection with our redemption until we liquidate or you are able to sell your shares in the open market.
The requirement that we consummate an initial business combination within 24 months after the closing of the initial public offering may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our shareholders.
Any potential target business with which we enter into negotiations concerning a business combination will be aware that we must consummate an initial business combination within 24 months from the closing of the initial public offering unless we obtain the required shareholder vote for any Extension Period. Consequently, such target business may obtain leverage over us in negotiating a business combination, knowing that if we do not complete our initial business combination with that particular target business then we may be unable to complete our initial business combination with any target business. This risk will increase as we get closer to the timeframe described above. In addition, we may have limited time to conduct due diligence and may enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation.
We may not be able to consummate an initial business combination within 24 months after the closing of the initial public offering, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate.
We may not be able to find a suitable target business and consummate an initial business combination within 24 months after the closing of the initial public offering. Our ability to complete our initial business combination may be negatively impacted by general market conditions, volatility in the capital and debt markets and the other risks described herein. For example, the outbreak
of COVID-19 continues
to grow both in the U.S. and globally and, while the extent of the impact of the outbreak on us will depend on future developments, it could limit our ability to complete our initial business combination, including as a result of increased market volatility, decreased market liquidity and third-party financing being unavailable on terms acceptable to us or at all. Additionally, the outbreak
of COVID-19 may
negatively impact businesses we may seek to acquire. If we have not consummated an initial business combination within such applicable time period, we will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at
a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. Our amended and restated memorandum and articles of association will provide that, if we wind up for any other reason prior to the consummation of our initial business combination, we will follow the foregoing procedures with respect to the liquidation of the trust account as promptly as reasonably possible but not more than ten business days thereafter, subject to applicable Cayman Islands law. In either such case, our public shareholders may receive only $10.00 per public share, or less than $10.00 per public share, on the redemption of their shares, and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and
the per-share redemption
amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.
 
24
If we seek shareholder approval of our initial business combination, our sponsor, directors, officers, advisors and their affiliates may elect to purchase public shares or warrants, which may influence a vote on a proposed business combination and reduce the public “float” of our Class A ordinary shares or public warrants.
If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, directors, officers, advisors or their affiliates may purchase public shares or warrants in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination, although they are under no obligation to do so. However, they have no current commitments, plans or intentions to engage in such transactions and have not formulated any terms or conditions for any such transactions. None of the funds in the trust account will be used to purchase public shares or warrants in such transactions. In the event that our sponsor, directors, officers, advisors or their affiliates purchase shares in privately negotiated transactions from public shareholders who have already elected to exercise their redemption rights, such selling shareholders would be required to revoke their prior elections to redeem their shares. The purpose of any such transaction could be to (i) vote in favor of the business combination and thereby increase the likelihood of obtaining shareholder approval of the business combination, (ii) reduce the number of public warrants outstanding or vote such warrants on any matters submitted to the warrant holders for approval in connection with our initial business combination or (iii) satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our initial business combination, where it appears that such requirement would otherwise not be met. Any such purchases of our securities may result in the completion of our initial business combination that may not otherwise have been possible. In addition, if such purchases are made, the public “float” of our Class A ordinary shares or public warrants may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements. See “Item 1. Business—Effecting Our Initial Business Combination—Permitted Purchases and Other Transactions with Respect to Our Securities” for a description of how our sponsor, directors, officers, advisors or their affiliates will select which shareholders to purchase securities from in any private transaction.
If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed.
We will comply with the proxy rules or tender offer rules, as applicable, when conducting redemptions in connection with our initial business combination. Despite our compliance with these rules, if a shareholder fails to receive our proxy solicitation or tender offer materials, as applicable, such shareholder may not become aware of the opportunity to redeem its shares. In addition, the proxy solicitation or tender offer materials, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination will describe the various procedures that must be complied with in order to validly redeem or tender public shares. In the event that a shareholder fails to comply with these procedures, its shares may not be redeemed. See “Item 1. Business —Effecting Our Initial Business Combination—Tendering Share Certificates in Connection with a Tender Offer or Redemption Rights.”
You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.
 
25
Our public shareholders will be entitled to receive funds from the trust account only upon the earliest to occur of: (i) our completion of an initial business combination, and then only in connection with those Class A ordinary shares that such shareholder properly elected to redeem, subject to the limitations described herein, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of the initial public offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares, and (iii) the redemption of our public shares if we have not consummated an initial business combination within 24 months from the closing of the initial public offering, subject to applicable law and as further described herein. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (ii) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent completion of an initial business combination or liquidation if we have not consummated an initial business combination within 24 months from the closing of the initial public offering, with respect to such Class A ordinary shares so redeemed. In no other circumstances will a public shareholder have any right or interest of any kind in the trust account. Holders of warrants also will not have any right to the proceeds held in the trust account with respect to the warrants. Accordingly, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.
Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.
We have been approved to list our units on Nasdaq. Although after giving effect to the initial public offering we expect to meet, on a pro forma basis, the minimum initial listing standards set forth in the Nasdaq listing standards, we cannot assure you that our securities will be, or will continue to be, listed on Nasdaq in the future or prior to our initial business combination. In order to continue listing our securities on Nasdaq prior to our initial business combination, we must maintain certain financial, distribution and share price levels. Generally, we must maintain a minimum market capitalization (generally $2,500,000) and a minimum number of holders of our securities (generally 300 public holders).
Additionally, our units will not be traded after the completion of our initial business combination and, in connection with our initial business combination, we will be required to demonstrate compliance with the Nasdaq initial listing requirements, which are more rigorous than the Nasdaq continued listing requirements, in order to continue to maintain the listing of our securities on Nasdaq.
For instance, our stock price would generally be required to be at least $4.00 per share and our shareholders’ equity would generally be required to be at least $5.0 million and we would be required to have a minimum of 300 round lot holders (with at least 50% of such round lot holding securities with a market value of at last $2,500) of our securities. We cannot assure you that we will be able to meet those listing requirements at that time.
If Nasdaq delists any of our securities from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect such securities could be quoted on
an over-the-counter market.
If this were to occur, we could face significant material adverse consequences, including:
 
  •  
a limited availability of market quotations for our securities;
 
  •  
reduced liquidity for our securities;
 
  •  
a determination that our Class A ordinary shares are a “penny stock,” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;
 
  •  
a limited amount of news and analyst coverage; and
 
  •  
a decreased ability to issue additional securities or obtain additional financing in the future.
 
26
The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” Because we expect that our units and eventually our Class A ordinary shares and warrants will be listed on Nasdaq, our units, Class A ordinary shares and warrants qualify as covered securities under the statute. Although the states are preempted from regulating the sale of covered securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the sale of securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if we were no longer listed on Nasdaq, our securities would not qualify as covered securities under the statute and we would be subject to regulation in each state in which we offer our securities.
You will not be entitled to protections normally afforded to investors of many other blank check companies.
Since the net proceeds of the initial public offering and the sale of the private placement warrants and forward purchase securities are intended to be used to complete an initial business combination with a target business that has not been selected, we may be deemed to be a “blank check” company under the United States securities laws. However, because we will have net tangible assets in excess of $5,000,000 upon the completion of the initial public offering and the sale of the private placement warrants and will file a Current Report on
Form 8-K, including
an audited balance sheet demonstrating this fact, we are exempt from rules promulgated by the SEC to protect investors in blank check companies, such as Rule 419. Accordingly, investors will not be afforded the benefits or protections of those rules. Among other things, this means our units will be immediately tradable and we will have a longer period of time to complete our initial business combination than do companies subject to Rule 419. Moreover, if the initial public offering were subject to Rule 419, that rule would prohibit the release of any interest earned on funds held in the trust account to us unless and until the funds in the trust account were released to us in connection with our completion of an initial business combination. For a more detailed comparison of our offering to offerings that comply with Rule 419, please see “Proposed Business—Comparison of The initial public offering to Those of Blank Check Companies Subject to Rule 419.”
If we seek shareholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of shareholders are deemed to hold in excess of 15% of our Class A ordinary shares, you will lose the ability to redeem all such shares in excess of 15% of our Class A ordinary shares.
If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, then, pursuant to our amended and restated memorandum and articles of association, a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares sold in the initial public offering, which we refer to as the “Excess Shares,” without our prior consent. However, we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete our initial business combination and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions. Additionally, you will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And as a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares, would be required to sell your shares in open market transactions, potentially at a loss.
Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.
 
27
We expect to encounter intense competition from other entities having a business objective similar to ours, including private investors (which may be individuals or investment partnerships), other blank check companies and other entities, domestic and international, competing for the types of businesses we intend to acquire. Many of these individuals and entities are well established and have extensive experience in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing services to various industries. Many of these competitors possess greater technical, human and other resources or more local industry knowledge than we do and our financial resources will be relatively limited when contrasted with those of many of these competitors. While we believe there are numerous target businesses we could potentially acquire with the net proceeds of the initial public offering and the sale of the private placement warrants, our ability to compete with respect to the acquisition of certain target businesses that are sizable will be limited by our available financial resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition of certain target businesses. Furthermore, we are obligated to offer holders of our public shares the right to redeem their shares for cash at the time of our initial business combination in conjunction with a shareholder vote or via a tender offer. Target companies will be aware that this may reduce the resources available to us for our initial business combination. Any of these obligations may place us at a competitive disadvantage in successfully negotiating a business combination. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and
the per-share redemption
amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.
As the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive targets. This could increase the cost of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination.
In recent years, the number of special purpose acquisition companies that have been formed has increased substantially. Many potential targets for special purpose acquisition companies have already entered into an initial business combination, and there are still many special purpose acquisition companies preparing for an initial public offering, as well as many such companies currently in registration. As a result, at times, fewer attractive targets may be available to consummate an initial business combination.
In addition, because there are more special purpose acquisition companies seeking to enter into an initial business combination with available targets, the competition for available targets with attractive fundamentals or business models may increase, which could cause target companies to demand improved financial terms. Attractive business combinations could also become scarcer for other reasons, such as economic or industry sector downturns, geopolitical tensions, or increases in the cost of additional capital needed to close business combinations or operate targets post-business combination. This could increase the cost of, delay or otherwise complicate or frustrate our ability to find and consummate an initial business combination, and may result in our inability to consummate an initial business combination on terms favorable to our investors altogether.
If the net proceeds of the initial public offering and the sale of the private placement warrants not being held in the trust account are insufficient to allow us to operate for the 24 months following the closing of the initial public offering, it could limit the amount available to fund our search for a target business or businesses and our ability to complete our initial business combination, and we will depend on loans from our sponsor, its affiliates or members of our management team to fund our search and to complete our initial business combination.
Of the net proceeds of the initial public offering and the sale of the private placement warrants, only approximately $1,000,000 will be available to us initially outside the trust account to fund our working capital requirements. We believe that, upon the closing of the initial public offering, the funds available to us outside of the trust account, together with funds available from loans from our sponsor, its affiliates or members of our management team, will be sufficient to allow us to operate for at least the 24 months following the closing of the initial public offering; however, we cannot assure you that our estimate is accurate, and our sponsor, its affiliates or members of our management team are under no obligation to advance funds to us in such circumstances. Of the funds available to us, we expect to use a portion of the funds available to us to pay fees to consultants to assist us with our search for a target business. We could also use a portion of the funds as a down payment or to fund
a “no-shop” provision
(a provision in letters of intent designed to keep target businesses from “shopping” around for transactions with other companies or investors on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to do so. If we entered into a letter of intent where we paid for the right to receive exclusivity from a target business and were subsequently required to forfeit such funds (whether as a result of our breach or otherwise), we might not have sufficient funds to continue searching for, or conduct due diligence with respect to, a target business.
 
28
In the event that our offering expenses exceed our estimate of $1,000,000, we may fund such excess with funds not to be held in the trust account. In such case, unless funded by the proceeds of loans available from our sponsor, its affiliates or members of our management team, the amount of funds we intend to be held outside the trust account would decrease by a corresponding amount. Conversely, in the event that the offering expenses are less than our estimate of $1,000,000, the amount of funds we intend to be held outside the trust account would increase by a corresponding amount. The amount held in the trust account will not be impacted as a result of such increase or decrease. If we are required to seek additional capital, we would need to borrow funds from our sponsor, its affiliates, members of our management team or other third parties to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor their affiliates is under any obligation to us in such circumstances. Any such advances may be repaid only from funds held outside the trust account or from funds released to us upon the completion of our initial business combination. Up to $1,500,000 of such loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender, which would be identical to the private placement warrants. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we have not consummated our initial business combination within the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may only receive an estimated $10.00 per public share, or possibly less, on our redemption of our public shares, and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and
the per-share redemption
amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.
In evaluating a prospective target business for our initial business combination, our management may consider the availability of all of the funds from the sale of the forward purchase securities, which may be used as part of the consideration to the sellers in the initial business combination. If the sale of some or all of the forward purchase securities fails to close, we may lack sufficient funds to consummate our initial business combination.
We have entered into forward purchase agreements pursuant to which the anchor investors have agreed to purchase an aggregate of 3,000,000 forward purchase shares plus 750,000 redeemable warrants for a purchase price of $10.00 per forward purchase share, or $30,000,000 in the aggregate, in a private placement to close concurrently with our initial business combination. The funds from the sale of forward purchase securities may be used as part of the consideration to the sellers in our initial business combination, expenses in connection with our initial business combination or for working capital in the post-business combination company. The obligations under the forward purchase agreements do not depend on whether any public shareholders elect to redeem their shares and provide us with a minimum funding level for the initial business combination. However, if the sale of the forward purchase securities does not close for any reason, including by reason of the failure by some or all of the anchor investors to fund the purchase price for their forward purchase securities, for example, we may lack sufficient funds to consummate our initial business combination. Additionally, the anchor investors’ obligations to purchase the forward purchase securities are subject to termination prior to the closing of the sale of the forward purchase securities by mutual written consent of the company and each anchor investor, or automatically: (i) if the initial public offering is not consummated on or prior to July 31, 2021; (ii) if our initial business combination is not consummated within 24 months from the closing of the initial public offering or an extended period; or (iii) if our sponsor or the Company becomes subject to any voluntary or involuntary petition under the United States federal bankruptcy laws or any state insolvency law, in each case which is not withdrawn within sixty (60) after being filed, or a receiver, fiscal agent or similar officer is appointed by a court for business or property of us or our sponsor, in each case which is not removed, withdrawn or terminated within sixty (60) after such appointment. The anchor investors’ obligations to purchase their forward purchase securities are also subject to fulfillment of customary closing conditions, including the following: (i) our initial business combination must be consummated substantially concurrently with, and immediately following, the purchase of forward purchase securities, and (ii) the Company must have delivered to the anchor investors a certificate evidencing the company’s good standing as a Cayman Islands exempted company, as of a date within ten (10) business days of the closing of the sale of forward purchase securities. In the event of any such failure to fund by an anchor investor, any obligation is so terminated or any such condition is not satisfied and not waived by an anchor investor, we may not be able to obtain additional funds to account for such shortfall on terms favorable to us, or at all. Any such shortfall would also reduce the amount of funds that we have available for working capital of the post-business combination company. While each anchor investor has represented to us that it has sufficient funds to satisfy its obligations under the respective forward purchase agreement, the anchor investors are not obligated to reserve funds for such obligations.
 
29
If the anchor investors purchase large amounts of public shares in the open market, they may attempt to leverage their redemption rights in order to affect the outcome of a potential initial business combination.
The anchor investors have redemption rights with respect to any public shares they own, subject to the limitation that under the Company’s amended and restated memorandum and articles of association that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of Exchange Act), is restricted from redeeming its public shares with respect to more than an aggregate of 15% or more of the public shares, without the prior consent of the Company. If management proposes an initial business combination that some or all of the anchor investors are not in favor of, such anchor investors may decide to purchase public shares in the open market and seek to leverage their redemption rights to influence whether such business combination can be consummated. This could result in our having to negotiate for more favorable terms for the anchor investors, which could jeopardize our ability to successfully consummate an initial business combination.
Subsequent to our completion of our initial business combination, we may be required to take write-downs or write-offs, restructure our operations or incur impairment or other charges that could have a significant negative effect on our financial condition, results of operations and the price of our securities, which could cause you to lose some or all of your investment.
Even if we conduct extensive due diligence on a target business with which we combine, we cannot assure you that this diligence will identify all material issues with a particular target business, that it would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside of the target business and outside of our control will not later arise. As a result of these factors, we may be forced to later write down or write off assets, restructure our operations, or incur impairment or other charges that could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may
be non-cash items
and not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute to negative market perceptions about us or our securities. In addition, charges of this nature may cause us to violate net worth or other covenants to which we may be subject as a result of
assuming pre-existing debt
held by a target business or by virtue of our obtaining post-combination debt financing. Accordingly, any holders who choose to retain their securities following the business combination could suffer a reduction in the value of their securities. Such holders are unlikely to have a remedy for such reduction in value.
If third parties bring claims against us, the proceeds held in the trust account could be reduced and
the per-share redemption
amount received by shareholders may be less than $10.00 per public share.
Our placing of funds in the trust account may not protect those funds from third-party claims against us. Although we will seek to have all vendors, service providers (other than our independent registered public accounting firm), prospective target businesses and other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public shareholders, such parties may not execute such agreements, or even if they execute such agreements, they may not be prevented from bringing claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such third party’s engagement would be significantly more beneficial to us than any alternative.
 
30
Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption of our public shares, if we have not consummated an initial business combination within 24 months from the closing of the initial public offering, or upon the exercise of a redemption right in connection with our initial business combination, we will be required to provide for payment of claims of creditors that were not waived that may be brought against us within the ten years following redemption. Accordingly,
the per-share redemption
amount received by public shareholders could be less than the $10.00 per public share initially held in the trust account, due to claims of such creditors. Pursuant to a letter agreement, our sponsor has agreed that it will be liable to us if and to the extent any claims by a third party (other than our independent registered public accounting firm) for services rendered or products sold to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the amounts in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations,
 provided
 that such liability will not apply to any claims by a third party or prospective target business that executed a waiver of any and all rights to seek access to the trust account nor will it apply to any claims under our indemnity of the underwriter of the initial public offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims.
However, we have not asked our sponsor to reserve for such indemnification obligations nor have we independently verified whether our sponsor has sufficient funds to satisfy its indemnity obligations, and we believe that our sponsor’s only assets are securities of our company. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the trust account, the funds available for our initial business combination and redemptions could be reduced to less than $10.00 per public share. In such event, we may not be able to complete our initial business combination, and you would receive such lesser amount per share in connection with any redemption of your public shares. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
Our directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in the trust account available for distribution to our public shareholders.
In the event that the proceeds in the trust account are reduced below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, and our sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against our sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their business judgment and subject to their fiduciary duties may choose not to do so in any particular instance. If our independent directors choose not to enforce these indemnification obligations, the amount of funds in the trust account available for distribution to our public shareholders may be reduced below $10.00 per public share.
We may not have sufficient funds to satisfy indemnification claims of our officers and directors.
We have agreed to indemnify our officers and directors to the fullest extent permitted by law. However, our officers and directors have agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account and to not seek recourse against the trust account for any reason whatsoever (except to the extent they are entitled to funds from the trust account due to their ownership of public shares). Accordingly, any indemnification provided will be able to be satisfied by us only if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination. Our obligation to indemnify our officers and directors may discourage shareholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an action, if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification provisions.
 
31
If, after we distribute the proceeds in the trust account to our public shareholders, we file a bankruptcy
or winding-up petition
or an involuntary bankruptcy
or winding-up petition
is filed against us that is not dismissed, a bankruptcy or insolvency court may seek to recover such proceeds, and the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our board of directors and us to claims of punitive damages.
If, after we distribute the proceeds in the trust account to our public shareholders, we file a bankruptcy
or winding-up petition
or an involuntary bankruptcy
or winding-up petition
is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor and/or bankruptcy or insolvency laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy or insolvency court could seek to recover some or all amounts received by our shareholders. In addition, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing itself and us to claims of punitive damages, by paying public shareholders from the trust account prior to addressing the claims of creditors.
If, before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy
or winding-up petition
or an involuntary bankruptcy
or winding-up petition
is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our shareholders and
the per-share amount
that would otherwise be received by our shareholders in connection with our liquidation may be reduced.
If, before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy
or winding-up petition
or an involuntary bankruptcy
or winding-up petition
is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy or insolvency law and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our shareholders. To the extent any bankruptcy claims deplete the trust account,
the per-share amount
that would otherwise be received by our shareholders in connection with our liquidation may be reduced.
Our shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.
If we are forced to enter into an insolvent liquidation, any distributions received by shareholders could be viewed as an unlawful payment if it was proved that immediately following the date on which the distribution was made, we were unable to pay our debts as they fall due in the ordinary course of business. As a result, a liquidator could seek to recover some or all amounts received by our shareholders. Furthermore, our directors may be viewed as having breached their fiduciary duties to us or our creditors and/or may have acted in bad faith, thereby exposing themselves and our company to claims, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons. We and our officers and directors who knowingly and willfully authorized or permitted any distribution to be paid out of our share premium account while we were unable to pay our debts as they fall due in the ordinary course of business would be guilty of an offence and may be liable for a fine of $18,292.68 and imprisonment for five years in the Cayman Islands.
We may not hold an annual general meeting until after the consummation of our initial business combination.
In accordance with the Nasdaq corporate governance requirements, we are not required to hold an annual general meeting until one year after our first fiscal year end following our listing on Nasdaq. There is no requirement under the Companies Act for us to hold annual or extraordinary general meetings to appoint directors. Until we hold an annual general meeting, public shareholders may not be afforded the opportunity to discuss company affairs with management.
Because we are neither limited to evaluating a target business in a particular industry sector nor have we selected any specific target businesses with which to pursue our initial business combination, you will be unable to ascertain the merits or risks of any particular target business’s operations.
 
 
32
We may pursue business combination opportunities in any sector, except that we will not, under our amended and restated memorandum and articles of association, be permitted to effectuate our initial business combination solely with another blank check company or similar company with nominal operations. Because we have not yet selected or approached any specific target business with respect to a business combination, there is no basis to evaluate the possible merits or risks of any particular target business’s operations, results of operations, cash flows, liquidity, financial condition or prospects. To the extent we complete our initial business combination, we may be affected by numerous risks inherent in the business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable or a development stage entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we cannot assure you that we will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a target business. We also cannot assure you that an investment in our units will ultimately prove to be more favorable to investors than a direct investment, if such opportunity were available, in a business combination target. Accordingly, any holders who choose to retain their securities following the business combination could suffer a reduction in the value of their securities. Such holders are unlikely to have a remedy for such reduction in value.
We may seek acquisition opportunities in industries or sectors that may or may not be outside of our management’s area of expertise.
We will consider a business combination outside of our management’s area of expertise if a business combination target is presented to us and we determine that such candidate offers an attractive acquisition opportunity for our company. Although our management will endeavor to evaluate the risks inherent in any particular business combination target, we cannot assure you that we will adequately ascertain or assess all of the significant risk factors. We also cannot assure you that an investment in our units will not ultimately prove to be less favorable to investors in the initial public offering than a direct investment, if an opportunity were available, in a business combination target. In the event we elect to pursue an acquisition outside of the areas of our management’s expertise, our management’s expertise may not be directly applicable to its evaluation or operation, and the information contained in this annual report regarding the areas of our management’s expertise would not be relevant to an understanding of the business that we elect to acquire. As a result, our management may not be able to adequately ascertain or assess all of the significant risk factors. Accordingly, any holders who choose to retain their securities following the business combination could suffer a reduction in the value of their securities. Such holders are unlikely to have a remedy for such reduction in value.
Although we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria and guidelines.
Although we have identified general criteria and guidelines for evaluating prospective target businesses, it is possible that a target business with which we enter into our initial business combination will not have all of these positive attributes. If we complete our initial business combination with a target that does not meet some or all of these guidelines, such combination may not be as successful as a combination with a business that does meet all of our general criteria and guidelines. In addition, if we announce a prospective business combination with a target that does not meet our general criteria and guidelines, a greater number of shareholders may exercise their redemption rights, which may make it difficult for us to meet any closing condition with a target business that requires us to have a minimum net worth or a certain amount of cash. In addition, if shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or we decide to obtain shareholder approval for business or other reasons, it may be more difficult for us to attain shareholder approval of our initial business combination if the target business does not meet our general criteria and guidelines. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.
We are not required to obtain an opinion from an independent accounting or investment banking firm, and, consequently, you may have no assurance from an independent source that the price we are paying for the business is fair to our shareholders from a financial point of view.
 
33
Unless we complete our initial business combination with an affiliated entity, we are not required to obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that the price we are paying is fair to our shareholders from a financial point of view. If no opinion is obtained, our shareholders will be relying on the judgment of our board of directors, who will determine fair market value based on standards generally accepted by the financial community. Such standards used will be disclosed in our proxy solicitation or tender offer materials, as applicable, related to our initial business combination.
Because we must furnish our shareholders with target business financial statements, we may lose the ability to complete an otherwise advantageous initial business combination with some prospective target businesses.
The federal proxy rules require that a proxy statement with respect to a vote on a business combination meeting certain financial significance tests include historical and/or pro forma financial statement disclosure in periodic reports. We will include the same financial statement disclosure in connection with our tender offer documents, whether or not they are required under the tender offer rules. These financial statements may be required to be prepared in accordance with, or be reconciled to, accounting principles generally accepted in the United States of America, or GAAP, or international financial reporting standards as issued by the International Accounting Standards Board, or IFRS, depending on the circumstances and the historical financial statements may be required to be audited in accordance with the standards of the Public Company Accounting Oversight Board (United States), or PCAOB. These financial statement requirements may limit the pool of potential target businesses we may acquire because some targets may be unable to provide such statements in time for us to disclose such statements in accordance with federal proxy rules and complete our initial business combination within the prescribed timeframe.
Resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.
We anticipate that the investigation of each specific target business and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require substantial management time and attention and substantial costs for accountants, attorneys and others. If we decide not to complete a specific initial business combination, the costs incurred up to that point for the proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a specific target business, we may fail to complete our initial business combination for any number of reasons including those beyond our control. Any such event will result in a loss to us of the related costs incurred, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.
Compliance obligations under the Sarbanes-Oxley Act may make it more difficult for us to effectuate a business combination, require substantial financial and management resources, and increase the time and costs of completing an acquisition.
Section 404 of the Sarbanes-Oxley Act requires that we evaluate and report on our system of internal controls beginning with our Annual Report on
Form 10-K for
the year ending December 31, 2022. Only in the event we are deemed to be a large accelerated filer or an accelerated filer and no longer qualify as an emerging growth company will we be required to comply with the independent registered public accounting firm attestation requirement on our internal control over financial reporting. The fact that we are a blank check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on us as compared to other public companies because a target business with which we seek to complete our initial business combination may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of its internal controls. The development of the internal control of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.
 
34
We do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete our initial business combination with which a substantial majority of our shareholders do not agree.
Our amended and restated memorandum and articles of association will not provide a specified maximum redemption threshold, except that in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that we do not then become subject to the SEC’s “penny stock” rules). As a result, we may be able to complete our initial business combination even though a substantial majority of our public shareholders do not agree with the transaction and have redeemed their shares or, if we seek shareholder approval of our initial business combination and do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to our sponsor, officers, directors, advisors or their affiliates. In the event the aggregate cash consideration we would be required to pay for all Class A ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the business combination or redeem any shares, all Class A ordinary shares submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate business combination.
In order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions of their charters and other governing instruments, including their warrant agreements. We cannot assure you that we will not seek to amend our amended and restated memorandum and articles of association or governing instruments in a manner that will make it easier for us to complete our initial business combination that our shareholders may not support.
In order to effectuate a business combination, blank check companies have, in the recent past, amended various provisions of their charters and governing instruments, including their warrant agreements. For example, blank check companies have amended the definition of business combination, increased redemption thresholds, extended the time to consummate an initial business combination and, with respect to their warrants, amended their warrant agreements to require the warrants to be exchanged for cash and/or other securities. Amending our amended and restated memorandum and articles of association will require at least a special resolution of our shareholders as a matter of Cayman Islands law, meaning the approval of holders of at least
two-thirds
of our ordinary shares who attend and vote at a general meeting of the company, and amending our warrant agreement will require a vote of holders of at least 50% of the public warrants and private placement warrants and, solely with respect to any amendment to the terms of the private placement warrants or forward purchase warrants or any provision of the warrant agreement with respect to the private placement warrants or forward purchase warrants, 50% of the number of the then outstanding private placement warrants or forward purchase warrants, respectively. In addition, our amended and restated memorandum and articles of association will require us to provide our public shareholders with the opportunity to redeem their public shares for cash if we propose an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of the initial public offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares. To the extent any of such amendments would be deemed to fundamentally change the nature of any of the securities offered hereby, we would register, or seek an exemption from registration for, the affected securities.
The provisions of our amended and restated memorandum and articles of association that relate to the rights of holders of our Class A ordinary shares (and corresponding provisions of the agreement governing the release of funds from our trust account) may be amended with the approval of a special resolution, which requires the approval of the holders of at
least two-thirds of
our ordinary shares who attend and vote at a general meeting of the company, which is a lower amendment threshold than that of some other blank check companies. It may be easier for us, therefore, to amend our amended and restated memorandum and articles of association to facilitate the completion of an initial business combination that some of our shareholders may not support.
 
35
Some other blank check companies have a provision in their charter that prohibits the amendment of certain of its provisions, including those which relate to the rights of a company’s shareholders, without approval by a certain percentage of the company’s shareholders. In those companies, amendment of these provisions typically requires approval by between 90% and 100% of the company’s shareholders. Our amended and restated memorandum and articles of association will provide that any of its provisions related to the rights of holders of our Class A ordinary shares (including the requirement to deposit proceeds of the initial public offering and the private placement warrants into the trust account and not release such amounts except in specified circumstances, and to provide redemption rights to public shareholders as described herein) may be amended if approved by special resolution, meaning holders of at least
two-thirds
of our ordinary shares who attend and vote at a general meeting of the company, and corresponding provisions of the trust agreement governing the release of funds from our trust account may be amended if approved by holders of at least 65% of our ordinary shares;
 provided
 that the provisions of our amended and restated memorandum and articles of association governing the appointment or removal of directors prior to our initial business combination may only be amended by a special resolution passed by not less
than two-thirds of
our ordinary shares who attend and vote at our general meeting which shall include the affirmative vote of a simple majority of our Class B ordinary shares. Our sponsor and its permitted transferees, if any, who will collectively beneficially own, on
an as-converted basis,
20% of the sum of the total number of our issued and outstanding Class A ordinary shares upon the closing of the initial public offering plus 3,000,000 Class A ordinary shares to be sold pursuant to the forward purchase agreements, will participate in any vote to amend our amended and restated memorandum and articles of association and/or trust agreement and will have the discretion to vote in any manner they choose. As a result, we may be able to amend the provisions of our amended and restated memorandum and articles of association which govern
our pre-business combination
behavior more easily than some other blank check companies, and this may increase our ability to complete a business combination with which you do not agree. Our shareholders may pursue remedies against us for any breach of our amended and restated memorandum and articles of association.
Our sponsor, officers and directors have agreed, pursuant to agreements with us, that they will not propose any amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of the initial public offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares, unless we provide our public shareholders with the opportunity to redeem their Class A ordinary shares upon approval of any such amendment at
a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares, subject to the limitations described herein. Our shareholders are not parties to, or third-party beneficiaries of, these agreements and, as a result, will not have the ability to pursue remedies against our sponsor, officers, or directors for any breach of these agreements. As a result, in the event of a breach, our shareholders would need to pursue a shareholder derivative action, subject to applicable law.
We may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target business, which could compel us to restructure or abandon a particular business combination. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.
Although we believe that the net proceeds of the initial public offering and the sale of the private placement warrants and forward purchase securities will be sufficient to allow us to complete our initial business combination, because we have not yet selected any prospective target business we cannot ascertain the capital requirements for any particular transaction. If the net proceeds of the initial public offering and the sale of the private placement warrants and forward purchase securities prove to be insufficient, either because of the size of our initial business combination, the depletion of the available net proceeds in search of a target business, the obligation to redeem for cash a significant number of shares from shareholders who elect redemption in connection with our initial business combination or the terms of negotiated transactions to purchase shares in connection with our initial business combination, we may be required to seek additional financing or to abandon the proposed business combination. We cannot assure you that such financing will be available on acceptable terms, if at all. The current economic environment may make it difficult for companies to obtain acquisition financing. To the extent that additional financing proves to be unavailable when needed to complete our initial business combination, we would be compelled to either restructure the transaction or abandon that particular business combination and seek an alternative target business candidate. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless. In addition, even if we do not need additional financing to complete our initial business combination, we may require such financing to fund the operations or growth of the target business. The failure to secure additional financing could have a material adverse effect on the continued development or growth of the target business. None of our officers, directors or shareholders is required to provide any financing to us in connection with or after our initial business combination.
 
36
We may seek business combination opportunities with a high degree of complexity that require significant operational improvements, which could delay or prevent us from achieving our desired results.
We may seek business combination opportunities with large, highly complex companies that we believe would benefit from operational improvements. While we intend to implement such improvements, to the extent that our efforts are delayed or we are unable to achieve the desired improvements, the business combination may not be as successful as we anticipate.
To the extent we complete our initial business combination with a large, complex business or entity with a complex operating structure, we may also be affected by numerous risks inherent in the operations of the business with which we combine, which could delay or prevent us from implementing our strategy. Although our management team will endeavor to evaluate the risks inherent in a particular target business and its operations, we may not be able to properly ascertain or assess all of the significant risk factors until we complete our business combination. If we are not able to achieve our desired operational improvements, or the improvements take longer to implement than anticipated, we may not achieve the gains that we anticipate. Furthermore, some of these risks and complexities may be outside of our control and leave us with no ability to control or reduce the chances that those risks and complexities will adversely impact a target business. Such combination may not be as successful as a combination with a smaller, less complex organization.
We may have a limited ability to assess the management of a prospective target business and, as a result, may affect our initial business combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company.
When evaluating the desirability of effecting our initial business combination with a prospective target business, our ability to assess the target business’s management may be limited due to a lack of time, resources or information. Our assessment of the capabilities of the target business’s management, therefore, may prove to be incorrect and such management may lack the skills, qualifications or abilities we suspected. Should the target business’s management not possess the skills, qualifications or abilities necessary to manage a public company, the operations and profitability of the post-combination business may be negatively impacted. Accordingly, any holders who choose to retain their securities following the business combination could suffer a reduction in the value of their securities. Such holders are unlikely to have a remedy for such reduction in value.
We may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely affect our leverage and financial condition and thus negatively impact the value of our shareholders’ investment in us.
Although we have no commitments as of the date of this annual report to issue any notes or other debt securities, or to otherwise incur outstanding debt following the initial public offering, we may choose to incur substantial debt to complete our initial business combination. We and our officers and directors have agreed that we will not incur any indebtedness unless we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust account. As such, no issuance of debt will affect
the per-share amount
available for redemption from the trust account. Nevertheless, the incurrence of debt could have a variety of negative effects, including:
 
  •  
default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
 
37
  •  
acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
 
  •  
our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;
 
  •  
our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;
 
  •  
our inability to pay dividends on our Class A ordinary shares;
 
  •  
using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;
 
  •  
limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;
 
  •  
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and
 
  •  
limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.
We may only be able to complete one business combination with the proceeds of the initial public offering and the sale of the private placement warrants, which will cause us to be solely dependent on a single business that may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability.
The net proceeds from the initial public offering and the sale of the private placement warrants and forward purchase securities will provide us with up to $223,000,000 (including amounts to be received pursuant to the forward purchase agreements) that we may use to complete our initial business combination (after taking into account the $7,000,000 of deferred underwriting commissions being held in the trust account and the
estimated non-reimbursed expenses
of the initial public offering).
We may effectuate our initial business combination with a single-target business or multiple-target businesses simultaneously or within a short period of time. However, we may not be able to effectuate our initial business combination with more than one target business because of various factors, including the existence of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that present operating results and the financial condition of several target businesses as if they had been operated on a combined basis. By completing our initial business combination with only a single entity, our lack of diversification may subject us to numerous economic, competitive and regulatory developments. Further, we would not be able to diversify our operations or benefit from the possible spreading of risks or offsetting of losses, unlike other entities that may have the resources to complete several business combinations in different industries or different areas of a single industry. Accordingly, the prospects for our success may be:
 
  •  
solely dependent upon the performance of a single business, property or asset; or
 
  •  
dependent upon the development or market acceptance of a single or limited number of products, processes or services.
This lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a substantial adverse impact upon the particular industry in which we may operate subsequent to our initial business combination.
We may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete our initial business combination and give rise to increased costs and risks that could negatively impact our operations and profitability.
 
38
If we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers to agree that our purchase of its business is contingent on the simultaneous closings of the other business combinations, which may make it more difficult for us, and delay our ability, to complete our initial business combination. With multiple business combinations, we could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence (if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations and services or products of the acquired companies in a single operating business. If we are unable to adequately address these risks, it could negatively impact our profitability and results of operations.
We may attempt to complete our initial business combination with a private company about which little information is available, which may result in a business combination with a company that is not as profitable as we suspected, if at all.
In pursuing our acquisition strategy, we may seek to effectuate our initial business combination with a privately held company. Very little public information generally exists about private companies, and we could be required to make our decision on whether to pursue a potential initial business combination on the basis of limited information, which may result in a business combination with a company that is not as profitable as we suspected, if at all.
The military action in Ukraine has adversely affected economic and business conditions in Europe and may continue to adversely affect conditions in that region as well as the business and prospects of potential targets. This could reduce the number of attractive targets, increase the cost of our initial business combination and could result in our inability to find a suitable target or to consummate a business combination.
On February 24, 2022, Russian forces launched significant military action against Ukraine, and sustained conflict and disruption in the region is possible. The impact to Ukraine as well as actions taken by other countries, including new and stricter sanctions imposed by Canada, the United Kingdom, the European Union, the U.S. and other countries and companies and organizations against officials, individuals, regions and industries in Russia and Ukraine, and actions taken by Russia in response to such sanctions, tensions, and military actions could have a material adverse effect on the business or prospects of potential healthcare target companies in the northern part of Europe, where we may consider on our search. Any such material adverse effect from the conflict and enhanced sanctions activity may include reduced trading and business activity levels, disruption of financial markets, increased costs, and disruption of services, inability to complete financial or banking transactions, and inability to service existing or new customers in the region. Prolonged unrest, military activities, or broad-based sanctions, should they be implemented, could have a material adverse effect on our ability to complete a business combination with a suitable target.
Risks Relating to Our Securities
The securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the
per-share
redemption amount received by public shareholders may be less than $10.00 per share.
The proceeds held in the trust account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
under the Investment Company Act, which invest only in direct U.S. government treasury obligations. While short-term U.S. government treasury obligations currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event that we do not to complete our initial business combination or make certain amendments to our amended and restated memorandum and articles of association, our public shareholders are entitled to receive their
pro-rata
share of the proceeds held in the trust account, plus any interest income, net of taxes paid or payable (less, in the case we are unable to complete our initial business combination, $100,000 of interest). Negative interest rates could reduce the value of the assets held in trust such that the
per-share
redemption amount received by public shareholders may be less than $10.00 per share.
 
39
If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial business combination.
If we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including restrictions on the nature of our investments and restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. In addition, we may have imposed upon us burdensome requirements, including registration as an investment company with the SEC, adoption of a specific form of corporate structure, and reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are currently not subject to.
In order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing, reinvesting or trading of securities and that our activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our business will be to identify and complete a business combination and thereafter to operate the post-transaction business or assets for the long term. We do not plan to buy businesses or assets with a view to resale or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive investor.
We do not believe that our anticipated principal activities will subject us to the Investment Company Act. To this end, the proceeds held in the trust account may only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under
Rule 2a-7 promulgated
under the Investment Company Act that invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we intend to avoid being deemed an “investment company” within the meaning of the Investment Company Act. The initial public offering is not intended for persons who are seeking a return on investments in government securities or investment securities. The trust account is intended as a holding place for funds pending the earliest to occur of either: (i) the completion of our initial business combination; (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of the initial public offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares; or (iii) absent our completing an initial business combination within 24 months from the closing of the initial public offering, our return of the funds held in the trust account to our public shareholders as part of our redemption of the public shares. If we do not invest the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to complete a business combination. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.
We have identified a material weakness in our internal control over financial reporting as of December 31, 2021. If we are unable to develop and maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results.
 
40
As required by Rules
13a-15
and
15d-15
under the Exchange Act, our principal executive and financial officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2021 and December 31, 2021. Based upon his evaluation, our Chief Executive Officer concluded that our disclosure controls and procedures (as defined in Rules
13a-15(e)
and
15d-15(e)
under the Exchange Act) were not effective as of September 30, 2021 and December 31, 2021, due solely to the material weakness in our internal control over financial reporting described below in “Management’s Discussion and Analysis –– Changes in Internal Control Over Financial Reporting.” In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected and corrected on a timely basis.
To address the material weakness, management has devoted, and plans to continue to devote, significant effort and resources to the remediation and improvement of its internal control over financial reporting and to provide processes and controls over the internal communications within the Company, financial advisors and other third-party professionals. Management has implemented remediation steps to address the material weakness and to improve our internal control over financial reporting. Specifically, we expanded and improved our review process for complex securities and related accounting standards. We plan to further improve this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. We continue to evaluate steps to remediate the material weakness. These remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately have the intended effects.
As we continue to evaluate and improve our financial reporting process, we may take additional actions to modify certain of the remediation measures described above. If we identify any new material weaknesses in the future, any such newly identified material weakness could limit our ability to prevent or detect a misstatement of our accounts or disclosures that could result in a material misstatement of our annual or interim financial statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting and our stock price may decline as a result. We cannot assure you that the measures we have taken to date, or any measures we may take in the future, will be sufficient to avoid potential future material weaknesses.
We may face litigation and other risks as a result of the
 material
 weakness
 in our internal control over financial reporting.
As a result of the material weaknesses we’ve identified, the changes in accounting for the warrants and for Class A ordinary shares subject to redemption, and other matters raised or that may in the future be raised by the SEC, we face potential for litigation or other disputes which may include, among others, claims invoking the federal and state securities laws, contractual claims or other claims arising from the material weaknesses in our internal control over financial reporting and the preparation of our financial statements. As of the date of this Annual Report on Form
10-K,
we have no knowledge of any such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not arise in the future. Any such litigation or dispute, whether successful or not, could have a material adverse effect on our business, results of operations and financial condition or our ability to complete a business combination.
 
41
We may issue additional Class A ordinary shares or preference shares to complete our initial business combination or under an employee incentive plan after the completion of our initial business combination. We may also issue Class A ordinary shares upon the conversion of the founder shares at a ratio greater
than one-to-one at
the time of our initial business combination as a result of the anti-dilution provisions contained in our amended and restated memorandum and articles of association. Any such issuances would dilute the interest of our shareholders and likely present other risks.
Our amended and restated memorandum and articles of association authorizes the issuance of up to 500,000,000 Class A ordinary shares, par value $0.0001 per share, 50,000,000 Class B ordinary shares, par value $0.0001 per share, and 5,000,000 preference shares, par value $0.0001 per share. Immediately after the initial public offering, there will be 480,000,000 and 44,250,000 authorized but unissued Class A ordinary shares and Class B ordinary shares, respectively, available for issuance, which amount does not take into account shares reserved for issuance upon exercise of outstanding warrants and forward purchase warrants or shares issuable upon conversion of the Class B ordinary shares, or shares issued upon the sale of the forward purchase shares. The Class B ordinary shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have any redemption rights or be entitled to liquidating distributions from the trust account if we fail to consummate an initial business combination) at the time of our initial business combination or earlier at the option of the holders thereof as described herein and in our amended and restated memorandum and articles of association. Immediately after the initial public offering, there will be no preference shares issued and outstanding.
Our board of directors will be able to at any time and without shareholder approval, issue preference shares with voting and other rights that could have a dilutive effect and could adversely affect the voting power and other rights of the holders of our Class A ordinary shares. Further, the issuance of preference shares may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares. We have no preference shares issued and outstanding at the date hereof, and while we do not currently intend to issue any preference shares, we cannot assure you that we will not do so in the future.
At the time of our initial business combination, we may issue a substantial number of additional Class A ordinary shares or preference shares to complete our initial business combination, or we may issue additional Class A ordinary shares upon conversion of the Class B ordinary shares at a ratio greater
than one-to-one as
a result of the anti-dilution provisions as set forth herein. While our amended and restated memorandum and articles of association will provide, among other things, that prior to or in connection with our initial business combination, we may not issue additional shares that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote as a class with public shareholders on any initial business combination or on any other proposal presented to shareholders prior to or in connection with the completion of an initial business combination, these provisions of our amended and restated memorandum and articles of association, like all provisions of our amended and restated memorandum and articles of association, may be amended with a shareholder vote. Following our initial business combination, we may issue additional Class A ordinary shares or preference shares under an employee incentive plan, or we may also issue Class A ordinary shares in connection with our redeeming the warrants.
The issuance of any additional ordinary or preference shares:
 
  •  
may significantly dilute the equity interest of investors in the initial public offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than
one-to-one
basis upon conversion of the Class B ordinary shares;
 
  •  
could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;
 
  •  
may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us;
 
  •  
may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and
 
  •  
may not result in adjustment to the exercise price of our warrants.
 
42
Unlike some other similarly structured blank check companies, our sponsor will receive additional Class A ordinary shares if we issue shares to consummate an initial business combination.
The founder shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have any redemption rights or be entitled to liquidating distributions from the trust account if we fail to consummate an initial business combination) at the time of our initial business combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, on
an as-converted basis,
20% of the sum of (i) the total number of ordinary shares issued and outstanding upon the completion of the initial public offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination (including the forward purchase shares, but not the forward purchase warrants), excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued or to be issued to any seller in the initial business combination and any private placement warrants issued to our sponsor, its affiliates or any members of our management team upon conversion of working capital loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less
than one-to-one.
We are not registering the Class A ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time, and such registration may not be in place when an investor desires to exercise warrants, thus precluding such investor from being able to exercise its warrants except on a cashless basis and potentially causing such warrants to expire worthless.
We are not registering the Class A ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time. However, under the terms of the warrant agreement, we have agreed that, as soon as practicable, but in no event later than 20 business days after the closing of our initial business combination, we will use our commercially reasonable efforts to file with the SEC a registration statement covering the issuance of such shares, and we will use our commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of our initial business combination and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed. We cannot assure you that we will be able to do so if, for example, any facts or events arise that represent a fundamental change in the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference therein are not current, complete or correct or the SEC issues a stop order. If the shares issuable upon exercise of the warrants are not registered under the Securities Act in accordance with the above requirements, we will be required to permit holders to exercise their warrants on a cashless basis, in which case, the number of Class A ordinary shares that you will receive upon cashless exercise will be based on a formula subject to a maximum amount of shares equal to 0.361 Class A ordinary shares per warrant (subject to adjustment). However, we will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. Notwithstanding the above, if our Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, but we will use our commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Exercising the warrants on a cashless basis could have the effect of reducing the potential “upside” of the holder’s investment in our company because the warrant holder will hold a smaller number of Class A ordinary shares upon a cashless exercise of the warrants they hold. In no event will we be required to net cash settle any warrant, or issue securities or other compensation in exchange for the warrants in the event that we are unable to register or qualify the shares underlying the warrants under applicable state securities laws and no exemption is available. If the issuance of the shares upon exercise of the warrants is not so registered or qualified or exempt from registration or qualification, the holder of such warrant shall not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In such event, holders who acquired their warrants as part of a purchase of units will have paid the full unit purchase price solely for the Class A ordinary shares included in the units. There may be a circumstance where an exemption from registration exists for holders of our private placement warrants to exercise their warrants while a corresponding exemption does not exist for holders of the public warrants included as part of units sold in the initial public offering. In such an instance, our sponsor and its permitted transferees (which may include our officers and directors) would be able to exercise their warrants and sell the ordinary shares underlying their warrants while holders of our public warrants would not be able to exercise their warrants and sell the underlying ordinary shares. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying Class A ordinary shares for sale under all applicable state securities laws. As a result, we may redeem the warrants as set forth above even if the holders are otherwise unable to exercise their warrants.
 
 
43
We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then-outstanding public warrants and private placement warrants. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of our Class A ordinary shares purchasable upon exercise of a warrant could be decreased, all without your approval.
Our warrants have been issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder for the purpose of (i) curing any ambiguity or correcting any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement set forth in in our prospectus filed with the Securities and Exchange Commission on June 10, 2021 pursuant to Rule 424b(4) under the Securities Act (Securities Act File
No.333-255722)
incorporated by reference into this annual report, or defective provision (ii) amending the provisions relating to cash dividends on ordinary shares as contemplated by and in accordance with the warrant agreement, (iii) to make any amendments that are necessary in the good faith determination of our board of directors (taking into account then existing market precedents) to allow for the warrants to be classified as equity in our financial statements, or (iv) adding or changing any provisions with respect to matters or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants in any material respect. All other modifications or amendments shall require the vote or written consent of the holders of at least 50% of the then-outstanding public warrants and private placement warrants, provided that any amendment that solely affects the terms of the private placement warrants or forward purchase warrants or any provision of the warrant agreement solely with respect to the private placement warrants or forward purchase warrants will also require the vote or written consent of at least 50% of the then outstanding private placement warrants or forward purchase warrants, respectively. Accordingly, we may amend the terms of the public warrants in a manner adverse to a holder if holders of at least 50% of the then-outstanding public warrants and private placement warrants approve of such amendment and, solely with respect to any amendment to the terms of the private placement warrants or forward purchase warrants, respectively or any provision of the warrant agreement with respect to the private placement warrants, 50% of the number of the then outstanding private placement warrants. Although our ability to amend the terms of the public warrants with the consent of at least 50% of the then-outstanding public warrants and private placement warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash, shorten the exercise period or decrease the number of Class A ordinary shares purchasable upon exercise of a warrant.
Our warrants are accounted for as a warrant liability and are recorded at fair value upon issuance with any changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our securities or may make it more difficult for us to consummate an initial business combination.
Following the consummation of the initial public offering and the concurrent private placement of warrants, we have 16,000,000 warrants outstanding (comprised of the 10,000,000 warrants included in the units and the 6,000,000 private placement warrants). We currently account for these warrants as a warrant liability, which means that we record them at fair value upon issuance with any changes in fair value each period reported in earnings. The impact of changes in fair value on earnings may have an adverse effect on the market price of our securities. In addition, potential targets may seek a business combination partner that does not have warrants that are accounted for as a warrant liability, which may make it more difficult for us to consummate an initial business combination with a target business.
 
44
Our warrant agreement will designate the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with our company.
Our warrant agreement will provide that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.
Notwithstanding the foregoing, these provisions of the warrant agreement will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Accordingly, our exclusive forum provision will not relieve us of our duties to comply with the federal securities laws and the rules and regulations thereunder, and holders of our warrants will not be deemed to have waived our compliance with these laws, rules and regulations. Any person or entity purchasing or otherwise acquiring any interest in any of our warrants shall be deemed to have notice of and to have consented to the forum provisions in our warrant agreement. If any action, the subject matter of which is within the scope the forum provisions of the warrant agreement, is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any holder of our warrants, such holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder.
This choice-of-forum provision
may limit a warrant holder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits. Alternatively, if a court were to find this provision of our warrant agreement inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management and board of directors.
We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.
We have the ability to redeem the outstanding public warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant,
 provided
 that the closing price of our Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described in the Exhibit 4.1 titled “Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended” under the heading “—Warrants—Public Shareholders’ Warrants and Forward Purchase Warrants—Anti-Dilution Adjustments”) for any 20 trading days within a
30 trading-day period
ending on the third trading day prior to proper notice of such redemption and
 provided
 that certain other conditions are met. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. As a result, we may redeem the warrants as set forth above even if the holders are otherwise unable to exercise the warrants. Redemption of the outstanding warrants could force you to (i) exercise your warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so, (ii) sell your warrants at the then-current market price when you might otherwise wish to hold your warrants or (iii) accept the nominal redemption price which, at the time the outstanding warrants are called for redemption, we expect would be substantially less than the market value of your warrants.
 
45
In addition, we have the ability to redeem the outstanding public warrants at any time after they become exercisable and prior to their expiration, at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption
 provided
 that the closing price of our Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described in the Exhibit 4.1 titled “Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended” under the heading “—Warrants—Public Shareholders’ Warrants and Forward Purchase Warrants—Anti-Dilution Adjustments”) for any 20 trading days within a
30 trading-day period
ending on the third trading day prior to proper notice of such redemption and
 provided
 that certain other conditions are met, including that holders will be able to exercise their warrants prior to redemption for a number of Class A ordinary shares determined based on the redemption date and the fair market value of our Class A ordinary shares. Please see Exhibit 4.1 titled “Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended” under the heading “—Warrants —Public Shareholders’ Warrants and Forward Purchase Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00.” The value received upon exercise of the warrants (1) may be less than the value the holders would have received if they had exercised their warrants at a later time where the underlying share price is higher and (2) may not compensate the holders for the value of the warrants, including because the number of ordinary shares received is capped at 0.361 Class A ordinary shares per warrant (subject to adjustment) irrespective of the remaining life of the warrants.
None of the private placement warrants will be redeemable by us (except as set forth in the Exhibit 4.1 titled “Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended” under the heading “—Warrants —Public Shareholders’ Warrants and Forward Purchase Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00”) so long as they are held by our sponsor or its permitted transferees.
Our warrants may have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our initial business combination.
We have issued 10,000,000 warrants to purchase our Class A ordinary shares as part of the units offered in our IPO and, simultaneously with the closing of the IPO, we issued in a private placement an aggregate of 6,000,000 private placement warrants, each exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. We will also issue 750,000 forward purchase warrants concurrently with the sale of the forward purchase shares. In addition, if the sponsor, its affiliates or a member of our management team makes any working capital loans, it may convert up to $1,500,000 of such loans into up to an additional 1,500,000 private placement warrants, at the price of $1.00 per warrant.
To the extent we issue ordinary shares for any reason, including to effectuate a business combination, the potential for the issuance of a substantial number of additional Class A ordinary shares upon exercise of these warrants could make us a less attractive acquisition vehicle to a target business. Such warrants, when exercised, will increase the number of issued and outstanding Class A ordinary shares and reduce the value of the Class A ordinary shares issued to complete the business transaction. Therefore, our warrants may make it more difficult to effectuate a business transaction or increase the cost of acquiring the target business.
Because each unit
contains one-half of
one redeemable warrant and only a whole warrant may be exercised, the units may be worth less than units of other blank check companies.
Each unit
contains one-half of
one redeemable warrant. Pursuant to the warrant agreement, no fractional warrants will be issued upon separation of the units, and only whole units will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of Class A ordinary shares to be issued to the warrant holder. This is different from other offerings similar to ours whose units include one ordinary share and one whole warrant to purchase one whole share. We have established the components of the units in this way in order to reduce the dilutive effect of the warrants upon the completion of a business combination since the warrants will be exercisable in the aggregate
for one-half of
the number of shares compared to units that each contain a whole warrant to purchase one whole share, thus making us, we believe, a more attractive merger partner for target businesses. Nevertheless, this unit structure may cause our units to be worth less than if a unit included a warrant to purchase one whole share.
A provision of our warrant agreement may make it more difficult for us to consummate an initial business combination.
 
46
Unlike most blank check companies, if (i) we issue additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at a Newly Issued Price of less than $9.20 per ordinary share, (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and (iii) the Market Value is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger prices described below in the Exhibit 4.1 titled “Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended” under the heading “—Warrants —Public Shareholders’ Warrants and Forward Purchase Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “—Warrants—Public Shareholders’ Warrants and Forward Purchase Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below in the Exhibit 4.1 titled “Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended” under the heading “—Warrants —Public Shareholders’ Warrants and Forward Purchase Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. This may make it more difficult for us to consummate an initial business combination with a target business.
The determination of the offering price of our units and the size of the initial public offering is more arbitrary than the pricing and size of an offering of an operating company in a particular industry. You may have less assurance, therefore, that the offering price of our units properly reflects the value of such units than you would have in a typical offering of an operating company.
Prior to the initial public offering there has been no public market for any of our securities. The public offering price of the units and the terms of the warrants were negotiated between us and the underwriter. In determining the size of the initial public offering, management held customary organizational meetings with the underwriter, both prior to our inception and thereafter, with respect to the state of capital markets, generally, and the amount the underwriter believed they reasonably could raise on our behalf. Factors considered in determining the size of the initial public offering, prices and terms of the units, including the Class A ordinary shares and warrants underlying the units, include:
 
  •  
the history and prospects of companies whose principal business is the acquisition of other companies;
 
  •  
prior offerings of those companies;
 
  •  
our prospects for acquiring an operating business at attractive values;
 
  •  
a review of
debt-to-equity
ratios in leveraged transactions;
 
  •  
our capital structure;
 
  •  
an assessment of our management and their experience in identifying operating companies;
 
  •  
general conditions of the securities markets at the time of the initial public offering; and
 
  •  
other factors as were deemed relevant.
Although these factors were considered, the determination of our offering price is more arbitrary than the pricing of securities of an operating company in a particular industry since we have no historical operations or financial results.
There is currently no market for our securities and a market for our securities may not develop, which would adversely affect the liquidity and price of our securities.
There is currently no market for our securities. Shareholders therefore have no access to information about prior market history on which to base their investment decision. Following the initial public offering, the price of our securities may vary significantly due to one or more potential business combinations and general market or economic conditions, including as a result of
the COVID-19 outbreak.
Furthermore, an active trading market for our securities may never develop or, if developed, it may not be sustained. You may be unable to sell your securities unless a market can be established and sustained.
 
47
Provisions in our amended and restated memorandum and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our Class A ordinary shares and could entrench management.
Our amended and restated memorandum and articles of association will contain provisions that may discourage unsolicited takeover proposals that shareholders may consider to be in their best interests. These provisions will include a staggered board of directors, the ability of the board of directors to designate the terms of and issue new series of preference shares, and the fact that prior to the completion of our initial business combination only holders of our Class B ordinary shares, which have been issued to our sponsor, are entitled to vote on the appointment and removal of directors, which may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.
An investment in our securities may result in uncertain or adverse U.S. federal income tax consequences.
An investment in our securities may result in uncertain U.S. federal income tax consequences. For instance, because there are no authorities that directly address instruments similar to the units we issued in our initial public offering, the allocation an investor makes with respect to the purchase price of a unit between the Class A ordinary shares and
the one-half of
a warrant to purchase one Class A ordinary share included in each unit could be challenged by the Internal Revenue Service or courts. Furthermore, the U.S. federal income tax consequences of a cashless exercise of our warrants is unclear under current law. Finally, it is unclear whether the redemption rights with respect to our ordinary shares would suspend the running of a U.S. investor’s holding period for purposes of determining whether any gain or loss realized by such holder on the sale or exchange of Class A ordinary shares is long-term capital gain or loss and for determining whether any dividend we pay would be considered “qualified dividend income” for U.S. federal income tax purposes. See the section titled “Taxation—United States Federal Income Tax Considerations” in our prospectus filed with the Securities and Exchange Commission on June 10, 2021 pursuant to Rule 424b(4) under the Securities Act (Securities Act File
No.333-255722)
incorporated by reference into this annual report for a summary of the U.S. federal income tax considerations of an investment in our securities.
Because we are incorporated under the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. federal courts may be limited.
We are an exempted company incorporated under the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service of process within the United States upon our directors or officers, or enforce judgments obtained in the United States courts against our directors or officers.
Our corporate affairs will be governed by our amended and restated memorandum and articles of association, the Companies Act (as the same may be supplemented or amended from time to time) and the common law of the Cayman Islands. We are also subject to the federal securities laws of the United States. The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedents in the Cayman Islands as well as from English common law, the decisions of whose courts are of persuasive authority, but are not binding on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are different from what they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a different body of securities laws as compared to the United States, and certain states, such as Delaware, may have more fully developed and judicially interpreted bodies of corporate law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative action in a federal court of the United States.
 
48
We have been advised by our Cayman Islands legal counsel that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.
As a result of all of the above, public shareholders may have more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or controlling shareholders than they would as public shareholders of a United States company.
Our amended and restated memorandum and articles of association provide that the courts of the Cayman Islands will be the exclusive forums for certain disputes between us and our shareholders, which could limit our shareholders’ ability to obtain a favorable judicial forum for complaints against us or our directors, officers or employees.
Our amended and restated memorandum and articles of association provide that unless we consent in writing to the selection of an alternative forum, the courts of the Cayman Islands shall have exclusive jurisdiction over any claim or dispute arising out of or in connection with our amended and restated memorandum and articles of association or otherwise related in any way to each shareholder’s shareholding in us, including but not limited to (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of any fiduciary or other duty owed by any of our current or former director, officer or other employee to us or our shareholders, (iii) any action asserting a claim arising pursuant to any provision of the Companies Act or our amended and restated memorandum and articles of association, or (iv) any action asserting a claim against us governed by the internal affairs doctrine (as such concept is recognized under the laws of the United States of America) and that each shareholder irrevocably submits to the exclusive jurisdiction of the courts of the Cayman Islands over all such claims or disputes.
Our amended and restated memorandum of association will provide this exclusive jurisdiction provision will not apply to claims under the Securities Act of 1933, as amended or the Exchange Act 1934, as amended, and that claims under such laws must be brought in the federal courts of the United States of America and that any shareholder will be deemed to have consented to such jurisdictions. Our amended and restated memorandum and articles of association also provide that, without prejudice to any other rights or remedies that we may have, each of our shareholders acknowledges that damages alone would not be an adequate remedy for any breach of the selection of the courts of the Cayman Islands as exclusive forum and that accordingly we shall be entitled, without proof of special damages, to the remedies of injunction, specific performance or other equitable relief for any threatened or actual breach of the selection of the courts of the Cayman Islands as exclusive forum.
This choice of forum provision may increase a shareholder’s cost and limit the shareholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. Any person or entity purchasing or otherwise acquiring any of our shares or other securities, whether by transfer, sale, operation of law or otherwise, shall be deemed to have notice of and have irrevocably agreed and consented to these provisions. There is uncertainty as to whether a court would enforce such provisions, and the enforceability
Since only holders of our founder shares will have the right to vote on the appointment of directors, upon the listing of our shares on Nasdaq, Nasdaq may consider us to be a “controlled company” within the meaning of Nasdaq rules and, as a result, we may qualify for exemptions from certain corporate governance requirements.
 
49
After the completion of the initial public offering, only holders of our founder shares will have the right to vote on the appointment of directors. As a result, Nasdaq may consider us to be a “controlled company” within the meaning of the Nasdaq corporate governance standards. Under the Nasdaq corporate governance standards, a company of which more than 50% of the voting power is held by an individual, group or another company is a “controlled company” and may elect not to comply with certain corporate governance requirements, including the requirements that:
 
  •  
we have a board that includes a majority of “independent directors,” as defined under the rules of Nasdaq;
 
  •  
we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and
 
  •  
we have a nominating and corporate governance committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities.
We intend to comply with the corporate governance requirements of Nasdaq, subject to applicable
phase-in
rules. However, if we determine to utilize some or all of these exemptions, you will not have the same protections afforded to shareholders of companies that are subject to all of the Nasdaq corporate governance requirements.
If we have not consummated an initial business combination within 24 months from the closing of the initial public offering, our public shareholders may be forced to wait beyond such 24 months before redemption from our trust account.
If we have not consummated an initial business combination within 24 months from the closing of the initial public offering, the proceeds then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), will be used to fund the redemption of our public shares, as further described herein. Any redemption of public shareholders from the trust account will be effected automatically by function of our amended and restated memorandum and articles of association prior to any voluntary winding up. If we are required to wind up, liquidate the trust account and distribute such amount therein, pro rata, to our public shareholders, as part of any liquidation process, such winding up, liquidation and distribution must comply with the applicable provisions of the Companies Act. In that case, investors may be forced to wait beyond 24 months from the closing of the initial public offering before the redemption proceeds of our trust account become available to them and they can receive the return of their pro rata portion of the proceeds from our trust account. We have no obligation to return funds to investors prior to the date of our redemption or liquidation unless, prior thereto, we consummate our initial business combination or amend certain provisions of our amended and restated memorandum and articles of association, and only then in cases where investors have sought to redeem their Class A ordinary shares. Only upon our redemption or any liquidation will public shareholders be entitled to distributions if we do not complete our initial business combination and do not amend certain provisions of our amended and restated memorandum and articles of association. Our amended and restated memorandum and articles of association will provide that, if we wind up for any other reason prior to the consummation of our initial business combination, we will follow the foregoing procedures with respect to the liquidation of the trust account as promptly as reasonably possible but not more than ten business days thereafter, subject to applicable Cayman Islands law.
Holders of Class A ordinary shares will not be entitled to vote on any appointment of directors we hold prior to our initial business combination.
Prior to our initial business combination, only holders of our founder shares will have the right to vote on the appointment of directors. Holders of our public shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to our initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason. Accordingly, you may not have any say in the management of our company prior to the consummation of an initial business combination.
 
50
The warrants may become exercisable and redeemable for a security other than the Class A ordinary shares, and you will not have any information regarding such other security at this time.
In certain situations, including if we are not the surviving entity in our initial business combination, the warrants may become exercisable for a security other than the Class A ordinary shares. As a result, if the surviving company redeems your warrants for securities pursuant to the warrant agreement, you may receive a security in a company of which you do not have information at this time. Pursuant to the warrant agreement, the surviving company will be required to use commercially reasonable efforts to register the issuance of the security underlying the warrants within 20 business days of the closing of an initial business combination.
The grant of registration rights to our sponsor may make it more difficult to complete our initial business combination, and the future exercise of such rights may adversely affect the market price of our Class A ordinary shares.
Pursuant to an agreement to be entered into on or prior to the closing of the initial public offering and the forward purchase agreements, our initial shareholders can demand that we register the resale of the Class A ordinary shares into which founder shares are convertible, the private placement warrants, the forward purchase warrants and the Class A ordinary shares issuable upon exercise of the private placement warrants, the forward purchase warrants and warrants that may be issued upon conversion of working capital loans and the Class A ordinary shares issuable upon conversion of such warrants. The registration rights will be exercisable with respect to the founder shares and the private placement warrants and the Class A ordinary shares issuable upon exercise of such private placement warrants. We will bear the costs of registering these securities. The registration and availability of such a significant number of securities for trading in the public market may have an adverse effect on the market price of our Class A ordinary shares. In addition, the existence of the registration rights may make our initial business combination more costly or difficult to conclude. This is because the shareholders of the target business may increase the equity stake they seek in the combined entity or ask for more cash consideration to offset the negative impact on the market price of our securities that is expected when the securities owned by our sponsor or its permitted transferees are registered for resale.
We may reincorporate, or combine with a company located, in another jurisdiction in connection with our initial business combination and such reincorporation or business combination may result in taxes imposed on shareholders.
We may, in connection with our initial business combination and subject to requisite shareholder approval under the Companies Act, merge with a company located in another jurisdiction, or reincorporate in the jurisdiction in which the target company or business is located or in another jurisdiction. The transaction may require a shareholder or warrant holder to recognize taxable income in the jurisdiction in which the shareholder or warrant holder is a tax resident or in which its members are resident if it is a tax transparent entity. Such tax liability may attach prior to the consummation of redemptions of any of our public shares properly submitted to us for redemption in connection with such business combination. We do not intend to make any cash distributions to shareholders or warrant holders to pay such taxes. Shareholders or warrant holders may be subject to withholding taxes or other taxes with respect to their ownership of us after the reincorporation or business combination. In addition, even if we do not reincorporate or merge with a company in another jurisdiction, depending on the fact at the time of the business combination or thereafter, we could be treated as tax resident in the jurisdiction in which the target company or its management is located, which could result in adverse tax consequences to us and our shareholders or warrant holders.
Risks Relating to our Sponsor and Management Team
Our ability to successfully effect our initial business combination and to be successful thereafter will be totally dependent upon the efforts of our key personnel, some of whom may join us following our initial business combination. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.
Our ability to successfully effect our initial business combination is dependent upon the efforts of our key personnel. The role of our key personnel in the target business, however, cannot presently be ascertained. Although some of our key personnel may remain with the target business in senior management, director oradvisory positions following our initial business combination, it is likely that some or all of the management of the target business will remain in place. While we intend to closely scrutinize any individuals we engage after our initial business combination, we cannot assure you that our assessment of these individuals will prove to be correct. These individuals may be unfamiliar with the requirements of operating a company regulated by the SEC, which could cause us to have to expend time and resources helping them become familiar with such requirements.
 
 
51
Our key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination, and a particular business combination may be conditioned on the retention or resignation of such key personnel. These agreements may provide for them to receive compensation following our initial business combination and as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous.
Our key personnel may be able to remain with our company after the completion of our initial business combination only if they are able to negotiate employment or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously with the negotiation of the business combination and could provide for such individuals to receive compensation in the form of cash payments and/or our securities for services they would render to us after the completion of the business combination. Such negotiations also could make such key personnel’s retention or resignation a condition to any such agreement. The personal and financial interests of such individuals may influence their motivation in identifying and selecting a target business. In addition, pursuant to an agreement to be entered into on or prior to the closing of the initial public offering, our sponsor, upon and following the consummation of an initial business combination, will be entitled to nominate three individuals for election to our board of directors, as long as the sponsor holds any securities covered by the registration and shareholder rights agreement, which is described in the Exhibit 4.1 titled “Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended” under the heading “—Registration and Shareholder Rights.”
The officers and directors of an acquisition candidate may resign upon the completion of our initial business combination. The loss of a business combination target’s key personnel could negatively impact the operations and profitability of our post-combination business.
The role of an acquisition candidate’s key personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we contemplate that certain members of an acquisition candidate’s management team will remain associated with the acquisition candidate following our initial business combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place.
Our officers, directors and senior advisor will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business combination.
Our officers, directors and senior advisor are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. In particular, Wei Fu, our senior advisor, will devote a majority of his business time and attention to the affairs of CBC Group and has limited capacity to advise on our initial business combination. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our officers, directors and senior advisor is engaged in, or may in the future engage in, several other business endeavors for which he or she may be entitled to substantial compensation, and our officers, directors and senior advisor are not obligated to contribute any specific number of hours per week to our affairs. Our independent directors also serve as officers and board members for other entities. If our officers’, directors’ and senior advisor’s other business affairs require them to devote substantial amounts of time to such affairs in excess of their current commitment levels, it could limit their ability to devote time to our affairs which may have a negative impact on our ability to complete our initial business combination. For a complete discussion of our officers’ and directors’ other business affairs, please see “Item 10. Directors, Executive Officers and Corporate Governance—Officers and Directors.”
Each of our officers, directors, and senior advisor presently is, and any of them in the future may have additional, fiduciary or contractual obligations to other entities, including another blank check company, and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
 
52
Following the completion of the initial public offering and until we consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses or entities. Each of our officers, directors, and senior advisor presently has, and any of them in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity, subject to his or her fiduciary duties under Cayman Islands law. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us, subject to their fiduciary duties under Cayman Islands law. In particular, Wei Fu, our senior advisor, has fiduciary and contractual obligations to the CBC Group and is therefore required to present business combination opportunities to the CBC Group.
In addition, our sponsor, officers, directors and senior advisor may in the future become affiliated with, and are not prohibited from sponsoring investing or otherwise becoming involved in, other blank check companies that may have acquisition objectives that are similar to ours. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to such other blank check companies prior to its presentation to us, subject to our officers’, directors’ and senior advisor’s fiduciary duties under Cayman Islands law. Our amended and restated memorandum and articles of association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer, on the one hand, and us, on the other.
For a complete discussion of our officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see “Item 10. Directors, Executive Officers and Corporate Governance—Officers and Directors,” “Item 10. Directors, Executive Officers and Corporate Governance—Conflicts of Interest” and “Item 13. Certain Relationships and Related Transactions, and Director Independence.”
Our officers, directors, senior advisor, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.
We have not adopted a policy that expressly prohibits our directors, officers, senior advisor, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business combination with a target business that is affiliated with our sponsor, directors, officers or senior advisor, although we do not intend to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours.
The personal and financial interests of our officers, directors and senior advisor may influence their motivation in timely identifying and selecting a target business and completing a business combination. Consequently, our officers’ and directors’ discretion in identifying and selecting a suitable target business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination are appropriate and in our shareholders’ best interest. If this were the case, it would be a breach of their fiduciary duties to us as a matter of Cayman Islands law and we or our shareholders might have a claim against such individuals for infringing on our shareholders’ rights. See the Exhibit 4.1 titled “Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended” under the heading “—Certain Differences in Corporate Law—Shareholders’ Suits” for further information on the ability to bring such claims. However, we might not ultimately be successful in any claim we may make against them for such reason.
We may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated with our sponsor, officers, directors, senior advisor or initial shareholders, which may raise potential conflicts of interest.
 
53
In light of the involvement of our sponsor, officers, directors and senior advisor with other entities, we may decide to acquire one or more businesses affiliated with our sponsor, officers, directors, senior advisor or initial shareholders. Members of our management team also serve as officers and board members for other entities, including, without limitation, those described under “Item 10. Directors, Executive Officers and Corporate Governance—Management—Conflicts of Interest.” Our sponsor, officers, directors and senior advisor may sponsor, form or participate in other blank check companies similar to ours during the period in which we are seeking an initial business combination. Such entities may compete with us for business combination opportunities. Our sponsor, officers, directors and senior advisor are not currently aware of any specific opportunities for us to complete our initial business combination with any entities with which they are affiliated, and there have been no substantive discussions concerning a business combination with any such entity or entities. Although we will not be specifically focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria and guidelines for a business combination as set forth in “Item 1. Business—Effecting Our Initial Business Combination—Evaluation of a Target Business and Structuring of Our Initial Business Combination” and such transaction was approved by a majority of our independent and disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions regarding the fairness to our company from a financial point of view of a business combination with one or more domestic or international businesses affiliated with our sponsor, officers, directors or initial shareholders, potential conflicts of interest still may exist and, as a result, the terms of the business combination may not be as advantageous to our public shareholders as they would be absent any conflicts of interest.
Since our sponsor, our officers and directors will lose their entire investment in us if our initial business combination is not completed (other than with respect to public shares they may acquire during or after the initial public offering), a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.
On December 31, 2020, our sponsor paid $25,000, or approximately $0.004 per share, to cover certain expenses on our behalf in consideration of 5,750,000 Class B ordinary shares, par value $0.0001. Following a share capitalization on April 30, 2021, our sponsor held an aggregate of 6,500,000 founder shares and then, in connection with entering into the forward purchase agreements, transferred to the anchor investors an aggregate of 375,000 founder shares for no cash consideration. These 375,000 founder shares were not subject to forfeiture. Prior to the initial investment in the company of $25,000 by the sponsor, the company had no assets, tangible or intangible. On April 30, 2021, our sponsor transferred 25,000 founder shares to each of our independent directors. These 75,000 founder shares were not subject to forfeiture. The per share price of the founder shares was determined by dividing the amount contributed to the company by the number of founder shares issued. The founder shares will be worthless if we do not complete an initial business combination. In addition, our sponsor purchased an aggregate of 6,000,000 private placement warrants, each exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment, at a price of $1.00 per warrant ($6,000,000 in the aggregate), in a private placement that closed simultaneously with the closing of the initial public offering. If we do not consummate an initial business combination within 24 months from the closing of the initial public offering, the private placement warrants will expire worthless. The personal and financial interests of our officers and directors may influence their motivation in identifying and selecting a target business combination, completing an initial business combination and influencing the operation of the business following the initial business combination. This risk may become more acute as
the 24-month anniversary
of the closing of the initial public offering nears, which is the deadline for our consummation of an initial business combination.
Our management may not be able to maintain control of a target business after our initial business combination. Upon the loss of control of a target business, new management may not possess the skills, qualifications or abilities necessary to profitably operate such business.
We may structure our initial business combination so that the post-business combination company in which our public shareholders own shares will own less than 100% of the equity interests or assets of a target business, but we will only complete such business combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for us not to be required to register as an investment company under the Investment Company Act. We will not consider any transaction that does not meet such criteria. Even if the post-business combination company owns 50% or more of the voting securities of the target, our shareholders prior to our initial business combination may collectively own a minority interest in the post-business combination company, depending on valuations ascribed to the target and us in the business combination. For example, we could pursue a transaction in which we issue a substantial number of new Class A ordinary shares in exchange for all of the outstanding capital stock, shares or other entity interests of a target. In this case, we would acquire a 100% interest in the target. However, as a result of the issuance of a substantial number of new Class A ordinary shares, our shareholders immediately prior to such transaction could own less than a majority of our outstanding Class A ordinary shares subsequent to such transaction. In addition, other minority shareholders may subsequently combine their holdings resulting in a single person or group obtaining a larger portion the company’s shares than we initially acquired. Accordingly, this may make it more likely that our management will not be able to maintain control of the target business.
 
54
Our initial shareholders control a substantial interest in us and thus may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support.
Upon closing of the initial public offering, our initial shareholders will own, on
an as-converted basis,
20% of the sum of the total number of our issued and outstanding ordinary shares plus 3,000,000 Class A ordinary shares to be sold pursuant to the forward purchase agreements. Accordingly, they may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support, including amendments to our amended and restated memorandum and articles of association. If our initial shareholders purchase any units in the initial public offering or any additional Class A ordinary shares in the aftermarket or in privately negotiated transactions, this would increase its control. Neither our sponsor nor, to our knowledge, any of our officers or directors, have any current intention to purchase additional securities, other than as disclosed in this annual report. Factors that would be considered in making such additional purchases would include consideration of the current trading price of our Class A ordinary shares. Further, because only holders of our Class B ordinary shares will have the right to vote on the appointment of directors and to remove directors prior to our initial business combination, our initial shareholders will continue to exert control at least until the completion of our initial business combination. In addition, we have agreed not to enter into a definitive agreement regarding an initial business combination without the prior consent of our sponsor.
After our initial business combination, it is possible that a majority of our officers and directors will live outside the United States and all of our assets will be located outside the United States. Therefore, investors may not be able to enforce federal securities laws or their other legal rights.
It is possible that after our initial business combination, a majority of our officers and directors will reside outside of the United States and all of our assets will be located outside of the United States. As a result, it may be difficult, or in some cases not possible, for investors in the United States to enforce their legal rights, to effect service of process upon all of our directors or officers or to enforce judgments of United States courts predicated upon civil liabilities and criminal penalties on our officers and directors under United States laws.
We are dependent upon our officers and directors and their loss could adversely affect our ability to operate.
Our operations are dependent upon a relatively small group of individuals and, in particular, our officers and directors. We believe that our success depends on the continued service of our officers and directors, at least until we have completed our initial business combination. In addition, our officers and directors are not required to commit any specified amount of time to our affairs and, accordingly, will have conflicts of interest in allocating their time among various business activities, including identifying potential business combinations and monitoring the related due diligence. We do not have an employment agreement with,
or key-man insurance
on the life of, any of our directors or officers.
The unexpected loss of the services of one or more of our directors or officers could have a detrimental effect on us.
Risks Associated with Acquiring and Operating a Business in Foreign Countries
If we pursue a target company with operations or opportunities outside of the United States for our initial business combination, we may face additional burdens in connection with investigating, agreeing to and completing such initial business combination, and if we effect such initial business combination, we would be subject to a variety of additional risks that may negatively impact our operations.
If we pursue a target company with operations or opportunities outside of the United States for our initial business combination, we would be subject to risks associated with cross-border business combinations, including in connection with investigating, agreeing to and completing our initial business combination, conducting due diligence in a foreign jurisdiction, having such transaction approved by any local governments, regulators or agencies and changes in the purchase price based on fluctuations in foreign exchange rates.
 
55
If we effect our initial business combination with such a company, we would be subject to any special considerations or risks associated with companies operating in an international setting, including any of the following:
 
  •  
costs and difficulties inherent in managing cross-border business operations;
 
  •  
rules and regulations regarding currency redemption;
 
  •  
complex corporate withholding taxes on individuals;
 
  •  
laws governing the manner in which future business combinations may be effected;
 
  •  
exchange listing and/or delisting requirements;
 
  •  
tariffs and trade barriers;
 
  •  
regulations related to customs and import/export matters;
 
  •  
local or regional economic policies and market conditions;
 
  •  
unexpected changes in regulatory requirements;
 
  •  
longer payment cycles;
 
  •  
tax issues, such as tax law changes and variations in tax laws as compared to the United States;
 
  •  
currency fluctuations and exchange controls;
 
  •  
rates of inflation;
 
  •  
challenges in collecting accounts receivable;
 
  •  
cultural and language differences;
 
  •  
employment regulations;
 
  •  
underdeveloped or unpredictable legal or regulatory systems;
 
  •  
corruption;
 
  •  
protection of intellectual property;
 
  •  
social unrest, crime, strikes, riots and civil disturbances;
 
  •  
regime changes and political upheaval;
 
  •  
terrorist attacks, natural disasters and wars; and
 
  •  
deterioration of political relations with the United States.
We may not be able to adequately address these additional risks. If we were unable to do so, we may be unable to complete such initial business combination, or, if we complete such combination, our operations might suffer, either of which may adversely impact our business, financial condition and results of operations.
If our management following our initial business combination is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws, which could lead to various regulatory issues
.
Following our initial business combination, our management may resign from their positions as officers or directors of the company and the management of the target business at the time of the business combination will remain in place. Management of the target business may not be familiar with United States securities laws. If new management is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws. This could be expensive and time-consuming and could lead to various regulatory issues that may adversely affect our operations.
If the government of the country in which we effect our initial business combination finds that the agreements we entered into to acquire control of a target business through contractual arrangements with one or more operating businesses do not comply with local governmental restrictions on foreign investment, or if these regulations or the interpretation of existing regulations change in the future, we could be subject to significant penalties or be forced to relinquish our interests in those operations.
 
56
Some countries in Asia currently prohibit and/or restrict foreign ownership in certain “important industries,” including telecommunications, food production and heavy equipment. There are uncertainties under certain regulations whether obtaining a majority interest through contractual arrangements will comply with regulations prohibiting or restricting foreign ownership in certain industries. In addition, there can be restrictions on the foreign ownership of businesses that are determined from time to time to be in “important industries” that may affect the national economic security or those having “famous brand names” or “well-established brand names.”
If we or any of our potential future target businesses are found to be in violation of any existing or future local laws or regulations (for example, if we are deemed to be holding equity interests in certain of our affiliated entities in which direct foreign ownership is prohibited), the relevant regulatory authorities might have the discretion to:
 
  •  
revoke the business and operating licenses of the potential future target business;
 
  •  
confiscate relevant income and impose fines and other penalties;
 
  •  
discontinue or restrict the operations of the potential future target business;
 
  •  
require us or the potential future target business to restructure the relevant ownership structure or operations;
 
  •  
restrict or prohibit our use of the proceeds of the initial public offering to finance our businesses and operations in the relevant jurisdiction; or
 
  •  
impose conditions or requirements with which we or the potential future target business may not be able to comply.
After our initial business combination, substantially all of our assets may be located in a foreign country and substantially all of our revenue may be derived from our operations in any such country. Accordingly, our results of operations and prospects will be subject, to a significant extent, to the economic, political and social conditions and government policies, developments and conditions in the country in which we operate.
The economic, political and social conditions, as well as government policies, of the country in which our operations are located could affect our business. Economic growth could be uneven, both geographically and among various sectors of the economy and such growth may not be sustained in the future. If in the future such country’s economy experiences a downturn or grows at a slower rate than expected, there may be less demand for spending in certain industries. A decrease in demand for spending in certain industries could materially and adversely affect our ability to find an attractive target business with which to consummate our initial business combination and if we effect our initial business combination, the ability of that target business to become profitable.
Exchange rate fluctuations and currency policies may cause a target business’ ability to succeed in the international markets to be diminished.
In the event we acquire a
non-U.S.
target, all revenues and income would likely be received in a foreign currency, and the dollar equivalent of our net assets and distributions, if any, could be adversely affected by reductions in the value of the local currency. The value of the currencies in our target regions fluctuate and are affected by, among other things, changes in political and economic conditions. Any change in the relative value of such currency against our reporting currency may affect the attractiveness of any target business or, following the consummation of our initial business combination, our financial condition and results of operations. Additionally, if a currency appreciates in value against the dollar prior to the consummation of our initial business combination, the cost of a target business as measured in dollars will increase, which may make it less likely that we are able to consummate such transaction.
We may reincorporate in another jurisdiction in connection with our initial business combination, and the laws of such jurisdiction may govern some or all of our future material agreements and we may not be able to enforce our legal rights.
In connection with our initial business combination, we may relocate the home jurisdiction of our business from the Cayman Islands to another jurisdiction. If we determine to do this, the laws of such jurisdiction may govern some or all of our future material agreements. The system of laws and the enforcement of existing laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The inability to enforce or obtain a remedy under any of our future agreements could result in a significant loss of business, business opportunities or capital.
 
57
Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations.
We are subject to laws and regulations enacted by national, regional and local governments. In particular, we are required to comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial business combination, and results of operations.
We may be exposed to liabilities under the Foreign Corrupt Practices Act, and any determination that we violated the Foreign Corrupt Practices Act could have a material adverse effect on our business.
We are subject to the Foreign Corrupt Practice Act, or FCPA, and other laws that prohibit improper payments or offers of payments to foreign governments and their officials and political parties by U.S. persons and issuers as defined by the statute for the purpose of obtaining or retaining business. Payments by anyone acting on our behalf create the risk of unauthorized payments or offers of payments, for which we might be held responsible. Violations of the FCPA may result in severe criminal or civil sanctions, and we may be subject to other liabilities, which could negatively affect our business, operating results and financial condition. In addition, the U.S. government may seek to hold our Company liable for successor liability for FCPA violations committed by companies in which we invest or that we acquire.
Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination.
In recent months, the market for directors and officers liability insurance for special purpose acquisition companies has changed in ways adverse to us and our management team. Fewer insurance companies are offering quotes for directors and officers liability coverage, the premiums charged for such policies have generally increased and the terms of such policies have generally become less favorable. These trends may continue into the future.
The increased cost and decreased availability of directors and officers liability insurance could make it more difficult and more expensive for us to negotiate an initial business combination. In order to obtain directors and officers liability insurance or modify its coverage as a result of becoming a public company, the post-business combination entity might need to incur greater expense, accept less favorable terms or both. However, any failure to obtain adequate directors and officers liability insurance could have an adverse impact on the post-business combination’s ability to attract and retain qualified officers and directors.
In addition, even after we were to complete an initial business combination, our directors and officers could still be subject to potential liability from claims arising from conduct alleged to have occurred prior to the initial business combination. As a result, in order to protect our directors and officers, the post-business combination entity may need to purchase additional insurance with respect to any such claims
(“run-off
insurance”). The need for run-off insurance would be an added expense for the post-business combination entity, and could interfere with or frustrate our ability to consummate an initial business combination on terms favorable to our investors.
 
58
General Risk Factors
Cyber incidents or attacks directed at us could result in information theft, data corruption, operational disruption and/or financial loss.
We depend on digital technologies, including information systems, infrastructure and cloud applications and services, including those of third parties with which we may deal. Sophisticated and deliberate attacks on, or security breaches in, our systems or infrastructure, or the systems or infrastructure of third parties or the cloud, could lead to corruption or misappropriation of our assets, proprietary information and sensitive or confidential data. As an early stage company without significant investments in data security protection, we may not be sufficiently protected against such occurrences. We may not have sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have adverse consequences on our business and lead to financial loss.
We are subject to changing laws and regulations regarding regulatory matters, corporate governance and public disclosure that have increased both our costs and the risk
of non-compliance.
We are subject to laws and regulations by various governing bodies, including, for example, the SEC, which is charged with the protection of investors and the oversight of companies whose securities are publicly traded, and to new and evolving regulatory measures under applicable law. Our efforts to comply with new and changing laws and regulations have resulted in and are likely to continue to result in, increased general and administrative expenses and a diversion of management time and attention from seeking a business combination target.
Moreover, because these laws, regulations and standards are subject to varying interpretations, their application in practice may evolve over time as new guidance becomes available. This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing revisions to our disclosure and governance practices. If we fail to address and comply with these regulations and any subsequent changes, we may be subject to penalty and our business may be harmed.
We may be a passive foreign investment company, or “PFIC,” which could result in adverse U.S. federal income tax consequences to U.S. investors.
If we are a PFIC for any taxable year (or portion thereof) that is included in the holding period of a U.S. investor that owns our Class A ordinary shares or warrants, the U.S. investor may be subject to adverse U.S. federal income tax consequences and may be subject to additional reporting requirements. Our PFIC status for our previous, current and subsequent taxable years may depend on whether we qualify for the
PFIC start-up exception.
Depending on the particular circumstances, the application of the
start-up
exception may be subject to uncertainty, and may also depend on the timing and structure of our business combinations, which are not known yet. Therefore there cannot be any assurance that we will qualify for
the start-up exception.
In addition, we may be a PFIC due to a business combination with a target company that is a PFIC. Accordingly, there can be no assurances with respect to our status as a PFIC for our prior, current taxable year or any subsequent taxable year. Our actual PFIC status for any taxable year, will not be determinable until after the end of such taxable year (and, in the case of the start-up exception, possibly not until after the close of the first two taxable years following
our start-up year
of 2021). Moreover, if we determine we are a PFIC for any taxable year, upon written request, we will endeavor to provide to a U.S. shareholder a PFIC Annual Information Statement in order to enable the U.S. shareholder to make and maintain a “qualified electing fund” election, but there can be no assurance that we will timely provide such required information, and such election would be unavailable with respect to our warrants in all cases. We urge U.S. investors to consult their tax advisors regarding the possible application of the PFIC rules. For a more detailed discussion, see the section captioned “Taxation—United States Federal Income Tax Considerations—U.S. Holders—Passive Foreign Investment Company Rules” in our prospectus filed with the Securities and Exchange Commission on June 10, 2021 pursuant to Rule 424b(4) under the Securities Act (Securities Act File
No.333-255722)
incorporated by reference into this annual report.
 
59
We are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements available to “emerging growth companies” or “smaller reporting companies,” this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.
We are an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. As a result, our shareholders may not have access to certain information they may deem important. We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of the initial public offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our Class A ordinary shares that are held
by non-affiliates equals
or exceeds $700 million as of the prior June 30, and (2) the date on which we have issued more than $1.0 billion
in non-convertible debt
during the prior three-year period. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply
to non-emerging growth
companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Additionally, we are a “smaller reporting company” as defined in Item 10(f)(1) of
Regulation S-K. Smaller
reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of any fiscal year for so long as either (1) the market value of our ordinary shares held
by non-affiliates is
less than $250 million as of the end of that year’s second fiscal quarter or (2) our annual revenues are less than $100 million during such completed fiscal year and the market value of our ordinary shares held
by non-affiliates is
less than $700 million as of the end of that year’s second fiscal quarter. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with other public companies difficult or impossible.
Item 1B. Unresolved Staff Comments
None.
Item 2. Property
We currently maintain our executive offices at Unit 11C/D, Kimley Commercial Building, 142 – 146 Queen’s Road Central, Hong Kong. The cost for the space is included in the up to $10,000 monthly fee that we pay our sponsor for office space, administrative and support services. We consider our current office space adequate for our current operations.
 
60
Item 3. Legal Proceedings
To the knowledge of our management, there is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.
Item 4. Mine Safety Disclosures
Not applicable.
 
61
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
(a) Market Information
Our units, Class A ordinary shares and warrants are each traded on the Nasdaq under the symbols “SMIHU,” “SMIH” and “SMIHW,” respectively. Our units commenced public trading on June 9, 2021. Our Class A ordinary shares and warrants began separate trading on July 30, 2021.
(b) Holders
On March 11, 2022, there were one holder of record of our units, one holder of record of our Class A ordinary shares, seven holder of our Class B ordinary shares and two holders of record of our warrants.
(c) Dividends
We have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination will be within the discretion of our board of directors at such time. In addition, our board of directors is not currently contemplating and does not anticipate declaring any share dividends in the foreseeable future. Further, if we incur any indebtedness in connection with a business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.
(d) Securities Authorized for Issuance Under Equity Compensation Plans
None.
(e) Performance Graph
Not applicable.
(f) Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings
Unregistered Sales
Following a share capitalization on April 30, 2021, our sponsor held an aggregate of 6,500,000 founder shares.
In connection with entering into the forward purchase agreements, our sponsor transferred to the anchor investors an aggregate of 375,000 founder shares for no cash consideration.
On April 30, 2021, our sponsor transferred 25,000 founder shares to each of our independent directors.
On July 23, 2021, the 750,000 Class B ordinary shares were forfeited when the overallotment option was mpt exercised and expired.
As a result, as of the date of this annual report, our sponsor now owns 5,300,000 founder shares.
 
62
The founder shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination on a
one-for-one
basis, subject to adjustment for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with our initial business combination, the number of Class A ordinary shares issuable upon conversion of the Class B ordinary shares issued and outstanding upon completion of our initial public offering will equal, in the aggregate, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon the completion of the initial public offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination (including the forward purchase shares, but not the forward purchase warrants), excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued or to be issued to any seller in the initial business combination and any private placement warrants issued to our sponsor, its affiliates or any member of our management team upon conversion of working capital loans.
With certain limited exceptions, the founder shares are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with our sponsor, each of whom will be subject to the same transfer restrictions) until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day
period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property.
Our sponsor purchased 6,000,000 private placement warrants at a price of $1.00 per warrant in a private placement that occurred concurrently with the closing of our initial public offering and generated gross proceeds of $6,000,000. Each private placement warrant is exercisable for one Class A ordinary share at a price of $11.50 per share. The proceeds from the sale of the private placement warrants were added to the net proceeds from the initial public offering held in the trust account. If we do not complete a business combination within 24 months from the closing of our initial public offering, the private placement warrants will expire worthless. The private placement warrants are
non-redeemable
and exercisable on a cashless basis so long as they are held by our sponsor or its permitted transferees. The sale of the private placement warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
Use of Proceeds
Of the proceeds we received from our initial public offering and the sale of the private placement warrants, a total of $206,000,000, including $7,000,000 payable to the underwriter for deferred underwriting commissions, was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee.
There has been no material change in the planned use of proceeds from such use as described in the our prospectus filed with the Securities and Exchange Commission on June 10, 2021 pursuant to Rule 424b(4).
(g) Purchases of Equity Securities by the Issuer and Affiliated Purchasers
None.
Item 6. Selected Financial Data
Not applicable.
 
63
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Forward-Looking Statements
All statements other than statements of historical fact included in this annual report including, without limitation, statements under this “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding our financial position, business strategy and the plans and objectives of management for future operations, are forward looking statements. When used in this annual report, words such “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions, as they relate to us or our management, identify forward looking statements. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings. Such forward looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, our management. No assurance can be given that results in any forward-looking statement will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially. The cautionary statements made in this annual report should be read as being applicable to all forward-looking statements whenever they appear in this annual report. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act. Actual results could differ materially from those contemplated by the forward looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.
Overview
We are a blank check company incorporated on December 22, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of the initial public offering and the sale of the private placement warrants and forward purchase securities, the proceeds of the sale of our shares in connection with our initial business combination (pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of the initial public offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing or other sources.
The issuance of additional shares in connection with a business combination, including the issuance of forward purchase securities, to the owners of the target or other investors:
 
  •
may significantly dilute the equity interest of investors in the initial public offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than
one-to-one
basis upon conversion of the Class B ordinary shares;
 
  •
may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares;
 
  •
could cause a change in control if a substantial number of our Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;
 
  •
may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us;
 
  •
may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and
 
  •
may not result in adjustment to the exercise price of our warrants.
Similarly, if we issue debt or otherwise incur significant debt, it could result in:
 
  •
default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
 
  •
acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
 
  •
our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;
 
64
  •
our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;
 
  •
our inability to pay dividends on our Class A ordinary shares;
 
  •
using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;
 
  •
limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;
 
  •
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and
 
  •
limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.
As indicated in the accompanying financial statements, as of December 31, 2021, we had cash of $885,198 and working capital of $884,244. Further, we expect to incur significant costs in the pursuit of our initial business combination. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities in the year of 2021 were organizational activities, those necessary to prepare for our initial public offering, described below, and after our initial public offering, identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We will generate
non-operating
income in the form of interest income on marketable securities after our initial public offering. We are incurring expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a Business Combination.
For the year ended December 31, 2021, we had a net loss of $545,727, which consists of operating and formation costs of $549,179, change in fair value of FPA $2,785,941, transaction costs allocable to warrants $507,417, offset by change in fair value of warrant liabilities of $3,289,535, and interest income on investments held in the Trust Account of $7,275.
For the period from December 22, 2020 (Inception) to December 31, 2020, we had a net loss of $3,636, which consists of operating and formation costs.
Liquidity and Capital Resources
On June 11, 2021, we consummated our Initial Public Offering of 20,000,000 Units, at a price of $10.00 per Unit, generating gross proceeds of $200,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 6,000,000 Private Placement Warrants to our sponsor at a price of $1.00 per warrant, generating gross proceeds of $6,000,000.
Following our Initial Public Offering and the sale of the Private Placement Warrants, a total of $200,000,000 was placed in the Trust Account. We incurred $11,587,941 in transaction costs, including $4,000,000 of underwriting fees, $7,000,000 of deferred underwriting fees and $587,941 of other cash offering costs.
 
65
For the year ended December 31, 2021, cash used in operating activities was $613,225. Net loss of $545,727 consists of transaction costs allocable to warrants of $507,417, offset by an unrealized gain on change on fair value of warrants and FPA liability of $503,594, interest earned on investments held in the Trust Account of $7,275, and changes in operating assets and liabilities, which used $64,046 of cash from operating activities.
As of December 31, 2021, we had investments held in the Trust Account of $200,007,275. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (which interest shall be net of taxes payable and excluding deferred underwriting commissions) to complete our Business Combination. To the extent that our share capital is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of December 31, 2021, we had cash of $885,198 for working capital purposes. We intend to use the funds for working capital purposes primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant unit at the option of the lender. The warrants would be identical to the Private Placement Warrants.
If our estimate of the costs of identifying a target business,
undertaking in-depth
due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.
Off-balance
sheet financing arrangements
We have no obligations, assets or liabilities, which would be considered
off-balance
sheet arrangements as of December 31, 2021.
We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating
off-balance
sheet arrangements. We have not entered into any
off-balance
sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any
non-financial
assets.
Contractual obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay our sponsor a monthly fee of $10,000 for office space, and administrative and support services, provided to the Company. We began incurring these fees on June 8, 2021 and will continue to incur these fees monthly until the earlier of the completion of a Business Combination and the Company’s liquidation.
The underwriters are entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the our Initial Public Offering upon the completion of our initial Business Combination
Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
 
66
Derivative Financial Instruments
We evaluate our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is
then re-valued at
each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current
or non-current
based on whether or
not net-cash
settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Warrant Liability and Forward Purchase Agreement
We account for the 16,000,000 warrants issued in connection with the IPO (the 10,000,000 Public Warrants and the 6,000,000 Private Placement Warrants) and Forward Purchase Agreement (“FPA”) in accordance with the guidance contained in FASB ASC 815 “Derivatives and Hedging” whereby under that provision the warrants and FPA do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, we will classify warrants and FPA as liabilities at their fair value. These liabilities are subject
to re-measurement
at each reporting period. With
such re-measurement,
the changes in fair value are recognized in the Statement of Operations in the period of change. Derivative warrant liabilities and FPA are classified
as non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Ordinary Shares Subject to Possible Redemption
We account for our Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2021 and December 31, 2020, 20,000,000 and 0 Class A ordinary shares, respectively, subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ (deficit) equity section of our balance sheet.
Net Income (Loss) Per Share of Ordinary Shares
We have two classes of shares, which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Earnings and losses are shared pro rata between the two classes of shares. The 16,000,000 potential ordinary shares for outstanding warrants to purchase our stock were excluded from diluted earnings per share for the year ended December 31, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods.
Item 7A. Quantitative and Qualitative Disclosures about Market Risk
Following the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in U.S. government treasury bills, notes or bonds with a maturity of 180 days or less or in certain money market funds that invest solely in US treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
Item 8. Financial Statements and Supplementary Data
This information appears following Item 15 of this Report and is included herein by reference.
 
67
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and President, to allow timely decisions regarding required disclosure.
As required by Rules
13a-15
and
15d-15
under the Exchange Act, our management carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures under the supervision of our Chief Executive Officer and our Principal Financial Officer and concluded that our disclosure controls and procedures are not effective as of December 31, 2021 because of the identification of a material weakness in our internal control over financial reporting relating to the accounting treatment for complex financial instruments. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Report present fairly in all material respects our financial position, results of operations and cash flows for the periods presented.
Management’s Report on Internal Controls Over Financial Reporting
This Annual Report on Form
10-K
does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting firm due to a transition period established by rules of the SEC for newly public companies.
Changes in Internal Control over Financial Reporting
Other than as described below, there were no changes in our internal control over financial reporting (as such term is defined in
Rules 13a-15(f) and
15d-15(f) of
the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Management has identified a material weakness in internal controls related to the accounting for complex financial instruments. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to continue to enhance our system of evaluating and implementing the accounting standards that apply to our financial statements, including through enhanced analyses by our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.
Remediation Plan
To address the material weakness, management has devoted, and plans to continue to devote, significant effort and resources to the remediation and improvement of its internal control over financial reporting and to provide processes and controls over the internal communications within the Company, financial advisors and other third-party professionals. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance these processes to better evaluate our research and understanding of the nuances of the complex accounting standards that apply to our financial statements. We plan to include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. Other than this issue, our disclosure controls and procedures were effective at a reasonable assurance level and, accordingly, provided reasonable assurance that the information required to be disclosed by us in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.
 
68
As we continue to evaluate and improve our financial reporting process, we may take additional actions to modify certain of the remediation measures described above. We cannot assure you that the measures we have taken to date, or any measures we may take in the future, will be sufficient to remediate the material weakness we have identified or avoid potential future material weaknesses.
Item 9B. Other Information.
None.
PART III
Item 10. Directors, Executive Officers and Corporate Governance
Directors and Executive Officers
 
Name
   
Age
     
Title
Bo Tan
      48     
Chief Executive
Officer, Co-Chief Investment
Officer and Director
Ken Poon
      55     
President, Co-Chief Investment
Officer and Director
Ian Stone
      71     
Independent Director
Thomas Folinsbee
      55     
Independent Director
Tao Bai
      57     
Independent Director
Bo Tan, our Chief Executive Officer
and Co-Chief Investment
Officer, has over 20 years of extensive experience in the financial and pharmaceutical industries and was the President and Chief Financial Officer of 3S Bio from December 2016 to December 2019. During his tenure at 3S Bio, Mr. Tan led the privatization of 3SBio and
its re-listing in
Hong Kong in 2015, as well as the acquisition and integration of Sciprogen, Sirton (Italy), Wanma and CP Guojian, as well as investments in various landmark healthcare assets, including Ascentage, Sorrento and Refuge. From 2015 to 2019, Mr. Tan was voted the “Best CFO” for consecutive years in the Institutional
Investor All-Asia Executive
Team poll. Mr. Tan joined 3SBio in 2009 and 3SBio’s market capitalization increased approximately 10 times from 2009 to 2018. Before joining 3S Bio, Mr. Tan served as the executive director and a member of Investment Committee of Bohai Industrial Investment Fund Management Company,
a PRC-based private
equity firm, and presided over the investment in The Chengdu Commercial Bank, from April 2007 to September 2008. Prior to that, Mr. Tan served as a vice president in the equity research division of Lehman Brothers Asia Limited from March 2006 to March 2007 and as a senior analyst at Macquarie Securities Asia in Hong Kong from October 2004 to February 2006. Mr. Tan is widely acclaimed for his stellar track record of combining business operations and capital market prowess and has long-standing strategic relationships with major MNCs. Mr. Tan received his Bachelor’s degree in Economics from Renmin University of China in July 1994, Master’s degree in Economics from the University of Connecticut in December 1996 and a Master of International Management from Thunderbird School of Global Management in August 1998.
Ken Poon, our President
and Co-Chief Investment
Officer, has nearly 30 years of capital markets experiences in Asia and is the founding partner of XCap Partners Limited, a boutique advisory firm in Hong Kong. Prior to founding XCap Partners Limited in 2019, Mr. Poon served as the Asia Pacific Head of Capital Markets Origination at Citigroup, running the Equity Capital Markets, Debt Capital Markets and Acquisition Finance businesses for all
Asia ex-Japan. Prior
to his tenure at Citigroup, Mr. Poon served as the Head of Asia Equity Capital Markets at Merrill Lynch from August 1998 to May 2004. Mr. Poon has led a series of landmark transactions globally, including Alibaba’s US$25 billion NYSE IPO, Luye Pharmaceutical’s US$878 million HKSE IPO, Samsung Biologic’s US$2 billion KOSE IPO, Chungwha Telecom Taiwan’s US$1.6 billion NYSE IPO and privatization, Melco’s US$1.3 billion Nasdaq IPO, TSMC’s US$2.0 billion registered ADR offering, China Mobile’s US$7.2 billion simultaneous placement of equity and convertibles, China Netcom’s US$1.2 billion dual listed NYSE and HKSE IPO, China CITIC Bank’s US$5.9 billion HKSE IPO, Longor Group’s US$1.0 billion HKSE IPO, CRCC’s US$2.3 billion HKSE IPO, Global Logistics Property US$3 billion SGX IPO, PetroChina’s US$2.4 billion Equity Placement, Sands China’s US$2.5 billion HKSE IPO and AIA’s US$20 billion HKSE IPO. He also led numerous billion-dollar bond offerings for companies such as Hutshison/Vodafone, Temasek/Singapore Telecom and Korea Telecom. Mr. Poon holds a Bachelor of Commerce degree in Finance from The University of British Columbia
 
69
Ian Stone, our independent director, joined Pontis Partners, a consulting business specializing in the telecom, internet and media industries, in 2001, where he is currently a director. Through his position at Pontis Partners, Mr. Stone serves as a board member and advisor to a number of listed and private companies in the Asia and Middle East North Africa regions. In particular, Mr. Stone currently serves as an independent director of Tencent Holding Company (HKEX: 0700), one of Chinese largest online technology companies, and an independent director at Panther Media Group, a MENA region media company, between October 2018 and September 2021. From 2001 to 2014 Mr. Stone served in various positions at PCCW, a leading telecommunications and media company in Hong Kong, including as managing director of various business units.
Thomas Folinsbee, our independent director, has over 25 years of experience as a financial and securities professional. Mr. Folinsbee has been the business development consultant of Shanghai Alebund Pharmaceuticals Ltd., a China-based pharmaceutical company, since 2019, where he is responsible for pharmaceutical inlicensing and outlicensing transactions. Prior to joining Alebund, Mr. Folinsbee was Director of Corporate Development of the strategic investment division of 3SBio Inc., a biotechnology company, from 2009 to 2019, focusing on sourcing business development opportunities in Canada, Australia, and Japan, including licensing, distribution, and M&A. Mr. Folinsbee joined 3SBio to manage its investor relations activities and was a member of the management group that delisted 3SBio from Nasdaq in May 2013 and relisted it on the Hong Kong Stock Exchange in June 2016. From 2017 to 2019, Mr. Folinsbee also served as independent director of Bison Capital Acquisition Corporation, a special purpose acquisition company that acquired Xynomic Pharmaceuticals Holdings, Inc. in 2019. Mr. Folinsbee continued to serve as independent director and was a member of the audit and compensation committees after the acquisition. From 2011 to 2016, Mr. Folinsbee also worked for Hisanaga Seisakusho Co. Ltd., a Japanese manufacturing company, where he helped launch Hisanaga’s sales platform in India and designed a business intelligence system to support a corporate turnaround. Before joining 3SBio Inc., Mr. Folinsbee also worked at Macquarie Equities, BNP Paribas and Optivest Systems Ltd. Mr. Folinsbee graduated in 1990 from McGill University with a Bachelor of Commerce degree concentrating in finance and international business (with distinction).
Tao Bai, our independent director, is a partner at the Beijing and Tianjin offices of JunHe Law Offices. Prior to joining JunHe Law Offices in 2002, Ms. Bai was a founding partner at Commerce & Finance Law offices from 1992 to 2002. Prior to that, Ms. Bai practiced with C&C Law Offices in Beijing from 1989 to 1992. Over the years, Ms. Bai has provided comprehensive legal services to many international clients, including multinational corporations and international organizations, as well as large Chinese enterprises and trade organizations, in the fields of IP protection, anti-dumping, M&A, project financing, IPOs, litigation, arbitration and administrative actions. Ms. Bai is a member of the
All-China
Bar Association, a Standing Director of Beijing Intellectual Property Protection Association, a member of the Chinese Society of International Law and the Inter-Pacific Bar Association, the Vice President of Beijing Bar Association and an arbitrator of the China International Economic and Trade Arbitration Commission, Shanghai International Economic and Trade Arbitration Commission and Hainan Arbitration Commission. Ms. Bai received the Outstanding and Lifetime Achievement for Asia Women in Business Law award from the Euromoney Legal Media Group in 2016. Ms. Bai received her LL.B. degree from Peking University Law School in 1985 and her J.D. degree from Cornell Law School in 1988.
Number, Terms of Office and Election of Officers and Directors
Prior to the completion of an initial business combination, any vacancy on the board of directors may be filled by a nominee chosen by holders of a majority of our founder shares. In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason.
Pursuant to an agreement to be entered into on or prior to the closing of the initial public offering, our sponsor, upon and following the consummation of an initial business combination, will be entitled to nominate three individuals for election to our board of directors, as long as the sponsor holds any securities covered by the registration and shareholder rights agreement.
 
70
Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate. Our amended and restated memorandum and articles of association will provide that our officers may consist of one or more chairman of the board, chief executive officer, president, chief financial officer, vice presidents, secretary, treasurer and such other offices as may be determined by the board of directors.
Director Independence
The rules of the Nasdaq require that a majority of our board of directors be independent within one year of our initial public offering. An “independent director” is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. We have three “independent directors” as defined in the Nasdaq rules and applicable SEC rules. Our board of directors has determined that each of Ian Stone, Thomas Folinsbee and Tao Bai is an “independent director” as defined in the Nasdaq listing standards and applicable SEC rules. Our independent directors have regularly scheduled meetings at which only independent directors are present.
Committees of the Board of Directors
We have three standing committees: an audit committee, a nominating committee and a compensation committee. Subject
to phase-in rules
and a limited exception, the rules of Nasdaq and
Rule 10A-3 of
the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors. Subject
to phase-in rules
and a limited exception, the rules of Nasdaq require that the compensation committee and the nominating committee of a listed company be comprised solely of independent directors.
Audit Committee
Ian Stone, Thomas Folinsbee and Tao Bai serve as members of our audit committee. Our board of directors has determined that each of Ian Stone, Thomas Folinsbee and Tao Bai are independent under the Nasdaq listing standards and applicable SEC rules. Thomas Folinsbee serves as the chairman of the audit committee. Under the Nasdaq listing standards and applicable SEC rules, all the directors on the audit committee must be independent. Each member of the audit committee is financially literate and our board of directors has determined that Thomas Folinsbee qualifies as an “audit committee financial expert” as defined in applicable SEC rules.
We have adopted an audit committee charter, which details the principal functions of the audit committee, including:
 
  •
meeting with our independent registered public accounting firm regarding, among other issues, audits, and the adequacy of our accounting and control systems;
 
  •
monitoring the independence of the independent registered public accounting firm;
 
  •
verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law;
 
  •
inquiring and discussing with management our compliance with applicable laws and regulations;
 
  •
pre-approving
all audit services and permitted
non-audit
services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed;
 
  •
appointing or replacing the independent registered public accounting firm;
 
  •
determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent registered public accounting firm regarding financial reporting) for the purpose of preparing or issuing an audit report or related work;
 
71
  •
establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies;
 
  •
monitoring compliance on a quarterly basis with the terms of the initial public offering and, if any
non-compliance
is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of the initial public offering; and
 
  •
reviewing and approving all payments made to our existing shareholders, executive officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our board of directors, with the interested director or directors abstaining from such review and approval.
Compensation Committee
The members of our compensation committee are Ian Stone, Thomas Folinsbee and Tao Bai, and Ian Stone serves as chairman of the compensation committee.
Under the Nasdaq listing standards, we are required to have a compensation committee composed entirely of independent directors. Our board of directors has determined that each of Ian Stone, Thomas Folinsbee and Tao Bai are independent. We have adopted a compensation committee charter, which details the principal functions of the compensation committee, including:
 
  •
reviewing and approving on an annual basis the corporate goals and objectives relevant to our President’s, Chief Executive Officer’s and Chief Investment Officer’s, evaluating our President’s, Chief Executive Officer’s and Chief Investment Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our President, Chief Executive Officer and Chief Investment Officer based on such evaluation;
 
  •
reviewing and approving the compensation of all of our other Section 16 executive officers;
 
  •
reviewing our executive compensation policies and plans;
 
  •
implementing and administering our incentive compensation and equity-based remuneration plans;
 
  •
assisting management in complying with our proxy statement and annual report disclosure requirements;
 
  •
approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees;
 
  •
producing a report on executive compensation to be included in our annual proxy statement; and
 
  •
reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.
The charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.
Nominating and Corporate Governance Committee
The members of our nominating committee are Ian Stone, Thomas Folinsbee and Tao Bai, and Tao Bai serves as chairman of the nominating committee. Under the Nasdaq listing standards, we are required to have a nominating committee composed entirely of independent directors. Our board of directors has determined that each of Ian Stone, Thomas Folinsbee and Tao Bai are independent.
 
72
The nominating committee is responsible for overseeing the selection of persons to be nominated to serve on our board of directors. The nominating committee considers persons identified by its members, management, shareholders, investment bankers and others.
Guidelines for Selecting Director Nominees
The guidelines for selecting director nominees, which is specified in our charter, provide that persons to be nominated:
 
  •
should have demonstrated notable or significant achievements in business, education or public service;
 
  •
should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and
 
  •
should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders.
The nominating committee will consider a number of qualifications relating to management and leadership experience, background, integrity and professionalism in evaluating a person’s candidacy for membership on the board of directors. The nominating committee may require certain skills or attributes, such as financial or accounting experience, to meet specific board needs that arise from time to time and will also consider the overall experience and makeup of its members to obtain a broad and diverse mix of board members. The nominating committee does not distinguish among director nominees recommended by shareholders and other persons.
Compensation Committee Interlocks and Insider Participation
None of our officers currently serves, or in the past year has served, as a member of the compensation committee of any entity that has one or more officers serving on our board of directors.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires our officers, directors and persons who beneficially own more than ten percent of our ordinary shares to file reports of ownership and changes in ownership with the SEC. These reporting persons are also required to furnish us with copies of all Section 16(a) forms they file. Based solely upon a review of such forms, we believe that during the year ended December 31, 2021 there were no delinquent filers.
Code of Business Conduct Ethics
We have adopted a Code of Business Conduct and Ethics applicable to our directors, officers and employees. A copy of the Code of Business Conduct and Ethics and the charters of the committees of our board of directors is provided without charge upon request from us. If we make any amendments to our Code of Business Conduct and Ethics other than technical, administrative or other
non-substantive
amendments, or grant any waiver, including any implicit waiver, from a provision of the Code of Business Conduct and Ethics applicable to our principal executive officer, principal financial officer principal accounting officer or controller or persons performing similar functions requiring disclosure under applicable SEC or Nasdaq rules, we will disclose the nature of such amendment or waiver on Form
8-K.
Conflicts of Interest
All of our executive officers and certain of our directors have or may have fiduciary and contractual duties to certain companies in which they have invested. These entities may compete with us for acquisition opportunities. If these entities decide to pursue any such opportunity, we may be precluded from pursuing it. However, we do not expect these duties to present a significant conflict of interest with our search for an initial business combination.
 
73
Under Cayman Islands law, directors and officers owe the following fiduciary duties:
 
  •
duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole;
 
  •
duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;
 
  •
directors should not improperly fetter the exercise of future discretion;
 
  •
duty to exercise powers fairly as between different sections of shareholders;
 
  •
duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and
 
  •
duty to exercise independent judgment.
In addition to the above, directors also owe a duty of care that is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge skill and experience of that director.
As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the amended and restated memorandum and articles of association or alternatively by shareholder approval at general meetings.
Certain of our officers or directors presently have, and any of them in the future may have additional, fiduciary and contractual duties to other entities. As a result, if any of our officers or directors becomes aware of a business combination opportunity that is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, then, subject to their fiduciary duties under Cayman Islands law, he or she will need to honor such fiduciary or contractual obligations to present such business combination opportunity to such entity, before we can pursue such opportunity. If these other entities decide to pursue any such opportunity, we may be precluded from pursuing the same. However, we do not expect these duties to materially affect our ability to complete our initial business combination. Our amended and restated memorandum and articles of association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer, on the one hand, and us, on the other.
Below is a table summarizing the entities to which our officers and directors currently have fiduciary duties, contractual obligations or other material management relationships:
 
Individual
   
Entity
   
Entity’s Business
   
Affiliation
Ken Poon
   
XCap Partners Limited
   
Financial Advisory
   
Founding Partner
Ian Stone    Tencent Holdings Ltd.    Tech Investment Management    Independent Director
Thomas Folinsbee    Shanghai Alebund Pharmaceuticals Ltd.    Pharmaceutical    Business Development Director
 
74
Potential investors should also be aware of the following other potential conflicts of interest:
 
  •
Our officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our officers and directors is engaged in, or may in the future engage in, several other business endeavors for which he or she may be entitled to substantial compensation, and our officers and directors are not obligated to contribute any specific number of hours per week to our affairs.
 
  •
Our sponsor subscribed for founder shares prior to the completion of the IPO and purchased private placement warrants in a transaction that closed simultaneously with the closing of the IPO.
 
  •
Our sponsor, officers and directors have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion of our initial business combination and (ii) a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of the initial public offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares.
Additionally, our sponsor has agreed to waive its rights to liquidating distributions from the trust account with respect to its founder shares if we fail to complete our initial business combination within the prescribed timeframe. If we do not complete our initial business combination within the prescribed timeframe, the private placement warrants will expire worthless. Except as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day
period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement warrants will not be transferable until 30 days following the completion of our initial business combination. Because each of our officers and directors will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.
 
  •
Our sponsor, officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors is included by a target business as a condition to any agreement with respect to our initial business combination. In addition, our sponsor, officers and directors may sponsor, form or participate in other blank check companies similar to ours during the period in which we are seeking an initial business combination. Any such companies may present additional conflicts of interest in pursuing an acquisition target, particularly in the event there is overlap among investment mandates.
We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors. In the event we seek to complete our initial business combination with a company that is affiliated with our sponsor or any of our officers or directors, we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that such initial business combination is fair to our company from a financial point of view. We are not required to obtain such an opinion in any other context.
 
75
Furthermore, in no event will our sponsor or any of our existing officers or directors, or their respective affiliates, be paid by us any finder’s fee, consulting fee or other compensation prior to, or for any services they render in order to effectuate, the completion of our initial business combination. Further, commencing on the date our securities are first listed on Nasdaq, we will also reimburse an affiliate of our sponsor for office space, utilities, administrative services and remote support services provided to us in the amount of $10,000 per month.
We cannot assure you that any of the above mentioned conflicts will be resolved in our favor.
If we seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. A quorum for such meeting will be present if holders of
one-third
of the issued and outstanding shares entitled to vote at the meeting are represented in person or by proxy. In such case, our initial shareholders have agreed to vote their founder shares and public shares in favor of our initial business combination.
Limitation on Liability and Indemnification of Officers and Directors
Cayman Islands law does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against willful default, willful neglect, civil fraud or the consequences of committing a crime. Our amended and restated memorandum and articles of association will provide for indemnification of our officers and directors to the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through their own actual fraud, willful default or willful neglect. We will enter into agreements with our officers and directors to provide contractual indemnification in addition to the indemnification provided for in our amended and restated memorandum and articles of association. We expect to purchase a policy of officers’ and directors’ liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.
Our officers and directors have agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account, and have agreed to waive any right, title, interest or claim of any kind they may have in the future as a result of, or arising out of, any services provided to us and will not seek recourse against the trust account for any reason whatsoever (except to the extent they are entitled to funds from the trust account due to their ownership of public shares). Accordingly, any indemnification provided will only be able to be satisfied by us if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination.
Our indemnification obligations may discourage shareholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an action, if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification provisions.
We believe that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented and experienced officers and directors.
 
76
Item 11. Executive Compensation.
None of our executive officers or directors have received any cash compensation for services rendered to us. Commencing on the date that our securities are first listed on Nasdaq through the earlier of consummation of our initial business combination and our liquidation, we will reimburse an affiliate of our sponsor for office space, utilities, administrative services and remote support services provided to us in the amount of $10,000 per month. In addition, our sponsor, executive officers and directors, or their respective affiliates will be reimbursed for
any out-of-pocket expenses
incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our sponsor, executive officers or directors, or their respective affiliates. Any such payments prior to an initial business combination will be made using funds held outside the trust account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional controls in place governing our reimbursement payments to our directors and executive officers for
their out-of-pocket expenses
incurred in connection with our activities on our behalf in connection with identifying and consummating an initial business combination. Other than these payments and reimbursements, no compensation of any kind, including finder’s and consulting fees, will be paid by the company to our sponsor, officers and directors, or their respective affiliates, for services rendered prior to completion of our initial business combination.
After the completion of our initial business combination, members of our management team who remain with us may be paid consulting or management fees from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the proxy solicitation materials or tender offer materials furnished to our shareholders in connection with a proposed business combination. We have not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation will be known at the time of the proposed business combination, because the directors of the post-combination business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our executive officers will be determined, or recommended to the board of directors for determination, either by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our board of directors.
We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our executive officers and directors may negotiate employment or consulting arrangements to remain with us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our executive officers and directors that provide for benefits upon termination of employment.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The following table sets forth information regarding the beneficial ownership of our ordinary shares available to us at March 31, 2022, with respect to our ordinary shares held by:
 
  •
each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares;
 
  •
each of our officers and directors; and
 
  •
all our officers and directors as a group.
Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary shares beneficially owned by them. The following table does not reflect record or beneficial ownership of the private placement warrants as these warrants are not exercisable within 60 days of March 31, 2022. The approximate percentage of voting control in the following table assume that all Class B ordinary shares there are 25,750,000 ordinary shares issued and outstanding after the initial public offering.
 
77
    
Class B ordinary shares
(2)
    
Class A ordinary shares
        
Name of Beneficial Owners
(1)
   
Number of

Shares

Beneficially

Owned
    
Approximate

Percentage of

Class
    
Number of

Shares

Beneficially

Owned
     
Approximate

Percentage of

Class
    
Approximate

Percentage of

Voting

Control
(3)
  
Summit Healthcare Acquisition Sponsor LLC
(4)
      5,300,000       92.17 %      —          —         20.58 % 
Millennium Group
(5)
      —         —         1,194,960        5.97 %      4.64 % 
BFAM Partners Group
(6)
      —         —         1,110,000        5.55 %      4.31 % 
Bo Tan
      —         —         —          —         —    
Ken Poon
      —         —         —          —         —    
Ian Stone
      25,000 *        —          —   *   
Thomas Folinsbee
      25,000 *        —          —   *   
Tao Bai
      25,000 *        —          —   *   
All officers, directors and director nominees as a group (five individuals)
      75,000       1.30 %      —          —   *   
 
*
Less than one percent.
 
(1)
Unless otherwise noted, the business address of each of our shareholders is Unit 1101, 11th Floor, 1 Lyndhurst Tower, 1 Lyndhurst Terrace, Central, Hong Kong.
 
(2)
Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination on a
one-for-one
basis, subject to adjustment. Excludes forward purchase shares that will only be issued, if at all, at the time of our initial business combination.
 
(3)
Assume Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination on a
one-for-one
basis and there are 25,750,000 ordinary shares issued and outstanding within 60 days of March 31, 2022.
 
(4)
The shares reported are held in the name of our sponsor. There are three managers of our sponsor. Each manager has one vote, and the approval of two of the three directors of the board of managers is required to approve an action of our sponsor. Under the
so-called
“rule of three,” if voting and dispositive decisions regarding an entity’s securities are made by two or more individuals, and a voting and dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity’s securities. This is the situation with regard to our sponsor. Based upon the foregoing analysis, no individual manager of our sponsor exercises voting or dispositive control over any of the securities held by our sponsor, even those in which he directly holds a pecuniary interest. Accordingly, none of them will be deemed to have or share beneficial ownership of such shares.
 
(5)
The 1,194,960 Class A ordinary shares as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Israel A. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities. The address of Millennium Group is 399 Park Avenue New York, New York 10022. Information set forth above is based upon Millennium Group’s Schedule 13G/A filing with the SEC on January 31, 2022.
 
(6)
The 1,110,000 Class A ordinary shares are held, or may be acquired, for the account of BFAM Asian Opportunities Master FUND, L.P. (the “Master Fund”). BFAM Partners (Cayman) Limited (the “BFAM Cayman”) serves as the investment adviser to the Master Fund. BFAM Partners (North America) LLC (the “BFAM North America”) and BFAM Partners (Hong Kong) Limited (the “BFAM Hong Kong”) are wholly-owned subsidiaries of BFAM Cayman and serve as
sub-advisers
to the Master Fund. BFAM Asian Opportunities Master GP Limited (the “Master GP”) serves as the general partner of the Master Fund. In such capacities, BFAM Cayman, BFAM North America, BFAM Hong Kong, the Master GP and Benjamin Fuchs (“Mr. Fuchs”) may be deemed to have voting and dispositive power over the shares held for the Master Fund. he address of the principal business office of BFAM Cayman, BFAM Hong Kong, the Master Fund and the Master GP is c/o BFAM Partners (Hong Kong) Limited, 35th Floor, Suite
1-3A,
148 Electric Road, North Point, Hong Kong. The address of the principal business office of BFAM North America is 900 Third Avenue, 11th Floor, Suite 1102, New York, NY 10022. Information set forth above is based upon the Master Fund’s Schedule 13G/A filing with the SEC on February 11, 2022.
 
78
Our initial shareholders will beneficially own 20% of the sum of the total number of the then issued and outstanding ordinary shares plus 3,000,000 Class A ordinary shares to be sold pursuant to the forward purchase agreements and will have the right to elect all of our directors prior to our initial business combination. Holders of our public shares will not have the right to elect any directors to our board of directors prior to our initial business combination. Because of this ownership block, our initial shareholders may be able to effectively influence the outcome of all other matters requiring approval by our shareholders, including amendments to our amended and restated memorandum and articles of association and approval of significant corporate transactions including our initial business combination.
In connection with our initial public offering, we entered into forward purchase agreements pursuant to which the anchor investors agreed to purchase an aggregate of 3,000,000 Class A ordinary shares plus 750,000 redeemable warrants for a purchase price of $10.00 per Class A ordinary share, as applicable, or $30,000,000 in the aggregate, in a private placement to close concurrently with the closing of our initial business combination. In connection with entering into these forward purchase agreements, our sponsor transferred to the anchor investors an aggregate of 375,000 founder shares for no cash consideration. The founder shares transferred to the anchor investors are subject to similar contractual conditions and restrictions as the founder shares issued to our sponsor. The anchor investors will have redemption rights with respect to any public shares they own. The forward purchase warrants will have the same terms as our public warrants. The forward purchase agreements also provide that the anchor investors are entitled to registration rights with respect to (A) the forward purchase securities and Class A ordinary shares underlying the forward purchase warrants and founder shares, (B) any other Class A ordinary shares or warrants acquired by the anchor investors any time after we complete our initial business combination, and (C) any other equity security of the Company issued or issuable with respect to the securities referred to in (A) and (B) by way of a share capitalization or share
sub-division
or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization.
Under the forward purchase agreements, we will provide a right of first offer to the anchor investors, if we propose to raise additional capital by issuing any equity, or securities convertible into, exchangeable or exercisable for equity securities, other than the units offered in the initial public offering and certain excluded securities.
Our sponsor has agreed (a) to vote any founder shares and public shares held by it in favor of any proposed business combination and (b) not to redeem any founder shares or public shares held by it in connection with a shareholder vote to approve a proposed initial business combination.
Our sponsor is deemed to be our “promoter” as such term is defined under the federal securities laws.
Transfers of Founder Shares and Private Placement Warrants
The founder shares, private placement warrants and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant
to lock-up provisions
in the agreements entered into by our initial shareholders. Our initial shareholders have agreed not to transfer, assign or sell any of their founder shares until the earliest of (a) one year after the completion of our initial business combination and (b) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day
period commencing at least 150 days after our initial business combination or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The private placement warrants and the respective Class A ordinary shares underlying such warrants are not transferable or salable until 30 days after the completion of our initial business combination. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement warrants or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination;
 provided
, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement.
 
79
Registration Rights
The holders of the founder shares, private placement warrants and any warrants that may be issued upon conversion of working capital loans (and any Class A ordinary shares issuable upon the exercise of the private placement warrants and warrants that may be issued upon conversion of working capital loans) will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. However, the registration and shareholder rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period, which occurs (i) in the case of the founder shares, as described in the following paragraph, and (ii) in the case of the private placement warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such registration statements.
Pursuant to the forward purchase agreements, we have agreed that we will use our reasonable best efforts (i) to file within 30 days after the closing of the initial business combination (and, with respect to (ii)(B) below, within 30 days following announcement of the results of the shareholder vote relating to our initial business combination or the results of our offer to shareholders to redeem their Class A ordinary shares in connection with our initial business combination (whichever is later), which we refer to as the “disclosure date”) a registration statement with the SEC for a secondary offering of (A) the forward purchase securities, Class A ordinary shares underlying the forward purchase warrants and the Class A ordinary shares into which the anchor investors’ founder shares are convertible, (B) any other Class A ordinary shares or warrants acquired by the anchor investors any time after we complete our initial business combination, and (C) any other equity security of the Company issued or issuable with respect to the securities referred to in (i)(A) and (i)(B) by way of a share capitalization or share
sub-division
or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization, (ii) to cause such registration statement to be declared effective promptly thereafter, but in no event later than 60 days after the closing of the initial business combination, and (iii) to maintain the effectiveness of such registration statement until the earliest of (A) the date on which the anchor investor or its assignee ceases to hold the securities covered thereby and (B) the date all of the securities covered thereby can be sold publicly without restriction or limitation under Rule 144 under the Securities Act and without the requirement to be in compliance with Rule 144(c)(1) under the Securities Act, subject to certain conditions and limitations set forth in the forward purchase agreements. We will bear the cost of registering these securities.
Except as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day
period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of our initial shareholders with respect to any founder shares. We refer to such transfer restrictions throughout this annual report as
the lock-up.
In addition, pursuant to the registration and shareholder rights agreement, our sponsor, upon and following consummation of an initial business combination, will be entitled to nominate three individuals for election to our board of directors, as long as the sponsor holds any securities covered by the registration and shareholder rights agreement.
 
80
Equity Compensation Plans
As of December 31, 2021, we had no compensation plans (including individual compensation arrangements) under which equity securities were authorized for issuance.
Item 13. Certain Relationships and Related Transactions, and Director Independence
On December 31, 2020, our sponsor paid $25,000, or approximately $0.004 per share, to cover certain expenses on our behalf in consideration of 5,750,000 Class B ordinary shares, par value $0.0001. Following a share capitalization on April 30, 2021, our sponsor held an aggregate of 6,500,000 founder shares and then, in connection with entering into the forward purchase agreements, transferred to the anchor investors an aggregate of 375,000 founder shares for no cash consideration. These 375,000 founder shares were not subject to forfeiture. On April 30, 2021, our sponsor transferred 25,000 founder shares to each of our independent directors. These 75,000 founder shares were not subject to forfeiture. The number of founder shares issued was determined based on the expectation that such founder shares would represent 20% of the sum of the total number of the issued and outstanding ordinary shares upon the completion of the initial public offering plus 3,000,000 Class A ordinary shares to be sold pursuant to the forward purchase agreements.
Our sponsor purchased, pursuant to a written agreement, an aggregate of 6,000,000 private placement warrants for a purchase price of $1.00 per warrant in a private placement that occurred simultaneously with the closing of the initial public offering. As such, our sponsor’s interest in this transaction is valued at $6,000,000. Each private placement warrant entitles the holder to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement warrants (including the Class A ordinary shares issuable upon exercise thereof) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of our initial business combination.
As more fully discussed in the section of this annual report entitled “Item 10. Directors, Executive Officers and Corporate Governance—Conflicts of Interest,” if any of our officers or directors becomes aware of a business combination opportunity that falls within the line of business of any entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such entity. Our officers and directors currently have certain relevant fiduciary duties or contractual obligations that may take priority over their duties to us.
We currently maintain our executive offices at Unit 1101, 11th Floor, 1 Lyndhurst Tower, 1 Lyndhurst Terrace, Central, Hong Kong. The cost for our use of this space is included in the $10,000 per month fee we will pay to an affiliate of our sponsor for office space, utilities, administrative services and remote support services, commencing on the date that our securities are first listed on Nasdaq. Upon the completion of our initial business combination or our liquidation, we will cease paying these monthly fees.
No compensation of any kind, including finder’s and consulting fees, will be paid to our sponsor, officers and directors, or their respective affiliates, for services rendered prior to or in connection with the completion of an initial business combination. However, these individuals will be reimbursed for
any out-of-pocket expenses
incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our sponsor, officers, directors or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement
of out-of-pocket expenses
incurred by such persons in connection with activities on our behalf.
Prior to the consummation of the initial public offering, our sponsor has agreed to loan us up to $300,000 to be used for a portion of the expenses of the initial public offering. These loans
are non-interest bearing,
unsecured and are due at the earlier of June 30, 2021 and the closing of the initial public offering. The loan will be repaid upon the closing of the initial public offering out of the offering proceeds not held in the trust account.
 
81
In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants, including as to exercise price, exercisability and exercise period. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor, its affiliates or our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
After our initial business combination, members of our management team who remain with us may be paid consulting, management or other fees from the combined company with any and all amounts being fully disclosed to our shareholders, to the extent then known, in the tender offer or proxy solicitation materials, as applicable, furnished to our shareholders. It is unlikely the amount of such compensation will be known at the time of distribution of such tender offer materials or at the time of a general meeting held to consider our initial business combination, as applicable, as it will be up to the directors of the post-combination business to determine executive and director compensation.
We have entered into agreements with our initial shareholders pursuant to which they will be entitled to certain registration rights with respect to their founder shares, private placement warrants, the warrants issuable upon conversion of working capital loans (if any) and the Class A ordinary shares issuable upon exercise of the foregoing and upon conversion of the founder shares, and, upon the consummation of our initial business combination, to nominate three individuals for election to our board of directors, as long as the sponsor holds any securities covered by the registration and shareholder rights agreement, which is described under the heading “Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters—Registration Rights.”
The audit committee of our board of directors will adopt a charter, providing for the review, approval and/or ratification of “related party transactions,” which are those transactions required to be disclosed pursuant to Item 404 of
Regulation S-K as
promulgated by the SEC, by the audit committee. At its meetings, the audit committee shall be provided with the details of each new, existing, or proposed related party transaction, including the terms of the transaction, any contractual restrictions that the company has already committed to, the business purpose of the transaction, and the benefits of the transaction to the company and to the relevant related party. Any member of the committee who has an interest in the related party transaction under review by the committee shall abstain from voting on the approval of the related party transaction, but may, if so requested by the chairman of the committee, participate in some or all of the committee’s discussions of the related party transaction. Upon the completion of its review of the related party transaction, the committee may determine to permit or to prohibit the related party transaction.
Policy for Approval of Related Party Transactions
The audit committee of our board of directors has adopted a policy setting forth the policies and procedures for its review and approval or ratification of “related party transactions.” A “related party transaction” is any consummated or proposed transaction or series of transactions: (i) in which the company was or is to be a participant; (ii) the amount of which exceeds (or is reasonably expected to exceed) the lesser of $120,000 or 1% of the average of the company’s total assets at year end for the prior two completed fiscal years in the aggregate over the duration of the transaction (without regard to profit or loss); and (iii) in which a “related party” had, has or will have a direct or indirect material interest. “Related parties” under this policy include: (i) our directors, nominees for director or officers; (ii) any record or beneficial owner of more than 5% of any class of our voting securities; (iii) any immediate family member of any of the foregoing if the foregoing person is a natural person; and (iv) any other person who maybe a “related person” pursuant to Item 404 of Regulation
S-K
under the Exchange Act. Pursuant to the policy, the audit committee considers (i) the relevant facts and circumstances of each related party transaction, including if the transaction is on terms comparable to those that could be obtained in
arm’s-length
dealings with an unrelated third party, (ii) the extent of the related party’s interest in the transaction, (iii) whether the transaction contravenes our code of ethics or other policies, (iv) whether the audit committee believes the relationship underlying the transaction to be in the best interests of the company and its shareholders and (v) the effect that the transaction may have on a director’s status as an independent member of the board and on his or her eligibility to serve on the board’s committees. Management will present to the audit committee each proposed related party transaction, including all relevant facts and circumstances relating thereto. Under the policy, we may consummate related party transactions only if our audit committee approves or ratifies the transaction in accordance with the guidelines set forth in the policy. The policy will not permit any director or officer to participate in the discussion of, or decision concerning, a related person transaction in which he or she is the related party.
 
82
Director Independence
Nasdaq listing standards require that a majority of our board of directors be independent within one year of our initial public offering. An “independent director” is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our board of directors has determined that Ian Stone, Thomas Folinsbee and Tao Bai are “independent directors” as defined in the Nasdaq listing standards and applicable SEC rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present.
Item 14. Principal Accounting Fees and Services
The following is a summary of fees paid or to be paid to WithumSmith+Brown, PC, or Withum, for services rendered.
Audit Fees
. Audit fees consist of fees billed for professional services rendered for the audit of our
year-end
financial statements and services that are normally provided by Withum in connection with regulatory filings. The aggregate fees billed by Withum for professional services rendered for the audit of our annual financial statements, review of the financial information included in our required filings with the SEC for the period for the year ended December 31, 2021 totaled $89,610. The above amounts include interim procedures and audit fees, as well as attendance at audit committee meetings.
Audit-Related Fees.
Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards. We did not pay Withum for consultations concerning financial accounting and reporting standards for the period for the year ended December 31, 2021.
Tax Fees
. We did not pay Withum for tax planning and tax advice for the period for the year ended December 31, 2021.
All Other Fees
. We did not pay Withum for other services for the year ended December 31, 2021.
Pre-Approval
Policy
Our audit committee was formed upon the consummation of our Initial Public Offering. As a result, the audit committee did not
pre-approve
all of the foregoing services, although any services rendered prior to the formation of our audit committee were approved by our board of directors. Since the formation of our audit committee, and on a going-forward basis, the audit committee has and will
pre-approve
all auditing services and permitted
non-audit
services to be performed for us by our auditors, including the fees and terms thereof (subject to the
de minimis
exceptions for
non-audit
services described in the Exchange Act which are approved by the audit committee prior to the completion of the audit).
 
83
PART IV
Item 15
.
Exhibits, Financial Statement Schedules
 
  (a)
The following documents are filed as part of this Form
10-K:
 
  (1)
Financial Statements:
 
    
Page
  
    
F-2
  
    
F-3
  
    
F-4
  
    
F-5
  
    
F-6
  
    
F-7
  
 
  (2)
Financial Statement Schedules:
None.
 
  (3)
Exhibits
We hereby file as part of this Report the exhibits listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference can be inspected and copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Copies of such material can also be obtained from the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C. 20549, at prescribed rates or on the SEC website at www.sec.gov.
 
84
Exhibit

No.
   
Description
3.1    Amended and Restated Memorandum and Articles of Association (incorporated herein by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on June 14, 2021)
4.1*    Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended*
4.2    Warrant Agreement, dated June 8, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated herein by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed with the SEC on January 14, 2021)
10.1    Private Placement Warrants Purchase Agreement, dated June 8, 2021, between the Company and Summit Healthcare Acquisition Sponsor LLC (incorporated herein by reference to Exhibit 10.1 of the Company’s Current Report on Form
8-K
filed with the SEC on June 14, 2021)
10.2    Investment Management Trust Agreement, dated June 8, 2021, between Continental Stock Transfer & Trust Company and the Company (incorporated herein by reference to Exhibit 10.2 of the Company’s Current Report on Form
8-K
filed with the SEC on June 14, 2021)
10.3    Registration and Shareholder Rights Agreement, dated June 8, 2021, among the Company, Summit Healthcare Acquisition Sponsor LLC and the other holders party thereto (incorporated herein by reference to Exhibit 10.3 of the Company’s Current Report on Form
8-K
filed with the SEC on June 14, 2021)
10.4    Letter Agreement, dated June 8, 2021, among the Company, and Summit Healthcare Acquisition Sponsor LLC and each director and executive officer of the Company (incorporated herein by reference to Exhibit 10.4 of the Company’s Current Report on Form
8-K
filed with the SEC on June 14, 2021)
10.5    Administrative Services Agreement, dated June 8, 2021, between the Company and Summit Healthcare Acquisition Sponsor LLC (incorporated herein by reference to Exhibit 10.5 of the Company’s Current Report on Form
8-K
filed with the SEC on June 14, 2021)
10.6    Forward Purchase Agreement, dated April 30, 2021, between the Registrant, Summit Healthcare Acquisition Sponsor LLC and Snow Lake Capital (HK) Limited (incorporated herein by reference to Exhibit 10.6 of the Company’s Current Report on Form
8-K
filed with the SEC on June 14, 2021)
10.7    Forward Purchase Agreement, dated April 30, 2021, between the Registrant, Summit Healthcare Acquisition Sponsor LLC and The Valliance Fund (incorporated herein by reference to Exhibit 10.7 of the Company’s Current Report on Form
8-K
filed with the SEC on June 14, 2021)
31.1*    Certification of the Registrant’s Chief Executive Officer Pursuant to Rules 13a-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2*    Certification of the Registrant’s Principal Financial Officer Pursuant to Rules 13a-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1**    Certification of the Registrant’s Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
32.2**    Certification of the Registrant’s Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
101.INS*    XBRL Instance Document
101.SCH*    XBRL Taxonomy Extension Schema
101.CAL*    XBRL Taxonomy Extension Calculation Linkbase
101.DEF*    XBRL Taxonomy Extension Definition Linkbase
101.LAB*    XBRL Taxonomy Extension Label Linkbase
101.PRE*    XBRL Taxonomy Extension Presentation Linkbase
104*    Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
*
Filed herewith.
**
Furnished herewith.
 
85
Item 16. Form
10-K
Summary
Not applicable.
 
86
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Act of 1934, as amended, the registrant has duly caused this Annual Report on Form
10-K
to be signed on its behalf by the undersigned, thereunto duly authorized, on March 31, 2022.
 
Summit Healthcare Acquisition Corp.
By:  
/s/ Bo Tan
  Name: Bo Tan
  Title: Chief Executive Officer,
Co-Chief
Investment Officer and Director
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form
10-K
has been signed by the following persons in the capacity and on the dates indicated.
 
Name
   
Positon
   
Date
/s/ Bo Tan
Bo Tan
   
Chief Executive
Officer, Co-Chief Investment
Officer and Director
(Principal Executive Officer and Principal Financial and Accounting Officer)
    March 31, 2022
/s/ Ken Poon
   
President, Co-Chief Investment
Officer and Director		    March 31, 2022
Ken Poon
/s/ Ian Stone
    Director    March 31, 2022
Ian Stone
/s/ Thomas Folinsbee
    Director    March 31, 2022
Thomas Folinsbee
/s/ Tao Bai
    Director    March 31, 2022
Tao Bai
 
87
SUMMIT HEALTHCARE ACQUISITION CORP.
INDEX TO FINANCIAL STATEMENTS
 
 
  
Page
 
  
 
F-2
 
Financial Statements:
  
  
 
F-3
 
  
 
F-4
 
  
 
F-5
 
  
 
F-6
 
  
 
F-7
 
 
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and the Board of Directors of
Summit Healthcare Acquisition Corp.
Opinion on the Financial Statements
We have audited the accompanying balance sheets of Summit Healthcare Acquisition Corp. (the “Company”) as of December 31, 2021 and 2020, the related statements of operations, changes in shareholders’ (deficit) equity and cash flows for the year ended December 31, 2021 and the period from December 22, 2020 (inception) through December 31, 2020 and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the year ended December 31, 2021 and the period from December 22, 2020 (inception) through December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ WithumSmith+Brown, PC
We have served as the Company’s auditor since 2020.
New York, New York
March 31, 2022
F-2
SUMMIT HEALTHCARE ACQUISITION CORP.
BALANCE SHEETS
 
 
  
December 31,

2021
 
 
December 31,

2020
 
Assets
  
 
Current assets:
  
 
Cash
    $ 885,198     $ —    
Prepaid expenses
      141,677       —    
    
 
 
    
 
 
  
Total current assets
      1,026,875       —    
Deferred offering costs
      —         91,374  
Investments held in Trust Account
      200,007,275       —    
    
 
 
    
 
 
  
Total Assets
    $ 201,034,150     $ 91,374  
    
 
 
    
 
 
  
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ (Deficit) Equity
                 
Current liabilities:
                 
Accrued offering costs and expenses
    $ 142,631     $ 65,000  
Note payable - related party
      —         5,010  
    
 
 
    
 
 
  
Total current liabilities
      142,631       70,010  
FPA liability
      2,785,941       —    
Warrant liability
      10,423,429       —    
Deferred underwriting commissions
      7,000,000       —    
    
 
 
    
 
 
  
Total Liabilities
      20,352,001       70,010  
    
 
 
    
 
 
  
Commitments and Contingencies (Note 7)
             
Class A ordinary shares subject to possible redemption, $0.0001 par value; 20,000,000 shares and
-0-
shares

issued and outstanding at redemption value of $10.00 per share
      200,000,000       —    
Shareholders’ (Deficit) Equity:
                 
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
      —         —    
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized;
      —         —    
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 and 6,500,000 shares issued
and outstanding at December 31, 2021 and 2020, respectively
      575       650
(1)
 
Additional
paid-in
capital
      —         24,350  
Accumulated deficit
      (19,318,426 )      (3,636 ) 
    
 
 
    
 
 
  
Total shareholders’ (Deficit) Equity
      (19,317,851 )      21,364  
    
 
 
    
 
 
  
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ (Deficit)
Equity
    $ 201,034,150     $ 91,374  
    
 
 
    
 
 
  

(1)
This number includes up to 750,000 Class B ordinary shares subject to forfeiture as of December 31, 2020. On July 23, 2021, the 750,000 Class B ordinary shares were forfeited when the overallotment option expired.
 
F-3
SUMMIT HEALTHCARE ACQUISITION CORP.
STATEMENTS OF OPERATIONS

 
  
Year

Ended December
31, 2021
 
 
For the period

from December 22,

2020 (Inception)

through

December 31, 2020
 
General and administrative expenses
    $ 549,179     $ 3,636  
    
 
 
    
 
 
  
Loss from operations
   
 
(549,179
) 
  
 
(3,636
) 
    
 
 
    
 
 
  
Other income (expense):
                 
Change in fair value of FPA
      (2,785,941 )      —    
Change in fair value of warrant liability
      3,289,535       —    
Transaction costs allocable to warrants
      (507,417 )      —    
Interest earned on investments held in Trust Account
      7,275       —    
    
 
 
    
 
 
  
Other income (loss)
      3,452       —    
    
 
 
    
 
 
  
Net Loss
   
$
(545,727
) 
  
$
(3,636
) 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption
   
 
11,178,082
 
  
 
—  
 
    
 
 
    
 
 
  
Basic and diluted net loss per ordinary share, Class A ordinary shares subject to possible redemption
   
$
(0.03
) 
  
$
—  
 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding, Class B ordinary shares
   
 
5,750,000
 
  
 
5,750,000
 
    
 
 
    
 
 
  
Basic and diluted net loss per share, Class B ordinary shares
   
$
(0.03
) 
  
$
(0.00
) 
    
 
 
    
 
 
  
The accompanying notes are an integral part of these financial statements.
 
F-4
SUMMIT HEALTHCARE ACQUISITION CORP.
STATEMENTS OF CHANGES IN SHAREHOLDERS’ (DEFICIT) EQUITY
FOR THE PERIOD FROM DECEMBER 22, 2020 (INCEPTION) THROUGH DECCEMBER 31, 2021
 
 
  
Class A
Ordinary Shares
 
  
Class B
Ordinary Shares
 
 
Additional

Paid-in

Capital
 
 
Accumulated

Deficit
 
 
Total

Shareholders’

(Deficit) Equity
 
 
  
Shares
 
  
Amount
 
  
Shares
 
 
Amount
 
Balance as of December 22, 2020 (Inception)
   
 
—  
 
   
$
—  
        —       $ —       $ —       $ —       $ —    
Class B ordinary shares issued to initial shareholders
   
 
—  
 
   
 
—  
 
      6,500,000     $ 650     $ 24,350     $ —       $ 25,000  
Net loss
   
 
—  
 
   
 
—  
 
      —         —         —         (3,636 )      (3,636 ) 
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
Balance as of December 31, 2020
   
 
—  
     
$
—  
 
   
 
6,500,000
 
  
$
650
 
  
$
24,350
 
  
$
(3,636
) 
  
$
21,364
 
Excess of private placement proceeds over fair value as
capital contribution
      —          —          —         —         798,445       —         798,445  
Accretion of Class A ordinary shares to redemption value
      —          —          —         —         (822,795 )      (18,769,138 )      (19,591,933 ) 
Forfeiture of founder shares
      —          —          (750,000 )      (75 )      —         75       —    
Net loss
      —          —          —         —         —         (545,727 )      (545,727 ) 
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
Balance as of December 31, 2021
   
 
—  
     
$
—  
 
   
 
5,750,000
 
  
$
575
 
  
$
—  
 
  
$
(19,318,426
) 
  
$
(19,317,851
) 
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of these financial statements.
 
F-5
SUMMIT HEALTHCARE ACQUISITION CORP.
STATEMENTS OF CASH FLOWS

 
  
Year

Ended

December

31, 2021
 
 
For the period

from December

22, 2020

(Inception)

through

December 31,

2020
 
Cash Flows from Operating Activities:
  
 
Net loss
    $ (545,727 )    $ (3,636 ) 
Adjustments to reconcile net loss to net cash provided by operating activities:
                 
Interest earned on investments held in Trust Account
      (7,275 )      3,636  
Change in fair value of FPA liability
      2,785,941       —    
Change in fair value of warrant liability
      (3,289,535 )      —    
Transaction costs allocable to warrants
      507,417       —    
Changes in operating assets and liabilities:
                 
Prepaid expenses
      (141,677 )      —    
Accrued offering costs and expenses
      77,631       —    
    
 
 
    
 
 
  
Net cash used in operating activities
   
 
(613,225
) 
  
 
—  
 
    
 
 
    
 
 
  
Cash Flows from Investing Activities
                 
Investment of cash in Trust Account
      (200,000,000 )      —    
    
 
 
    
 
 
  
Net cash used in investing activities
      (200,000,000 )      —    
    
 
 
    
 
 
  
Cash Flows from Financing Activities:
                 
Proceeds received from initial public offering, net of underwriters’ discount
      196,000,000       —    
Proceeds from private placement
      6,000,000       —    
Payment of offering costs
      (140,554 )      —    
Repayment of note payable from related party
      (361,023 )      —    
    
 
 
    
 
 
  
Net cash provided by financing activities
      201,498,423       —    
    
 
 
    
 
 
  
Net change in cash
      885,198       —    
Cash, beginning of the period
      —         —    
    
 
 
    
 
 
  
Cash, end of the period
   
$
885,198
 
  
$
—  
 
    
 
 
    
 
 
  
Supplemental
Non-cash
disclosure of cash flow information:
                 
Deferred offering costs paid by Sponsor under promissory note
    $ 135,544     $ 1,374  
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares
    $ —       $ 25,000  
Deferred underwriting discount
    $ 7,000,000     $ —    
Accrued deferred offering costs
    $ —       $ 65,000  

F-6

SUMMIT HEALTHCARE ACQUISITION CORP.
NOTES TO FINANCIAL STATEMENTS
Note 1 - Organization, Business Operation, Liquidity and Capital Resources
Summit Healthcare Acquisition Corp. (the “Company”) is a blank check company incorporated on December 22, 2020 as a Cayman Islands exempted company. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target under consideration or contemplation and the Company has not, nor has anyone on its behalf, contacted any prospective target business or had any discussions, formal or otherwise, with respect to such a transaction. The Company’s efforts to identify a prospective target business will not be limited to a particular geographic region or industry, although it intends to focus on healthcare.
As of December 31, 2021, the Company had not commenced any operations. All activity for the period from December 22, 2020 (inception) through December 31, 2021 relates to the Company’s formation and the initial public offering (the “IPO”). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.
The Company’s Sponsor is Summit Healthcare Acquisition Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on June 8, 2021 (the “Effective Date”). On June 11, 2021, the Company consummated the IPO of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”) 10.00 per Unit, generating gross proceeds of $200,000,000, which is discussed in Note 3.
Simultaneously with the consummation of the IPO and the issuance and sale of the Units, the Company consummated the private placement of 6,000,000 Private Placement Warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, to the Sponsor, generating total proceeds of $6,000,000. Transaction costs amounted to $11,587,941 consisting of $4,000,000 of underwriting commissions, $7,000,000 of deferred underwriting commissions and $587,941 of other cash offering costs. In addition, $1,827,347 of cash was held in the Trust Account (as defined below) temporarily and is available for working capital purposes.
Following the closing of the IPO on June 11, 2021, $200,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account and, will be held in a U.S.-based trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee, and will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain
conditions under Rule 2a-7 under the
Investment Company Act.
Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income taxes, if any, the Company’s amended and restated memorandum and articles of association and subject to the requirements of law and regulation, will provide that the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account (1) to the Company, until the completion of the initial Business Combination, or (2) to the Company’s public shareholders until the earliest of: (i) the completion of an initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association, and (iii) the redemption of the Company’s public shares if the Company has not consummated its Business Combination within 24 months from the closing of the IPO, subject to applicable law.
The ordinary shares subject to redemption are recorded at a $10 redemption value and classified as temporary equity in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”
 
F-7
The Company will have 24 months from the closing of the IPO to complete the initial Business Combination (the “Combination Period”) or during any Extension Period. However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares,
at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
The Sponsor and the Company’s officers and directors agreed to (i) waive their redemption rights with respect to their Founder Shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association, (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period or during any Extension Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete its initial Business Combination within the prescribed timeframe), and (iv) vote any Founder Shares and public shares held by them in favor of the initial Business Combination.
The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per public share or (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay the Company’s tax obligations, provided that such liability will not apply to any claims by a third party or prospective target business that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriter of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked it Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure you that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
Liquidity and Capital Resources
As of December 31, 2021, the Company had approximately $0.89 million of cash for working capital purposes, and working capital of approximately $0.88 million.
The Company’s liquidity needs up to December 31, 2021 had been satisfied through a payment from the Sponsor of $25,000 (see Note 5) for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of $300,000 (see Note 5).
The promissory note was fully repaid on June 11, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 5). As of December 31, 2021, there were no amounts outstanding under any Working Capital Loans.
 
F-8
Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
Note 2 - Significant Accounting Policies
Basis of Presentation
The accompanying financial statements of
the
Company are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Security and Exchange Commission (“SEC”). In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.
Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability and Forward Purchase Agreement (“FPA”) liability.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have cash equivalents as of December 31, 2021 and December 31, 2020.
 
F-9
Investments Held in Trust Account
As of December 31, 2021, the assets held in the Trust Account were held in a money market fund. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At December 31, 2021 and 2020, the Company had $200,007,275 and nil held in the Trust Account.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Offering Costs Associated with IPO
The Company complies with the requirements of the ASC
340-10-S99-1and
SEC Staff Accounting Bulletin (“SAB”) Topic 5A“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering. Offering costs are charged to ordinary shares subject to possible redemption or the statement of operations based on the relative value of the Public and Private Warrants to the proceeds received from the Units and Private Placement Warrants sold upon the completion of the IPO. Accordingly, on December 31, 2021, offering costs totaling $11,587,941 (consisting of $4,000,000 of underwriting fees, $7,000,000 of deferred underwriting fees and $587,941 of other offering costs), of which $507,417 was allocated to the Public Warrants and Private Warrants and was charged to operations in accordance with ASC
825-10
and $11,080,524 was charged to ordinary shares subject to possible redemption.
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then
re-valued
at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or
non-current
based on whether or not
net-cash
settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Warrant Liability and Forward Purchase Agreement
The Company accounts for the 16,000,000 warrants issued in connection with the IPO (the 10,000,000 Public Warrants and the 6,000,000 Private Placement Warrants) and Forward Purchase Agreement (“FPA”) in accordance with the guidance contained in FASB ASC 815 “Derivatives and Hedging” whereby under that provision the warrants and FPA do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company will classify warrants and FPA as liabilities at their fair value. These liabilities are subject to
re-measurement
at each reporting period. With such
re-measurement,
the changes in fair value are recognized in the Statement of Operations in the period of change. Derivative warrant liabilities and FPA are classified as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Fair Value Measurements
The fair value of the Company’s assets and liabilities, excluding the warrant liability and FPA liability,
which
qualify as financial instruments under FASB ASC Topic 820, Fair Value Measurement (“ASC 820”), approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

F-10
Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
  •  
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2021 and December 31, 2020, 20,000,000 and 0 Class A ordinary shares, respectively, subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
At December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:

Gross proceeds
    $ 200,000,000  
Less: Proceeds allocated to Public Warrants
      (8,511,409)  
Less: Class A ordinary shares issuance costs
      (11,080,524)  
Add: Accretion of carrying value to redemption value
      19,591,933  
    
 
 
  
Class A ordinary shares subject to possible redemption
    $ 200,000,000  
    
 
 
  
 
Net Income (Loss) Per Share of Ordinary Shares
The Company has two classes of shares, which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Earnings and losses are shared pro rata between the two classes of shares. The 16,000,000 potential ordinary shares for outstanding warrants to purchase the Company’s stock were excluded from diluted earnings per share for the year ended December 31, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares:
 
F-11
                                 
    
For the Year Ended

December 31, 2021
     
For the Period

from December 22, 2020
(Inception) to

December 31, 2020
  
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income per share:
                                    
Numerator:
                                    
Allocation of net loss
    $ (360,359)      $ (185,368)      $ —        $ (3,636)  
Denominator:
                                    
Weighted-average shares outstanding
      11,178,082        5,750,000        —          5,750,000  
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net loss per share
    $ (0.03)      $ (0.03)      $ —        $ (0.00)  
    
 
 
     
 
 
     
 
 
     
 
 
  
Income Taxes
ASC 740 clarifies the accounting for uncertainty in income taxes recognized in a Company’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position
must be more-likely-than-not to be
sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Pronouncements
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2020-06,
Debt - Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic
815-40)
(“ASU
2020-06”)
to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use the
if-converted
method for all convertible instruments. ASU
2020-06
is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that
ASU 2020-06
would have on its financial position, results of operations or cash flows.
Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
Note 3 - Initial Public Offering
On June 11, 2021, the Company consummated its IPO of 20,000,000 Units (the “Units”), at a price of $10.00 per unit, generating gross proceeds to the Company of $200,000,000. Each Unit consists of one Class A ordinary share and
one-half
of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable on the later of 30 days after the completion of the initial Business Combination or 12 months from the closing of the IPO, and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation (see Note 8).
 
F-12
Note 4 - Private Placement
Simultaneously with the closing of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of an aggregate 6,000,000 Private Placement Warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $6,000,000. If the Company does not complete an initial Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants
will be non-redeemable by the
Company and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.
If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the IPO.
Note 5 - Related Party Transactions
Founder Shares
On December 31, 2020, the Company issued to the Sponsor 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”), for $25,000 for certain expenses paid on behalf of the Company, or approximately $0.004 per share. On April 30, 2021, the Company effected a share capitalization, pursuant to which the Company’s initial shareholders held an aggregate of 6,500,000 Class B ordinary shares. The accompanying financial statements have been retroactively adjusted to reflect the stock dividend in the share capitalization. On April 30, 2021, the Company entered into forward purchase agreements (see Note 6) with anchor investors, in connection with entering into the forward purchase agreements, the Sponsor transferred to the anchor investors an aggregate of 375,000 Class B ordinary shares for no cash. On April 30, 2021, the Sponsor transferred 25,000 Class B ordinary shares each to three independent director nominees. Up to 750,000 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. On July 23, 2021, the Sponsor surrendered 750,000 Founder Shares, with no return of capital or payment by the Sponsor, after the expiration of the unexercised underwriters’ over-allotment option. As a result of the foregoing, at December 31, 2021 and December 31, 2020, the Sponsor owned 5,750,000 and 6,500,000 Class B ordinary shares, respectively.
The Sponsor, officers and directors have agreed not to transfer, assign or sell any of their Founder Shares until earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s public shareholders having the right to exchange their ordinary shares for cash, securities or other property
(the “Lock-up”).
Any permitted transferees would be subject to the same restrictions and other agreements of our Sponsor, officers and directors with respect to any Founder Shares.
Promissory Note - Related Party
The Sponsor has agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. These loans were
non-interest
bearing, unsecured and were due at the earlier of September 30, 2021 or the closing of the IPO. The loan was to be repaid upon completion of the IPO out of the $1,000,000 of offering proceeds that has been allocated to the payment of offering expenses. The Company had drawn down $140,068 under the promissory note which was fully repaid as of June 11, 2021. The note was terminated at June 11, 2021.
Related Party Loans
In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. As of December 31, 2021 and December 31, 2020, the Company had no borrowings under the Working Capital Loans.
 
F-13
Administrative Service Fee
Commencing on the Effective Date, the Company paid an affiliate of the Sponsor $10,000 per month for office space, utilities, administrative services and remote support services. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company accrued $67,667 for the administrative service fee for the period from June 8, 2021 (the Effective Date) to December 31, 2021.
Note 7 - Recurring Fair Value Measurements
Warrant Liability and FPA Liability
At December 31, 2021, the fair value of Company’s Warrant liability was $10,423,429, and the fair value of FPA liability was $2,785,941. Under the guidance in
ASC 815-40 the
Public and Private Warrants and the FPA do not meet the criteria for equity treatment. As such, the Public and Private Warrants and the FPA must be recorded on the balance sheet at fair value. This valuation is subject to
re-measurement
each balance sheet date. With each
re-measurement,
the valuations will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.
Recurring Fair Value Measurements
The following table presents fair value information as of December 31, 2021 of the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. The Company’s Warrant liability is based on a valuation models utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the Warrant liability and FPA liability is classified within Level 3 of the fair value hierarchy. The investments held in Trust Account includes money market funds. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its level 1 investments.
The following table sets forth by level within the fair value hierarchy the Company’s assets and liabilities as of December 31, 2021, that were accounted for at fair value on a recurring basis:

 
  
(Level 1)
 
  
(Level 2)
 
  
(Level 3)
 
Assets
  
  
  
Investments held in Trust Account
    $ 200,007,275      $ —        $ —    
Liabilities
                           
Public Warrants
    $ —        $ 6,500,000      $ —    
Private Warrants
    $ —        $ —        $ 3,923,429  
FPA liability
    $ —        $ —        $ 2,785,941  
 
Measurement of the Warrants
The Company established the initial fair value for the Warrants on June 11, 2021, the date of the consummation of the Company’s IPO. The Company used a Monte Carlo simulation model to value the Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Class A ordinary share and
one-half
of one Public Warrant), (ii) the sale of Private Warrants, and (iii) the issuance of Class B ordinary shares, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption (temporary equity), and Class B ordinary shares (permanent equity) based on their relative fair values at the initial measurement date. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement in August 2021 after detachment of the Public Warrants from the Units and were separately listed and traded. As of December 31, 2021, the Public Warrants were valued using the observed price for Public Warrants and the Private Warrants were valued using a Monte Carlo simulation model.
 
F-14
The key inputs for the valuation of Public and Private Warrants are as follows:

Input
  
June 11,
2021
 
 
December
31, 2021
 
Volatility
      16.30 %      13.4 % 
Risk Free Rate
      0.89 %      1.29 % 
Stock Price
    $ 9.57     $ 9.72  
Est. Term Remaining (Yrs)
      5.65       5.35  
The following table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s derivative warrant liabilities classified as Level 3:

 
  
Warrant
liabilities
 
Fair value at January 1, 2021
    $ —    
Initial value at IPO date
      13,712,964  
Change in fair value
      (3,289,535 ) 
Transfer of Public warrants from Level 3 to Level 1
      (6,500,000 ) 
    
 
 
  
Fair Value at December 31, 2021
    $ 3,923,429  
FPA
To arrive the conclusion of Fair Value of the Forward Purchase Agreements, the Company analyzed the agreements and other documentation. The Company utilized the underlying shares and warrant values determined above and the following inputs in order to project the net asset or liability value of the FPA:​​​​​​​
 
Input
  
June 11,
2021
 
 
December 31,
2021
 
Volatility
      16.30 %      13.4 % 
Stock Price
    $ 9.57     $ 9.72  
Warrant Price
    $ 0.85     $ 0.65  
Est. Term to Business Combination (Yrs)
      0.65       0.33  
Probability of Business Combination
      85 %      85 % 
Purchase price of FPA unit
    $ 10.00     $ 10.00  
The
following
table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s FPA liability classified as Level 3:
 

 
  
FPA liability
 
Fair value at January 1, 2021
    $ —    
Initial value at IPO date
      2,322,741  
Change in fair value
      463,200  
    
 
 
  
Fair Value at December 31, 2021
    $ 2,785,941  
 
 
F-15
Transfers between levels of the fair
value
hierarchy are recognized at the end of the reporting period.
Note 7 - Commitments & Contingencies
Risks and Uncertainties
Management continues to evaluate the impact
of the COVID-19 pandemic on
the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of this financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.
Registration Rights
The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of the IPO. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its initial Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable
Lock-up
period, which occurs (i) in the case of the Founder Shares, and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriters Agreement
The underwriters
had a 45-day option to
purchase up to an additional 3,000,000 units to cover over-allotments, if any. The over-allotment option expired unexercised on July 23, 2021.
The underwriters were paid a cash underwriting discount of two percent (2%) of the gross proceeds of the IPO, or $4,000,000. Additionally, the underwriters are entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the IPO upon the completion of the Company’s initial Business Combination.
Forward Purchase Agreements
On April 30, 2021, the Company entered into forward purchase agreements with the Sponsor, Snow Lake Capital (HK) Limited and Valliance Fund (the “anchor investors”), pursuant to which the anchor investors agreed to subscribe for an aggregate of 3,000,000 Class A ordinary shares plus 750,000 redeemable warrants for a purchase price of $10.00 multiplied by the number of Class A ordinary shares, or $30,000,000 in the aggregate, in a private placement to close concurrently with the closing of the initial business combination. The Company issued 750,000 additional Class B ordinary shares to the Sponsor, which represent the adjustment to the ratio applicable to the conversion of the Class B ordinary shares that the Sponsor would have been entitled to at the closing of the initial business combination as a result of the issuance of 3,000,000 additional Class A ordinary shares under the forward purchase agreements. As a result, the issuance of the Class A ordinary shares at the closing of the initial business combination will not trigger a further adjustment to this ratio. Further, prior to the IPO, the Sponsor transferred to the anchor investors an aggregate of 375,000 Founder Shares for no cash consideration. Subject to certain exceptions to forfeiture and transfer provisions, the Founder Shares transferred in connection with these agreements are subject to similar contractual conditions and restrictions as the Founder Shares issued to the Sponsor in connection with the IPO. The forward purchase warrants will have the same terms as the public warrants.
 
F-16
The forward purchase agreements provide that the anchor investors are entitled to registration rights with respect to the forward purchase securities and Class A ordinary shares underlying the forward purchase warrants and founder shares.
The proceeds from the sale of the forward purchase securities may be used as part of the consideration to the sellers in the initial Business Combination, expenses in connection with the initial Business Combination or for working capital in the post Business Combination company. These purchases will be required to be made regardless of whether any Class A ordinary shares are redeemed by the public shareholders and are intended to provide the Company with a minimum funding level for the initial Business Combination. The anchor investors will not have the ability to approve the initial Business Combination prior to the signing of a material definitive agreement and, if the Company seeks shareholder approval, have agreed to vote their Founder Shares and any public shares held by them in favor of the initial Business Combination. The forward purchase securities will be issued only in connection with the closing of the initial Business Combination.
Note 8 - Warrant Liability
As of December 31, 2021, 16,000,000 warrants (the 10,000,000 Public Warrants and the 6,000,000 Private Placement Warrants) are outstanding. Each warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants will become exercisable on the later of 12 months from the closing of the IPO or 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation
Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00.
Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
 
  •  
if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within
a 30-trading day
period ending three trading days before the Company sends the notice of redemption to the warrant holders.
If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
 
  •  
in whole and not in part;
 
  •  
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by referenc e to the table below, based on the redemption date and the “fair market value” of the Class A ordinary shares;
 
  •  
if, and only if, the closing price of our Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise p rice of a warrant) for any 20 trading days within
the 30-trading day
period ending three trading days before the Company sends the notice of redemption to the warrant holders; and
 
F-17
  •  
if the closing price of the Class A ordinary shares for any 20 trading days within
a 30-trading day
period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Company’s Sponsors or its affiliate, without taking into account any Founder Shares held by the Company’s Sponsor or such affiliates, as applicable, prior to such issuance (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
Note 9 - Shareholders’ (Deficit) Equity
Preference shares
The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2021 and December 30, 2020, there were no preference shares issued or outstanding.
Class A Ordinary Shares
The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of December 31, 2021 and 2020, there were 20,000,000 and 0 Class A ordinary shares issued and outstanding, including the 20,000,000 and 0 shares presented in ordinary shares subject to redemption.
Class B Ordinary Shares
The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. As of December 31, 2021 and December 31, 2020, there were 5,750,000 and 6,500,000 Class B ordinary shares issued and outstanding, respectively. Of the 6,500,000 Class B ordinary shares, an aggregate of up to 750,000 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the initial shareholders will collectively own 20% of the Company’s issued and outstanding ordinary shares after the IPO. On July 23, 2021, the Sponsor surrendered 750,000 Founder Shares, with no return of capital or payment by the Sponsor, after the expiration of the unexercised underwriters’ over-allotment option.
Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law. Prior to the initial Business Combination, only holders of the Founder Shares will have the right to vote on the election of directors. Holders of the public shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to the completion of an initial Business Combination, holders of a majority of the Founder Shares may remove a member of the board of directors for any reason.
 
F-18
The Class B ordinary shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate,
on an as-converted basis, 20%
of the sum of (i) the total number of ordinary shares issued and outstanding upon the completion of the IPO, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued or to be issued to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of our management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than
one-to-one.
Note 10 - Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on this review, other than disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statement.
On February 24, 2022, Russian forces launched significant military action against Ukraine, and sustained conflict and disruption in the region is possible. The impact to Ukraine as well as actions taken by other countries, including new and stricter sanctions imposed by Canada, the United Kingdom, the European Union, the U.S. and other countries and companies and organizations against officials, individuals, regions, and industries in Russia and Ukraine, and actions taken by Russia in response to such sanctions, and each country’s potential response to such sanctions, tensions, and military actions could have a material adverse effect on the business or prospects of potential target companies in Europe as the Company’s efforts to identify a prospective target business are not be limited to a particular geographic region. Any such material adverse effect from the conflict and enhanced sanctions activity may include reduced trading and business activity levels, disruption of financial markets, increased costs, disruption of services, inability to complete financial or banking transactions, and inability to service existing or new customers in the region. Prolonged unrest, military activities, or broad-based sanctions, should they be implemented, could have a material adverse effect on our ability to complete a business combination with a suitable target.
 
F-19
EX-4.1 2 d190177dex41.htm EX-4.1 EX-4.1

Exhibit 4.1

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, As Amended

The following description sets forth certain material terms and provisions of the securities of Summit Healthcare Acquisition Corp. (“we,” “us” or “our”) that are registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The following description of our securities is not complete and may not contain all the information you should consider before investing in our securities. This description is summarized from, and qualified in its entirety by reference to, our amended and restated memorandum and articles of association, which are incorporated herein by reference. The summary below is also qualified by reference to the Companies Law and common law of the Cayman Islands.

As of December 31, 2021, we had three classes of securities registered under the Exchange Act: our Class A ordinary shares, $0.0001 par value per share; warrants to purchase shares of our Class A ordinary shares; and units consisting of one Class A ordinary share and one-half of one redeemable warrant to purchase one Class A ordinary share. In addition, this Description of Securities also contains a description of our Class B ordinary shares, par value $0.0001 per share (“founder shares”), which are not registered pursuant to Section 12 of the Exchange Act but are convertible into shares of the Class A ordinary shares. The description of the founder shares is necessary to understand the material terms of the Class A ordinary shares. Further, this Description of Securities also contains a description of our Forward Purchase Warrants to be issued under the forward purchase agreements entered in connection with the IPO, which are not registered pursuant to Section 12 of the Exchange Act but will have the same terms as Public Shareholders’ Warrants.

Units

Public Units

Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as described in this prospectus. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of the Company’s Class A ordinary shares. This means only a whole warrant may be exercised at any given time by a warrant holder. For example, if a warrant holder holds one-half of one warrant to purchase a Class A ordinary share, such warrant will not be exercisable. If a warrant holder holds two-halves of one warrant, such whole warrant will be exercisable for one Class A ordinary share at a price of $11.50 per share. The Class A ordinary shares and warrants comprising the units had commenced separate trading on July 30, 2021. Holders have the option to continue to hold units or separate their units into the component securities. Holders need to have their brokers contact our transfer agent in order to separate the units into Class A ordinary shares and warrants. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase at least two units, you will not be able to receive or trade a whole warrant.

Ordinary Shares

On December 31, 2020, our sponsor purchased an aggregate of 5,750,000 Class B ordinary shares (our “founder shares”) for an aggregate purchase price of $25,000, or approximately $0.004 per share. On April 30, 2021, we effected a share capitalization, pursuant to which our initial shareholders held an aggregate of 6,500,000 Class B ordinary shares. On April 30, we entered into forward purchase agreements with anchor investors, in connection with entering into the forward purchase agreements, our sponsor transferred to the anchor investors an aggregate of 375,000 Class B ordinary shares for no cash. On April 30, 2021, the Sponsor transferred 25,000 Class B ordinary shares each to three independent director nominees. On July 23, 2021, the 750,000 Class B ordinary shares were forfeited when the overallotment option expired. As a result of the foregoing, the Sponsor owns 5,300,000 Class B ordinary shares. As of the date hereof, 25,750,000 of our ordinary shares are outstanding including:

 

  •  

20,000,000 Class A ordinary shares underlying units issued as part of the IPO; and

 

  •  

5,750,000 Class B ordinary shares held by our initial shareholders.

Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of our shareholders except as required by law. Unless specified in our amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable stock exchange rules, the affirmative vote of a majority of our ordinary shares that are voted is required to approve any such matter voted on by our shareholders. Approval of certain actions will require a special resolution under Cayman Islands law, which requires the affirmative vote of a majority of at least two-thirds of the shareholders who attend and vote at a general meeting of the company, and pursuant to our amended and restated memorandum and articles of association; such actions include amending our amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. Our board of directors is divided into three classes, each of which will generally serve for a term of three years with only one class of directors being appointed in each year. There is no cumulative voting with respect to the appointment of directors, with the result that the holders of more than 50% of the shares voted for the appointment of directors can appoint all of the directors. However, only holders of Class B ordinary shares will have the right to appoint directors in any general meeting held prior to or in connection with the completion of our initial business combination, meaning that holders of Class A ordinary shares will not have the right to appoint any directors until after the completion of our initial business combination. Our shareholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.

Because our amended and restated memorandum and articles of association authorize the issuance of up to 500,000,000 Class A ordinary shares, if we were to enter into a business combination, we may (depending on the terms of such a business combination) be required to increase the number of Class A ordinary shares which we are authorized to issue at the same time as our shareholders vote on the business combination to the extent we seek shareholder approval in connection with our initial business combination.

In accordance with Nasdaq corporate governance requirements, we are not required to hold an annual general meeting until one year after our first fiscal year end following our listing on Nasdaq. There is no requirement under the Companies Act for us to hold annual or extraordinary general meetings or appoint directors. We may not hold an annual general meeting to appoint new directors prior to the consummation of our initial business combination.

We will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of our initial business combination, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters. Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares and public shares in connection with the completion of our initial business combination. Unlike many special purpose acquisition companies that hold shareholder votes and conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of public shares for cash upon completion of such initial business combinations even when a vote is not required by law, if a shareholder vote is not required by law and we do not decide to hold a shareholder vote for business or other legal reasons, we will, pursuant to our amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with the SEC prior to completing our initial business combination. Our amended and restated memorandum and articles of association require these tender offer documents to contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under the SEC’s proxy rules. If, however, a shareholder approval of the transaction is required by law, or we decide to obtain shareholder approval for business or other reasons, we will, like many special purpose acquisition companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If we seek shareholder approval, we will complete our initial business combination only if we obtain an ordinary resolution under Cayman Islands law, being the affirmative vote of a majority of the shareholders represented in person or by proxy and entitled to vote thereon who attend and vote at a general meeting of the company. However, the participation of our sponsor, officers, directors, advisors or their affiliates in privately-negotiated transactions (as described in this prospectus), if any, could result in the approval of our initial business combination even if a majority of our public shareholders vote, or indicate their intention to vote, against such initial business combination. For purposes of seeking approval of an ordinary resolution, non-votes will have no effect on the approval of our initial business combination once a quorum is obtained. Our amended and restated memorandum and articles of association require that at least five days’ notice will be given of any general meeting.

 

 

2

If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to Excess Shares without our prior consent. However, we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Our shareholders’ inability to redeem the Excess Shares will reduce their influence over our ability to complete our initial business combination, and such shareholders could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such shareholders will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And, as a result, such shareholders will continue to hold that number of shares exceeding 15% and, in order to dispose such shares would be required to sell their shares in open market transactions, potentially at a loss.

If we seek shareholder approval in connection with our initial business combination, our sponsor, officers and directors have agreed to vote their founder shares and any public shares purchased during or after this offering (including in open market and privately-negotiated transactions) in favor of our initial business combination. As a result, in addition to our initial shareholders’ founder shares, we would need 7,125,001, or 35.6%, of the 20,000,000 public shares sold in this offering to be voted in favor of an initial business combination in order to have our initial business combination approved (assuming all outstanding shares are voted and the over-allotment option is not exercised). Additionally, each public shareholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction or whether they were a public shareholder on the record date for the general meeting held to approve the proposed transaction.

Pursuant to our amended and restated memorandum and articles of association, if we do not complete our initial business combination within 24 months from the closing of this offering, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to our obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if we fail to complete our initial business combination within 24 months from the closing of this offering. However, if our sponsor or management team acquire public shares in or after this offering, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our initial business combination within the prescribed time period.

 

3

In the event of a liquidation, dissolution or winding up of the company after a business combination, our shareholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of shares, if any, having preference over the ordinary shares. Our shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the ordinary shares, except that we will provide our public shareholders with the opportunity to redeem their public shares for cash at a per share price equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, divided by the number of then outstanding public shares, upon the completion of our initial business combination, subject to the limitations and on the conditions described herein.

Founder Shares

The founder shares are designated as Class B ordinary shares and, except as described below, are identical to the Class A ordinary shares included in the units being sold in this offering, and holders of founder shares have the same shareholder rights as public shareholders, except that: (a) prior to our initial business combination, only holders of the founder shares have the right to vote on the appointment of directors and holders of a majority of our founder shares may remove a member of the board of directors for any reason; (b) the founder shares are subject to certain transfer restrictions, as described in more detail below; (c) our initial shareholders have entered into agreements with us, pursuant to which they have agreed to (i) waive their redemption rights with respect to their founder shares in connection with the completion of our initial business combination, (ii) waive their redemption rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares; and (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if we fail to consummate an initial business combination within 24 months from the closing of this offering or during any Extension Period (although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within the prescribed timeframe); and (d) the founder shares are entitled to registration rights. If we seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. A quorum for such meeting will be present if holders of one-third of the issued and outstanding shares entitled to vote at the meeting are represented in person or by proxy. In such case, our initial shareholders have agreed to vote their founder shares and public shares in favor of our initial business combination.

The founder shares are designated as Class B ordinary shares and will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the trust account if we do not consummate an initial business combination) at the time of our initial business combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon the completion of this offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination (including the forward purchase shares, but not the forward purchase warrants), excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued or to be issued to any seller in the initial business combination and any private placement warrants issued to our sponsor, its affiliates or any member of our management team upon conversion of working capital loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.

 

4

In connection with the forward purchase agreements, our sponsor transferred to the anchor investors 375,000 founder shares. The founder shares transferred to the anchor investors are subject to similar contractual conditions and restrictions as the founder shares issued to our sponsor. The anchor investors will have redemption rights with respect to any public shares they own.

Except as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell any of their founder shares until earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. We refer to such transfer restrictions throughout this prospectus as the lock-up. Any permitted transferees would be subject to the same restrictions and other agreements of our sponsor, officers and directors with respect to any founder shares.

Register of Members

Under Cayman Islands law, we must keep a register of members and there will be entered therein:

 

  •  

the names and addresses of the members, together a statement of the shares held by each member, and such statement shall confirm (i) the amount paid or agreed to be considered as paid on the shares of each member, (ii) the number and category of shares held by each member, and (iii) whether each relevant category of shares held by a member carries voting rights under the articles of association of the company, and if so, whether such voting rights are conditional;

 

  •  

the date on which the name of any person was entered on the register as a member; and

 

  •  

the date on which any person ceased to be a member.

Under Cayman Islands law, the register of members of our company is prima facie evidence of the matters set out therein (i.e., the register of members will raise a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register of members will be deemed as a matter of Cayman Islands law to have legal title to the shares as set against its name in the register of members. Upon the closing of this public offering, the register of members will be immediately updated to reflect the issue of shares by us. Once our register of members has been updated, the shareholders recorded in the register of members will be deemed to have legal title to the shares set against their name. However, there are certain limited circumstances where an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct legal position. Further, the Cayman Islands court has the power to order that the register of members maintained by a company should be rectified where it considers that the register of members does not reflect the correct legal position. If an application for an order for rectification of the register of members were made in respect of our ordinary shares, then the validity of such shares may be subject to re-examination by a Cayman Islands court.

 

5

Preferred Shares

Our amended and restated memorandum and articles of association authorizes 5,000,000 preference shares and provide that preference shares may be issued from time to time in one or more series. Our board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our board of directors will be able to, without shareholder approval, issue preference shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. The ability of our board of directors to issue preference shares without shareholder approval could have the effect of delaying, deferring or preventing a change of control of us or the removal of existing management. We have no preference shares issued and outstanding at the date hereof. Although we do not currently intend to issue any preference shares, we cannot assure you that we will not do so in the future. No preference shares are being issued or registered in this offering.

Warrants

Public Shareholders’ Warrants and Forward Purchase Warrants

Each whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing on the later of twelve months from the closing of this offering and 30 days after the completion of our initial business combination, except as discussed in the immediately succeeding paragraph. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of Class A ordinary shares. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase at least two units, you will not be able to receive or trade a whole warrant. The warrants will expire five years after the completion of our initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

We will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and we will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit.

We have agreed that as soon as practicable, but in no event later than 20 business days after the closing of our initial business combination, we will use our commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants, and we will use our commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of our initial business combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that, if our Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, but we will use our commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when we will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but we will use our commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” (defined below) less the exercise price of the warrants by (y) the fair market value and (B) 0.361. The “fair market value” as used in this paragraph shall mean the volume weighted average price of the Class A ordinary shares for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.

 

6

Redemptions of warrants when the price per Class A ordinary share equals or exceeds $18.00

Once the warrants become exercisable, we may redeem the outstanding warrants (except as described herein with respect to the private placement warrants):

 

  •  

in whole and not in part;

 

  •  

at a price of $0.01 per warrant;

 

  •  

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

 

  •  

if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending three business days before we send to the notice of redemption to the warrant holders (which we refer to as the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like).

We will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws.

We have established the last of the redemption criteria discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the Class A ordinary shares may fall below the $18.00 redemption trigger price (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “—Anti-dilution Adjustments”) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.

Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00

Once the warrants become exercisable, we may redeem the outstanding warrants:

 

  •  

in whole and not in part;

 

7

  •  

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined below);

 

  •  

if, and only if, the Reference Value (as defined above under “Redemptions for warrants when the price per Class A ordinary share equals or exceeds $18.00”) equals or exceeds $10.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like); and

 

  •  

if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.

Beginning on the date the notice of redemption is given until the warrants are redeemed or exercised, holders may elect to exercise their warrants on a cashless basis. The numbers in the table below represent the number of Class A ordinary shares that a warrant holder will receive upon such cashless exercise in connection with a redemption by us pursuant to this redemption feature, based on the “fair market value” of our Class A ordinary shares on the corresponding redemption date (assuming holders elect to exercise their warrants and such warrants are not redeemed for $0.10 per warrant), determined for these purposes based on the volume weighted average price of our Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants, and the number of months that the corresponding redemption date precedes the expiration date of the warrants, each as set forth in the table below. We will provide our warrant holders with the final fair market value no later than one business day after the 10-trading day period described above ends.

Pursuant to the warrant agreement, references above to Class A ordinary shares shall include a security other than Class A ordinary shares into which the Class A ordinary shares have been converted or exchanged for in the event we are not the surviving company in our initial business combination. The numbers in the table below will not be adjusted when determining the number of Class A ordinary shares to be issued upon exercise of the warrants if we are not the surviving entity following our initial business combination.

The share prices set forth in the column headings of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a warrant or the exercise price of a warrant is adjusted as set forth under the heading “—Anti-dilution Adjustments” below. If the number of shares issuable upon exercise of a warrant is adjusted, the adjusted share prices in the column headings will equal the share prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a warrant as so adjusted. The number of shares in the table below shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a warrant. If the exercise price of a warrant is adjusted, (a) in the case of an adjustment pursuant to the fifth paragraph under the heading “—Anti-dilution Adjustments” below, the adjusted share prices in the column headings will equal the unadjusted share price multiplied by a fraction, the numerator of which is the higher of the Market Value and the Newly Issued Price as set forth under the heading “—Anti-dilution Adjustments” and the denominator of which is $10.00 and (b) in the case of an adjustment pursuant to the second paragraph under the heading “—Anti-dilution Adjustments” below, the adjusted share prices in the column headings will equal the unadjusted share price less the decrease in the exercise price of a warrant pursuant to such exercise price adjustment.

 

8

     Fair Market Value of Class A Ordinary Shares  
Redemption Date
(period to expiration of warrants)		    ≤$10.00      $11.00      $12.00      $13.00      $14.00      $15.00      $16.00      $17.00      ≥$18.00  

60 months

      0.261        0.281        0.297        0.311        0.324        0.337        0.348        0.358        0.361  

57 months

      0.257        0.277        0.294        0.310        0.324        0.337        0.348        0.358        0.361  

54 months

      0.252        0.272        0.291        0.307        0.322        0.335        0.347        0.357        0.361  

51 months

      0.246        0.268        0.287        0.304        0.320        0.333        0.346        0.357        0.361  

48 months

      0.241        0.263        0.283        0.301        0.317        0.332        0.344        0.356        0.361  

45 months

      0.235        0.258        0.279        0.298        0.315        0.330        0.343        0.356        0.361  

42 months

      0.228        0.252        0.274        0.294        0.312        0.328        0.342        0.355        0.361  

39 months

      0.221        0.246        0.269        0.290        0.309        0.325        0.340        0.354        0.361  

36 months

      0.213        0.239        0.263        0.285        0.305        0.323        0.339        0.353        0.361  

33 months

      0.205        0.232        0.257        0.280        0.301        0.320        0.337        0.352        0.361  

30 months

      0.196        0.224        0.250        0.274        0.297        0.316        0.335        0.351        0.361  

27 months

      0.185        0.214        0.242        0.268        0.291        0.313        0.332        0.350        0.361  

24 months

      0.173        0.204        0.233        0.260        0.285        0.308        0.329        0.348        0.361  

21 months

      0.161        0.193        0.223        0.252        0.279        0.304        0.326        0.347        0.361  

18 months

      0.146        0.179        0.211        0.242        0.271        0.298        0.322        0.345        0.361  

15 months

      0.130        0.164        0.197        0.230        0.262        0.291        0.317        0.342        0.361  

12 months

      0.111        0.146        0.181        0.216        0.250        0.282        0.312        0.339        0.361  

9 months

      0.090        0.125        0.162        0.199        0.237        0.272        0.305        0.336        0.361  

6 months

      0.065        0.099        0.137        0.178        0.219        0.259        0.296        0.331        0.361  

3 months

      0.034        0.065        0.104        0.150        0.197        0.243        0.286        0.326        0.361  

0 months

      —          —          0.042        0.115        0.179        0.233        0.281        0.323        0.361  

The exact fair market value and redemption date may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption date is between two redemption dates in the table, the number of Class A ordinary shares to be issued for each warrant exercised will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values and the earlier and later redemption dates, as applicable, based on a 365 or 366-day year, as applicable. For example, if the volume weighted average price of our Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of the warrants is $11.00 per share, and at such time there are 57 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.277 Class A ordinary shares for each whole warrant. For an example where the exact fair market value and redemption date are not as set forth in the table above, if the volume weighted average price of our Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of the warrants is $13.50 per share, and at such time there are 38 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.298 Class A ordinary shares for each whole warrant. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). Finally, as reflected in the table above, if the warrants are out of the money and about to expire, they cannot be exercised on a cashless basis in connection with a redemption by us pursuant to this redemption feature, since they will not be exercisable for any Class A ordinary shares.

 

9

This redemption feature differs from the typical warrant redemption features used in many other blank check offerings, which typically only provide for a redemption of warrants for cash (other than the private placement warrants) when the trading price for the Class A ordinary shares exceeds $18.00 per share for a specified period of time. This redemption feature is structured to allow for all of the outstanding warrants to be redeemed when the Class A ordinary shares are trading at or above $10.00 per public share, which may be at a time when the trading price of our Class A ordinary shares is below the exercise price of the warrants. We have established this redemption feature to provide us with the flexibility to redeem the warrants without the warrants having to reach the $18.00 per share threshold set forth above under “—Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00.” Holders choosing to exercise their warrants in connection with a redemption pursuant to this feature will, in effect, receive a number of shares for their warrants based on an option pricing model with a fixed volatility input as of the date of this prospectus. This redemption right provides us with an additional mechanism by which to redeem all of the outstanding warrants, and therefore have certainty as to our capital structure as the warrants would no longer be outstanding and would have been exercised or redeemed. We will be required to pay the applicable redemption price to warrant holders if we choose to exercise this redemption right and it will allow us to quickly proceed with a redemption of the warrants if we determine it is in our best interest to do so. As such, we would redeem the warrants in this manner when we believe it is in our best interest to update our capital structure to remove the warrants and pay the redemption price to the warrant holders.

As stated above, we can redeem the warrants when the Class A ordinary shares are trading at a price starting at $10.00, which is below the exercise price of $11.50, because it will provide certainty with respect to our capital structure and cash position while providing warrant holders with the opportunity to exercise their warrants on a cashless basis for the applicable number of shares. If we choose to redeem the warrants when the Class A ordinary shares are trading at a price below the exercise price of the warrants, which could result in the warrant holders receiving fewer Class A ordinary shares than they would have received if they had chosen to wait to exercise their warrants for Class A ordinary shares if and when such Class A ordinary shares were trading at a price higher than the exercise price of $11.50.

No fractional Class A ordinary shares will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, we will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder. If, at the time of redemption, the warrants are exercisable for a security other than the Class A ordinary shares pursuant to the warrant agreement (for instance, if we are not the surviving company in our initial business combination), the warrants may be exercised for such security. At such time as the warrants become exercisable for a security other than the Class A ordinary shares, our company (or the surviving company) will use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.

Redemption Procedures. A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) of the Class A ordinary shares issued and outstanding immediately after giving effect to such exercise.

Anti-dilution Adjustments. If the number of outstanding Class A ordinary shares is increased by a capitalization or share dividend paid in Class A ordinary shares to all or substantially all holders of Class A ordinary shares, or by a split-up of Class A ordinary shares or other similar event, then, on the effective date of such capitalization or share dividend, split-up or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding Class A ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class A ordinary shares at a price less than the “historical fair market value” (as defined below) will be deemed a share dividend of a number of Class A ordinary shares equal to the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A ordinary shares) and (ii) one, minus the quotient of (x) the price per Class A ordinary share paid in such rights offering and (y) the historical fair market value. For these purposes, (i) if the rights offering is for securities convertible into or exercisable for Class A ordinary shares, in determining the price payable for Class A ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “historical fair market value” means the volume weighted average price of Class A ordinary shares as reported during the 10 trading day period ending on the trading day prior to the first date on which the Class A ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 

10

In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to all or substantially all of the holders of the Class A ordinary shares on account of such Class A ordinary shares (or other securities into which the warrants are convertible), other than (a) as described above, (b) any cash dividends or cash distributions which, when combined on a per share basis with all other cash dividends and cash distributions paid on the Class A ordinary shares during the 365-day period ending on the date of declaration of such dividend or distribution does not exceed $0.50 per share (as adjusted to appropriately reflect any other adjustments and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of Class A ordinary shares issuable on exercise of each warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50 per share, (c) to satisfy the redemption rights of the holders of Class A ordinary shares in connection with a proposed initial business combination, (d) to satisfy the redemption rights of the holders of Class A ordinary shares in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares, or (e) in connection with the redemption of our public shares upon our failure to complete our initial business combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each Class A ordinary share in respect of such event.

If the number of outstanding Class A ordinary shares is decreased by a consolidation, combination or reclassification of Class A ordinary shares or other similar event, then, on the effective date of such consolidation, combination, reclassification or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding Class A ordinary shares.

Whenever the number of Class A ordinary shares purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of Class A ordinary shares purchasable upon the exercise of the warrants immediately prior to such adjustment and (y) the denominator of which will be the number of Class A ordinary shares so purchasable immediately thereafter.

In addition, if (i) we issue additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our sponsor or its affiliates, without taking into account any founder shares held by our sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and (iii) the volume weighted average trading price of our Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which we consummate our initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above under “—Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “—Redemption of warrants when the price per Class A ordinary shares equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above under “—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

 

11

In case of any reclassification or reorganization of the outstanding Class A ordinary shares (other than those described above or that solely affects the par value of such Class A ordinary shares), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of our outstanding Class A ordinary shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the Class A ordinary shares immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of Class A ordinary shares or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event. However, if such holders were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which each warrant will become exercisable will be deemed to be the weighted average of the kind and amount received per share by such holders in such consolidation or merger that affirmatively make such election, and if a tender, exchange or redemption offer has been made to and accepted by such holders (other than a tender, exchange or redemption offer made by the company in connection with redemption rights held by shareholders of the company as provided for in the company’s amended and restated memorandum and articles of association or as a result of the redemption of Class A ordinary shares by the company if a proposed initial business combination is presented to the shareholders of the company for approval) under circumstances in which, upon the completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the issued and outstanding Class A ordinary shares, the holder of a warrant will be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such warrant holder had exercised the warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Class A ordinary shares held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustment (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in the warrant agreement. If less than 70% of the consideration receivable by the holders of Class A ordinary shares in such a transaction is payable in the form of Class A ordinary shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants.

The warrants will be issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder for the purpose of (i) curing any ambiguity or correcting any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement set forth in this prospectus, or defective provision (ii) amending the provisions relating to cash dividends on ordinary shares as contemplated by and in accordance with the warrant agreement, (iii) to make any amendments that are necessary in the good faith determination of our board of directors (taking into account then existing market precedents) to allow for the warrants to be classified as equity in our financial statements, or (iv) adding or changing any provisions with respect to matters or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants in any material respect. All other modifications or amendments shall require the vote or written consent of the holders of at least 50% of the then-outstanding public warrants and private placement warrants, provided that any amendment that solely affects the terms of the private placement warrants or forward purchase warrants provided that any amendment that solely affects the terms of the private placement warrants or any provision of the warrant agreement solely with respect to the private placement warrants or forward purchase warrants will also require the vote or written consent of at least 50% of the then outstanding private placement warrants or forward purchase warrants, respectively. You should review the warrant agreement for a complete description of the terms and conditions applicable to the warrants.

 

12

The warrant holders do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and receive Class A ordinary shares. After the issuance of Class A ordinary shares upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by shareholders.

No fractional warrants will be issued upon separation of the units and only whole warrants will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of Class A ordinary shares to be issued to the warrant holder.

We have agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. See “Risk Factors—Our warrant agreement will designate the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with our company.” This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of America are the sole and exclusive forum.

The forward purchase warrants will have the same terms as our public warrants.

Private Placement Warrants

Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering. The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Warrants”) and they will not be redeemable by us (except as described under “—Public Shareholders’ Warrants and Forward Purchase Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00”) so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than our sponsor or its permitted transferees, the private placement warrants will be redeemable by us in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in our initial public offering. Any amendment to the terms of the private placement warrants or any provision of the warrant agreement with respect to the private placement warrants will require a vote of holders of at least 50% of the number of the then outstanding private placement warrants.

 

13

Except as described above under “—Public Shareholders’ Warrants and Forward Purchase Warrants—Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00,” if holders of the private placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or its warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “Sponsor fair market value” (defined below) over the exercise price of the warrants by (y) the Sponsor fair market value. For these purposes, the “Sponsor fair market value” shall mean the average reported closing price of the Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. The reason that we have agreed that these warrants will be exercisable on a cashless basis so long as they are held by our sponsor and its permitted transferees is because it is not known at this time whether they will be affiliated with us following a business combination. If they remain affiliated with us, their ability to sell our securities in the open market will be significantly limited. We expect to have policies in place that restrict insiders from selling our securities except during specific periods of time. Even during such periods of time when insiders will be permitted to sell our securities, an insider cannot trade in our securities if he or she is in possession of material non-public information. Accordingly, unlike public shareholders who could exercise their warrants and sell the Class A ordinary shares received upon such exercise freely in the open market in order to recoup the cost of such exercise, the insiders could be significantly restricted from selling such securities. As a result, we believe that allowing the holders to exercise such warrants on a cashless basis is appropriate.

In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants of the post business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants

 

14

EX-31.1 3 d190177dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Bo Tan, certify that:

 

1.

I have reviewed this annual report on Form 10-K of Summit Healthcare Acquisition Corp. (the “Company”);

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

 

4.

The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b.

[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

 

  c.

Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter (the Company’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

5.

The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

Date: March 31, 2022

 

/s/ Bo Tan

Bo Tan

Chief Executive Officer

(Principal Executive Officer)

 EX-31.2 4 d190177dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Bo Tan, certify that:

 

1.

I have reviewed this annual report on Form 10-K of Summit Healthcare Acquisition Corp. (the “Company”);

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

 

4.

The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b.

[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

 

  c.

Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter (the Company’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

5.

The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

Date: March 31, 2022

 

/s/ Bo Tan

Bo Tan

Co-Chief Investment Officer

(Principal Financial Officer)

 EX-32.1 5 d190177dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. § 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Bo Tan, Chief Executive Officer of Summit Healthcare Acquisition Corp. (the “Company”), certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1.

The Annual Report of the Company on Form 10-K for the fiscal year ended December 31, 2021 (the “Annual Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

2.

The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 31, 2022

 

/s/ Bo Tan

Bo Tan

Chief Executive Officer

(Principal Executive Officer)

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the U.S. Securities and Exchange Commission or its staff upon request.

EX-32.2 6 d190177dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. § 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Bo Tan, Co-Chief Investment Officer of Summit Healthcare Acquisition Corp. (the “Company”), certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1.

The Annual Report of the Company on Form 10-K for the fiscal year ended December 31, 2021 (the “Annual Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

2.

The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 31, 2022

 

/s/ Bo Tan

Bo Tan

Co-Chief Investment Officer

(Principal Financial Officer)

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the U.S. Securities and Exchange Commission or its staff upon request.

EX-101.SCH 7 smihu-20211231.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Statements of Changes in Shareholders' (Deficit) Equity link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Organization, Business Operation, Liquidity and Capital Resources link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Private Placement link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Recurring Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Commitments & Contingencies link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Warrant Liability link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Shareholders' (Deficit) Equity link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Recurring Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Organization, Business Operation, Liquidity and Capital Resources - Additional information (Detail) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Significant Accounting Policies - Additional information (Detail) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Common Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Significant Accounting Policies - Summary of Class A ordinary shares subject to possible redemption (Detail) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Initial Public Offering - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Private Placement - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Recurring Fair Value Measurements - Summary of Fair Value Hierarchy the Company's Assets and Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants (Detail) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants of FPA (Detail) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Recurring Fair Value Measurements - Summary of reconciliation of changes in fair value of derivative warrant liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Recurring Fair Value Measurements - Additional information (Detail) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Commitments & Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Warrant Liability - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Shareholders' (Deficit) Equity - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 smihu-20211231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 smihu-20211231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 smihu-20211231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 smihu-20211231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover Page - USD ($)
 12 Months Ended
Dec. 31, 2021
Mar. 31, 2022
Jun. 30, 2021
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Entity Registrant Name SUMMIT HEALTHCARE ACQUISITION CORP.    
Entity Central Index Key 0001839185    
Document Period End Date Dec. 31, 2021    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Current Fiscal Year End Date --12-31    
Entity Incorporation, State or Country Code E9    
Entity File Number 001-40466    
Entity Tax Identification Number 98-1574360    
Entity Address, Address Line One Unit 1101    
Entity Address, Address Line Two 11th Floor    
Entity Address, Address Line Three 1 Lyndhurst Tower 1 Lyndhurst Terrace    
Entity Address, City or Town Central    
Entity Address, Country HK    
Entity Address, Postal Zip Code 00000    
City Area Code 852    
Local Phone Number 9162 5199    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Shell Company true    
ICFR Auditor Attestation Flag false    
Entity Public Float     $ 0
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Auditor Name WithumSmith+Brown, PC    
Auditor Firm ID 100    
Auditor Location New York    
Common Class A      
Document Information [Line Items]      
Title of 12(b) Security Class A ordinary shares, par value $0.0001 per share    
Trading Symbol SMIH    
Security Exchange Name NASDAQ    
Entity Common Stock, Shares Outstanding   20,000,000  
Common Class B      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   5,750,000  
Warrant      
Document Information [Line Items]      
Title of 12(b) Security Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50    
Trading Symbol SMIHW    
Security Exchange Name NASDAQ    
Capital Units      
Document Information [Line Items]      
Title of 12(b) Security Units, each consisting of one Class A ordinary share and one half redeemable warrant    
Trading Symbol SMIHU    
Security Exchange Name NASDAQ    
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash $ 885,198  
Prepaid expenses 141,677  
Total current assets 1,026,875  
Deferred offering costs   $ 91,374
Investments held in Trust Account 200,007,275  
Total Assets 201,034,150 91,374
Current liabilities:    
Accrued offering costs and expenses 142,631 65,000
Note payable – related party   5,010
Total current liabilities 142,631 70,010
Warrant liability 10,423,429  
Deferred underwriting commissions 7,000,000  
Total Liabilities 20,352,001 70,010
Commitments and Contingencies (Note 7)
Class A ordinary shares subject to possible redemption, $0.0001 par value; 20,000,000 shares and -0- shares issued and outstanding at redemption value of $10.00 per share 200,000,000  
Shareholders' (Deficit) Equity:    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding  
Additional paid-in capital   24,350
Accumulated deficit (19,318,426) (3,636)
Total shareholders' (Deficit) Equity (19,317,851) 21,364
Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders' (Deficit) Equity 201,034,150 91,374
Common Class A    
Current liabilities:    
Class A ordinary shares subject to possible redemption, $0.0001 par value; 20,000,000 shares and -0- shares issued and outstanding at redemption value of $10.00 per share 200,000,000  
Shareholders' (Deficit) Equity:    
Common Stock 0  
Common Class B    
Shareholders' (Deficit) Equity:    
Common Stock [1] 575 $ 650
FPA    
Current liabilities:    
Warrant liability $ 2,785,941  
[1] This number includes up to 750,000 Class B ordinary shares subject to forfeiture as of December 31, 2020. On July 23, 2021, the 750,000 Class B ordinary shares were forfeited when the overallotment option expired.
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Balance Sheets (Parenthetical) - $ / shares
Jul. 23, 2021
Dec. 31, 2021
Dec. 31, 2020
Temporary Equity, Redemption Price Per Share   $ 10  
Preferred stock par or stated value per share   $ 0.0001 $ 0.0001
Preferred stock shares authorized   5,000,000 5,000,000
Preferred stock shares issued   0 0
Preferred stock shares outstanding   0 0
Number of Shares Forfeited During the Period   0  
Common Class A      
Temporary Equity, Par or Stated Value Per Share   $ 0.0001 $ 0.0001
Temporary Equity, Shares Issued   20,000,000 0
Temporary Equity, Shares Outstanding   20,000,000 0
Temporary Equity, Redemption Price Per Share   $ 10.00 $ 10.00
Common stock par or stated value per share   $ 0.0001 $ 0.0001
Common stock shares authorized   500,000,000 500,000,000
Common stock shares issued   20,000,000 0
Common stock shares outstanding   20,000,000 0
Common Class B      
Common stock par or stated value per share   $ 0.0001 $ 0.0001
Common stock shares authorized   50,000,000 50,000,000
Common stock shares issued   5,750,000 6,500,000
Common stock shares outstanding   5,750,000 6,500,000
Number of Shares Forfeited During the Period     750,000
Number of Overallotment Shares Forfeited During the Period 750,000    
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
General and administrative expenses $ 3,636 $ 549,179
Loss from operations (3,636) (549,179)
Other income (expense):    
Change in fair value of FPA 0 (2,785,941)
Change in fair value of warrant liability 0 3,289,535
Transaction costs allocable to warrants 0 (507,417)
Interest earned on investments held in Trust Account 0 7,275
Other income (loss) 0 3,452
Net Loss $ (3,636) $ (545,727)
Class A Common Stock Subject To Possible Redemption    
Other income (expense):    
Basic and diluted weighted average shares outstanding 0 11,178,082
Basic and diluted net loss per ordinary shares $ 0 $ (0.03)
Common Class B    
Other income (expense):    
Basic and diluted weighted average shares outstanding 5,750,000 5,750,000
Basic and diluted net loss per ordinary shares $ 0.00 $ (0.03)
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Changes in Shareholders' (Deficit) Equity - USD ($)
Total
Additional Paid-in Capital
Accumulated Deficit
Common Class A
Common Class A
Ordinary Shares
Common Class B
Ordinary Shares
Balances at beginning at Dec. 21, 2020 $ 0 $ 0 $ 0   $ 0 $ 0
Balances at beginning, Shares at Dec. 21, 2020         0 0
Class B ordinary shares issued to initial shareholders 25,000 24,350 0     $ 650
Class B ordinary shares issued to initial shareholders,Shares           6,500,000
Net loss (3,636)   (3,636)   $ 0 $ (3,636)
Balances at end at Dec. 31, 2020 21,364 24,350 (3,636)   $ 0 $ 650
Balances at end, Shares at Dec. 31, 2020         0 6,500,000
Excess of private placement proceed over fair value as capital contribution 798,445 798,445        
Accretion of Class A ordinary shares to redemption value (19,591,933) (822,795) (18,769,138) $ (19,591,933)    
Forfeiture of founder shares     75     $ (75)
Forfeiture of founder shares, Shares           (750,000)
Net loss (545,727)   (545,727)   $ (360,359) $ (185,368)
Balances at end at Dec. 31, 2021 $ (19,317,851) $ 0 $ (19,318,426)   $ 0 $ 575
Balances at end, Shares at Dec. 31, 2021         0 5,750,000
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Statement of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net loss $ (3,636) $ (545,727)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Interest earned on investments held in Trust Account 3,636 (7,275)
Change in fair value of FPA liability 0 2,785,941
Change in fair value of warrant liability 0 (3,289,535)
Transaction costs allocable to warrants 0 507,417
Changes in operating assets and liabilities:    
Prepaid expenses   (141,677)
Accrued offering costs and expenses   77,631
Net cash used in operating activities   (613,225)
Cash Flows from Investing Activities    
Investment of cash in Trust Account   (200,000,000)
Net cash used in investing activities   (200,000,000)
Cash Flows from Financing Activities:    
Proceeds received from initial public offering, net of underwriters' discount   196,000,000
Proceeds from private placement   6,000,000
Payment of offering costs   (140,554)
Repayment of note payable from related party   (361,023)
Net cash provided by financing activities   201,498,423
Net change in cash   885,198
Cash, beginning of the period   0
Cash, end of the period 0 885,198
Supplemental Non-cash disclosure of cash flow information:    
Deferred offering costs paid by Sponsor under promissory note 1,374 135,544
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares 25,000 0
Deferred underwriting commissions   7,000,000
Accrued deferred offering costs $ 65,000 $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Organization, Business Operation, Liquidity and Capital Resources
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Business Operation, Liquidity and Capital Resources
Note 1 - Organization, Business Operation, Liquidity and Capital Resources
Summit Healthcare Acquisition Corp. (the “Company”) is a blank check company incorporated on December 22, 2020 as a Cayman Islands exempted company. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target under consideration or contemplation and the Company has not, nor has anyone on its behalf, contacted any prospective target business or had any discussions, formal or otherwise, with respect to such a transaction. The Company’s efforts to identify a prospective target business will not be limited to a particular geographic region or industry, although it intends to focus on healthcare.
As of December 31, 2021, the Company had not commenced any operations. All activity for the period from December 22, 2020 (inception) through December 31, 2021 relates to the Company’s formation and the initial public offering (the “IPO”). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.
The Company’s Sponsor is Summit Healthcare Acquisition Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on June 8, 2021 (the “Effective Date”). On June 11, 2021, the Company consummated the IPO of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”) 10.00 per Unit, generating gross proceeds of $200,000,000, which is discussed in Note 3.
Simultaneously with the consummation of the IPO and the issuance and sale of the Units, the Company consummated the private placement of 6,000,000 Private Placement Warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, to the Sponsor, generating total proceeds of $6,000,000. Transaction costs amounted to $11,587,941 consisting of $4,000,000 of underwriting commissions, $7,000,000 of deferred underwriting commissions and $587,941 of other cash offering costs. In addition, $1,827,347 of cash was held in the Trust Account (as defined below) temporarily and is available for working capital purposes.
Following the closing of the IPO on June 11, 2021, $200,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account and, will be held in a U.S.-based trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee, and will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain
conditions under Rule 2a-7 under the
Investment Company Act.
Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income taxes, if any, the Company’s amended and restated memorandum and articles of association and subject to the requirements of law and regulation, will provide that the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account (1) to the Company, until the completion of the initial Business Combination, or (2) to the Company’s public shareholders until the earliest of: (i) the completion of an initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association, and (iii) the redemption of the Company’s public shares if the Company has not consummated its Business Combination within 24 months from the closing of the IPO, subject to applicable law.
The ordinary shares subject to redemption are recorded at a $10 redemption value and classified as temporary equity in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”
 
The Company will have 24 months from the closing of the IPO to complete the initial Business Combination (the “Combination Period”) or during any Extension Period. However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares,
at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
The Sponsor and the Company’s officers and directors agreed to (i) waive their redemption rights with respect to their Founder Shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association, (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period or during any Extension Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete its initial Business Combination within the prescribed timeframe), and (iv) vote any Founder Shares and public shares held by them in favor of the initial Business Combination.
The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per public share or (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay the Company’s tax obligations, provided that such liability will not apply to any claims by a third party or prospective target business that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriter of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked it Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure you that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
Liquidity and Capital Resources
As of December 31, 2021, the Company had approximately $0.89 million of cash for working capital purposes, and working capital of approximately $0.88 million.
The Company’s liquidity needs up to December 31, 2021 had been satisfied through a payment from the Sponsor of $25,000 (see Note 5) for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of $300,000 (see Note 5).
The promissory note was fully repaid on June 11, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 5). As of December 31, 2021, there were no amounts outstanding under any Working Capital Loans.
 
Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Significant Accounting Policies
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Significant Accounting Policies
Note 2 - Significant Accounting Policies
Basis of Presentation
The accompanying financial statements of
the
Company are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Security and Exchange Commission (“SEC”). In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.
Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability and Forward Purchase Agreement (“FPA”) liability.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have cash equivalents as of December 31, 2021 and December 31, 2020.
 
Investments Held in Trust Account
As of December 31, 2021, the assets held in the Trust Account were held in a money market fund. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At December 31, 2021 and 2020, the Company had $200,007,275 and nil held in the Trust Account.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Offering Costs Associated with IPO
The Company complies with the requirements of the ASC
340-10-S99-1and
SEC Staff Accounting Bulletin (“SAB”) Topic 5A“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering. Offering costs are charged to ordinary shares subject to possible redemption or the statement of operations based on the relative value of the Public and Private Warrants to the proceeds received from the Units and Private Placement Warrants sold upon the completion of the IPO. Accordingly, on December 31, 2021, offering costs totaling $11,587,941 (consisting of $4,000,000 of underwriting fees, $7,000,000 of deferred underwriting fees and $587,941 of other offering costs), of which $507,417 was allocated to the Public Warrants and Private Warrants and was charged to operations in accordance with ASC
825-10
and $11,080,524 was charged to ordinary shares subject to possible redemption.
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then
re-valued
at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or
non-current
based on whether or not
net-cash
settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Warrant Liability and Forward Purchase Agreement
The Company accounts for the 16,000,000 warrants issued in connection with the IPO (the 10,000,000 Public Warrants and the 6,000,000 Private Placement Warrants) and Forward Purchase Agreement (“FPA”) in accordance with the guidance contained in FASB ASC 815 “Derivatives and Hedging” whereby under that provision the warrants and FPA do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company will classify warrants and FPA as liabilities at their fair value. These liabilities are subject to
re-measurement
at each reporting period. With such
re-measurement,
the changes in fair value are recognized in the Statement of Operations in the period of change. Derivative warrant liabilities and FPA are classified as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Fair Value Measurements
The fair value of the Company’s assets and liabilities, excluding the warrant liability and FPA liability,
which
qualify as financial instruments under FASB ASC Topic 820, Fair Value Measurement (“ASC 820”), approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
  •  
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2021 and December 31, 2020, 20,000,000 and 0 Class A ordinary shares, respectively, subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
At December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:

Gross proceeds
    $ 200,000,000  
Less: Proceeds allocated to Public Warrants
      (8,511,409)  
Less: Class A ordinary shares issuance costs
      (11,080,524)  
Add: Accretion of carrying value to redemption value
      19,591,933  
    
 
 
  
Class A ordinary shares subject to possible redemption
    $ 200,000,000  
    
 
 
  
 
Net Income (Loss) Per Share of Ordinary Shares
The Company has two classes of shares, which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Earnings and losses are shared pro rata between the two classes of shares. The 16,000,000 potential ordinary shares for outstanding warrants to purchase the Company’s stock were excluded from diluted earnings per share for the year ended December 31, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares:
 
                                 
    
For the Year Ended

December 31, 2021
     
For the Period

from December 22, 2020
(Inception) to

December 31, 2020
  
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income per share:
                                    
Numerator:
                                    
Allocation of net loss
    $ (360,359)      $ (185,368)      $ —        $ (3,636)  
Denominator:
                                    
Weighted-average shares outstanding
      11,178,082        5,750,000        —          5,750,000  
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net loss per share
    $ (0.03)      $ (0.03)      $ —        $ (0.00)  
    
 
 
     
 
 
     
 
 
     
 
 
  
Income Taxes
ASC 740 clarifies the accounting for uncertainty in income taxes recognized in a Company’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position
must be more-likely-than-not to be
sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Pronouncements
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2020-06,
Debt - Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic
815-40)
(“ASU
2020-06”)
to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use the
if-converted
method for all convertible instruments. ASU
2020-06
is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that
ASU 2020-06
would have on its financial position, results of operations or cash flows.
Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Initial Public Offering
 12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Initial Public Offering
Note 3 - Initial Public Offering
On June 11, 2021, the Company consummated its IPO of 20,000,000 Units (the “Units”), at a price of $10.00 per unit, generating gross proceeds to the Company of $200,000,000. Each Unit consists of one Class A ordinary share and
one-half
of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable on the later of 30 days after the completion of the initial Business Combination or 12 months from the closing of the IPO, and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation (see Note 8).
 
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Private Placement
 12 Months Ended
Dec. 31, 2021
Private Placement Warrants [Abstract]  
Private Placement
Note 4 - Private Placement
Simultaneously with the closing of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of an aggregate 6,000,000 Private Placement Warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $6,000,000. If the Company does not complete an initial Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants
will be non-redeemable by the
Company and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.
If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the IPO.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transactions
 12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
Related Party Transactions
Note 5 - Related Party Transactions
Founder Shares
On December 31, 2020, the Company issued to the Sponsor 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”), for $25,000 for certain expenses paid on behalf of the Company, or approximately $0.004 per share. On April 30, 2021, the Company effected a share capitalization, pursuant to which the Company’s initial shareholders held an aggregate of 6,500,000 Class B ordinary shares. The accompanying financial statements have been retroactively adjusted to reflect the stock dividend in the share capitalization. On April 30, 2021, the Company entered into forward purchase agreements (see Note 6) with anchor investors, in connection with entering into the forward purchase agreements, the Sponsor transferred to the anchor investors an aggregate of 375,000 Class B ordinary shares for no cash. On April 30, 2021, the Sponsor transferred 25,000 Class B ordinary shares each to three independent director nominees. Up to 750,000 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. On July 23, 2021, the Sponsor surrendered 750,000 Founder Shares, with no return of capital or payment by the Sponsor, after the expiration of the unexercised underwriters’ over-allotment option. As a result of the foregoing, at December 31, 2021 and December 31, 2020, the Sponsor owned 5,750,000 and 6,500,000 Class B ordinary shares, respectively.
The Sponsor, officers and directors have agreed not to transfer, assign or sell any of their Founder Shares until earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s public shareholders having the right to exchange their ordinary shares for cash, securities or other property
(the “Lock-up”).
Any permitted transferees would be subject to the same restrictions and other agreements of our Sponsor, officers and directors with respect to any Founder Shares.
Promissory Note - Related Party
The Sponsor has agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. These loans were
non-interest
bearing, unsecured and were due at the earlier of September 30, 2021 or the closing of the IPO. The loan was to be repaid upon completion of the IPO out of the $1,000,000 of offering proceeds that has been allocated to the payment of offering expenses. The Company had drawn down $140,068 under the promissory note which was fully repaid as of June 11, 2021. The note was terminated at June 11, 2021.
Related Party Loans
In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. As of December 31, 2021 and December 31, 2020, the Company had no borrowings under the Working Capital Loans.
 
Administrative Service Fee
Commencing on the Effective Date, the Company paid an affiliate of the Sponsor $10,000 per month for office space, utilities, administrative services and remote support services. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company accrued $67,667 for the administrative service fee for the period from June 8, 2021 (the Effective Date) to December 31, 2021.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Recurring Fair Value Measurements
 12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Recurring Fair Value Measurements
Note 7 - Recurring Fair Value Measurements
Warrant Liability and FPA Liability
At December 31, 2021, the fair value of Company’s Warrant liability was $10,423,429, and the fair value of FPA liability was $2,785,941. Under the guidance in
ASC 815-40 the
Public and Private Warrants and the FPA do not meet the criteria for equity treatment. As such, the Public and Private Warrants and the FPA must be recorded on the balance sheet at fair value. This valuation is subject to
re-measurement
each balance sheet date. With each
re-measurement,
the valuations will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.
Recurring Fair Value Measurements
The following table presents fair value information as of December 31, 2021 of the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. The Company’s Warrant liability is based on a valuation models utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the Warrant liability and FPA liability is classified within Level 3 of the fair value hierarchy. The investments held in Trust Account includes money market funds. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its level 1 investments.
The following table sets forth by level within the fair value hierarchy the Company’s assets and liabilities as of December 31, 2021, that were accounted for at fair value on a recurring basis:

 
  
(Level 1)
 
  
(Level 2)
 
  
(Level 3)
 
Assets
  
  
  
Investments held in Trust Account
    $ 200,007,275      $ —        $ —    
Liabilities
                           
Public Warrants
    $ —        $ 6,500,000      $ —    
Private Warrants
    $ —        $ —        $ 3,923,429  
FPA liability
    $ —        $ —        $ 2,785,941  
 
Measurement of the Warrants
The Company established the initial fair value for the Warrants on June 11, 2021, the date of the consummation of the Company’s IPO. The Company used a Monte Carlo simulation model to value the Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Class A ordinary share and
one-half
of one Public Warrant), (ii) the sale of Private Warrants, and (iii) the issuance of Class B ordinary shares, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption (temporary equity), and Class B ordinary shares (permanent equity) based on their relative fair values at the initial measurement date. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement in August 2021 after detachment of the Public Warrants from the Units and were separately listed and traded. As of December 31, 2021, the Public Warrants were valued using the observed price for Public Warrants and the Private Warrants were valued using a Monte Carlo simulation model.
 
The key inputs for the valuation of Public and Private Warrants are as follows:

Input
  
June 11,
2021
 
 
December
31, 2021
 
Volatility
      16.30 %      13.4 % 
Risk Free Rate
      0.89 %      1.29 % 
Stock Price
    $ 9.57     $ 9.72  
Est. Term Remaining (Yrs)
      5.65       5.35  
The following table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s derivative warrant liabilities classified as Level 3:

 
  
Warrant
liabilities
 
Fair value at January 1, 2021
    $ —    
Initial value at IPO date
      13,712,964  
Change in fair value
      (3,289,535 ) 
Transfer of Public warrants from Level 3 to Level 1
      (6,500,000 ) 
    
 
 
  
Fair Value at December 31, 2021
    $ 3,923,429  
FPA
To arrive the conclusion of Fair Value of the Forward Purchase Agreements, the Company analyzed the agreements and other documentation. The Company utilized the underlying shares and warrant values determined above and the following inputs in order to project the net asset or liability value of the FPA:​​​​​​​
 
Input
  
June 11,
2021
 
 
December 31,
2021
 
Volatility
      16.30 %      13.4 % 
Stock Price
    $ 9.57     $ 9.72  
Warrant Price
    $ 0.85     $ 0.65  
Est. Term to Business Combination (Yrs)
      0.65       0.33  
Probability of Business Combination
      85 %      85 % 
Purchase price of FPA unit
    $ 10.00     $ 10.00  
The
following
table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s FPA liability classified as Level 3:
 

 
  
FPA liability
 
Fair value at January 1, 2021
    $ —    
Initial value at IPO date
      2,322,741  
Change in fair value
      463,200  
    
 
 
  
Fair Value at December 31, 2021
    $ 2,785,941  
 
Transfers between levels of the fair
value
hierarchy are recognized at the end of the reporting period.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments & Contingencies
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments & Contingencies
Note 7 - Commitments & Contingencies
Risks and Uncertainties
Management continues to evaluate the impact
of the COVID-19 pandemic on
the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of this financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.
Registration Rights
The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of the IPO. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its initial Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable
Lock-up
period, which occurs (i) in the case of the Founder Shares, and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriters Agreement
The underwriters
had a 45-day option to
purchase up to an additional 3,000,000 units to cover over-allotments, if any. The over-allotment option expired unexercised on July 23, 2021.
The underwriters were paid a cash underwriting discount of two percent (2%) of the gross proceeds of the IPO, or $4,000,000. Additionally, the underwriters are entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the IPO upon the completion of the Company’s initial Business Combination.
Forward Purchase Agreements
On April 30, 2021, the Company entered into forward purchase agreements with the Sponsor, Snow Lake Capital (HK) Limited and Valliance Fund (the “anchor investors”), pursuant to which the anchor investors agreed to subscribe for an aggregate of 3,000,000 Class A ordinary shares plus 750,000 redeemable warrants for a purchase price of $10.00 multiplied by the number of Class A ordinary shares, or $30,000,000 in the aggregate, in a private placement to close concurrently with the closing of the initial business combination. The Company issued 750,000 additional Class B ordinary shares to the Sponsor, which represent the adjustment to the ratio applicable to the conversion of the Class B ordinary shares that the Sponsor would have been entitled to at the closing of the initial business combination as a result of the issuance of 3,000,000 additional Class A ordinary shares under the forward purchase agreements. As a result, the issuance of the Class A ordinary shares at the closing of the initial business combination will not trigger a further adjustment to this ratio. Further, prior to the IPO, the Sponsor transferred to the anchor investors an aggregate of 375,000 Founder Shares for no cash consideration. Subject to certain exceptions to forfeiture and transfer provisions, the Founder Shares transferred in connection with these agreements are subject to similar contractual conditions and restrictions as the Founder Shares issued to the Sponsor in connection with the IPO. The forward purchase warrants will have the same terms as the public warrants.
 
The forward purchase agreements provide that the anchor investors are entitled to registration rights with respect to the forward purchase securities and Class A ordinary shares underlying the forward purchase warrants and founder shares.
The proceeds from the sale of the forward purchase securities may be used as part of the consideration to the sellers in the initial Business Combination, expenses in connection with the initial Business Combination or for working capital in the post Business Combination company. These purchases will be required to be made regardless of whether any Class A ordinary shares are redeemed by the public shareholders and are intended to provide the Company with a minimum funding level for the initial Business Combination. The anchor investors will not have the ability to approve the initial Business Combination prior to the signing of a material definitive agreement and, if the Company seeks shareholder approval, have agreed to vote their Founder Shares and any public shares held by them in favor of the initial Business Combination. The forward purchase securities will be issued only in connection with the closing of the initial Business Combination.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Warrant Liability
 12 Months Ended
Dec. 31, 2021
Warrant Liability [Abstract]  
Warrant Liability
Note 8 - Warrant Liability
As of December 31, 2021, 16,000,000 warrants (the 10,000,000 Public Warrants and the 6,000,000 Private Placement Warrants) are outstanding. Each warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants will become exercisable on the later of 12 months from the closing of the IPO or 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation
Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00.
Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
 
  •  
if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within
a 30-trading day
period ending three trading days before the Company sends the notice of redemption to the warrant holders.
If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
 
  •  
in whole and not in part;
 
  •  
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by referenc e to the table below, based on the redemption date and the “fair market value” of the Class A ordinary shares;
 
  •  
if, and only if, the closing price of our Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise p rice of a warrant) for any 20 trading days within
the 30-trading day
period ending three trading days before the Company sends the notice of redemption to the warrant holders; and
 
  •  
if the closing price of the Class A ordinary shares for any 20 trading days within
a 30-trading day
period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Company’s Sponsors or its affiliate, without taking into account any Founder Shares held by the Company’s Sponsor or such affiliates, as applicable, prior to such issuance (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' (Deficit) Equity
 12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Shareholders' (Deficit) Equity
Note 9 - Shareholders’ (Deficit) Equity
Preference shares
The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2021 and December 30, 2020, there were no preference shares issued or outstanding.
Class A Ordinary Shares
The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of December 31, 2021 and 2020, there were 20,000,000 and 0 Class A ordinary shares issued and outstanding, including the 20,000,000 and 0 shares presented in ordinary shares subject to redemption.
Class B Ordinary Shares
The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. As of December 31, 2021 and December 31, 2020, there were 5,750,000 and 6,500,000 Class B ordinary shares issued and outstanding, respectively. Of the 6,500,000 Class B ordinary shares, an aggregate of up to 750,000 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the initial shareholders will collectively own 20% of the Company’s issued and outstanding ordinary shares after the IPO. On July 23, 2021, the Sponsor surrendered 750,000 Founder Shares, with no return of capital or payment by the Sponsor, after the expiration of the unexercised underwriters’ over-allotment option.
Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law. Prior to the initial Business Combination, only holders of the Founder Shares will have the right to vote on the election of directors. Holders of the public shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to the completion of an initial Business Combination, holders of a majority of the Founder Shares may remove a member of the board of directors for any reason.
 
The Class B ordinary shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate,
on an as-converted basis, 20%
of the sum of (i) the total number of ordinary shares issued and outstanding upon the completion of the IPO, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued or to be issued to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of our management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than
one-to-one.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events
 12 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
Subsequent Events
Note 10 - Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on this review, other than disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statement.
On February 24, 2022, Russian forces launched significant military action against Ukraine, and sustained conflict and disruption in the region is possible. The impact to Ukraine as well as actions taken by other countries, including new and stricter sanctions imposed by Canada, the United Kingdom, the European Union, the U.S. and other countries and companies and organizations against officials, individuals, regions, and industries in Russia and Ukraine, and actions taken by Russia in response to such sanctions, and each country’s potential response to such sanctions, tensions, and military actions could have a material adverse effect on the business or prospects of potential target companies in Europe as the Company’s efforts to identify a prospective target business are not be limited to a particular geographic region. Any such material adverse effect from the conflict and enhanced sanctions activity may include reduced trading and business activity levels, disruption of financial markets, increased costs, disruption of services, inability to complete financial or banking transactions, and inability to service existing or new customers in the region. Prolonged unrest, military activities, or broad-based sanctions, should they be implemented, could have a material adverse effect on our ability to complete a business combination with a suitable target.
 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying financial statements of
the
Company are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Security and Exchange Commission (“SEC”). In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows.
Emerging Growth Company Status
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
Use of Estimates
The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.
Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability and Forward Purchase Agreement (“FPA”) liability.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have cash equivalents as of December 31, 2021 and December 31, 2020.
Investments Held in Trust Account
Investments Held in Trust Account
As of December 31, 2021, the assets held in the Trust Account were held in a money market fund. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At December 31, 2021 and 2020, the Company had $200,007,275 and nil held in the Trust Account.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Offering Costs Associated with IPO
Offering Costs Associated with IPO
The Company complies with the requirements of the ASC
340-10-S99-1and
SEC Staff Accounting Bulletin (“SAB”) Topic 5A“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering. Offering costs are charged to ordinary shares subject to possible redemption or the statement of operations based on the relative value of the Public and Private Warrants to the proceeds received from the Units and Private Placement Warrants sold upon the completion of the IPO. Accordingly, on December 31, 2021, offering costs totaling $11,587,941 (consisting of $4,000,000 of underwriting fees, $7,000,000 of deferred underwriting fees and $587,941 of other offering costs), of which $507,417 was allocated to the Public Warrants and Private Warrants and was charged to operations in accordance with ASC
825-10
and $11,080,524 was charged to ordinary shares subject to possible redemption.
Derivative Financial Instruments
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then
re-valued
at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or
non-current
based on whether or not
net-cash
settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Warrant Liability and Forward Purchase Agreement
Warrant Liability and Forward Purchase Agreement
The Company accounts for the 16,000,000 warrants issued in connection with the IPO (the 10,000,000 Public Warrants and the 6,000,000 Private Placement Warrants) and Forward Purchase Agreement (“FPA”) in accordance with the guidance contained in FASB ASC 815 “Derivatives and Hedging” whereby under that provision the warrants and FPA do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company will classify warrants and FPA as liabilities at their fair value. These liabilities are subject to
re-measurement
at each reporting period. With such
re-measurement,
the changes in fair value are recognized in the Statement of Operations in the period of change. Derivative warrant liabilities and FPA are classified as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Fair Value Measurements
Fair Value Measurements
The fair value of the Company’s assets and liabilities, excluding the warrant liability and FPA liability,
which
qualify as financial instruments under FASB ASC Topic 820, Fair Value Measurement (“ASC 820”), approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
  •  
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Class A Ordinary Shares Subject to Possible Redemption
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2021 and December 31, 2020, 20,000,000 and 0 Class A ordinary shares, respectively, subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
At December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:

Gross proceeds
    $ 200,000,000  
Less: Proceeds allocated to Public Warrants
      (8,511,409)  
Less: Class A ordinary shares issuance costs
      (11,080,524)  
Add: Accretion of carrying value to redemption value
      19,591,933  
    
 
 
  
Class A ordinary shares subject to possible redemption
    $ 200,000,000  
    
 
 
  
 
Net Income (Loss) Per Share of Ordinary Shares
Net Income (Loss) Per Share of Ordinary Shares
The Company has two classes of shares, which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Earnings and losses are shared pro rata between the two classes of shares. The 16,000,000 potential ordinary shares for outstanding warrants to purchase the Company’s stock were excluded from diluted earnings per share for the year ended December 31, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares:
                                 
    
For the Year Ended

December 31, 2021
     
For the Period

from December 22, 2020
(Inception) to

December 31, 2020
  
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income per share:
                                    
Numerator:
                                    
Allocation of net loss
    $ (360,359)      $ (185,368)      $ —        $ (3,636)  
Denominator:
                                    
Weighted-average shares outstanding
      11,178,082        5,750,000        —          5,750,000  
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net loss per share
    $ (0.03)      $ (0.03)      $ —        $ (0.00)  
    
 
 
     
 
 
     
 
 
     
 
 
  
Income Taxes
Income Taxes
ASC 740 clarifies the accounting for uncertainty in income taxes recognized in a Company’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position
must be more-likely-than-not to be
sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2020-06,
Debt - Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic
815-40)
(“ASU
2020-06”)
to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use the
if-converted
method for all convertible instruments. ASU
2020-06
is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that
ASU 2020-06
would have on its financial position, results of operations or cash flows.
Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Summary of basic and diluted net income (loss) per common share
At December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:

Gross proceeds
    $ 200,000,000  
Less: Proceeds allocated to Public Warrants
      (8,511,409)  
Less: Class A ordinary shares issuance costs
      (11,080,524)  
Add: Accretion of carrying value to redemption value
      19,591,933  
    
 
 
  
Class A ordinary shares subject to possible redemption
    $ 200,000,000  
    
 
 
  
 
Summary of Class A ordinary shares subject to possible redemption The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares:
                                 
    
For the Year Ended

December 31, 2021
     
For the Period

from December 22, 2020
(Inception) to

December 31, 2020
  
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic and diluted net income per share:
                                    
Numerator:
                                    
Allocation of net loss
    $ (360,359)      $ (185,368)      $ —        $ (3,636)  
Denominator:
                                    
Weighted-average shares outstanding
      11,178,082        5,750,000        —          5,750,000  
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net loss per share
    $ (0.03)      $ (0.03)      $ —        $ (0.00)  
    
 
 
     
 
 
     
 
 
     
 
 
  
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Recurring Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2021
Summary of Fair Value Hierarchy the Company's Assets and Liabilities
The following table sets forth by level within the fair value hierarchy the Company’s assets and liabilities as of December 31, 2021, that were accounted for at fair value on a recurring basis:

 
  
(Level 1)
 
  
(Level 2)
 
  
(Level 3)
 
Assets
  
  
  
Investments held in Trust Account
    $ 200,007,275      $ —        $ —    
Liabilities
                           
Public Warrants
    $ —        $ 6,500,000      $ —    
Private Warrants
    $ —        $ —        $ 3,923,429  
FPA liability
    $ —        $ —        $ 2,785,941  
 
Public and Private Warrants  
Summary of Valuation of Public and Private Warrants
The key inputs for the valuation of Public and Private Warrants are as follows:

Input
  
June 11,
2021
 
 
December
31, 2021
 
Volatility
      16.30 %      13.4 % 
Risk Free Rate
      0.89 %      1.29 % 
Stock Price
    $ 9.57     $ 9.72  
Est. Term Remaining (Yrs)
      5.65       5.35  
FPA liability  
Summary of Valuation of Public and Private Warrants The Company utilized the underlying shares and warrant values determined above and the following inputs in order to project the net asset or liability value of the FPA:
 
Input
  
June 11,
2021
 
 
December 31,
2021
 
Volatility
      16.30 %      13.4 % 
Stock Price
    $ 9.57     $ 9.72  
Warrant Price
    $ 0.85     $ 0.65  
Est. Term to Business Combination (Yrs)
      0.65       0.33  
Probability of Business Combination
      85 %      85 % 
Purchase price of FPA unit
    $ 10.00     $ 10.00  
Summary of reconciliation of changes in fair value of derivative warrant liabilities
The
following
table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s FPA liability classified as Level 3:
 

 
  
FPA liability
 
Fair value at January 1, 2021
    $ —    
Initial value at IPO date
      2,322,741  
Change in fair value
      463,200  
    
 
 
  
Fair Value at December 31, 2021
    $ 2,785,941  
Derivative Warrant Liabilities [Member]  
Summary of reconciliation of changes in fair value of derivative warrant liabilities
The following table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s derivative warrant liabilities classified as Level 3:

 
  
Warrant
liabilities
 
Fair value at January 1, 2021
    $ —    
Initial value at IPO date
      13,712,964  
Change in fair value
      (3,289,535 ) 
Transfer of Public warrants from Level 3 to Level 1
      (6,500,000 ) 
    
 
 
  
Fair Value at December 31, 2021
    $ 3,923,429  
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Organization, Business Operation, Liquidity and Capital Resources - Additional information (Detail) - USD ($)
 12 Months Ended 24 Months Ended
Jun. 11, 2021
Apr. 30, 2021
Dec. 31, 2021
Jun. 30, 2023
Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Shares issued, price per share     $ 10.00    
Proceeds from issuance initial public offering     $ 196,000,000    
Class of warrants and rights issued during the period     16,000,000    
Proceeds from issuance of private placement     $ 6,000,000    
Deferred underwriting commissions noncurrent     7,000,000    
Cash     885,198    
Working capital (deficit)     880,000    
Proceeds from unsecured notes payable     300,000    
Working capital loans     $ 0    
Temporary Equity, Redemption Price Per Share     $ 10    
Forecast          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Dissolution expense       $ 100,000  
Private Placement Warrants          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Class of warrants and rights issued during the period     6,000,000    
Sponsor          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from issuance of common stock     $ 25,000    
Sponsor | Private Placement Warrants          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Class of warrants and rights issued during the period     6,000,000    
Class of warrants and rights issued, price per warrant     $ 1.00    
Proceeds from issuance of private placement     $ 6,000,000    
IPO          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Shares issued, price per share $ 10.00        
Proceeds from issuance initial public offering $ 200,000,000   200,000,000    
Payments for underwriting expense     4,000,000    
Deferred underwriting commissions noncurrent     7,000,000    
Other offering costs     587,941    
Payments to acquire restricted certificates of deposit     1,827,347    
Stock issuance costs     $ 11,587,941    
Common Class A          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Temporary Equity, Redemption Price Per Share     $ 10.00   $ 10.00
Common Class A | Sponsor          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from issuance of common stock   $ 30,000,000      
Common Class A | IPO          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stock issued during period, shares, new issues 20,000,000        
Shares issued, price per share $ 10.00        
Proceeds from issuance initial public offering $ 200,000,000        
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Significant Accounting Policies - Additional information (Detail) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Equivalents $ 0 $ 0
FDIC insured amount 250,000  
Deferred underwriting commissions 7,000,000  
Offering costs charged to the shareholders' equity $ 11,080,524  
Class of warrants and rights issued during the period 16,000,000  
Warrant    
Antidilutive securities excluded from computation of earnings per share, Amount 16,000,000  
US Government Securities [Member]    
Restricted Investments Term 185 days  
IPO    
Stock issuance costs $ 11,587,941  
Payments for underwriting expense 4,000,000  
Deferred underwriting commissions 7,000,000  
Other offering costs 587,941  
Public Warrants And Private Warrants | IPO    
Other offering costs $ 507,417  
Private Placement Warrants    
Class of warrants and rights issued during the period 6,000,000  
Public Warrants    
Class of warrants and rights issued during the period 10,000,000  
Common Class A    
Offering costs charged to the shareholders' equity $ 11,080,524  
Temporary equity, shares outstanding 20,000,000 0
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Common Share (Detail) - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Class of Stock [Line Items]    
Allocation of net loss $ (3,636) $ (545,727)
Common Class A | Common Stock [Member]    
Class of Stock [Line Items]    
Allocation of net loss $ 0 $ (360,359)
Weighted-average shares outstanding 0 11,178,082
Basic and diluted net loss per share $ 0 $ (0.03)
Common Class B    
Class of Stock [Line Items]    
Weighted-average shares outstanding 5,750,000 5,750,000
Basic and diluted net loss per share $ 0.00 $ (0.03)
Common Class B | Common Stock [Member]    
Class of Stock [Line Items]    
Allocation of net loss $ (3,636) $ (185,368)
Weighted-average shares outstanding 5,750,000 5,750,000
Basic and diluted net loss per share $ 0.00 $ (0.03)
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Significant Accounting Policies - Summary of Class A ordinary shares subject to possible redemption (Detail) - USD ($)
 12 Months Ended
Jun. 11, 2021
Dec. 31, 2021
Temporary Equity [Line Items]    
Gross proceeds   $ 196,000,000
Less: Class A ordinary shares issuance costs   (11,080,524)
Add: Accretion of carrying value to redemption value   19,591,933
Class A ordinary shares subject to possible redemption   200,000,000
Common Class A [Member]    
Temporary Equity [Line Items]    
Less: Class A ordinary shares issuance costs   (11,080,524)
Add: Accretion of carrying value to redemption value   19,591,933
Class A ordinary shares subject to possible redemption   200,000,000
IPO [Member]    
Temporary Equity [Line Items]    
Gross proceeds $ 200,000,000 200,000,000
Less: Proceeds allocated to Public Warrants   $ (8,511,409)
IPO [Member] | Common Class A [Member]    
Temporary Equity [Line Items]    
Gross proceeds $ 200,000,000  
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Initial Public Offering - Additional Information (Detail) - USD ($)
 12 Months Ended
Jun. 11, 2021
Dec. 31, 2021
Shares issued, price per share   $ 10.00
Proceeds from issuance initial public offering   $ 196,000,000
Class of warrant or right, threshold period for exercise from date of closing public offering   12 months
Class of warrant or right redemption threshold consecutive trading days   30 days
IPO    
Shares issued, price per share $ 10.00  
Proceeds from issuance initial public offering $ 200,000,000 $ 200,000,000
Common Class A | IPO    
Stock shares issued during the period shares 20,000,000  
Shares issued, price per share $ 10.00  
Proceeds from issuance initial public offering $ 200,000,000  
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Private Placement - Additional Information (Detail)
 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Private Placement [Line Items]  
Class of warrants and rights issued during the period 16,000,000
Proceeds from private placement | $ $ 6,000,000
Private Placement Warrants  
Private Placement [Line Items]  
Class of warrants and rights issued during the period 6,000,000
Sponsor | Private Placement Warrants  
Private Placement [Line Items]  
Class of warrants and rights issued during the period 6,000,000
Class of warrants and rights issued, price per warrant | $ / shares $ 1.00
Proceeds from private placement | $ $ 6,000,000
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transactions - Additional Information (Detail)
 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Apr. 30, 2021
USD ($)
Nominees
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Related Party Transaction [Line Items]        
Offering proceeds allocated to payment of offering expenses       $ 1,000,000
Proceeds from issuance of debt       $ 140,068
Working Capital Loan        
Related Party Transaction [Line Items]        
Warrants issued price per warrant | $ / shares $ 1.00     $ 1.00
Due to related parties $ 0   $ 0 $ 0
Working capital loans convertible into warrants 1,500,000     1,500,000
Administrative Service Fee        
Related Party Transaction [Line Items]        
Due to related parties 67,667     67,667
Expenses from transactions with related party 10,000      
Sponsor        
Related Party Transaction [Line Items]        
Proceeds from issuance of common stock       25,000
Sponsor | Promissory Note        
Related Party Transaction [Line Items]        
Debt instrument, face amount $ 300,000     $ 300,000
Sponsor | Founder shares        
Related Party Transaction [Line Items]        
Class B ordinary share issued to initial shareholders, shares | shares   25,000    
Sponsor | Founder shares | Director        
Related Party Transaction [Line Items]        
Number of independent director nominees | Nominees   3    
Common Class B        
Related Party Transaction [Line Items]        
Common stock par or stated value per share | $ / shares $ 0.0001   $ 0.0001 $ 0.0001
Common stock shares outstanding | shares 5,750,000   6,500,000 5,750,000
Common Class B | Sponsor        
Related Party Transaction [Line Items]        
Common stock par or stated value per share | $ / shares $ 0.0001     $ 0.0001
Stock issued during period, value, issued for services     $ 25,000  
Proceeds from sponsor to cover certain offering costs per share value | $ / shares     $ 0.004  
Common stock shares outstanding | shares 5,750,000 6,500,000 6,500,000 5,750,000
Class B ordinary share issued to initial shareholders, shares | shares   750,000 5,750,000  
Share price | $ / shares $ 12.00     $ 12.00
Number of trading days for determining the share price       20 days
Number of consecutive trading days for determining the share price       30 days
Waiting period after which the share trading days are considered       150 days
Common Class B | Sponsor | Founder shares        
Related Party Transaction [Line Items]        
Common stock shares outstanding | shares 5,750,000   6,500,000 5,750,000
Common stock shares subject to forfeiture | shares       750,000
Common Class B | Anchor investors        
Related Party Transaction [Line Items]        
Class B ordinary share issued to initial shareholders, shares | shares   375,000    
Proceeds from issuance of common stock   $ 0    
Common Class B | Anchor investors | Founder shares        
Related Party Transaction [Line Items]        
Class B ordinary share issued to initial shareholders, shares | shares   375,000    
Proceeds from issuance of common stock   $ 0    
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Recurring Fair Value Measurements - Summary of Fair Value Hierarchy the Company's Assets and Liabilities (Detail)
Dec. 31, 2021
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant Liability $ 10,423,429
FPA liability  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant Liability 2,785,941
Fair Value, Recurring | Level 1  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Investments held in Trust Account 200,007,275
Fair Value, Recurring | Public Warrants | Level 1  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant Liability 0
Fair Value, Recurring | Public Warrants | Level 2  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant Liability 6,500,000
Fair Value, Recurring | Public Warrants | Level 3  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant Liability 0
Fair Value, Recurring | Private Warrants | Level 3  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant Liability 3,923,429
Fair Value, Recurring | FPA liability | Level 3  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant Liability $ 2,785,941
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants (Detail) - Public and Private Warrants
Dec. 31, 2021
$ / shares
yr
Jun. 11, 2021
$ / shares
yr
Volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and rights outstanding, measurement input 13.4 16.30
Risk Free Rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and rights outstanding, measurement input 1.29 0.89
Stock Price    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and rights outstanding, measurement input | $ / shares 9.72 9.57
Est. Term Remaining (Yrs)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and rights outstanding, measurement input | yr 5.35 5.65
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants of FPA (Detail) - FPA liability
Dec. 31, 2021
yr
$ / shares
Jun. 11, 2021
$ / shares
yr
Volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and rights outstanding, measurement input 13.4 16.30
Stock Price    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and rights outstanding, measurement input 9.72 9.57
Warrant Price    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and rights outstanding, measurement input 0.65 0.85
Est. Term to Business Combination (Yrs)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and rights outstanding, measurement input | yr 0.33 0.65
Probability of Business Combination    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and rights outstanding, measurement input 85 85
Purchase price of FPA unit    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and rights outstanding, measurement input 10.00 10.00
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Recurring Fair Value Measurements - Summary of reconciliation of changes in fair value of derivative warrant liabilities (Detail) - Fair Value, Inputs, Level 3 [Member]
 12 Months Ended
Dec. 31, 2021
USD ($)
FPA Liability [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning balance $ 0
Initial value at IPO date 2,322,741
Change in fair value 463,200
Ending balance 2,785,941
Warrant [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning balance 0
Initial value at IPO date 13,712,964
Change in fair value (3,289,535)
Transfer of Public warrants from level 3 to level 1 (6,500,000)
Ending balance $ 3,923,429
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Recurring Fair Value Measurements - Additional information (Detail)
Dec. 31, 2021
USD ($)
Warrant liability $ 10,423,429
FPA liability  
Warrant liability $ 2,785,941
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments & Contingencies - Additional Information (Detail) - USD ($)
 12 Months Ended
Jun. 11, 2021
Apr. 30, 2021
Dec. 31, 2020
Dec. 31, 2021
Loss Contingencies [Line Items]        
Overallotment option vesting period       45 days
Underwriting discount       (2.00%)
Deferred underwriting fee percent on gross proceeds of the IPO       3.50%
Class of warrant or right, exercise price of warrants or rights   $ 10.00   $ 11.50
Sponsor        
Loss Contingencies [Line Items]        
Proceeds from issuance of common stock       $ 25,000
Sponsor | Founder Shares [Member]        
Loss Contingencies [Line Items]        
Stock issued during period, shares, issued for services   25,000    
IPO        
Loss Contingencies [Line Items]        
Cash underwriting discount of the IPO paid to underwriters       $ 4,000,000
Common Class A | Anchor investors        
Loss Contingencies [Line Items]        
Stock issued during period, shares, issued for services   3,000,000    
Common Class A | Sponsor        
Loss Contingencies [Line Items]        
Proceeds from issuance of common stock   $ 30,000,000    
Common stock shares issued with effect of conversion   3,000,000    
Common Class A | IPO        
Loss Contingencies [Line Items]        
Stock shares issued during the period shares 20,000,000      
Common Class B | Anchor investors        
Loss Contingencies [Line Items]        
Stock issued during period, shares, issued for services   375,000    
Proceeds from issuance of common stock   $ 0    
Common Class B | Anchor investors | Founder Shares [Member]        
Loss Contingencies [Line Items]        
Stock issued during period, shares, issued for services   375,000    
Proceeds from issuance of common stock   $ 0    
Common Class B | Sponsor        
Loss Contingencies [Line Items]        
Stock issued during period, shares, issued for services   750,000 5,750,000  
Redeemable Warrants | Anchor investors        
Loss Contingencies [Line Items]        
Stock issued during period, shares, issued for services   750,000    
Maximum | Common Class A | Over-Allotment Option        
Loss Contingencies [Line Items]        
Stock shares issued during the period shares       3,000,000
Maximum | Private Placement Warrants        
Loss Contingencies [Line Items]        
Minimum lock in period required for warrant exercise from the date of business combination       30 days
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Warrant Liability - Additional Information (Detail) - $ / shares
 12 Months Ended
Dec. 31, 2021
Apr. 30, 2021
Disclosure of Warrant Liability [Line Items]    
Class of warrant or right, outstanding 16,000,000  
Class of warrant or right, exercise price of warrants or rights $ 11.50 $ 10.00
Class of warrant or right, threshold period for exercise from date of closing public offering 12 months  
Class of warrant or right redemption threshold consecutive trading days 30 days  
Common Class A | Share Price Equal or Exceeds Eighteen Rupees Per Dollar    
Disclosure of Warrant Liability [Line Items]    
Class of warrant or right, exercise price adjustment percentage higher of market value 180.00%  
Common Class A | Share Price Equal or Less Nine Point Two Rupees Per Dollar    
Disclosure of Warrant Liability [Line Items]    
Share redemption trigger price $ 9.20  
Minimum percentage gross proceeds required from issuance of equity 60.00%  
Class of warrant or right, exercise price adjustment percentage higher of market value 115.00%  
Public Warrants    
Disclosure of Warrant Liability [Line Items]    
Class of warrant or right, outstanding 10,000,000  
Public Warrants | Share Price Equal or Exceeds Eighteen Rupees Per Dollar    
Disclosure of Warrant Liability [Line Items]    
Class of warrants redemption price per unit $ 0.01  
Number of days of notice to be given for redemption of warrants 30 days  
Number of consecutive trading days for determining share price 20 days  
Number of trading days for determining the share price 30 days  
Public Warrants | Share Price Equal or Exceeds Ten Rupees Per Dollar    
Disclosure of Warrant Liability [Line Items]    
Class of warrants redemption price per unit $ 0.10  
Number of days of notice to be given for redemption of warrants 30 days  
Number of consecutive trading days for determining share price 20 days  
Number of trading days for determining the share price 30 days  
Public Warrants | Share Price Equal or Less Nine Point Two Rupees Per Dollar    
Disclosure of Warrant Liability [Line Items]    
Number of consecutive trading days for determining share price 20 days  
Public Warrants | Common Class A | Share Price Equal or Exceeds Eighteen Rupees Per Dollar    
Disclosure of Warrant Liability [Line Items]    
Share price $ 18.00  
Public Warrants | Common Class A | Share Price Equal or Exceeds Ten Rupees Per Dollar    
Disclosure of Warrant Liability [Line Items]    
Share price $ 10.00  
Private Placement Warrants    
Disclosure of Warrant Liability [Line Items]    
Class of warrant or right, outstanding 6,000,000  
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' (Deficit) Equity - Additional Information (Detail) - $ / shares
 12 Months Ended
Jul. 23, 2021
Dec. 31, 2021
Apr. 30, 2021
Dec. 31, 2020
Stock Holders Equity Note [Line Items]        
Preferred stock shares authorized   5,000,000   5,000,000
Preferred stock par or stated value per share   $ 0.0001   $ 0.0001
Preferred stock shares issued   0   0
Preferred stock shares outstanding   0   0
Sponsor        
Stock Holders Equity Note [Line Items]        
Preferred stock shares authorized   5,000,000    
Preferred stock par or stated value per share   $ 0.0001    
Preferred stock shares issued   0   0
Preferred stock shares outstanding   0   0
Number of shares forfeited during the period 750,000      
IPO | Sponsor        
Stock Holders Equity Note [Line Items]        
Percentage of number of shares of common stock outstanding   20.00%    
Common Class A        
Stock Holders Equity Note [Line Items]        
Common stock shares authorized   500,000,000   500,000,000
Common stock par or stated value per share   $ 0.0001   $ 0.0001
Common stock shares issued   20,000,000   0
Common stock shares outstanding   20,000,000   0
Temporary equity, shares outstanding   20,000,000   0
Temporary Equity, Shares Issued   20,000,000   0
Common Class A | Sponsor        
Stock Holders Equity Note [Line Items]        
Common stock shares authorized   500,000,000    
Common stock par or stated value per share   $ 0.0001    
Common Class B        
Stock Holders Equity Note [Line Items]        
Common stock shares authorized   50,000,000   50,000,000
Common stock par or stated value per share   $ 0.0001   $ 0.0001
Common stock shares issued   5,750,000   6,500,000
Common stock shares outstanding   5,750,000   6,500,000
Common Class B | Sponsor        
Stock Holders Equity Note [Line Items]        
Common stock shares authorized   50,000,000    
Common stock par or stated value per share   $ 0.0001    
Common stock shares issued   6,500,000    
Common stock shares outstanding   5,750,000 6,500,000 6,500,000
Common stock shares issued subject to forfeiture   750,000    
Common Class A and Class B | Sponsor        
Stock Holders Equity Note [Line Items]        
Common stock, Conversion basis   one-to-one    
XML 46 d190177d10k_htm.xml IDEA: XBRL DOCUMENT 0001839185 2021-12-31 0001839185 2020-12-31 0001839185 2021-01-01 2021-12-31 0001839185 2020-12-22 2020-12-31 0001839185 2021-04-30 0001839185 2021-06-30 0001839185 2020-12-21 0001839185 smihu:ForwardPurchaseAgreementsMember 2021-12-31 0001839185 us-gaap:CommonClassBMember 2021-12-31 0001839185 us-gaap:CommonClassAMember 2021-12-31 0001839185 us-gaap:IPOMember 2021-12-31 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember smihu:FounderSharesMember 2021-12-31 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember 2021-12-31 0001839185 smihu:PromissoryNoteMember smihu:SponsorMember 2021-12-31 0001839185 smihu:WorkingCapitalLoanMember 2021-12-31 0001839185 smihu:AdministrativeServiceFeeMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001839185 smihu:PublicAndPrivateWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001839185 smihu:PublicAndPrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001839185 smihu:PublicAndPrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001839185 smihu:PublicAndPrivateWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001839185 smihu:FpaLiabilityMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001839185 smihu:FpaLiabilityMember us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001839185 smihu:FpaLiabilityMember us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001839185 smihu:FpaLiabilityMember smihu:MeasurementInputEstimatedTermToBusinessCombinationsMember 2021-12-31 0001839185 smihu:FpaLiabilityMember smihu:MeasurementInputProbabilityOfBusinessCombinationsMember 2021-12-31 0001839185 smihu:FpaLiabilityMember smihu:MeasurementOfPurchasePriceOfFpaUnitMember 2021-12-31 0001839185 smihu:FpaLiabilityMember 2021-12-31 0001839185 smihu:SponsorMember 2021-12-31 0001839185 smihu:SponsorMember us-gaap:CommonClassAMember 2021-12-31 0001839185 smihu:PublicWarrantsMember 2021-12-31 0001839185 smihu:PrivatePlacementWarrantsMember 2021-12-31 0001839185 smihu:PublicWarrantsMember us-gaap:CommonClassAMember smihu:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2021-12-31 0001839185 smihu:PublicWarrantsMember us-gaap:CommonClassAMember smihu:SharePriceEqualOrExceedsTenRupeesPerDollarMember 2021-12-31 0001839185 smihu:PublicWarrantsMember smihu:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2021-12-31 0001839185 smihu:PublicWarrantsMember smihu:SharePriceEqualOrExceedsTenRupeesPerDollarMember 2021-12-31 0001839185 us-gaap:CommonClassAMember smihu:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel1Member smihu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member smihu:PrivateWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member smihu:FpaLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member smihu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel2Member smihu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001839185 us-gaap:CommonClassBMember 2020-12-31 0001839185 us-gaap:CommonClassAMember 2020-12-31 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember smihu:FounderSharesMember 2020-12-31 0001839185 smihu:WorkingCapitalLoanMember 2020-12-31 0001839185 smihu:SponsorMember 2020-12-31 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember 2020-12-31 0001839185 smihu:ClassACommonStockSubjectToPossibleRedemptionMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassBMember 2021-01-01 2021-12-31 0001839185 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001839185 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001839185 smihu:PrivatePlacementWarrantsMember smihu:SponsorMember 2021-01-01 2021-12-31 0001839185 us-gaap:IPOMember 2021-01-01 2021-12-31 0001839185 smihu:SponsorMember 2021-01-01 2021-12-31 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember smihu:FounderSharesMember 2021-01-01 2021-12-31 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember 2021-01-01 2021-12-31 0001839185 smihu:PublicWarrantsAndPrivateWarrantsMember us-gaap:IPOMember 2021-01-01 2021-12-31 0001839185 smihu:PublicWarrantsMember 2021-01-01 2021-12-31 0001839185 smihu:PrivatePlacementWarrantsMember 2021-01-01 2021-12-31 0001839185 smihu:FpaLiabilityMember 2021-01-01 2021-12-31 0001839185 smihu:PublicAndPrivateWarrantsMember 2021-01-01 2021-12-31 0001839185 srt:MaximumMember smihu:PrivatePlacementWarrantsMember 2021-01-01 2021-12-31 0001839185 srt:MaximumMember us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassAMember 2021-01-01 2021-12-31 0001839185 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001839185 us-gaap:CapitalUnitsMember 2021-01-01 2021-12-31 0001839185 smihu:PublicWarrantsMember smihu:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2021-01-01 2021-12-31 0001839185 smihu:PublicWarrantsMember smihu:SharePriceEqualOrExceedsTenRupeesPerDollarMember 2021-01-01 2021-12-31 0001839185 smihu:PublicWarrantsMember smihu:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassAMember smihu:SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassAMember smihu:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2021-01-01 2021-12-31 0001839185 smihu:SponsorMember smihu:CommonClassAClassBMember 2021-01-01 2021-12-31 0001839185 smihu:SponsorMember us-gaap:IPOMember 2021-01-01 2021-12-31 0001839185 smihu:UsGovernmentSecuritiesMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001839185 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001839185 smihu:DerivativeWarrantLiabilitiesMember 2021-01-01 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2021-01-01 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member smihu:FpaLiabilityMember 2021-01-01 2021-12-31 0001839185 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-06-11 2021-06-11 0001839185 us-gaap:IPOMember 2021-06-11 2021-06-11 0001839185 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-06-11 0001839185 us-gaap:IPOMember 2021-06-11 0001839185 smihu:PublicAndPrivateWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-06-11 0001839185 smihu:PublicAndPrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-06-11 0001839185 smihu:PublicAndPrivateWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-06-11 0001839185 smihu:PublicAndPrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2021-06-11 0001839185 smihu:FpaLiabilityMember us-gaap:MeasurementInputPriceVolatilityMember 2021-06-11 0001839185 smihu:FpaLiabilityMember us-gaap:MeasurementInputSharePriceMember 2021-06-11 0001839185 smihu:FpaLiabilityMember smihu:MeasurementInputEstimatedTermToBusinessCombinationsMember 2021-06-11 0001839185 smihu:FpaLiabilityMember smihu:MeasurementInputProbabilityOfBusinessCombinationsMember 2021-06-11 0001839185 smihu:FpaLiabilityMember us-gaap:MeasurementInputExpectedTermMember 2021-06-11 0001839185 smihu:FpaLiabilityMember smihu:MeasurementOfPurchasePriceOfFpaUnitMember 2021-06-11 0001839185 srt:ScenarioForecastMember 2021-07-01 2023-06-30 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember 2020-12-31 2020-12-31 0001839185 smihu:AnchorInvestorsMember us-gaap:CommonClassBMember 2021-04-30 2021-04-30 0001839185 smihu:SponsorMember smihu:FounderSharesMember 2021-04-30 2021-04-30 0001839185 srt:DirectorMember smihu:SponsorMember smihu:FounderSharesMember 2021-04-30 2021-04-30 0001839185 smihu:AnchorInvestorsMember us-gaap:CommonClassAMember 2021-04-30 2021-04-30 0001839185 smihu:AnchorInvestorsMember smihu:RedeemableWarrantsMember 2021-04-30 2021-04-30 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember 2021-04-30 2021-04-30 0001839185 smihu:AnchorInvestorsMember us-gaap:CommonClassBMember smihu:FounderSharesMember 2021-04-30 2021-04-30 0001839185 smihu:SponsorMember us-gaap:CommonClassAMember 2021-04-30 2021-04-30 0001839185 smihu:SponsorMember us-gaap:CommonClassBMember 2021-04-30 0001839185 smihu:AdministrativeServiceFeeMember 2021-12-31 2021-12-31 0001839185 smihu:SponsorMember 2021-07-23 2021-07-23 0001839185 us-gaap:CommonClassBMember 2021-07-23 2021-07-23 0001839185 smihu:ClassACommonStockSubjectToPossibleRedemptionMember 2020-12-22 2020-12-31 0001839185 us-gaap:CommonClassBMember 2020-12-22 2020-12-31 0001839185 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-22 2020-12-31 0001839185 us-gaap:AdditionalPaidInCapitalMember 2020-12-22 2020-12-31 0001839185 us-gaap:RetainedEarningsMember 2020-12-22 2020-12-31 0001839185 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-22 2020-12-31 0001839185 us-gaap:CommonClassAMember 2022-03-31 0001839185 us-gaap:CommonClassBMember 2022-03-31 0001839185 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001839185 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001839185 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001839185 us-gaap:RetainedEarningsMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2020-12-31 0001839185 us-gaap:FairValueInputsLevel3Member smihu:FpaLiabilityMember 2020-12-31 0001839185 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2021-12-31 0001839185 us-gaap:FairValueInputsLevel3Member smihu:FpaLiabilityMember 2021-12-31 0001839185 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-21 0001839185 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-21 0001839185 us-gaap:AdditionalPaidInCapitalMember 2020-12-21 0001839185 us-gaap:RetainedEarningsMember 2020-12-21 0001839185 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001839185 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001839185 us-gaap:RetainedEarningsMember 2020-12-31 0001839185 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 iso4217:USD shares utr:Month utr:Day pure iso4217:USD shares smihu:Nominees utr:Year utr:Y false 0001839185 FY --12-31 00000 0 10-K true 2021-12-31 2021 false 001-40466 SUMMIT HEALTHCARE ACQUISITION CORP. E9 98-1574360 Unit 1101 11th Floor 1 Lyndhurst Tower 1 Lyndhurst Terrace Central HK 852 9162 5199 Class A ordinary shares, par value $0.0001 per share SMIH NASDAQ Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 SMIHW NASDAQ Units, each consisting of one Class A ordinary share and one half redeemable warrant SMIHU NASDAQ No No Yes Yes Non-accelerated Filer true true false false true 0 20000000 5750000 100 WithumSmith+Brown, PC New York 885198 141677 1026875 91374 200007275 201034150 91374 142631 65000 5010 142631 70010 2785941 10423429 7000000 20352001 70010 0.0001 0.0001 20000000 20000000 0 0 10.00 10.00 200000000 0.0001 0.0001 5000000 5000000 0 0 0 0 0.0001 0.0001 500000000 500000000 0 0.0001 0.0001 50000000 50000000 5750000 5750000 6500000 6500000 575 650 24350 -19318426 -3636 -19317851 21364 201034150 91374 750000 750000 549179 3636 -549179 -3636 2785941 0 -3289535 0 507417 0 7275 0 3452 0 -545727 -3636 11178082 0 -0.03 0 5750000 5750000 -0.03 0.00 0 0 0 0 0 0 0 6500000 650 24350 0 25000 -3636 -3636 0 0 6500000 650 24350 -3636 21364 798445 798445 822795 18769138 19591933 750000 75 -75 -545727 -545727 0 0 5750000 575 0 -19318426 -19317851 -545727 -3636 7275 -3636 2785941 -3289535 507417 141677 77631 -613225 200000000 -200000000 196000000 6000000 140554 361023 201498423 885198 0 885198 135544 1374 0 25000 7000000 0 65000 <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Note 1 - Organization, Business Operation, Liquidity and Capital Resources </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Summit Healthcare Acquisition Corp. (the “Company”) is a blank check company incorporated on December 22, 2020 as a Cayman Islands exempted company. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target under consideration or contemplation and the Company has not, nor has anyone on its behalf, contacted any prospective target business or had any discussions, formal or otherwise, with respect to such a transaction. The Company’s efforts to identify a prospective target business will not be limited to a particular geographic region or industry, although it intends to focus on healthcare. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2021, the Company had not commenced any operations. All activity for the period from December 22, 2020 (inception) through December 31, 2021 relates to the Company’s formation and the initial public offering (the “IPO”). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate <div style="white-space:nowrap;display:inline;">non-operating</div> income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company’s Sponsor is Summit Healthcare Acquisition Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on June 8, 2021 (the “Effective Date”). On June 11, 2021, the Company consummated the IPO of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”) 10.00 per Unit, generating gross proceeds of $200,000,000, which is discussed in Note 3. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simultaneously with the consummation of the IPO and the issuance and sale of the Units, the Company consummated the private placement of 6,000,000 Private Placement Warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, to the Sponsor, generating total proceeds of $6,000,000. Transaction costs amounted to $11,587,941 consisting of $4,000,000 of underwriting commissions, $7,000,000 of deferred underwriting commissions and $587,941 of other cash offering costs. In addition, $1,827,347 of cash was held in the Trust Account (as defined below) temporarily and is available for working capital purposes. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the closing of the IPO on June 11, 2021, $200,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account and, will be held in a U.S.-based trust account (“Trust Account”) with Continental Stock Transfer &amp; Trust Company acting as trustee, and will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain <div style="white-space:nowrap;display:inline;">conditions under Rule 2a-7 under the</div> Investment Company Act. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income taxes, if any, the Company’s amended and restated memorandum and articles of association and subject to the requirements of law and regulation, will provide that the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account (1) to the Company, until the completion of the initial Business Combination, or (2) to the Company’s public shareholders until the earliest of: (i) the completion of an initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association, and (iii) the redemption of the Company’s public shares if the Company has not consummated its Business Combination within 24 months from the closing of the IPO, subject to applicable law. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ordinary shares subject to redemption are recorded at a $10 redemption value and classified as temporary equity in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will have 24 months from the closing of the IPO to complete the initial Business Combination (the “Combination Period”) or during any Extension Period. However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, <div style="white-space:nowrap;display:inline;">at a per-share price, payable</div> in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor and the Company’s officers and directors agreed to (i) waive their redemption rights with respect to their Founder Shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association, (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period or during any Extension Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete its initial Business Combination within the prescribed timeframe), and (iv) vote any Founder Shares and public shares held by them in favor of the initial Business Combination. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per public share or (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay the Company’s tax obligations, provided that such liability will not apply to any claims by a third party or prospective target business that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriter of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked it Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure you that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Liquidity and Capital Resources </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2021, the Company had approximately $0.89 million of cash for working capital purposes, and working capital of approximately $0.88 million. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company’s liquidity needs up to December 31, 2021 had been satisfied through a payment from the Sponsor of $25,000 (see Note 5) for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of $300,000 (see Note 5). </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The promissory note was fully repaid on June 11, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 5). As of December 31, 2021, there were no amounts outstanding under any Working Capital Loans. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. </div> 20000000 10.00 200000000 6000000 1.00 6000000 11587941 4000000 7000000 587941 1827347 200000000 10.00 10 100000 10.00 890000 880000 25000 300000 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 2 - Significant Accounting Policies </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Basis of Presentation </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying financial statements of <div style="letter-spacing: 0px; top: 0px;;display:inline;">the </div>Company are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Security and Exchange Commission (“SEC”). In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Emerging Growth Company Status </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability and Forward Purchase Agreement (“FPA”) liability. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Cash and Cash Equivalents </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have cash equivalents as of December 31, 2021 and December 31, 2020. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Investments Held in Trust Account </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2021, the assets held in the Trust Account were held in a money market fund. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At December 31, 2021 and 2020, the Company had $200,007,275 and nil held in the Trust Account. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Offering Costs Associated with IPO </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company complies with the requirements of the ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-10-S99-1and</div></div></div> SEC Staff Accounting Bulletin (“SAB”) Topic 5A“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering. Offering costs are charged to ordinary shares subject to possible redemption or the statement of operations based on the relative value of the Public and Private Warrants to the proceeds received from the Units and Private Placement Warrants sold upon the completion of the IPO. Accordingly, on December 31, 2021, offering costs totaling $11,587,941 (consisting of $4,000,000 of underwriting fees, $7,000,000 of deferred underwriting fees and $587,941 of other offering costs), of which $507,417 was allocated to the Public Warrants and Private Warrants and was charged to operations in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10</div> and $11,080,524 was charged to ordinary shares subject to possible redemption. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Derivative Financial Instruments </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-valued</div> at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> based on whether or not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">net-cash</div> settlement or conversion of the instrument could be required within 12 months of the balance sheet date. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Warrant Liability and Forward Purchase Agreement </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for the 16,000,000 warrants issued in connection with the IPO (the 10,000,000 Public Warrants and the 6,000,000 Private Placement Warrants) and Forward Purchase Agreement (“FPA”) in accordance with the guidance contained in FASB ASC 815 “Derivatives and Hedging” whereby under that provision the warrants and FPA do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company will classify warrants and FPA as liabilities at their fair value. These liabilities are subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> at each reporting period. With such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement,</div> the changes in fair value are recognized in the Statement of Operations in the period of change. Derivative warrant liabilities and FPA are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, excluding the warrant liability and FPA liability, <div style="display:inline;">which </div>qualify as financial instruments under FASB ASC Topic 820, Fair Value Measurement (“ASC 820”), approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2021 and December 31, 2020, 20,000,000 and 0 Class A ordinary shares, respectively, subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">200,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; white-space: nowrap;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Less: Proceeds allocated to Public Warrants</div></td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,511,409)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; white-space: nowrap;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Less: Class A ordinary shares issuance costs</div></td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,080,524)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; white-space: nowrap;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Add: Accretion of carrying value to redemption value</div></td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,591,933</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">200,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Net Income (Loss) Per Share of Ordinary Shares </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has two classes of shares, which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Earnings and losses are shared pro rata between the two classes of shares. The 16,000,000 potential ordinary shares for outstanding warrants to purchase the Company’s stock were excluded from diluted earnings per share for the year ended December 31, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr> <td style="width:59%"> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Period</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">from December 22, 2020<br/> (Inception) to</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per share:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net loss</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(360,359)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(185,368)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(3,636)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">11,178,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per share</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(0.03)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(0.03)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(0.00)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Income Taxes </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASC 740 clarifies the accounting for uncertainty in income taxes recognized in a Company’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">must be more-likely-than-not to be</div> sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> Debt - Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40)</div> (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06”)</div> to simplify accounting for certain financial instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> amends the diluted earnings per share guidance, including the requirement to use the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method for all convertible instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2020-06</div> would have on its financial position, results of operations or cash flows. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Basis of Presentation </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying financial statements of <div style="letter-spacing: 0px; top: 0px;;display:inline;">the </div>Company are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Security and Exchange Commission (“SEC”). In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Emerging Growth Company Status </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability and Forward Purchase Agreement (“FPA”) liability. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Cash and Cash Equivalents </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have cash equivalents as of December 31, 2021 and December 31, 2020. </div> 0 0 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Investments Held in Trust Account </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2021, the assets held in the Trust Account were held in a money market fund. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At December 31, 2021 and 2020, the Company had $200,007,275 and nil held in the Trust Account. </div> P185D <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div> 250000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Offering Costs Associated with IPO </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company complies with the requirements of the ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-10-S99-1and</div></div></div> SEC Staff Accounting Bulletin (“SAB”) Topic 5A“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering. Offering costs are charged to ordinary shares subject to possible redemption or the statement of operations based on the relative value of the Public and Private Warrants to the proceeds received from the Units and Private Placement Warrants sold upon the completion of the IPO. Accordingly, on December 31, 2021, offering costs totaling $11,587,941 (consisting of $4,000,000 of underwriting fees, $7,000,000 of deferred underwriting fees and $587,941 of other offering costs), of which $507,417 was allocated to the Public Warrants and Private Warrants and was charged to operations in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10</div> and $11,080,524 was charged to ordinary shares subject to possible redemption. </div> 11587941 4000000 7000000 587941 507417 11080524 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Derivative Financial Instruments </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-valued</div> at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> based on whether or not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">net-cash</div> settlement or conversion of the instrument could be required within 12 months of the balance sheet date. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Warrant Liability and Forward Purchase Agreement </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for the 16,000,000 warrants issued in connection with the IPO (the 10,000,000 Public Warrants and the 6,000,000 Private Placement Warrants) and Forward Purchase Agreement (“FPA”) in accordance with the guidance contained in FASB ASC 815 “Derivatives and Hedging” whereby under that provision the warrants and FPA do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company will classify warrants and FPA as liabilities at their fair value. These liabilities are subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> at each reporting period. With such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement,</div> the changes in fair value are recognized in the Statement of Operations in the period of change. Derivative warrant liabilities and FPA are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> 16000000 10000000 6000000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, excluding the warrant liability and FPA liability, <div style="display:inline;">which </div>qualify as financial instruments under FASB ASC Topic 820, Fair Value Measurement (“ASC 820”), approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2021 and December 31, 2020, 20,000,000 and 0 Class A ordinary shares, respectively, subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">200,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; white-space: nowrap;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Less: Proceeds allocated to Public Warrants</div></td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,511,409)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; white-space: nowrap;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Less: Class A ordinary shares issuance costs</div></td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,080,524)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; white-space: nowrap;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Add: Accretion of carrying value to redemption value</div></td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,591,933</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">200,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> 20000000 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">200,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; white-space: nowrap;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Less: Proceeds allocated to Public Warrants</div></td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,511,409)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; white-space: nowrap;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Less: Class A ordinary shares issuance costs</div></td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,080,524)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; white-space: nowrap;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Add: Accretion of carrying value to redemption value</div></td> <td style="vertical-align: bottom; white-space: nowrap;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,591,933</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class A ordinary shares subject to possible redemption</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">200,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> 200000000 8511409 11080524 19591933 200000000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Net Income (Loss) Per Share of Ordinary Shares </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has two classes of shares, which are referred to as Class A Ordinary Shares and Class B Ordinary Shares. Earnings and losses are shared pro rata between the two classes of shares. The 16,000,000 potential ordinary shares for outstanding warrants to purchase the Company’s stock were excluded from diluted earnings per share for the year ended December 31, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr> <td style="width:59%"> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Period</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">from December 22, 2020<br/> (Inception) to</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per share:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net loss</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(360,359)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(185,368)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(3,636)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">11,178,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per share</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(0.03)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(0.03)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(0.00)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 16000000 The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr> <td style="width:59%"> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:4%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Year Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Period</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">from December 22, 2020<br/> (Inception) to</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net income per share:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net loss</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(360,359)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(185,368)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(3,636)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">11,178,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per share</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(0.03)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(0.03)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">(0.00)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> -360359 -185368 0 -3636 11178082 5750000 0 5750000 -0.03 -0.03 0 0.00 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Income Taxes </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASC 740 clarifies the accounting for uncertainty in income taxes recognized in a Company’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">must be more-likely-than-not to be</div> sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> Debt - Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40)</div> (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06”)</div> to simplify accounting for certain financial instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> amends the diluted earnings per share guidance, including the requirement to use the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method for all convertible instruments. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2020-06</div> would have on its financial position, results of operations or cash flows. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 3 - Initial Public Offering </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June 11, 2021, the Company consummated its IPO of 20,000,000 Units (the “Units”), at a price of $10.00 per unit, generating gross proceeds to the Company of $200,000,000. Each Unit consists of one Class A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-half</div> of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable on the later of 30 days after the completion of the initial Business Combination or 12 months from the closing of the IPO, and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation (see Note 8). </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> 20000000 10.00 200000000 P30D P12M <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 4 - Private Placement </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of an aggregate 6,000,000 Private Placement Warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $6,000,000. If the Company does not complete an initial Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">will be non-redeemable by the</div> Company and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the IPO. </div> 6000000 1.00 6000000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 5 - Related Party Transactions </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Founder Shares </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December 31, 2020, the Company issued to the Sponsor 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”), for $25,000 for certain expenses paid on behalf of the Company, or approximately $0.004 per share. On April 30, 2021, the Company effected a share capitalization, pursuant to which the Company’s initial shareholders held an aggregate of 6,500,000 Class B ordinary shares. The accompanying financial statements have been retroactively adjusted to reflect the stock dividend in the share capitalization. On April 30, 2021, the Company entered into forward purchase agreements (see Note 6) with anchor investors, in connection with entering into the forward purchase agreements, the Sponsor transferred to the anchor investors an aggregate of 375,000 Class B ordinary shares for no cash. On April 30, 2021, the Sponsor transferred 25,000 Class B ordinary shares each to three independent director nominees. Up to 750,000 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. On July 23, 2021, the Sponsor surrendered 750,000 Founder Shares, with no return of capital or payment by the Sponsor, after the expiration of the unexercised underwriters’ over-allotment option. As a result of the foregoing, at December 31, 2021 and December 31, 2020, the Sponsor owned 5,750,000 and 6,500,000 Class B ordinary shares, respectively. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor, officers and directors have agreed not to transfer, assign or sell any of their Founder Shares until earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s public shareholders having the right to exchange their ordinary shares for cash, securities or other property <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(the “Lock-up”).</div> Any permitted transferees would be subject to the same restrictions and other agreements of our Sponsor, officers and directors with respect to any Founder Shares. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Promissory Note - Related Party </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor has agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. These loans were <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing, unsecured and were due at the earlier of September 30, 2021 or the closing of the IPO. The loan was to be repaid upon completion of the IPO out of the $1,000,000 of offering proceeds that has been allocated to the payment of offering expenses. The Company had drawn down $140,068 under the promissory note which was fully repaid as of June 11, 2021. The note was terminated at June 11, 2021. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Related Party Loans </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. As of December 31, 2021 and December 31, 2020, the Company had no borrowings under the Working Capital Loans. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Administrative Service Fee </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Commencing on the Effective Date, the Company paid an affiliate of the Sponsor $10,000 per month for office space, utilities, administrative services and remote support services. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company accrued $67,667 for the administrative service fee for the period from June 8, 2021 (the Effective Date) to December 31, 2021. </div> 5750000 0.0001 25000 0.004 6500000 375000 0 25000 3 750000 5750000 6500000 12.00 P20D P30D P150D 300000 1000000 140068 1500000 1.00 0 0 10000 67667 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 7 - Recurring Fair Value Measurements </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Warrant Liability and FPA Liability </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At December 31, 2021, the fair value of Company’s Warrant liability was $10,423,429, and the fair value of FPA liability was $2,785,941. Under the guidance in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC 815-40 the</div> Public and Private Warrants and the FPA do not meet the criteria for equity treatment. As such, the Public and Private Warrants and the FPA must be recorded on the balance sheet at fair value. This valuation is subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> each balance sheet date. With each <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement,</div> the valuations will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Recurring Fair Value Measurements </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents fair value information as of December 31, 2021 of the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. The Company’s Warrant liability is based on a valuation models utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the Warrant liability and FPA liability is classified within Level 3 of the fair value hierarchy. The investments held in Trust Account includes money market funds. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its level 1 investments. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth by level within the fair value hierarchy the Company’s assets and liabilities as of December 31, 2021, that were accounted for at fair value on a recurring basis: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(Level 1)</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(Level 2)</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(Level 3)</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments held in Trust Account</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">200,007,275</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Public Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">6,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Private Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">3,923,429</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">FPA liability</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">2,785,941</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Measurement of the Warrants </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company established the initial fair value for the Warrants on June 11, 2021, the date of the consummation of the Company’s IPO. The Company used a Monte Carlo simulation model to value the Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Class A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-half</div> of one Public Warrant), (ii) the sale of Private Warrants, and (iii) the issuance of Class B ordinary shares, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption (temporary equity), and Class B ordinary shares (permanent equity) based on their relative fair values at the initial measurement date. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement in August 2021 after detachment of the Public Warrants from the Units and were separately listed and traded. As of December 31, 2021, the Public Warrants were valued using the observed price for Public Warrants and the Private Warrants were valued using a Monte Carlo simulation model. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The key inputs for the valuation of Public and Private Warrants are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 79%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Input</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">June 11,</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">December</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">31, 2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">16.30</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">13.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk Free Rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">0.89</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1.29</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Price</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">9.57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">9.72</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Est. Term Remaining (Yrs)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.65</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s derivative warrant liabilities classified as Level 3: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 84%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; font-size: 8pt;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">liabilities</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at January 1, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Initial value at IPO date</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">13,712,964</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(3,289,535</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfer of Public warrants from Level 3 to Level 1</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(6,500,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value at December 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">3,923,429</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FPA </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To arrive the conclusion of Fair Value of the Forward Purchase Agreements, the Company analyzed the agreements and other documentation. The Company utilized the underlying shares and warrant values determined above and the following inputs in order to project the net asset or liability value of the FPA:​​​​​​​ </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 77%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="display:inline;">Input</div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">June 11,</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">December 31,</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">16.30</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">13.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Price</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">9.57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">9.72</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrant Price</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">0.85</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">0.65</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Est. Term to Business Combination (Yrs)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">0.65</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">0.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Probability of Business Combination</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">85</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">85</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase price of FPA unit</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">10.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">10.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="margin-top: 1em; margin-bottom: 1em"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The <div style="display:inline;">following </div>table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s FPA liability classified as Level 3: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 85%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">FPA liability</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at January 1, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Initial value at IPO date</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2,322,741</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">463,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value at December 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">2,785,941</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transfers between levels of the fair <div style="display:inline;">value </div>hierarchy are recognized at the end of the reporting period. </div> 10423429 2785941 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth by level within the fair value hierarchy the Company’s assets and liabilities as of December 31, 2021, that were accounted for at fair value on a recurring basis: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(Level 1)</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(Level 2)</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(Level 3)</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets</div></div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments held in Trust Account</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">200,007,275</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Public Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">6,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Private Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">3,923,429</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">FPA liability</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">2,785,941</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> 200007275 0 6500000 0 3923429 2785941 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The key inputs for the valuation of Public and Private Warrants are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 79%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Input</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">June 11,</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">December</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">31, 2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">16.30</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">13.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk Free Rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">0.89</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1.29</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Price</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">9.57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">9.72</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Est. Term Remaining (Yrs)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.65</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 16.30 13.4 0.89 1.29 9.57 9.72 5.65 5.35 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s derivative warrant liabilities classified as Level 3: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 84%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; font-size: 8pt;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">liabilities</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at January 1, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Initial value at IPO date</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">13,712,964</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(3,289,535</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfer of Public warrants from Level 3 to Level 1</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(6,500,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value at December 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">3,923,429</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 0 13712964 -3289535 -6500000 3923429 The Company utilized the underlying shares and warrant values determined above and the following inputs in order to project the net asset or liability value of the FPA:<div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 77%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="display:inline;">Input</div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">June 11,</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">December 31,</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">16.30</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">13.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Price</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">9.57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">9.72</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrant Price</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">0.85</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">0.65</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Est. Term to Business Combination (Yrs)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">0.65</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">0.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Probability of Business Combination</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">85</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">85</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase price of FPA unit</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">10.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">10.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 16.30 13.4 9.57 9.72 0.85 0.65 0.65 0.33 85 85 10.00 10.00 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The <div style="display:inline;">following </div>table provides a reconciliation of changes in fair value of the beginning and ending balances of the Company’s FPA liability classified as Level 3: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 85%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">FPA liability</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at January 1, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Initial value at IPO date</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2,322,741</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">463,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value at December 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">2,785,941</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 0 2322741 463200 2785941 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 7 - Commitments &amp; Contingencies </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Risks and Uncertainties </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management continues to evaluate the impact <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of the COVID-19 pandemic on</div> the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of this financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Registration Rights </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of the IPO. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its initial Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Lock-up</div> period, which occurs (i) in the case of the Founder Shares, and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Underwriters Agreement </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">had a 45-day option to</div> purchase up to an additional 3,000,000 units to cover over-allotments, if any. The over-allotment option expired unexercised on July 23, 2021. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters were paid a cash underwriting discount of two percent (2%) of the gross proceeds of the IPO, or $4,000,000. Additionally, the underwriters are entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the IPO upon the completion of the Company’s initial Business Combination. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Forward Purchase Agreements </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April 30, 2021, the Company entered into forward purchase agreements with the Sponsor, Snow Lake Capital (HK) Limited and Valliance Fund (the “anchor investors”), pursuant to which the anchor investors agreed to subscribe for an aggregate of 3,000,000 Class A ordinary shares plus 750,000 redeemable warrants for a purchase price of $10.00 multiplied by the number of Class A ordinary shares, or $30,000,000 in the aggregate, in a private placement to close concurrently with the closing of the initial business combination. The Company issued 750,000 additional Class B ordinary shares to the Sponsor, which represent the adjustment to the ratio applicable to the conversion of the Class B ordinary shares that the Sponsor would have been entitled to at the closing of the initial business combination as a result of the issuance of 3,000,000 additional Class A ordinary shares under the forward purchase agreements. As a result, the issuance of the Class A ordinary shares at the closing of the initial business combination will not trigger a further adjustment to this ratio. Further, prior to the IPO, the Sponsor transferred to the anchor investors an aggregate of 375,000 Founder Shares for no cash consideration. Subject to certain exceptions to forfeiture and transfer provisions, the Founder Shares transferred in connection with these agreements are subject to similar contractual conditions and restrictions as the Founder Shares issued to the Sponsor in connection with the IPO. The forward purchase warrants will have the same terms as the public warrants. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward purchase agreements provide that the anchor investors are entitled to registration rights with respect to the forward purchase securities and Class A ordinary shares underlying the forward purchase warrants and founder shares. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proceeds from the sale of the forward purchase securities may be used as part of the consideration to the sellers in the initial Business Combination, expenses in connection with the initial Business Combination or for working capital in the post Business Combination company. These purchases will be required to be made regardless of whether any Class A ordinary shares are redeemed by the public shareholders and are intended to provide the Company with a minimum funding level for the initial Business Combination. The anchor investors will not have the ability to approve the initial Business Combination prior to the signing of a material definitive agreement and, if the Company seeks shareholder approval, have agreed to vote their Founder Shares and any public shares held by them in favor of the initial Business Combination. The forward purchase securities will be issued only in connection with the closing of the initial Business Combination. </div> P30D P45D 3000000 -0.02 4000000 0.035 3000000 750000 10.00 30000000 750000 3000000 375000 0 <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Note 8 - Warrant Liability </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2021, 16,000,000 warrants (the 10,000,000 Public Warrants and the 6,000,000 Private Placement Warrants) are outstanding. Each warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants will become exercisable on the later of 12 months from the closing of the IPO or 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00. </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in whole and not in part; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at a price of $0.01 per warrant; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within </div></td></tr></table><div style="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><div style="white-space:nowrap;display:inline;">a 30-trading day</div> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">period ending three trading days before the Company sends the notice of redemption to the warrant holders. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once the warrants become exercisable, the Company may redeem the outstanding warrants: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in whole and not in part; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by referenc e to the table below, based on the redemption date and the “fair market value” of the Class A ordinary shares; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">if, and only if, the closing price of our Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise p rice of a warrant) for any 20 trading days within <div style="white-space:nowrap;display:inline;">the 30-trading day</div> period ending three trading days before the Company sends the notice of redemption to the warrant holders; and </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">if the closing price of the Class A ordinary shares for any 20 trading days within <div style="white-space:nowrap;display:inline;">a 30-trading day</div> period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Company’s Sponsors or its affiliate, without taking into account any Founder Shares held by the Company’s Sponsor or such affiliates, as applicable, prior to such issuance (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. </div> 16000000 10000000 6000000 11.50 P12M P30D 18.00 0.01 P30D 18.00 P20D P30D 10.00 0.10 P30D 10.00 P20D P30D P20D P30D 18.00 9.20 0.60 P20D 9.20 1.15 18.00 1.80 10.00 <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Note 9 - Shareholders’ (Deficit) Equity </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Preference shares </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2021 and December 30, 2020, there were no preference shares issued or outstanding. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Class A Ordinary Shares </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of December 31, 2021 and 2020, there were 20,000,000 and 0 Class A ordinary shares issued and outstanding, including the 20,000,000 and 0 shares presented in ordinary shares subject to redemption. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Class B Ordinary Shares </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. As of December 31, 2021 and December 31, 2020, there were 5,750,000 and 6,500,000 Class B ordinary shares issued and outstanding, respectively. Of the 6,500,000 Class B ordinary shares, an aggregate of up to 750,000 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the initial shareholders will collectively own 20% of the Company’s issued and outstanding ordinary shares after the IPO. On July 23, 2021, the Sponsor surrendered 750,000 Founder Shares, with no return of capital or payment by the Sponsor, after the expiration of the unexercised underwriters’ over-allotment option. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law. Prior to the initial Business Combination, only holders of the Founder Shares will have the right to vote on the election of directors. Holders of the public shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to the completion of an initial Business Combination, holders of a majority of the Founder Shares may remove a member of the board of directors for any reason. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Class B ordinary shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, <div style="white-space:nowrap;display:inline;">on an as-converted basis, 20%</div> of the sum of (i) the total number of ordinary shares issued and outstanding upon the completion of the IPO, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued or to be issued to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of our management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than <div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">one-to-one.</div></div> </div> 5000000 0.0001 0 0 0 0 500000000 0.0001 20000000 20000000 0 0 20000000 20000000 0 0 50000000 0.0001 5750000 6500000 6500000 750000 0.20 750000 0.20 one-to-one <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Note 10 - Subsequent Events </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on this review, other than disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statement. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February 24, 2022, Russian forces launched significant military action against Ukraine, and sustained conflict and disruption in the region is possible. The impact to Ukraine as well as actions taken by other countries, including new and stricter sanctions imposed by Canada, the United Kingdom, the European Union, the U.S. and other countries and companies and organizations against officials, individuals, regions, and industries in Russia and Ukraine, and actions taken by Russia in response to such sanctions, and each country’s potential response to such sanctions, tensions, and military actions could have a material adverse effect on the business or prospects of potential target companies in Europe as the Company’s efforts to identify a prospective target business are not be limited to a particular geographic region. Any such material adverse effect from the conflict and enhanced sanctions activity may include reduced trading and business activity levels, disruption of financial markets, increased costs, disruption of services, inability to complete financial or banking transactions, and inability to service existing or new customers in the region. Prolonged unrest, military activities, or broad-based sanctions, should they be implemented, could have a material adverse effect on our ability to complete a business combination with a suitable target. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> This number includes up to 750,000 Class B ordinary shares subject to forfeiture as of December 31, 2020. On July 23, 2021, the 750,000 Class B ordinary shares were forfeited when the overallotment option expired. EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ʺ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end XML 48 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 133 195 1 true 47 0 false 9 false false R1.htm 1001 - Document - Cover Page Sheet http://www.smihu.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Balance Sheets Sheet http://www.smihu.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Balance Sheets (Parenthetical) Sheet http://www.smihu.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Statements of Operations Sheet http://www.smihu.com/role/StatementsOfOperations Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Statements of Changes in Shareholders' (Deficit) Equity Sheet http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity Statements of Changes in Shareholders' (Deficit) Equity Statements 5 false false R6.htm 1006 - Statement - Statement of Cash Flows Sheet http://www.smihu.com/role/StatementOfCashFlows Statement of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - Organization, Business Operation, Liquidity and Capital Resources Sheet http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResources Organization, Business Operation, Liquidity and Capital Resources Notes 7 false false R8.htm 1008 - Disclosure - Significant Accounting Policies Sheet http://www.smihu.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Initial Public Offering Sheet http://www.smihu.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 1010 - Disclosure - Private Placement Sheet http://www.smihu.com/role/PrivatePlacement Private Placement Notes 10 false false R11.htm 1011 - Disclosure - Related Party Transactions Sheet http://www.smihu.com/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 1012 - Disclosure - Recurring Fair Value Measurements Sheet http://www.smihu.com/role/RecurringFairValueMeasurements Recurring Fair Value Measurements Notes 12 false false R13.htm 1013 - Disclosure - Commitments & Contingencies Sheet http://www.smihu.com/role/CommitmentsContingencies Commitments & Contingencies Notes 13 false false R14.htm 1014 - Disclosure - Warrant Liability Sheet http://www.smihu.com/role/WarrantLiability Warrant Liability Notes 14 false false R15.htm 1015 - Disclosure - Shareholders' (Deficit) Equity Sheet http://www.smihu.com/role/ShareholdersDeficitEquity Shareholders' (Deficit) Equity Notes 15 false false R16.htm 1016 - Disclosure - Subsequent Events Sheet http://www.smihu.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 1017 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.smihu.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.smihu.com/role/SignificantAccountingPolicies 17 false false R18.htm 1018 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.smihu.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.smihu.com/role/SignificantAccountingPolicies 18 false false R19.htm 1019 - Disclosure - Recurring Fair Value Measurements (Tables) Sheet http://www.smihu.com/role/RecurringFairValueMeasurementsTables Recurring Fair Value Measurements (Tables) Tables http://www.smihu.com/role/RecurringFairValueMeasurements 19 false false R20.htm 1020 - Disclosure - Organization, Business Operation, Liquidity and Capital Resources - Additional information (Detail) Sheet http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail Organization, Business Operation, Liquidity and Capital Resources - Additional information (Detail) Details 20 false false R21.htm 1021 - Disclosure - Significant Accounting Policies - Additional information (Detail) Sheet http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail Significant Accounting Policies - Additional information (Detail) Details 21 false false R22.htm 1022 - Disclosure - Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Common Share (Detail) Sheet http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Common Share (Detail) Details 22 false false R23.htm 1023 - Disclosure - Significant Accounting Policies - Summary of Class A ordinary shares subject to possible redemption (Detail) Sheet http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail Significant Accounting Policies - Summary of Class A ordinary shares subject to possible redemption (Detail) Details 23 false false R24.htm 1024 - Disclosure - Initial Public Offering - Additional Information (Detail) Sheet http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail Initial Public Offering - Additional Information (Detail) Details 24 false false R25.htm 1025 - Disclosure - Private Placement - Additional Information (Detail) Sheet http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail Private Placement - Additional Information (Detail) Details 25 false false R26.htm 1026 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 26 false false R27.htm 1027 - Disclosure - Recurring Fair Value Measurements - Summary of Fair Value Hierarchy the Company's Assets and Liabilities (Detail) Sheet http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail Recurring Fair Value Measurements - Summary of Fair Value Hierarchy the Company's Assets and Liabilities (Detail) Details 27 false false R28.htm 1028 - Disclosure - Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants (Detail) Sheet http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants (Detail) Details 28 false false R29.htm 1029 - Disclosure - Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants of FPA (Detail) Sheet http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants of FPA (Detail) Details 29 false false R30.htm 1030 - Disclosure - Recurring Fair Value Measurements - Summary of reconciliation of changes in fair value of derivative warrant liabilities (Detail) Sheet http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail Recurring Fair Value Measurements - Summary of reconciliation of changes in fair value of derivative warrant liabilities (Detail) Details 30 false false R31.htm 1031 - Disclosure - Recurring Fair Value Measurements - Additional information (Detail) Sheet http://www.smihu.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail Recurring Fair Value Measurements - Additional information (Detail) Details 31 false false R32.htm 1032 - Disclosure - Commitments & Contingencies - Additional Information (Detail) Sheet http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail Commitments & Contingencies - Additional Information (Detail) Details 32 false false R33.htm 1033 - Disclosure - Warrant Liability - Additional Information (Detail) Sheet http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail Warrant Liability - Additional Information (Detail) Details 33 false false R34.htm 1034 - Disclosure - Shareholders' (Deficit) Equity - Additional Information (Detail) Sheet http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail Shareholders' (Deficit) Equity - Additional Information (Detail) Details http://www.smihu.com/role/ShareholdersDeficitEquity 34 false false All Reports Book All Reports d190177d10k.htm d190177dex311.htm d190177dex312.htm d190177dex321.htm d190177dex322.htm d190177dex41.htm smihu-20211231.xsd smihu-20211231_cal.xml smihu-20211231_def.xml smihu-20211231_lab.xml smihu-20211231_pre.xml http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d190177d10k.htm": { "axisCustom": 1, "axisStandard": 16, "contextCount": 133, "dts": { "calculationLink": { "local": [ "smihu-20211231_cal.xml" ] }, "definitionLink": { "local": [ "smihu-20211231_def.xml" ] }, "inline": { "local": [ "d190177d10k.htm" ] }, "labelLink": { "local": [ "smihu-20211231_lab.xml" ] }, "presentationLink": { "local": [ "smihu-20211231_pre.xml" ] }, "schema": { "local": [ "smihu-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 334, "entityCount": 1, "hidden": { "http://www.smihu.com/20211231": 1, "http://xbrl.sec.gov/dei/2021q4": 5, "total": 6 }, "keyCustom": 53, "keyStandard": 142, "memberCustom": 24, "memberStandard": 20, "nsprefix": "smihu", "nsuri": "http://www.smihu.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.smihu.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "smihu:PrivatePlacementWarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Private Placement", "role": "http://www.smihu.com/role/PrivatePlacement", "shortName": "Private Placement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "smihu:PrivatePlacementWarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Related Party Transactions", "role": "http://www.smihu.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Recurring Fair Value Measurements", "role": "http://www.smihu.com/role/RecurringFairValueMeasurements", "shortName": "Recurring Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Commitments & Contingencies", "role": "http://www.smihu.com/role/CommitmentsContingencies", "shortName": "Commitments & Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "smihu:DisclosureOfWarrantLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Warrant Liability", "role": "http://www.smihu.com/role/WarrantLiability", "shortName": "Warrant Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "smihu:DisclosureOfWarrantLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Shareholders' (Deficit) Equity", "role": "http://www.smihu.com/role/ShareholdersDeficitEquity", "shortName": "Shareholders' (Deficit) Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Subsequent Events", "role": "http://www.smihu.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "smihu:ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Significant Accounting Policies (Tables)", "role": "http://www.smihu.com/role/SignificantAccountingPoliciesTables", "shortName": "Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "smihu:ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Recurring Fair Value Measurements (Tables)", "role": "http://www.smihu.com/role/RecurringFairValueMeasurementsTables", "shortName": "Recurring Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Balance Sheets", "role": "http://www.smihu.com/role/BalanceSheets", "shortName": "Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Organization, Business Operation, Liquidity and Capital Resources - Additional information (Detail)", "role": "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "shortName": "Organization, Business Operation, Liquidity and Capital Resources - Additional information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "-4", "lang": null, "name": "smihu:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Significant Accounting Policies - Additional information (Detail)", "role": "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Significant Accounting Policies - Additional information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P12_22_2020To12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Common Share (Detail)", "role": "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "shortName": "Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Common Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P12_22_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "lang": null, "name": "us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Significant Accounting Policies - Summary of Class A ordinary shares subject to possible redemption (Detail)", "role": "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail", "shortName": "Significant Accounting Policies - Summary of Class A ordinary shares subject to possible redemption (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "smihu:ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Initial Public Offering - Additional Information (Detail)", "role": "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "shortName": "Initial Public Offering - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R25": { "firstAnchor": { "ancestors": [ "div", "smihu:WarrantLiabilityAndForwardPurchaseAgreementPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "smihu:ClassOfWarrantsAndRightsIssuedDuringThePeriod", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Private Placement - Additional Information (Detail)", "role": "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail", "shortName": "Private Placement - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R26": { "firstAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "smihu:OfferingProceedsAllocatedToPaymentOfOfferingExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Related Party Transactions - Additional Information (Detail)", "role": "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "smihu:OfferingProceedsAllocatedToPaymentOfOfferingExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Recurring Fair Value Measurements - Summary of Fair Value Hierarchy the Company's Assets and Liabilities (Detail)", "role": "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail", "shortName": "Recurring Fair Value Measurements - Summary of Fair Value Hierarchy the Company's Assets and Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "lang": null, "name": "us-gaap:RestrictedInvestmentsAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_PublicAndPrivateWarrantsMemberusgaapFairValueByLiabilityClassAxis", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants (Detail)", "role": "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "shortName": "Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_PublicAndPrivateWarrantsMemberusgaapFairValueByLiabilityClassAxis", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021_FpaLiabilityMemberusgaapFairValueByLiabilityClassAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants of FPA (Detail)", "role": "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail", "shortName": "Recurring Fair Value Measurements - Summary of Valuation of Public and Private Warrants of FPA (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021_FpaLiabilityMemberusgaapFairValueByLiabilityClassAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "smihu:OrganizationBusinessOperationLiquidityAndCapitalResourcesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityRedemptionPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Balance Sheets (Parenthetical)", "role": "http://www.smihu.com/role/BalanceSheetsParenthetical", "shortName": "Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "lang": null, "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FpaLiabilityMemberusgaapFairValueByLiabilityClassAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Recurring Fair Value Measurements - Summary of reconciliation of changes in fair value of derivative warrant liabilities (Detail)", "role": "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail", "shortName": "Recurring Fair Value Measurements - Summary of reconciliation of changes in fair value of derivative warrant liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FpaLiabilityMemberusgaapFairValueByLiabilityClassAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Recurring Fair Value Measurements - Additional information (Detail)", "role": "http://www.smihu.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "shortName": "Recurring Fair Value Measurements - Additional information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "smihu:OverAllotmentOptionVestingPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Commitments & Contingencies - Additional Information (Detail)", "role": "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "shortName": "Commitments & Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "smihu:OverAllotmentOptionVestingPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "smihu:DisclosureOfWarrantLiabilityTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Warrant Liability - Additional Information (Detail)", "role": "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail", "shortName": "Warrant Liability - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "smihu:DisclosureOfWarrantLiabilityTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Shareholders' (Deficit) Equity - Additional Information (Detail)", "role": "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "shortName": "Shareholders' (Deficit) Equity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_31_2021_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P12_22_2020To12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Statements of Operations", "role": "http://www.smihu.com/role/StatementsOfOperations", "shortName": "Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P12_22_2020To12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_21_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Statements of Changes in Shareholders' (Deficit) Equity", "role": "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity", "shortName": "Statements of Changes in Shareholders' (Deficit) Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "PAsOn12_21_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P12_22_2020To12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Statement of Cash Flows", "role": "http://www.smihu.com/role/StatementOfCashFlows", "shortName": "Statement of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P12_22_2020To12_31_2020", "decimals": "0", "lang": null, "name": "smihu:InterestEarnedOnMarketableSecuritiesHeldInTrustAccount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "smihu:OrganizationBusinessOperationLiquidityAndCapitalResourcesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - Organization, Business Operation, Liquidity and Capital Resources", "role": "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResources", "shortName": "Organization, Business Operation, Liquidity and Capital Resources", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "smihu:OrganizationBusinessOperationLiquidityAndCapitalResourcesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Significant Accounting Policies", "role": "http://www.smihu.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "smihu:InitialPublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Initial Public Offering", "role": "http://www.smihu.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d190177d10k.htm", "contextRef": "P01_01_2021To12_31_2021", "decimals": null, "first": true, "lang": "en-US", "name": "smihu:InitialPublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 47, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r307", "r308", "r309" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r307", "r308", "r309" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r307", "r308", "r309" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r307", "r308", "r309" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r307", "r308", "r309" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "smihu_AccruedDeferredOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accrued deferred offering costs.", "label": "Accrued Deferred Offering Costs", "terseLabel": "Accrued deferred offering costs" } } }, "localname": "AccruedDeferredOfferingCosts", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "smihu_AccruedOfferingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued offering costs and expenses.", "label": "Accrued Offering Costs And Expenses", "terseLabel": "Accrued offering costs and expenses" } } }, "localname": "AccruedOfferingCostsAndExpenses", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "smihu_AdjustmentsToAdditionalPaidInCapitalExcessOfPrivatePlacementProceedOverFairValueAsCapitalContribution": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital excess of private placement proceed over fair value as capital contribution.", "label": "Adjustments to Additional Paid in Capital Excess of Private Placement Proceed Over Fair Value as Capital Contribution", "verboseLabel": "Excess of private placement proceed over fair value as capital contribution" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalExcessOfPrivatePlacementProceedOverFairValueAsCapitalContribution", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "smihu_AdministrativeServiceFeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Administrative Service Fee [Member]", "terseLabel": "Administrative Service Fee" } } }, "localname": "AdministrativeServiceFeeMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_AnchorInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Anchor Investors [Member]", "terseLabel": "Anchor investors" } } }, "localname": "AnchorInvestorsMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_CashHeldInTrustAccountPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash held in trust account.", "label": "Cash Held In Trust Account [Policy Text Block]", "terseLabel": "Investments Held in Trust Account" } } }, "localname": "CashHeldInTrustAccountPolicyTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "smihu_ClassACommonStockSubjectToPossibleRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class A Common Stock Subject To Possible Redemption [Member]", "terseLabel": "Class A Common Stock Subject To Possible Redemption" } } }, "localname": "ClassACommonStockSubjectToPossibleRedemptionMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "smihu_ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class A ordinary shares subject to possible redemption.", "label": "Class A Ordinary Shares Subject To Possible Redemption [Policy Text Block]", "terseLabel": "Class\u00a0A Ordinary Shares Subject to Possible Redemption" } } }, "localname": "ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "smihu_ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right, exercise price adjustment percentage higher of market value.", "label": "Class Of Warrant Or Right, Exercise Price Adjustment Percentage Higher Of Market Value", "terseLabel": "Class of warrant or right, exercise price adjustment percentage higher of market value" } } }, "localname": "ClassOfWarrantOrRightExercisePriceAdjustmentPercentageHigherOfMarketValue", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "smihu_ClassOfWarrantOrRightRedemptionThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right redemption threshold consecutive trading days.", "label": "Class Of Warrant Or Right Redemption Threshold Consecutive Trading Days", "terseLabel": "Class of warrant or right redemption threshold consecutive trading days" } } }, "localname": "ClassOfWarrantOrRightRedemptionThresholdConsecutiveTradingDays", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "smihu_ClassOfWarrantOrRightThresholdPeriodForExerciseFromDateOfClosingPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right threshold period for exercise from date of closing public offering.", "label": "Class Of Warrant Or Right Threshold Period For Exercise From Date Of Closing Public Offering", "terseLabel": "Class of warrant or right, threshold period for exercise from date of closing public offering" } } }, "localname": "ClassOfWarrantOrRightThresholdPeriodForExerciseFromDateOfClosingPublicOffering", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "smihu_ClassOfWarrantsAndRightsIssuedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants and rights issued during the period.", "label": "Class Of Warrants And Rights Issued During The Period", "terseLabel": "Class of warrants and rights issued during the period", "verboseLabel": "Class of warrants and rights issued during the period" } } }, "localname": "ClassOfWarrantsAndRightsIssuedDuringThePeriod", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "smihu_ClassOfWarrantsAndRightsIssuedPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants and rights issued price per warrant.", "label": "Class Of Warrants And Rights Issued Price Per Warrant", "terseLabel": "Class of warrants and rights issued, price per warrant", "verboseLabel": "Class of warrants and rights issued, price per warrant" } } }, "localname": "ClassOfWarrantsAndRightsIssuedPricePerWarrant", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "smihu_ClassOfWarrantsRedemptionPricePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants redemption price per unit.", "label": "Class Of Warrants Redemption Price Per Unit", "terseLabel": "Class of warrants redemption price per unit" } } }, "localname": "ClassOfWarrantsRedemptionPricePerUnit", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "smihu_CommonClassAClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Class A and Class B [Member].", "label": "Common Class A Class B [Member]", "terseLabel": "Common Class A and Class B" } } }, "localname": "CommonClassAClassBMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_CommonStockSharesIssuedSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock shares issued subject to forfeiture.", "label": "Common Stock Shares Issued Subject To Forfeiture", "terseLabel": "Common stock shares issued subject to forfeiture" } } }, "localname": "CommonStockSharesIssuedSubjectToForfeiture", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "smihu_CommonStockSharesSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock shares subject to forfeiture.", "label": "Common Stock Shares Subject To Forfeiture", "terseLabel": "Common stock shares subject to forfeiture" } } }, "localname": "CommonStockSharesSubjectToForfeiture", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "smihu_DeferredOfferingCostsNoncurrent": { "auth_ref": [], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs noncurrent.", "label": "Deferred Offering Costs Noncurrent", "terseLabel": "Deferred offering costs" } } }, "localname": "DeferredOfferingCostsNoncurrent", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "smihu_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs paid by Sponsor in exchange for issuance of Class\u00a0B ordinary shares", "label": "Deferred Offering Costs Paid By Sponsor in Exchange For Issuance Of Class B Ordinary Shares", "terseLabel": "Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares" } } }, "localname": "DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "smihu_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs paid by sponsor under promissory note.", "label": "Deferred Offering Costs Paid By Sponsor Under Promissory Note", "verboseLabel": "Deferred offering costs paid by Sponsor under promissory note" } } }, "localname": "DeferredOfferingCostsPaidBySponsorUnderPromissoryNote", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "smihu_DeferredUnderwritingCommissionsNoncurrent": { "auth_ref": [], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 17.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commissions noncurrent.", "label": "Deferred Underwriting Commissions Noncurrent", "terseLabel": "Deferred underwriting commissions", "verboseLabel": "Deferred underwriting commissions noncurrent" } } }, "localname": "DeferredUnderwritingCommissionsNoncurrent", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/BalanceSheets", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "smihu_DeferredUnderwritingFeePercentInGrossProceedsOfTheIpo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred underwriting fee percent on gross proceeds of the IPO.", "label": "Deferred Underwriting Fee Percent In Gross Proceeds Of The IPO", "terseLabel": "Deferred underwriting fee percent on gross proceeds of the IPO" } } }, "localname": "DeferredUnderwritingFeePercentInGrossProceedsOfTheIpo", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "smihu_DerivativeFinancialInstrumentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative financial instruments.", "label": "Derivative Financial Instruments [Policy Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativeFinancialInstrumentsPolicyTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "smihu_DerivativeWarrantLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative warrant liabilities.", "label": "Derivative Warrant Liabilities [Member]" } } }, "localname": "DerivativeWarrantLiabilitiesMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "domainItemType" }, "smihu_DisclosureOfWarrantLiabilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Warrant Liability [Line Items]" } } }, "localname": "DisclosureOfWarrantLiabilityLineItems", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "smihu_DisclosureOfWarrantLiabilityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Warrant Liability [Table]" } } }, "localname": "DisclosureOfWarrantLiabilityTable", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "smihu_DisclosureOfWarrantLiabilityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of warrant liability.", "label": "Disclosure Of Warrant Liability [Text Block]", "terseLabel": "Warrant Liability" } } }, "localname": "DisclosureOfWarrantLiabilityTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiability" ], "xbrltype": "textBlockItemType" }, "smihu_DissolutionExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dissolution expense.", "label": "Dissolution Expense", "verboseLabel": "Dissolution expense" } } }, "localname": "DissolutionExpense", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "smihu_EmergingGrowthCompanyStatusPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emerging growth company status.", "label": "Emerging Growth Company Status [Policy Text Block]", "terseLabel": "Emerging Growth Company Status" } } }, "localname": "EmergingGrowthCompanyStatusPolicyTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "smihu_FairValueAdjustmentOfFpaLiability": { "auth_ref": [], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.smihu.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value adjustment of FPA liability.", "label": "Fair Value Adjustment Of FPA Liability", "negatedLabel": "Change in fair value of FPA", "terseLabel": "Change in fair value of FPA liability" } } }, "localname": "FairValueAdjustmentOfFpaLiability", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows", "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "smihu_ForwardPurchaseAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreements [Member]", "terseLabel": "FPA" } } }, "localname": "ForwardPurchaseAgreementsMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "domainItemType" }, "smihu_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Founder Shares [Member]", "terseLabel": "Founder shares" } } }, "localname": "FounderSharesMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_FpaLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FPA Liability [Member]", "terseLabel": "FPA liability" } } }, "localname": "FpaLiabilityMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "domainItemType" }, "smihu_InitialPublicOfferingDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Public Offering Disclosure Text Block", "label": "Initial Public Offering Disclosure [Text Block]", "terseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOfferingDisclosureTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "smihu_InterestEarnedOnMarketableSecuritiesHeldInTrustAccount": { "auth_ref": [], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest earned on marketable securities held in Trust Account.", "label": "Interest Earned On Marketable Securities Held In Trust Account", "negatedLabel": "Interest earned on investments held in Trust Account" } } }, "localname": "InterestEarnedOnMarketableSecuritiesHeldInTrustAccount", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "smihu_MeasurementInputEstimatedTermToBusinessCombinationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Measurement Input Estimated Term To Business Combinations [Member]", "terseLabel": "Est. Term to Business Combination (Yrs)" } } }, "localname": "MeasurementInputEstimatedTermToBusinessCombinationsMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "domainItemType" }, "smihu_MeasurementInputProbabilityOfBusinessCombinationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Measurement Input Probability Of Business Combinations [Member]", "terseLabel": "Probability of Business Combination" } } }, "localname": "MeasurementInputProbabilityOfBusinessCombinationsMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "domainItemType" }, "smihu_MeasurementOfPurchasePriceOfFpaUnitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Measurement Of Purchase Price Of FPA Unit [Member]", "terseLabel": "Purchase price of FPA unit" } } }, "localname": "MeasurementOfPurchasePriceOfFpaUnitMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "domainItemType" }, "smihu_MinimumLockInPeriodRequiredForWarrantExerciseFromTheDateOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum lock in period required for warrant exercise from the date of business combination.", "label": "Minimum Lock In Period Required For Warrant Exercise From The Date Of Business Combination", "terseLabel": "Minimum lock in period required for warrant exercise from the date of business combination" } } }, "localname": "MinimumLockInPeriodRequiredForWarrantExerciseFromTheDateOfBusinessCombination", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "smihu_MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage gross proceeds required from issuance of equity.", "label": "Minimum Percentage Gross Proceeds Required From Issuance Of Equity", "terseLabel": "Minimum percentage gross proceeds required from issuance of equity" } } }, "localname": "MinimumPercentageGrossProceedsRequiredFromIssuanceOfEquity", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "smihu_NetIncomePerShareOfOrdinarySharesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Income Per Share of Ordinary Shares [Policy Text Block].", "label": "Net Income Per Share Of Ordinary Shares [Policy Text Block]", "terseLabel": "Net Income (Loss) Per Share of Ordinary Shares" } } }, "localname": "NetIncomePerShareOfOrdinarySharesPolicyTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "smihu_NumberOfConsecutiveTradingDaysForDeterminingSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive trading days for determining share price.", "label": "Number Of Consecutive Trading Days For Determining Share Price", "terseLabel": "Number of consecutive trading days for determining share price" } } }, "localname": "NumberOfConsecutiveTradingDaysForDeterminingSharePrice", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "smihu_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive trading days for determining the share price.", "label": "Number Of Consecutive Trading Days For Determining The Share Price", "terseLabel": "Number of consecutive trading days for determining the share price" } } }, "localname": "NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "smihu_NumberOfDaysOfNoticeToBeGivenForRedemptionOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of days of notice to be given for redemption of warrants.", "label": "Number Of Days Of Notice To Be Given For Redemption Of Warrants", "terseLabel": "Number of days of notice to be given for redemption of warrants" } } }, "localname": "NumberOfDaysOfNoticeToBeGivenForRedemptionOfWarrants", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "smihu_NumberOfIndependentDirectorNominees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of independent director nominees.", "label": "Number Of Independent Director Nominees", "terseLabel": "Number of independent director nominees" } } }, "localname": "NumberOfIndependentDirectorNominees", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "smihu_NumberOfOverallotmentSharesForfeitedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Overallotment Shares Forfeited During the Period.", "label": "Number of Overallotment Shares Forfeited During the Period", "terseLabel": "Number of Overallotment Shares Forfeited During the Period" } } }, "localname": "NumberOfOverallotmentSharesForfeitedDuringThePeriod", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "smihu_NumberOfSharesForfeitedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Shares Forfeited During the Period.", "label": "Number of Shares Forfeited During the Period", "terseLabel": "Number of Shares Forfeited During the Period" } } }, "localname": "NumberOfSharesForfeitedDuringThePeriod", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "smihu_NumberOfTradingDaysForDeterminingTheSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days for determining the share price.", "label": "Number Of Trading Days For Determining The Share Price", "terseLabel": "Number of trading days for determining the share price" } } }, "localname": "NumberOfTradingDaysForDeterminingTheSharePrice", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "smihu_OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering costs associated with the initial public offering.", "label": "Offering Costs Associated With The Initial Public Offering [Policy Text Block]", "terseLabel": "Offering Costs Associated with IPO" } } }, "localname": "OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "smihu_OfferingProceedsAllocatedToPaymentOfOfferingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering proceeds allocated to payment of offering expenses.", "label": "Offering Proceeds Allocated To Payment Of Offering Expenses", "terseLabel": "Offering proceeds allocated to payment of offering expenses" } } }, "localname": "OfferingProceedsAllocatedToPaymentOfOfferingExpenses", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "smihu_OrganizationBusinessOperationLiquidityAndCapitalResourcesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization, business operation, liquidity and capital resources.", "label": "Organization, Business Operation, Liquidity And Capital Resources [Text Block]", "terseLabel": "Organization, Business Operation, Liquidity and Capital Resources" } } }, "localname": "OrganizationBusinessOperationLiquidityAndCapitalResourcesTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResources" ], "xbrltype": "textBlockItemType" }, "smihu_OrganizationconsolidationandpresentationoffinancialstatementstableTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization Consolidation And Presentation Of Financial Statements Table.", "label": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable [Table]" } } }, "localname": "OrganizationconsolidationandpresentationoffinancialstatementstableTable", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "smihu_OtherOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other offering costs.", "label": "Other Offering Costs", "terseLabel": "Other offering costs", "verboseLabel": "Other offering costs" } } }, "localname": "OtherOfferingCosts", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "smihu_OverAllotmentOptionVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Over allotment Option Vesting Period.", "label": "Over Allotment Option Vesting Period", "terseLabel": "Overallotment option vesting period" } } }, "localname": "OverAllotmentOptionVestingPeriod", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "smihu_PercentageOfNumberOfSharesOfCommonStockOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of number of shares of common stock outstanding.", "label": "Percentage Of Number Of Shares Of Common Stock Outstanding", "terseLabel": "Percentage of number of shares of common stock outstanding" } } }, "localname": "PercentageOfNumberOfSharesOfCommonStockOutstanding", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "smihu_PrivatePlacementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Line Items", "label": "Private Placement [Line Items]" } } }, "localname": "PrivatePlacementLineItems", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "smihu_PrivatePlacementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Table", "label": "Private Placement [Table]" } } }, "localname": "PrivatePlacementTable", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "smihu_PrivatePlacementWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Warrants", "label": "Private Placement Warrants [Abstract]" } } }, "localname": "PrivatePlacementWarrantsAbstract", "nsuri": "http://www.smihu.com/20211231", "xbrltype": "stringItemType" }, "smihu_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_PrivatePlacementWarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Warrants Text Block", "label": "Private Placement Warrants [Text Block]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementWarrantsTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "smihu_PrivateWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Warrants [Member]", "terseLabel": "Private Warrants" } } }, "localname": "PrivateWarrantsMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "smihu_ProceedsFromSponsorToCoverCertainOfferingCostsPerShareValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proceeds from sponsor to cover certain offering costs per share value", "label": "Proceeds from sponsor to cover certain offering costs per share value", "terseLabel": "Proceeds from sponsor to cover certain offering costs per share value" } } }, "localname": "ProceedsFromSponsorToCoverCertainOfferingCostsPerShareValue", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "smihu_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory Note [Member]", "terseLabel": "Promissory Note" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_PublicAndPrivateWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public And Private Warrants [Member]", "terseLabel": "Public and Private Warrants" } } }, "localname": "PublicAndPrivateWarrantsMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "domainItemType" }, "smihu_PublicWarrantsAndPrivateWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Warrants And Private Warrants [Member]", "terseLabel": "Public Warrants And Private Warrants" } } }, "localname": "PublicWarrantsAndPrivateWarrantsMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Warrants [Member]", "terseLabel": "Public Warrants", "verboseLabel": "Public Warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_RedeemableWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable Warrants [Member]", "terseLabel": "Redeemable Warrants" } } }, "localname": "RedeemableWarrantsMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_RestrictedInvestmentsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted investments term.", "label": "Restricted Investments Term", "terseLabel": "Restricted Investments Term" } } }, "localname": "RestrictedInvestmentsTerm", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "smihu_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member]", "terseLabel": "Share Price Equal or Exceeds Eighteen Rupees Per Dollar" } } }, "localname": "SharePriceEqualOrExceedsEighteenRupeesPerDollarMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_SharePriceEqualOrExceedsTenRupeesPerDollarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price Equal Or Exceeds Ten Rupees Per Dollar [Member]", "terseLabel": "Share Price Equal or Exceeds Ten Rupees Per Dollar" } } }, "localname": "SharePriceEqualOrExceedsTenRupeesPerDollarMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price Equal Or Less Nine Point Two Rupees Per Dollar [Member]", "terseLabel": "Share Price Equal or Less Nine Point Two Rupees Per Dollar" } } }, "localname": "SharePriceEqualOrLessNinePointTwoRupeesPerDollarMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_ShareRedemptionTriggerPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share redemption trigger price.", "label": "Share Redemption Trigger Price", "terseLabel": "Share redemption trigger price" } } }, "localname": "ShareRedemptionTriggerPrice", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "smihu_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sponsor [Member]", "terseLabel": "Sponsor" } } }, "localname": "SponsorMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_StockHoldersEquityNoteLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Holders Equity Note Line Items", "label": "Stock Holders Equity Note [Line Items]" } } }, "localname": "StockHoldersEquityNoteLineItems", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "smihu_StockHoldersEquityNoteTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock holders Equity Note Table", "label": "Stock holders Equity Note [Table]" } } }, "localname": "StockHoldersEquityNoteTable", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "smihu_StockIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock issuance costs.", "label": "Stock Issuance Costs", "terseLabel": "Stock issuance costs" } } }, "localname": "StockIssuanceCosts", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "smihu_TransactionCostsAllocableToWarrants": { "auth_ref": [], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.smihu.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction costs allocable to warrants.", "label": "Transaction Costs Allocable To Warrants", "negatedLabel": "Transaction costs allocable to warrants", "verboseLabel": "Transaction costs allocable to warrants" } } }, "localname": "TransactionCostsAllocableToWarrants", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows", "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "smihu_TriggeringEventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Triggering Event [Axis]" } } }, "localname": "TriggeringEventAxis", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "smihu_TriggeringEventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Triggering Event [Domain]" } } }, "localname": "TriggeringEventDomain", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_UnderwritingCommissionsIncurredButNotYetPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Underwriting commissions incurred but not yet paid.", "label": "Underwriting Commissions Incurred but Not yet Paid", "verboseLabel": "Deferred underwriting commissions" } } }, "localname": "UnderwritingCommissionsIncurredButNotYetPaid", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "smihu_UnderwritingDiscount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting discount.", "label": "Underwriting Discount", "terseLabel": "Underwriting discount" } } }, "localname": "UnderwritingDiscount", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "smihu_UnderwritingDiscountAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Underwriting Discount [Axis]" } } }, "localname": "UnderwritingDiscountAxis", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "smihu_UnderwritingDiscountDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Underwriting Discount [Domain]" } } }, "localname": "UnderwritingDiscountDomain", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_UsGovernmentSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "US Government Securities [Member]", "terseLabel": "US Government Securities [Member]" } } }, "localname": "UsGovernmentSecuritiesMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Waiting period after which the share trading days are considered.", "label": "Waiting Period After Which The Share Trading Days Are Considered", "terseLabel": "Waiting period after which the share trading days are considered" } } }, "localname": "WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "smihu_WarrantLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability [Abstract]" } } }, "localname": "WarrantLiabilityAbstract", "nsuri": "http://www.smihu.com/20211231", "xbrltype": "stringItemType" }, "smihu_WarrantLiabilityAndForwardPurchaseAgreementPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant liability and forward purchase agreement.", "label": "Warrant Liability And Forward Purchase Agreement [Policy Text Block]", "terseLabel": "Warrant Liability and Forward Purchase Agreement" } } }, "localname": "WarrantLiabilityAndForwardPurchaseAgreementPolicyTextBlock", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "smihu_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Working capital (deficit).", "label": "Working Capital Deficit", "terseLabel": "Working capital (deficit)" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "smihu_WorkingCapitalLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Working Capital Loan [Member]", "terseLabel": "Working Capital Loan" } } }, "localname": "WorkingCapitalLoanMember", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "smihu_WorkingCapitalLoans": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital loans.", "label": "Working Capital Loans", "verboseLabel": "Working capital loans" } } }, "localname": "WorkingCapitalLoans", "nsuri": "http://www.smihu.com/20211231", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "srt_DirectorMember": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "Director" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r139", "r152", "r186", "r188", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r287", "r288", "r302", "r303" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r139", "r152", "r176", "r186", "r188", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r287", "r288", "r302", "r303" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r139", "r152", "r176", "r186", "r188", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r287", "r288", "r302", "r303" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r71", "r187" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r71", "r75", "r187" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r71", "r75", "r115", "r187", "r252" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r105", "r243" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r13", "r194", "r249" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 9.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional\u00a0paid-in\u00a0capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r63", "r64", "r65", "r191", "r192", "r193", "r211" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash provided by operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r166", "r173" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "negatedTerseLabel": "Less: Class A ordinary shares issuance costs", "terseLabel": "Offering costs charged to the shareholders' equity" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r60", "r97", "r99", "r103", "r107", "r124", "r125", "r126", "r128", "r129", "r130", "r131", "r132", "r133", "r135", "r136", "r203", "r205", "r227", "r247", "r249", "r277", "r282" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r6", "r26", "r60", "r107", "r124", "r125", "r126", "r128", "r129", "r130", "r131", "r132", "r133", "r135", "r136", "r203", "r205", "r227", "r247", "r249" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r57" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Investments held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalUnitsMember": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares.", "label": "Capital Units [Member]", "terseLabel": "Capital Units" } } }, "localname": "CapitalUnitsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r18", "r249", "r294", "r295" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r18", "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash, end of the period", "periodStartLabel": "Cash, beginning of the period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease)", "totalLabel": "Net change in cash" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r8", "r52" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r18" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash Equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "FDIC insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental Non-cash disclosure of cash flow information:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r58", "r60", "r76", "r77", "r78", "r80", "r82", "r85", "r86", "r87", "r107", "r124", "r129", "r130", "r131", "r135", "r136", "r150", "r151", "r155", "r159", "r227", "r311" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets", "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/CoverPage", "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://www.smihu.com/role/StatementsOfOperations", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r174", "r189" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Class of warrant or right, exercise price of warrants or rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Class of warrant or right, outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r23", "r114", "r279", "r285" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies (Note 7)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r111", "r112", "r113", "r121", "r301" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments & Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Common Class A" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets", "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/CoverPage", "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Common Class B" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets", "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/CoverPage", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockConversionBasis": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Description of basis for conversion of convertible common stock.", "label": "Common Stock, Conversion Basis", "terseLabel": "Common stock, Conversion basis" } } }, "localname": "CommonStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r63", "r64", "r211" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Ordinary Shares" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r166" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r12", "r249" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common Stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r90", "r281" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r53", "r54", "r55" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Issued", "terseLabel": "Common stock shares issued with effect of conversion" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r141" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Working capital loans convertible into warrants" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r138", "r142" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Warrants issued price per warrant" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r137", "r143", "r144", "r235", "r236", "r237" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r29", "r207", "r208", "r209", "r210" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r27", "r28", "r29", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Warrant Liability", "verboseLabel": "Warrant liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 16.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "terseLabel": "Warrant liability" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r20", "r61", "r127", "r129", "r130", "r134", "r135", "r136", "r241" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "verboseLabel": "Due to related parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "definitionGuidance": "Basic and diluted net loss per ordinary shares", "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "verboseLabel": "Basic and diluted net loss per share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r33", "r34", "r35", "r63", "r64", "r65", "r67", "r72", "r74", "r84", "r108", "r166", "r173", "r191", "r192", "r193", "r201", "r202", "r211", "r228", "r229", "r230", "r231", "r232", "r233", "r289", "r290", "r291", "r315" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r49", "r145" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.smihu.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liability", "verboseLabel": "Change in fair value of warrant liability" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows", "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r213", "r214", "r215", "r224" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of Valuation of Public and Private Warrants" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r140", "r143", "r144", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r185", "r214", "r254", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r223", "r224" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r213", "r214", "r217", "r218", "r225" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Recurring Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r140", "r177", "r178", "r183", "r185", "r214", "r254" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r140", "r143", "r144", "r177", "r178", "r183", "r185", "r214", "r255" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r140", "r143", "r144", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r185", "r214", "r256" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r219", "r224" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r219", "r224" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "verboseLabel": "Summary of reconciliation of changes in fair value of derivative warrant liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3": { "auth_ref": [ "r222" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3", "verboseLabel": "Transfer of Public warrants from level 3 to level 1" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r220" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "verboseLabel": "Change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r221" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "verboseLabel": "Initial value at IPO date" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r219" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r140", "r143", "r144", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r185", "r254", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r223", "r225" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r37" ], "calculation": { "http://www.smihu.com/role/StatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r32", "r195", "r196", "r197", "r198", "r199", "r200" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r48" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued offering costs and expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r48" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r38", "r96" ], "calculation": { "http://www.smihu.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest earned on investments held in Trust Account" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r21", "r60", "r100", "r107", "r124", "r125", "r126", "r129", "r130", "r131", "r132", "r133", "r135", "r136", "r204", "r205", "r206", "r227", "r247", "r248" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r17", "r60", "r107", "r227", "r249", "r278", "r284" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities, Class A ordinary shares subject to possible redemption and Shareholders' (Deficit) Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' (Deficit) Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r22", "r60", "r107", "r124", "r125", "r126", "r129", "r130", "r131", "r132", "r133", "r135", "r136", "r204", "r205", "r206", "r227", "r247", "r248", "r249" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 13.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r114", "r115", "r116", "r117", "r118", "r119", "r120", "r122", "r123" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Est. Term Remaining (Yrs)", "verboseLabel": "Warrant Price" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk Free Rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]", "terseLabel": "Stock Price" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r45" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r45" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r45", "r47", "r50" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r30", "r31", "r35", "r36", "r50", "r60", "r66", "r68", "r69", "r70", "r71", "r73", "r74", "r79", "r97", "r98", "r101", "r102", "r104", "r107", "r124", "r125", "r126", "r129", "r130", "r131", "r132", "r133", "r135", "r136", "r212", "r227", "r280", "r286" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.smihu.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net Loss", "verboseLabel": "Allocation of net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "http://www.smihu.com/role/StatementOfCashFlows", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r19", "r61", "r242" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "terseLabel": "Note payable \u2013 related party" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r97", "r98", "r101", "r102", "r104" ], "calculation": { "http://www.smihu.com/role/StatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r39" ], "calculation": { "http://www.smihu.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "totalLabel": "Other income (loss)" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForUnderwritingExpense": { "auth_ref": [ "r46" ], "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Cash underwriting discount of the IPO paid to underwriters", "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.", "label": "Payments for Underwriting Expense", "terseLabel": "Payments for underwriting expense", "verboseLabel": "Payments for underwriting expense" } } }, "localname": "PaymentsForUnderwritingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r44" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit": { "auth_ref": [ "r40" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from temporary investment with specific maturity and interest rate that are prohibited for current use.", "label": "Payments to Acquire Restricted Certificates of Deposit", "terseLabel": "Payments to acquire restricted certificates of deposit" } } }, "localname": "PaymentsToAcquireRestrictedCertificatesOfDeposit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRestrictedInvestments": { "auth_ref": [ "r40" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.", "label": "Payments to Acquire Restricted Investments", "negatedLabel": "Investment of cash in Trust Account" } } }, "localname": "PaymentsToAcquireRestrictedInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r11", "r150" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock par or stated value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r11", "r150" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r11", "r249" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r3", "r5", "r109", "r110" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r41" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Proceeds from issuance initial public offering", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "presentationGuidance": "Gross proceeds", "terseLabel": "Proceeds from issuance initial public offering", "verboseLabel": "Proceeds received from initial public offering, net of underwriters' discount" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail", "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r41" ], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Proceeds from issuance of common stock", "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "terseLabel": "Proceeds from issuance of debt" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r41" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from private placement", "verboseLabel": "Proceeds from issuance of private placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r41" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "negatedLabel": "Less: Proceeds allocated to Public Warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromUnsecuredNotesPayable": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from borrowings supported by a written promise to pay an obligation that is uncollateralized (where debt is not backed by the pledge of collateral).", "label": "Proceeds from Unsecured Notes Payable", "terseLabel": "Proceeds from unsecured notes payable" } } }, "localname": "ProceedsFromUnsecuredNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r184", "r240", "r241" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r184", "r240", "r241", "r244" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r240" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Expenses from transactions with related party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r184", "r240", "r244", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r238", "r239", "r241", "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r43" ], "calculation": { "http://www.smihu.com/role/StatementOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayment of note payable from related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedInvestmentsAtFairValue": { "auth_ref": [ "r297", "r298", "r299", "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate value of all restricted investments.", "label": "Restricted Investments, at Fair Value", "verboseLabel": "Investments held in Trust Account" } } }, "localname": "RestrictedInvestmentsAtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfFairValueHierarchyTheCompanySAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r14", "r173", "r194", "r249", "r283", "r292", "r293" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 10.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r63", "r64", "r65", "r67", "r72", "r74", "r108", "r191", "r192", "r193", "r201", "r202", "r211", "r289", "r291" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of basic and diluted net income (loss) per common share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r213", "r214" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Summary of Fair Value Hierarchy the Company's Assets and Liabilities" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r242", "r244" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r24", "r58", "r85", "r86", "r146", "r148", "r149", "r150", "r151", "r152", "r153", "r155", "r159", "r164", "r167", "r168", "r169", "r170", "r171", "r172", "r173" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued, price per share", "verboseLabel": "Shares issued, price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balances at end, Shares", "periodStartLabel": "Balances at beginning, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r56", "r62" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r10", "r11", "r12", "r58", "r60", "r76", "r77", "r78", "r80", "r82", "r85", "r86", "r87", "r107", "r124", "r129", "r130", "r131", "r135", "r136", "r150", "r151", "r155", "r159", "r166", "r227", "r311" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets", "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/CoverPage", "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://www.smihu.com/role/StatementsOfOperations", "http://www.smihu.com/role/WarrantLiabilityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r25", "r33", "r34", "r35", "r63", "r64", "r65", "r67", "r72", "r74", "r84", "r108", "r166", "r173", "r191", "r192", "r193", "r201", "r202", "r211", "r228", "r229", "r230", "r231", "r232", "r233", "r289", "r290", "r291", "r315" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets", "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsTables", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/StatementOfCashFlows", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r63", "r64", "r65", "r84", "r264" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets", "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsTables", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/StatementOfCashFlows", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity", "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Class\u00a0B ordinary share issued to initial shareholders, shares", "verboseLabel": "Stock issued during period, shares, issued for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r11", "r12", "r166", "r173" ], "lang": { "en-us": { "role": { "definitionGuidance": "Stock issued during period, shares, new issues", "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Class B ordinary shares issued to initial shareholders,Shares", "verboseLabel": "Stock shares issued during the period shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Number of shares forfeited during the period", "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "negatedLabel": "Forfeiture of founder shares, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "verboseLabel": "Stock issued during period, value, issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r11", "r12", "r166", "r173" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Class B ordinary shares issued to initial shareholders" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": { "auth_ref": [ "r190" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, Forfeited", "negatedLabel": "Forfeiture of founder shares" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r12", "r15", "r16", "r60", "r106", "r107", "r227", "r249" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balances at end", "periodStartLabel": "Balances at beginning", "totalLabel": "Total shareholders' (Deficit) Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' (Deficit) Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r59", "r151", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r165", "r173", "r175" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' (Deficit) Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/ShareholdersDeficitEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r234", "r251" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r234", "r251" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r250", "r253" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.smihu.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "negatedLabel": "Accretion of Class A ordinary shares to redemption value", "terseLabel": "Add: Accretion of carrying value to redemption value" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail", "http://www.smihu.com/role/StatementsOfChangesInShareholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityByClassOfStockTable": { "auth_ref": [ "r7", "r147" ], "lang": { "en-us": { "role": { "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.", "label": "Temporary Equity, by Class of Stock [Table]" } } }, "localname": "TemporaryEquityByClassOfStockTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r124", "r129", "r130", "r131", "r135", "r136" ], "calculation": { "http://www.smihu.com/role/BalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Class A ordinary shares subject to possible redemption", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Class A ordinary shares subject to possible redemption, $0.0001 par value; 20,000,000 shares and -0- shares issued and outstanding at redemption value of $10.00 per share" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheets", "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity Disclosure [Abstract]" } } }, "localname": "TemporaryEquityDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Temporary Equity [Line Items]" } } }, "localname": "TemporaryEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfClassAOrdinarySharesSubjectToPossibleRedemptionDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r7", "r147" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Temporary Equity, Par or Stated Value Per Share" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r7", "r147" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Temporary Equity, Redemption Price Per Share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/OrganizationBusinessOperationLiquidityAndCapitalResourcesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary Equity, Shares Issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "definitionGuidance": "Temporary equity, shares outstanding", "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Temporary Equity, Shares Outstanding", "verboseLabel": "Temporary equity, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/BalanceSheetsParenthetical", "http://www.smihu.com/role/ShareholdersDeficitEquityAdditionalInformationDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityTableTextBlock": { "auth_ref": [ "r7", "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity [Table Text Block]", "verboseLabel": "Summary of Class A ordinary shares subject to possible redemption" } } }, "localname": "TemporaryEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r88", "r89", "r91", "r92", "r93", "r94", "r95" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/CoverPage", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfReconciliationOfChangesInFairValueOfDerivativeWarrantLiabilitiesDetail", "http://www.smihu.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input", "terseLabel": "Warrants and rights outstanding, measurement input", "verboseLabel": "Warrants and rights outstanding, measurement input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsDetail", "http://www.smihu.com/role/RecurringFairValueMeasurementsSummaryOfValuationOfPublicAndPrivateWarrantsOfFpaDetail" ], "xbrltype": "decimalItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Basic and diluted weighted average shares outstanding", "verboseLabel": "Weighted-average shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.smihu.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedNetIncomeLossPerCommonShareDetail", "http://www.smihu.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r121": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r246": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r253": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12.6(c))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Footnote 11(c)))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r304": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r305": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r306": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r307": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r308": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r309": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r310": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r311": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r312": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r313": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r314": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r62": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" } }, "version": "2.1" } ZIP 54 0001193125-22-091035-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-091035-xbrl.zip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�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�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�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